{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Para realizar a **análise de literatura**, foi desenvolvida uma função com o objetivo de realizar a pesquisa de bibliografia na base de dados NCBI através do BioPython. Esta função oferece uma abordagem flexível uma vez que permite a adaptação de parâmetros conforme os objetivos desejados.\n",
    "\n",
    "A função escrita recebe um email e um termo de pesquisa como entrada, depois, oferece a capacidade de selecionar a base de dados desejada conforme o leque de bases de dados disponíveis. Por exemplo, podemos selecionar:\n",
    "\n",
    "- pubmed\n",
    "- gene\n",
    "- nuccore\n",
    "- protein\n",
    "- ...\n",
    "\n",
    "Além disso, o número de resultados que integram o output pode ser maleável, tal como o tipo de informação a ser extraído (como abstracts ou sequências genéticas) e também o formato do output. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Função **pesquisa_ncbi**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "def pesquisa_ncbi(email, term, db = 'pubmed', retmax = 10, rettype = 'abstract', retmode = 'text', display = 'Y' , save = 'N', ext='txt'):\n",
    "    '''\n",
    "    Função para a pesquisa de bibliografia na base de dados NCBI utilizando BioPython\n",
    "    Esta função contempla um conjunto de parâmetros para seleção de base de dados e outputs desejado adaptando-se\n",
    "    ao objetivo da pesquisa. \n",
    "\n",
    "    Por defeito a função pesquisa a base de dados pubmed e capta os 10 primeiros resultados para uma pesquisa\n",
    "    generalizada. \n",
    "\n",
    "    Tem a opção de gerar um ficheiro de texto com os resultados da pesquisa de artigos e respetivos abstracts.\n",
    "\n",
    "    No entanto a função pode ser especializada para uma pesquisa em base de dados de genes para captar ficheiros\n",
    "    GenBank e FASTA para posterior análise com as funções específicas que estamos a desenvolver.\n",
    "\n",
    "    Parâmetros\n",
    "    ----------\n",
    "\n",
    "    email : str\n",
    "        email a ser utilizado pelo módulo Entrez para  pesquisa (e.g. exempl@mail.com)\n",
    "\n",
    "    term : str\n",
    "        termo a ser utilizado na pesquisa (e.g. 'gene-123 functions')\n",
    "\n",
    "    db  : str\n",
    "        base de dados onde irá ser realizada a pesquisa. Por defeito é utilizada a 'pubmed'\n",
    "        Para efeitos deste trabalho iremos também utilizar: 'gene', 'nuccore' e 'protein'\n",
    "        Outras opções disponíveis podem ser encontradas aqui: https://www.ncbi.nlm.nih.gov/books/NBK25497/table/chapter2.T._entrez_unique_identifiers_ui/?report=objectonly\n",
    "\n",
    "    retmax : int\n",
    "        define o número de resultados que queremos retirar para o output final (10 por defeito)\n",
    "\n",
    "    rettype : str\n",
    "        define o tipo de resultado que pretendemos retirar da base de dados ('abstract' por defeito)\n",
    "        pode ser mudado para 'gb' para base de dados 'gene' ou 'fasta' para base de dados de nucleotidos ou proteina (sequencias)\n",
    "        \n",
    "    retmode : str\n",
    "        define o retmode para a captura de resultados da pesquisa na base de dados. Por defeito \n",
    "        o retmode é text mas pode ser adaptado para 'xml' quando é pretendido obter um ficheiro xml (e.g base de dados nucleotide, ou genbank)\n",
    "\n",
    "    display : str\n",
    "        define se é pretendido o output da função legível (útil para quando se quer refinar a pesquisa antes/sem gravar o ficheiro)\n",
    "        por defeito apresenta o resultado em formato legível\n",
    "    \n",
    "    save : str\n",
    "        define se é pretendido gravar ou não o ficheiro de resultados na pasta 'lit-search-output'\n",
    "        por defeito este parâmetro está inactivo\n",
    "\n",
    "            \n",
    "    \n",
    "    '''\n",
    "    \n",
    "    # Importação de módulos\n",
    "    from Bio import Entrez\n",
    "    import os\n",
    "\n",
    "    # Definimos o email para os fins de pesquisa\n",
    "    Entrez.email = email\n",
    "        \n",
    "    # Secção egquery que pode ser skipable\n",
    "\n",
    "    handle = Entrez.egquery(term=term)\n",
    "    egq_res = Entrez.read(handle)\n",
    "\n",
    "    for _ in egq_res['eGQueryResult']:\n",
    "        if db in _.values():\n",
    "            if retmax > 1:\n",
    "                print('Encontrados {} resultados em {}. Irão ser processados {} resultados.\\n'.format(_['Count'],db,retmax))\n",
    "            else:\n",
    "                print('Encontrados {} resultados em {}. Irá ser processado 1 resultado.\\n'.format(_['Count'],db))\n",
    "\n",
    "    \n",
    "    if rettype == 'fasta' or rettype == 'gb': retmax = 1\n",
    "\n",
    "    #IDs\n",
    "    handle      = Entrez.esearch(db=db,term=term, retmode=retmode, retmax=retmax)\n",
    "    esearch_res = Entrez.read(handle)\n",
    "\n",
    "    lista_ids = esearch_res['IdList']\n",
    "    # print('Top 10 artigos ->',lista_ids) # Converter para uma lista de títulos mais à frente'''\n",
    "    \n",
    "    \n",
    "\n",
    "    # Transfere a informação\n",
    "    handle = Entrez.efetch(db=db,id=','.join(lista_ids),rettype=rettype,retmode=retmode)\n",
    "    fetch_res = handle.read()\n",
    "\n",
    "    # ADICIONAR PARAMETRO save = 'Y' SE SE PRETENDER GUARDAR FICHEIRO \n",
    "    \n",
    "    if display.upper() == 'Y':\n",
    "        print(fetch_res,sep='\\n')\n",
    "\n",
    "    # Verifica a condição de gravação de output como ficheiro de texto\n",
    "    \n",
    "    if retmode == 'xml': save = 'n'\n",
    "    \n",
    "    if save.upper() == 'Y':  \n",
    "\n",
    "        # Definimos a extensão em função da base de dados e retmode\n",
    "        if rettype == 'gb':\n",
    "            ext = '.gbk'\n",
    "        \n",
    "        elif rettype == 'fasta':\n",
    "            ext = '.fasta'\n",
    "        \n",
    "        elif retmode == 'xml':\n",
    "            ext = '.xml'\n",
    "\n",
    "        else: ext = '.txt'\n",
    "\n",
    "        filename = term+ext\n",
    "\n",
    "        # Verifica se existe pasta para output e cria-a caso não exista\n",
    "        cwd = os.getcwd()\n",
    "        outputdir = os.path.join(cwd,'output')\n",
    "        if not os.path.exists(outputdir):\n",
    "            os.mkdir(outputdir)\n",
    "\n",
    "        # Muda o working directory para a pasta de output para gerar o ficheiro\n",
    "        os.chdir(outputdir)\n",
    "\n",
    "        if os.path.isfile(filename): print('Ficheiro já existe. Não será criado novo ficheiro.')\n",
    "\n",
    "        # Gera o ficheiro           \n",
    "        with open(term+ext , 'w', encoding='utf-8') as _:\n",
    "            _.write(fetch_res)\n",
    "\n",
    "        # Retorna ao working directory anterior\n",
    "        os.chdir(cwd)\n",
    "\n",
    "        print('Ficheiro gravado.')\n",
    "\n",
    "\n",
    "    handle.close()\n",
    "\n",
    "    print('Concluído.')\n",
    "\n",
    "    return fetch_res"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Função **pesquisa_ncbi** aplicada\n",
    "\n",
    "Passando agora à utilização da função com os parâmetros pretendidos. Foi definido o email e o termo de pesquisa pretendido de forma a diminuir o espetro de resultados"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "email = 'pg52648@alunos.uminho.pt'\n",
    "termo = 'hla-dqa1'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Encontrados 2009 resultados em pubmed. Irão ser processados 10 resultados.\n",
      "\n",
      "1. Mult Scler Relat Disord. 2023 Dec 14;82:105373. doi: \n",
      "10.1016/j.msard.2023.105373. Online ahead of print.\n",
      "\n",
      "Gene expression in multiple sclerosis during pregnancy based on integrated \n",
      "bioinformatics analysis.\n",
      "\n",
      "Hernández-Preciado MR(1), Torres-Mendoza BM(2), Mireles-Ramírez MA(3), \n",
      "Kobayashi-Gutiérrez A(4), Sánchez-Rosales NA(3), Vázquez-Valls E(5), \n",
      "Marquez-Pedroza J(6).\n",
      "\n",
      "Author information:\n",
      "(1)High Specialty Medical Unit, Pediatric Hospital, Western National Medical \n",
      "Center of the Mexican Institute of Social Security, Guadalajara 44340, Mexico; \n",
      "Department of Philosophical and Methodological Disciplines, University Health \n",
      "Sciences Center, University of Guadalajara, Guadalajara 44340, Mexico.\n",
      "(2)Department of Philosophical and Methodological Disciplines, University Health \n",
      "Sciences Center, University of Guadalajara, Guadalajara 44340, Mexico; \n",
      "Neurosciences Division, Western Biomedical Research Center (IMSS), Guadalajara \n",
      "44340, Mexico.\n",
      "(3)High Specialty Medical Unit, Western National Medical Center of the Mexican \n",
      "Institute of Social Security, Guadalajara 44340, Mexico.\n",
      "(4)High Specialty Medical Unit, Western National Medical Center of the Mexican \n",
      "Institute of Social Security, Guadalajara 44340, Mexico; PhD in Psychology of \n",
      "Health, University Health Sciences Center, University of Guadalajara, \n",
      "Guadalajara 44340, Mexico.\n",
      "(5)Directorate of Generation of Professional Resources, Research, and \n",
      "Development, Secretary of Health, Guadalajara 44100, Mexico.\n",
      "(6)Neurosciences Division, Western Biomedical Research Center (IMSS), \n",
      "Guadalajara 44340, Mexico. Electronic address: jaz180688@gmail.com.\n",
      "\n",
      "BACKGROUND: The modulation of the activity disease in patients with Multiple \n",
      "Sclerosis (MS) that occurs during pregnancy is a helpful model which could \n",
      "provide insight into central disease mechanisms and facilitate treatment. \n",
      "Therefore, the aim of the study was to identify differentially expressed genes \n",
      "in-silico to perform biological function pathway enrichment analysis and \n",
      "protein-protein interaction from pregnant women with MS.\n",
      "METHODS: Transcriptome data were obtained from the Gene Expression Omnibus (GEO) \n",
      "database. We selected the microarray dataset GSE17449. The gene expression \n",
      "dataset contains the data of mononuclear cells from four different groups \n",
      "sought, including seven healthy women (H), four healthy pregnant women (HP), \n",
      "eight women with multiple sclerosis (WMS), and nine women nine months pregnant \n",
      "with multiple sclerosis (PMS). The GSEA software was employed for enrichment \n",
      "analysis, and the REACTOME database was used for biological pathways. The \n",
      "protein-protein interaction (PPI) network was plotted with STRING. The databases \n",
      "used to identify the connection of DEGs with different signaling pathways were \n",
      "KEGG and WIKIPATHWAYS.\n",
      "RESULTS: We identified 42 differentially expressed genes in pregnant women with \n",
      "MS. The significant pathways included IL-10 signaling pathway, ErbB2 activates, \n",
      "the hemoglobin complex (HBD, HBB, HBA1, AHSP, and HBA2), IL-17 signaling pathway \n",
      "(LCN2 and MMP9), antigen processing and presentation, and Th17 cell \n",
      "differentiation (HLA-DQA1), Rap1 signaling pathway (ID1), NOD-Like receptor \n",
      "signaling pathway (CAMP and DEFA4), PD-L1 Signaling, Interferon gamma signaling \n",
      "(MMP9 and ARG1), Neutrophil degranulation (CAMP, DEFA4, ELANE, CEACAM8, S100P, \n",
      "CHI3L1, AZU1, OLFM4, CRISP3, LTF, ARG1, PGLYRP1, and TCN1). In the WIKIPATHWAYS \n",
      "set, significance was found Vitamin B12 metabolism (TCN1, HBB, and HBA2), and \n",
      "IL-18 signaling pathway (S100P).\n",
      "CONCLUSION: This study can be used to understand several essential target genes \n",
      "and pathways identified in the present study, which may serve as feasible \n",
      "targets for MS therapies.\n",
      "\n",
      "Copyright © 2023 Elsevier B.V. All rights reserved.\n",
      "\n",
      "DOI: 10.1016/j.msard.2023.105373\n",
      "PMID: 38154347\n",
      "\n",
      "Conflict of interest statement: Declaration of Competing Interest The authors \n",
      "declare that they have no known competing financial interests or personal \n",
      "relationships that could have appeared to influence the work reported in this \n",
      "paper.\n",
      "\n",
      "\n",
      "2. Biomedicines. 2023 Dec 11;11(12):3273. doi: 10.3390/biomedicines11123273.\n",
      "\n",
      "Genetic Susceptibility of HLA Alleles to Non-Steroidal Anti-Inflammatory Drug \n",
      "Hypersensitivity in the Taiwanese Population.\n",
      "\n",
      "Chang SL(1)(2)(3)(4), Lai CH(2)(4)(5), Lin GC(6), Chen YM(2)(4)(6)(7)(8), Lee \n",
      "MH(9), Hsu HS(3)(10), Chen IC(6).\n",
      "\n",
      "Author information:\n",
      "(1)Department of Anesthesiology, Taichung Veterans General Hospital, Taichung \n",
      "407219, Taiwan.\n",
      "(2)Department of Postbaccalaureate Medicine, College of Medicine, National Chung \n",
      "Hsing University, Taichung 402202, Taiwan.\n",
      "(3)Institute of Emergency and Critical Care Medicine, School of Medicine, \n",
      "National Yang Ming Chiao Tung University, Taipei 112304, Taiwan.\n",
      "(4)School of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, \n",
      "Taiwan.\n",
      "(5)Department of Medicine and Cardiovascular Center, Taichung Veterans General \n",
      "Hospital, Taichung 407219, Taiwan.\n",
      "(6)Department of Medical Research, Taichung Veterans General Hospital, Taichung \n",
      "407219, Taiwan.\n",
      "(7)Division of Allergy, Immunology and Rheumatology, Department of Medical \n",
      "Research, Taichung Veterans General Hospital, Taichung 407219, Taiwan.\n",
      "(8)Institute of Biomedical Science and Rong Hsing Research Center for \n",
      "Translational Medicine, National Chung Hsing University, Taichung 402202, \n",
      "Taiwan.\n",
      "(9)Institute of Clinical Medicine, National Yang Ming Chiao Tung University, \n",
      "Taipei 112304, Taiwan.\n",
      "(10)Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General \n",
      "Hospital, Taipei 112201, Taiwan.\n",
      "\n",
      "BACKGROUND: Human leukocyte antigen (HLA) genes are important in many immune \n",
      "processes and contribute to many adverse drug reactions. Whether genetic \n",
      "variations in the HLA region are associated with non-steroid anti-inflammatory \n",
      "drug (NSAID) hypersensitivity remains uncertain. Therefore, the aim of our study \n",
      "was to identify HLA genetic variations in patients with NSAID hypersensitivity \n",
      "in the Taiwanese population.\n",
      "METHODS: This hospital-based, retrospective case-control study enrolled 37,156 \n",
      "participants with NSAID exposure from the Taiwan Precision Medicine Initiative \n",
      "(TPMI), who were all genotyped and imputed to fine map HLA typing. Our study \n",
      "assigned 1217 cases to the NSAID allergy group and 12,170 controls to a matched \n",
      "group. Logistic regression analyses were utilized to explore associations \n",
      "between HLA alleles and NSAID hypersensitivity.\n",
      "RESULTS: Overall, 13,387 patients were genotyped for eight major HLA alleles. \n",
      "Allele frequencies were different between the two groups. In the NSAID allergy \n",
      "group, the genotype frequencies of HLA-A*02:01, HLA-A*34:01, and HLA-DQA1*06:01 \n",
      "were found to be markedly elevated compared to the control group, a significance \n",
      "that persisted even after applying the Bonferroni correction. Furthermore, the \n",
      "risk of NSAID allergy demonstrated a significant association with HLA-A*02:01 \n",
      "(OR = 1.29, p < 0.001) and HLA-A*34:01 (OR = 9.90, p = 0.001), in comparison to \n",
      "their respective counterparts. Notably, the genotype frequency of HLA-B*46:01 \n",
      "exhibited a significant increase in the severe allergy group when compared with \n",
      "the mild allergy group.\n",
      "CONCLUSIONS: We identified HLA genotypes linked to the onset and severity of \n",
      "NSAID hypersensitivity. Our findings establish a basis for precision \n",
      "prescription in future clinical applications.\n",
      "\n",
      "DOI: 10.3390/biomedicines11123273\n",
      "PMCID: PMC10741656\n",
      "PMID: 38137494\n",
      "\n",
      "Conflict of interest statement: The authors declare that the research was \n",
      "conducted in the absence of any commercial or financial relationship that could \n",
      "be construed as a potential conflict of interest. The authors have no relevant \n",
      "financial or non-financial interests to disclose. The funders had no role in the \n",
      "design of the study; in the collection, analyses, or interpretation of data; in \n",
      "the writing of the manuscript; or in the decision to publish the results.\n",
      "\n",
      "\n",
      "3. JCI Insight. 2023 Dec 8;8(23):e171417. doi: 10.1172/jci.insight.171417.\n",
      "\n",
      "Single-cell transcriptomics reveals variations in monocytes and Tregs between \n",
      "gout flare and remission.\n",
      "\n",
      "Yu H(1), Xue W(1), Yu H(1), Song Y(1), Liu X(1), Qin L(1), Wang S(1), Bao H(1), \n",
      "Gu H(1), Chen G(1), Zhao D(1), Tu Y(1), Cheng J(1), Wang L(1), Ai Z(2), Hu D(1), \n",
      "Wang L(1), Peng A(1).\n",
      "\n",
      "Author information:\n",
      "(1)Center for Nephrology and Clinical Metabolomics and Division of Nephrology, \n",
      "Shanghai Tenth People's Hospital, and.\n",
      "(2)Department of Medical Statistics, Tongji University School of Medicine, \n",
      "Shanghai, China.\n",
      "\n",
      "Gout commonly manifests as a painful, self-limiting inflammatory arthritis. \n",
      "Nevertheless, the understanding of the inflammatory and immune responses \n",
      "underlying gout flares and remission remains ambiguous. Here, based on \n",
      "single-cell RNA-Seq and an independent validation cohort, we identified the \n",
      "potential mechanism of gout flare, which likely involves the upregulation of \n",
      "HLA-DQA1+ nonclassical monocytes and is related to antigen processing and \n",
      "presentation. Furthermore, Tregs also play an essential role in the suppressive \n",
      "capacity during gout remission. Cell communication analysis suggested the \n",
      "existence of altered crosstalk between monocytes and other T cell types, such as \n",
      "Tregs. Moreover, we observed the systemic upregulation of inflammatory and \n",
      "cytokine genes, primarily in classical monocytes, during gout flares. All \n",
      "monocyte subtypes showed increased arachidonic acid metabolic activity along \n",
      "with upregulation of prostaglandin-endoperoxide synthase 2 (PTGS2). We also \n",
      "detected a decrease in blood arachidonic acid and an increase in leukotriene B4 \n",
      "levels during gout flares. In summary, our study illustrates the distinctive \n",
      "immune cell responses and systemic inflammation patterns that characterize the \n",
      "transition from gout flares to remission, and it suggests that blood monocyte \n",
      "subtypes and Tregs are potential intervention targets for preventing recurrent \n",
      "gout attacks and progression.\n",
      "\n",
      "DOI: 10.1172/jci.insight.171417\n",
      "PMID: 38063198 [Indexed for MEDLINE]\n",
      "\n",
      "\n",
      "4. Arthritis Rheumatol. 2023 Dec 7. doi: 10.1002/art.42768. Online ahead of\n",
      "print.\n",
      "\n",
      "Clinical features and immunogenetic risk factors associated with additional \n",
      "autoantibodies in anti-transcriptional intermediary factor 1γ juvenile-onset \n",
      "dermatomyositis.\n",
      "\n",
      "Sherman MA(1), Yang Q(2), Gutierrez-Alamillo L(2), Pak K(1), Flegel WA(3), \n",
      "Mammen AL(1)(4)(5), Rider LG(#)(6), Casciola-Rosen LA(#)(2); Childhood Myositis \n",
      "Heterogeneity Collaborative Study Group.\n",
      "\n",
      "Collaborators: Arabshahi B, Ballinger S, Bingham CA, Bohnsack JF, Carrasco R, \n",
      "Eberhardt BA, Edelheit BS, Farhadi PN, Finkel TH, Fuhlbrigge RC, Goldmuntz EA, \n",
      "Gottlieb BS, Griffin TA, Guirola R, Hannan W, Henrickson M, Hong S, Jones OY, \n",
      "Kingsbury DJ, Kishi T, Lindsley CB, Mamyrova G, McCarthy PL, Miller FW, Nativ S, \n",
      "Oral EA, Pachman LM, de la Pena W, Perez MD, Person DA, Pinal-Fernandez I, \n",
      "Sabbagh SE, Sarkar K, Schiffenbauer A, Schlefman A, Shaham B, Soep J, Sule S, \n",
      "Targoff IN, Vogelgesang SA, Volochayev R, Wahezi D.\n",
      "\n",
      "Author information:\n",
      "(1)Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and \n",
      "Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.\n",
      "(2)Division of Rheumatology, Johns Hopkins University School of Medicine, \n",
      "Baltimore, Maryland, USA.\n",
      "(3)Department of Transfusion Medicine, NIH Clinical Center, National Institutes \n",
      "of Health, Bethesda, Maryland, USA.\n",
      "(4)Department of Neurology, Johns Hopkins University School of Medicine, \n",
      "Baltimore, Maryland, USA.\n",
      "(5)Department of Medicine, Johns Hopkins University School of Medicine, \n",
      "Baltimore, Maryland, USA.\n",
      "(6)Environmental Autoimmunity Group, Clinical Research Branch, National \n",
      "Institute of Environmental Health Sciences, National Institutes of Health, \n",
      "Bethesda, Maryland, USA.\n",
      "(#)Contributed equally\n",
      "\n",
      "OBJECTIVE: Novel autoantibody specificities including anti-CCAR1 were recently \n",
      "discovered in adult patients with anti-TIF1γ-positive dermatomyositis (DM) and \n",
      "were associated with attenuated cancer emergence. The aims of the present study \n",
      "were to examine whether these autoantibodies occur in patients with \n",
      "juvenile-onset dermatomyositis (JDM) and to determine their associated features.\n",
      "METHODS: Sera from 150 patients with anti-TIF1γ autoantibody-positive JDM in a \n",
      "cross-sectional cohort and 90 juvenile healthy controls were assayed for \n",
      "anti-CCAR1, anti-C1Z1, anti-IMMT, anti-TBL1XR1, and anti-Sp4 autoantibodies. \n",
      "Demographics, myositis autoantibodies, clinical features, medications, outcomes, \n",
      "and HLA-DRB1 and HLA-DQA1 alleles were compared between those with and without \n",
      "these autoantibodies.\n",
      "RESULTS: Any one of the anti-TIF1γ-associated autoantibodies was present in 44 \n",
      "(29%) patients overall, including 25 (17%) with anti-Sp4, 22 (15%) with \n",
      "anti-TBL1XR1, 14 (9%) with anti-CCAR1, 2 (1%) with anti-C1Z1, and 2 (1%) with \n",
      "anti-IMMT autoantibodies. These anti-TIF1γ-associated autoantibodies frequently \n",
      "co-occurred. Patients with any of the anti-TIF1γ-associated autoantibodies had \n",
      "less frequent falling (34% [15] vs 53% [56], p=0.032) and lower peak muscle \n",
      "enzymes. None of the patients had cancer. Among White patients, HLA-DRB1*03 was \n",
      "protective against an anti-TIF1γ-associated autoantibody (OR 0.20, 95% CI \n",
      "0.07-0.52).\n",
      "CONCLUSION: Autoantibodies associated with anti-TIF1γ were found in isolation \n",
      "and in combination among a subset of patients with JDM. Patients with these \n",
      "autoantibodies had less severe muscle disease and were not enriched for \n",
      "HLA-DRB1*03. Additional autoantibodies among anti-TIF1γ-positive patients with \n",
      "JDM likely contribute to the heterogeneity of the anti-TIF1γ serologic subgroup. \n",
      "This article is protected by copyright. All rights reserved.\n",
      "\n",
      "This article is protected by copyright. All rights reserved.\n",
      "\n",
      "DOI: 10.1002/art.42768\n",
      "PMID: 38059274\n",
      "\n",
      "\n",
      "5. Nat Genet. 2023 Dec;55(12):2255-2268. doi: 10.1038/s41588-023-01586-6. Epub\n",
      "2023  Nov 30.\n",
      "\n",
      "Mapping the dynamic genetic regulatory architecture of HLA genes at single-cell \n",
      "resolution.\n",
      "\n",
      "Kang JB(1)(2)(3)(4)(5), Shen AZ(1)(2)(3)(4)(5), Gurajala S(1)(2)(3)(4)(5), \n",
      "Nathan A(1)(2)(3)(4)(5), Rumker L(1)(2)(3)(4)(5), Aguiar VRC(4)(6), Valencia \n",
      "C(1)(2)(3)(4)(5), Lagattuta KA(1)(2)(3)(4)(5), Zhang F(1)(2)(3)(4)(5)(7), \n",
      "Jonsson AH(5), Yazar S(8), Alquicira-Hernandez J(8), Khalili H(9), \n",
      "Ananthakrishnan AN(9), Jagadeesh K(10), Dey K(10)(11)(12); Accelerating \n",
      "Medicines Partnership Program: Rheumatoid Arthritis and Systemic Lupus \n",
      "Erythematosus (AMP RA/SLE) Network; Daly MJ(13)(14)(15)(16), Xavier \n",
      "RJ(17)(18)(19), Donlin LT(20)(21), Anolik JH(22), Powell JE(8), Rao DA(5), \n",
      "Brenner MB(5), Gutierrez-Arcelus M(4)(6), Luo Y(1)(2)(3)(4)(5)(23), Sakaue \n",
      "S(1)(2)(3)(4)(5), Raychaudhuri S(24)(25)(26)(27)(28).\n",
      "\n",
      "Collaborators: Albrecht J, Apruzzese W, Banda N, Barnas JL, Bathon JM, Ben-Artzi \n",
      "A, Boyce BF, Boyle DL, Bridges SL Jr, Bykerk VP, Campbell D, Carr HL, Ceponis A, \n",
      "Chicoine A, Cordle A, Curtis M, Deane KD, DiCarlo E, Dunn P, Filer A, Firestein \n",
      "GS, Forbess L, Geraldino-Pardilla L, Goodman SM, Gravallese EM, Gregersen PK, \n",
      "Guthridge JM, Holers VM, Horowitz D, Hughes LB, Ishigaki K, Ivashkiv LB, James \n",
      "JA, Keras G, Korsunsky I, Lakhanpal A, Lederer JA, Lewis M, Li ZJ, Li Y, Liao \n",
      "KP, Mandelin AM 2nd, Mantel I, Marks KE, Maybury M, McDavid A, McGeachy MJ, \n",
      "Mears J, Meednu N, Millard N, Moreland LW, Nayar S, Nerviani A, Orange DE, \n",
      "Perlman H, Pitzalis C, Rangel-Moreno J, Raza K, Reshef Y, Ritchlin C, Rivellese \n",
      "F, Robinson WH, Sahbudin I, Singaraju A, Seifert JA, Slowikowski K, Smith MH, \n",
      "Tabechian D, Scheel-Toellner D, Utz PJ, Watts GFM, Wei K, Weinand K, Weisenfeld \n",
      "D, Weisman MH, Wyse A, Xiao Q, Zhu Z.\n",
      "\n",
      "Author information:\n",
      "(1)Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.\n",
      "(2)Division of Genetics, Department of Medicine, Brigham and Women's Hospital \n",
      "and Harvard Medical School, Boston, MA, USA.\n",
      "(3)Department of Biomedical Informatics, Harvard Medical School, Boston, MA, \n",
      "USA.\n",
      "(4)Program in Medical and Population Genetics, Broad Institute of MIT and \n",
      "Harvard, Cambridge, MA, USA.\n",
      "(5)Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, \n",
      "Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.\n",
      "(6)Division of Immunology, Boston Children's Hospital, Harvard Medical School, \n",
      "Boston, MA, USA.\n",
      "(7)Division of Rheumatology and the Center for Health Artificial Intelligence, \n",
      "University of Colorado School of Medicine, Aurora, CO, USA.\n",
      "(8)Garvan Institute of Medical Research, Sydney, New South Wales, Australia.\n",
      "(9)Division of Gastroenterology, Massachusetts General Hospital and Harvard \n",
      "Medical School, Boston, MA, USA.\n",
      "(10)Harvard T. H. Chan School of Public Health, Boston, MA, USA.\n",
      "(11)Computational and Systems Biology Program, Sloan Kettering Institute, \n",
      "Memorial Sloan Kettering Cancer Center, New York, NY, USA.\n",
      "(12)Physiology, Biophysics and Systems Biology Program, Weill Cornell Medicine, \n",
      "New York, NY, USA.\n",
      "(13)Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General \n",
      "Hospital, Boston, MA, USA.\n",
      "(14)The Stanley Center for Psychiatric Research, The Broad Institute of MIT and \n",
      "Harvard, Cambridge, MA, USA.\n",
      "(15)Institute for Molecular Medicine Finland (FIMM), University of Helsinki, \n",
      "Helsinki, Finland.\n",
      "(16)Analytic and Translational Genetics Unit, Department of Medicine, \n",
      "Massachusetts General Hospital, Boston, MA, USA.\n",
      "(17)Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, \n",
      "USA.\n",
      "(18)Center for Computational and Integrative Biology, Massachusetts General \n",
      "Hospital and Harvard Medical School, Boston, MA, USA.\n",
      "(19)Department of Molecular Biology, Massachusetts General Hospital and Harvard \n",
      "Medical School, Boston, MA, USA.\n",
      "(20)Hospital for Special Surgery, New York, NY, USA.\n",
      "(21)Weill Cornell Medicine, New York, NY, USA.\n",
      "(22)Department of Medicine, University of Rochester Medical Center, Rochester, \n",
      "NY, USA.\n",
      "(23)Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.\n",
      "(24)Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA. \n",
      "soumya@broadinstitute.org.\n",
      "(25)Division of Genetics, Department of Medicine, Brigham and Women's Hospital \n",
      "and Harvard Medical School, Boston, MA, USA. soumya@broadinstitute.org.\n",
      "(26)Department of Biomedical Informatics, Harvard Medical School, Boston, MA, \n",
      "USA. soumya@broadinstitute.org.\n",
      "(27)Program in Medical and Population Genetics, Broad Institute of MIT and \n",
      "Harvard, Cambridge, MA, USA. soumya@broadinstitute.org.\n",
      "(28)Division of Rheumatology, Inflammation, and Immunity, Department of \n",
      "Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, \n",
      "USA. soumya@broadinstitute.org.\n",
      "\n",
      "Update of\n",
      "    medRxiv. 2023 Mar 20;:\n",
      "\n",
      "The human leukocyte antigen (HLA) locus plays a critical role in complex traits \n",
      "spanning autoimmune and infectious diseases, transplantation and cancer. While \n",
      "coding variation in HLA genes has been extensively documented, regulatory \n",
      "genetic variation modulating HLA expression levels has not been comprehensively \n",
      "investigated. Here we mapped expression quantitative trait loci (eQTLs) for \n",
      "classical HLA genes across 1,073 individuals and 1,131,414 single cells from \n",
      "three tissues. To mitigate technical confounding, we developed scHLApers, a \n",
      "pipeline to accurately quantify single-cell HLA expression using personalized \n",
      "reference genomes. We identified cell-type-specific cis-eQTLs for every \n",
      "classical HLA gene. Modeling eQTLs at single-cell resolution revealed that many \n",
      "eQTL effects are dynamic across cell states even within a cell type. HLA-DQ \n",
      "genes exhibit particularly cell-state-dependent effects within myeloid, B and T \n",
      "cells. For example, a T cell HLA-DQA1 eQTL ( rs3104371 ) is strongest in \n",
      "cytotoxic cells. Dynamic HLA regulation may underlie important interindividual \n",
      "variability in immune responses.\n",
      "\n",
      "© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.\n",
      "\n",
      "DOI: 10.1038/s41588-023-01586-6\n",
      "PMID: 38036787 [Indexed for MEDLINE]\n",
      "\n",
      "\n",
      "6. Inflamm Bowel Dis. 2023 Nov 29:izad273. doi: 10.1093/ibd/izad273. Online ahead\n",
      " of print.\n",
      "\n",
      "HLA-DQA1*05 Not Associated With Ustekinumab Loss of Response and Antidrug \n",
      "Antibodies in Ulcerative Colitis and Crohn's Disease Patients.\n",
      "\n",
      "Colombel JF(1), Martín-Arranz MD(2), Brinkman B(3), Guan M(4), Hart A(4), Gasink \n",
      "C(5).\n",
      "\n",
      "Author information:\n",
      "(1)Icahn School of Medicine at Mt Sinai, New York, NY, USA.\n",
      "(2)Gastroenterology Department, Hospital Universitario de La Paz, Institute for \n",
      "Health Research La Paz, Universidad Autónoma de Madrid, Madrid, Spain.\n",
      "(3)Janssen Pharmaceutica, Beerse, Belgium.\n",
      "(4)Janssen Research & Development, LLC, Spring House, PA, USA.\n",
      "(5)Janssen Scientific Affairs, LLC, Horsham, PA, USA.\n",
      "\n",
      "Plain Language Summary: It is unknown if inflammatory bowel disease patients \n",
      "carrying the HLA-DQA1*05 allele have a greater risk of immunogenicity to \n",
      "ustekinumab. We observed that ustekinumab-treated patients carrying the allele \n",
      "did not have increased immunogenicity or reduced efficacy/serum ustekinumab \n",
      "concentrations vs noncarriers.\n",
      "\n",
      "DOI: 10.1093/ibd/izad273\n",
      "PMID: 38029420\n",
      "\n",
      "\n",
      "7. Sci Rep. 2023 Nov 27;13(1):20820. doi: 10.1038/s41598-023-47632-5.\n",
      "\n",
      "A web-based genome-wide association study reveals the susceptibility loci of \n",
      "common adverse events following COVID-19 vaccination in the Japanese population.\n",
      "\n",
      "Nogawa S(1), Kanamori H(2)(3), Tokuda K(2)(3), Kawafune K(1), Chijiiwa M(1), \n",
      "Saito K(1), Takahashi S(4).\n",
      "\n",
      "Author information:\n",
      "(1)Genequest Inc., Siba 5-29-11, Minato-ku, Tokyo, 108-0014, Japan.\n",
      "(2)Department of Infectious Diseases, Internal Medicine, Tohoku University \n",
      "Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.\n",
      "(3)Division of Infection Control, Tohoku University Hospital, 1-1 Seiryo-machi, \n",
      "Aoba-ku, Sendai, 980-8574, Japan.\n",
      "(4)Genequest Inc., Siba 5-29-11, Minato-ku, Tokyo, 108-0014, Japan. \n",
      "takahashi@genequest.jp.\n",
      "\n",
      "The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly worldwide. \n",
      "To prevent its spread, mRNA-based vaccines made by Pfizer/BioNTech (BNT162b1) \n",
      "and Moderna (mRNA-1273) have been widely used, including in Japan. Various \n",
      "adverse events have been reported following the COVID-19 mRNA vaccination, with \n",
      "differences observed among individuals. However, analyses of the genetic \n",
      "background associated with the susceptibility to side effects have been limited. \n",
      "In the present study, we performed genome-wide association studies (GWAS) for \n",
      "self-reported adverse events of the COVID-19 mRNA vaccination in 4545 Japanese \n",
      "individuals and identified 14 associated loci. Among these, 6p21 was associated \n",
      "with 37.5 °C or higher fever, 38 °C or higher fever, and muscle pain. HLA allele \n",
      "association analysis revealed that various HLA alleles were associated with the \n",
      "adverse effects; HLA-DQA1*03:01 and HLA-A*11:01 were more reliably associated \n",
      "with the adverse effects. Our results may enable the preparation and management \n",
      "of adverse effects by identifying the susceptibility to these adverse events. \n",
      "Furthermore, we obtained valuable data that may lead to a better understanding \n",
      "of the mechanisms of action of the COVID-19 mRNA vaccines.\n",
      "\n",
      "© 2023. The Author(s).\n",
      "\n",
      "DOI: 10.1038/s41598-023-47632-5\n",
      "PMCID: PMC10682012\n",
      "PMID: 38012279 [Indexed for MEDLINE]\n",
      "\n",
      "Conflict of interest statement: S.N., K.K., and M.C. are employees of Genequest \n",
      "Inc.; K.S. and S.T. are board members of Genequest Inc.; H.K. and K.T. declare \n",
      "no competing interests.\n",
      "\n",
      "\n",
      "8. BMC Cancer. 2023 Nov 24;23(1):1141. doi: 10.1186/s12885-023-11579-7.\n",
      "\n",
      "Molecular subtyping based on immune cell marker genes predicts prognosis and \n",
      "therapeutic response in patients with lung adenocarcinoma.\n",
      "\n",
      "Liu ZT(#)(1), Shen JT(#)(1), Lei YJ(#)(1), Huang YC(1), Zhao GQ(1), Zheng CH(2), \n",
      "Wang X(1), Wang YT(1), Chen L(3), Li ZX(1), Li SZ(1), Liao J(1), Yu TD(4).\n",
      "\n",
      "Author information:\n",
      "(1)Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming \n",
      "Medical University, Kunming, China.\n",
      "(2)Department of Ultrasound, The Third Affiliated Hospital of Kunming Medical \n",
      "University, Yunnan Cancer Hospital, Kunming, China.\n",
      "(3)Department of PET/CT Center, Cancer Center of Yunnan Province, The Third \n",
      "Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, \n",
      "Kunming, China.\n",
      "(4)Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming \n",
      "Medical University, Kunming, China. yutingdong@outlook.com.\n",
      "(#)Contributed equally\n",
      "\n",
      "OBJECTIVE: Lung adenocarcinoma (LA) is one of the most common malignancies and \n",
      "is responsible for the greatest number of tumor-related deaths. Our research \n",
      "aimed to explore the molecular subtype signatures of LA to clarify the \n",
      "correlation among the immune microenvironment, clinical outcomes, and \n",
      "therapeutic response.\n",
      "METHODS: The LA immune cell marker genes (LICMGs) identified by single-cell RNA \n",
      "sequencing (scRNA-seq) analysis were used to discriminate the molecular subtypes \n",
      "and homologous immune and metabolic traits of GSE72094 LA cases. In addition, \n",
      "the model-building genes were identified from 1441 LICMGs by Cox-regression \n",
      "analysis, and a LA immune difference score (LIDscore) was developed to quantify \n",
      "individual differences in each patient, thereby predicting prognosis and \n",
      "susceptibility to immunotherapy and chemotherapy of LA patients.\n",
      "RESULTS: Patients of the GSE72094 cohort were divided into two distinct \n",
      "molecular subtypes based on LICMGs: immune activating subtype (Cluster-C1) and \n",
      "metabolically activating subtype (cluster-C2). The two molecular subtypes have \n",
      "distinct characteristics regarding prognosis, clinicopathology, genomics, immune \n",
      "microenvironment, and response to immunotherapy. Among the LICMGs, LGR4, GOLM1, \n",
      "CYP24A1, SFTPB, COL1A1, HLA-DQA1, MS4A7, PPARG, and IL7R were enrolled to \n",
      "construct a LIDscore model. Low-LIDscore patients had a higher survival rate due \n",
      "to abundant immune cell infiltration, activated immunity, and lower genetic \n",
      "variation, but probably the higher levels of Treg cells in the immune \n",
      "microenvironment lead to immune cell dysfunction and promote tumor immune \n",
      "escape, thus decreasing the responsiveness to immunotherapy compared with that \n",
      "of the high-LIDscore patients. Overall, high-LIDscore patients had a higher \n",
      "responsiveness to immunotherapy and a higher sensitivity to chemotherapy than \n",
      "the low-LIDscore group.\n",
      "CONCLUSIONS: Molecular subtypes based on LICMGs provided a promising strategy \n",
      "for predicting patient prognosis, biological characteristics, and immune \n",
      "microenvironment features. In addition, they helped identify the patients most \n",
      "likely to benefit from immunotherapy and chemotherapy.\n",
      "\n",
      "© 2023. The Author(s).\n",
      "\n",
      "DOI: 10.1186/s12885-023-11579-7\n",
      "PMCID: PMC10668343\n",
      "PMID: 38001428 [Indexed for MEDLINE]\n",
      "\n",
      "Conflict of interest statement: The authors declare that they have no competing \n",
      "interests.\n",
      "\n",
      "\n",
      "9. Immunogenetics. 2023 Nov 18. doi: 10.1007/s00251-023-01325-5. Online ahead of \n",
      "print.\n",
      "\n",
      "Investigating associations between HLA DQA1 ~ DQB1 haplotypes, H. pylori \n",
      "infection, metaplasia, and anti-CagA IgA seropositivity in a Turkish gastritis \n",
      "cohort.\n",
      "\n",
      "Colakogullari M(1), Karatas L(2), Tatar Z(2).\n",
      "\n",
      "Author information:\n",
      "(1)Izmir Democracy University, Izmir, Turkey. \n",
      "mukaddes.colakogullari@yahoo.co.uk.\n",
      "(2)Izmir Democracy University, Izmir, Turkey.\n",
      "\n",
      "Helicobacter pylori was reported as an important cause of gastritis, and gastric \n",
      "ulcers and CagA oncoprotein-producing H. pylori subgroups were blamed to \n",
      "increase the severity of gastritis. Disparities were reported in that the \n",
      "presence of serum anti-CagA IgA was not parallel with CagA-positive H. pylori \n",
      "cohabitation. We hypothesized that the HLA-DQA1 ~ DQB1 haplotypes in human \n",
      "populations include protective haplotypes that more effectively present \n",
      "immunogenic CagA peptides and susceptible haplotypes with an impaired capacity \n",
      "to present CagA peptides. We recruited patients (n = 201) admitted for \n",
      "gastroendoscopy procedures and performed high-resolution HLA-DQA1 and DQB1 \n",
      "typing. Serum anti-CagA IgA levels were analyzed by ELISA (23.0% positive), and \n",
      "H. pylori was classified as positive or negative in gastric mucosal tissue \n",
      "slides (72.6% positive). The HLA DQA1*05:05 allele (29.1%) and HLA DQB1*03:01 \n",
      "allele (32.8%) were found at the highest frequency among gastritis patients of \n",
      "Turkish descent. In HLA DQA1*05:05 ~ DQB1*03:01 double homozygous (7.3%) and \n",
      "heterozygous (40.7%) haplotype carriers, the presence of anti-CagA IgA decreased \n",
      "dramatically, the presence of H. pylori increased, and the presence of \n",
      "metaplasia followed a decreasing trend. The DQ protein encoded by HLA \n",
      "DQA1*05:05-DQ*03:01 showed a low binding affinity to the CagA peptide when \n",
      "binding capacity was analyzed by the NetMHCIIPan 4.0 prediction method. In \n",
      "conclusion, HLA DQA1 ~ DQB1 polymorphisms are crucial as host defense mechanisms \n",
      "against CagA H. pylori since antigen binding capacity plays a crucial role in \n",
      "anti-CagA IgA production.\n",
      "\n",
      "© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, \n",
      "part of Springer Nature.\n",
      "\n",
      "DOI: 10.1007/s00251-023-01325-5\n",
      "PMID: 37979046\n",
      "\n",
      "\n",
      "10. HLA. 2023 Nov 16. doi: 10.1111/tan.15291. Online ahead of print.\n",
      "\n",
      "Identification of the novel HLA-DQA1*01:138 allele by next-generation \n",
      "sequencing.\n",
      "\n",
      "Lee JK(1), Bae GE(1), Lee S(1), Park JW(1), Kang ES(1).\n",
      "\n",
      "Author information:\n",
      "(1)Department of Laboratory Medicine and Genetics, Samsung Medical Center, \n",
      "Sungkyunkwan University School of Medicine, Seoul, South Korea.\n",
      "\n",
      "HLA-DQA1*01:138 is identical to HLA-DQA1*01:03 except for a single nucleotide \n",
      "substitution in exon 3.\n",
      "\n",
      "© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.\n",
      "\n",
      "DOI: 10.1111/tan.15291\n",
      "PMID: 37971080\n",
      "Concluído.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "\"1. Mult Scler Relat Disord. 2023 Dec 14;82:105373. doi: \\n10.1016/j.msard.2023.105373. Online ahead of print.\\n\\nGene expression in multiple sclerosis during pregnancy based on integrated \\nbioinformatics analysis.\\n\\nHernández-Preciado MR(1), Torres-Mendoza BM(2), Mireles-Ramírez MA(3), \\nKobayashi-Gutiérrez A(4), Sánchez-Rosales NA(3), Vázquez-Valls E(5), \\nMarquez-Pedroza J(6).\\n\\nAuthor information:\\n(1)High Specialty Medical Unit, Pediatric Hospital, Western National Medical \\nCenter of the Mexican Institute of Social Security, Guadalajara 44340, Mexico; \\nDepartment of Philosophical and Methodological Disciplines, University Health \\nSciences Center, University of Guadalajara, Guadalajara 44340, Mexico.\\n(2)Department of Philosophical and Methodological Disciplines, University Health \\nSciences Center, University of Guadalajara, Guadalajara 44340, Mexico; \\nNeurosciences Division, Western Biomedical Research Center (IMSS), Guadalajara \\n44340, Mexico.\\n(3)High Specialty Medical Unit, Western National Medical Center of the Mexican \\nInstitute of Social Security, Guadalajara 44340, Mexico.\\n(4)High Specialty Medical Unit, Western National Medical Center of the Mexican \\nInstitute of Social Security, Guadalajara 44340, Mexico; PhD in Psychology of \\nHealth, University Health Sciences Center, University of Guadalajara, \\nGuadalajara 44340, Mexico.\\n(5)Directorate of Generation of Professional Resources, Research, and \\nDevelopment, Secretary of Health, Guadalajara 44100, Mexico.\\n(6)Neurosciences Division, Western Biomedical Research Center (IMSS), \\nGuadalajara 44340, Mexico. Electronic address: jaz180688@gmail.com.\\n\\nBACKGROUND: The modulation of the activity disease in patients with Multiple \\nSclerosis (MS) that occurs during pregnancy is a helpful model which could \\nprovide insight into central disease mechanisms and facilitate treatment. \\nTherefore, the aim of the study was to identify differentially expressed genes \\nin-silico to perform biological function pathway enrichment analysis and \\nprotein-protein interaction from pregnant women with MS.\\nMETHODS: Transcriptome data were obtained from the Gene Expression Omnibus (GEO) \\ndatabase. We selected the microarray dataset GSE17449. The gene expression \\ndataset contains the data of mononuclear cells from four different groups \\nsought, including seven healthy women (H), four healthy pregnant women (HP), \\neight women with multiple sclerosis (WMS), and nine women nine months pregnant \\nwith multiple sclerosis (PMS). The GSEA software was employed for enrichment \\nanalysis, and the REACTOME database was used for biological pathways. The \\nprotein-protein interaction (PPI) network was plotted with STRING. The databases \\nused to identify the connection of DEGs with different signaling pathways were \\nKEGG and WIKIPATHWAYS.\\nRESULTS: We identified 42 differentially expressed genes in pregnant women with \\nMS. The significant pathways included IL-10 signaling pathway, ErbB2 activates, \\nthe hemoglobin complex (HBD, HBB, HBA1, AHSP, and HBA2), IL-17 signaling pathway \\n(LCN2 and MMP9), antigen processing and presentation, and Th17 cell \\ndifferentiation (HLA-DQA1), Rap1 signaling pathway (ID1), NOD-Like receptor \\nsignaling pathway (CAMP and DEFA4), PD-L1 Signaling, Interferon gamma signaling \\n(MMP9 and ARG1), Neutrophil degranulation (CAMP, DEFA4, ELANE, CEACAM8, S100P, \\nCHI3L1, AZU1, OLFM4, CRISP3, LTF, ARG1, PGLYRP1, and TCN1). In the WIKIPATHWAYS \\nset, significance was found Vitamin B12 metabolism (TCN1, HBB, and HBA2), and \\nIL-18 signaling pathway (S100P).\\nCONCLUSION: This study can be used to understand several essential target genes \\nand pathways identified in the present study, which may serve as feasible \\ntargets for MS therapies.\\n\\nCopyright © 2023 Elsevier B.V. All rights reserved.\\n\\nDOI: 10.1016/j.msard.2023.105373\\nPMID: 38154347\\n\\nConflict of interest statement: Declaration of Competing Interest The authors \\ndeclare that they have no known competing financial interests or personal \\nrelationships that could have appeared to influence the work reported in this \\npaper.\\n\\n\\n2. Biomedicines. 2023 Dec 11;11(12):3273. doi: 10.3390/biomedicines11123273.\\n\\nGenetic Susceptibility of HLA Alleles to Non-Steroidal Anti-Inflammatory Drug \\nHypersensitivity in the Taiwanese Population.\\n\\nChang SL(1)(2)(3)(4), Lai CH(2)(4)(5), Lin GC(6), Chen YM(2)(4)(6)(7)(8), Lee \\nMH(9), Hsu HS(3)(10), Chen IC(6).\\n\\nAuthor information:\\n(1)Department of Anesthesiology, Taichung Veterans General Hospital, Taichung \\n407219, Taiwan.\\n(2)Department of Postbaccalaureate Medicine, College of Medicine, National Chung \\nHsing University, Taichung 402202, Taiwan.\\n(3)Institute of Emergency and Critical Care Medicine, School of Medicine, \\nNational Yang Ming Chiao Tung University, Taipei 112304, Taiwan.\\n(4)School of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, \\nTaiwan.\\n(5)Department of Medicine and Cardiovascular Center, Taichung Veterans General \\nHospital, Taichung 407219, Taiwan.\\n(6)Department of Medical Research, Taichung Veterans General Hospital, Taichung \\n407219, Taiwan.\\n(7)Division of Allergy, Immunology and Rheumatology, Department of Medical \\nResearch, Taichung Veterans General Hospital, Taichung 407219, Taiwan.\\n(8)Institute of Biomedical Science and Rong Hsing Research Center for \\nTranslational Medicine, National Chung Hsing University, Taichung 402202, \\nTaiwan.\\n(9)Institute of Clinical Medicine, National Yang Ming Chiao Tung University, \\nTaipei 112304, Taiwan.\\n(10)Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General \\nHospital, Taipei 112201, Taiwan.\\n\\nBACKGROUND: Human leukocyte antigen (HLA) genes are important in many immune \\nprocesses and contribute to many adverse drug reactions. Whether genetic \\nvariations in the HLA region are associated with non-steroid anti-inflammatory \\ndrug (NSAID) hypersensitivity remains uncertain. Therefore, the aim of our study \\nwas to identify HLA genetic variations in patients with NSAID hypersensitivity \\nin the Taiwanese population.\\nMETHODS: This hospital-based, retrospective case-control study enrolled 37,156 \\nparticipants with NSAID exposure from the Taiwan Precision Medicine Initiative \\n(TPMI), who were all genotyped and imputed to fine map HLA typing. Our study \\nassigned 1217 cases to the NSAID allergy group and 12,170 controls to a matched \\ngroup. Logistic regression analyses were utilized to explore associations \\nbetween HLA alleles and NSAID hypersensitivity.\\nRESULTS: Overall, 13,387 patients were genotyped for eight major HLA alleles. \\nAllele frequencies were different between the two groups. In the NSAID allergy \\ngroup, the genotype frequencies of HLA-A*02:01, HLA-A*34:01, and HLA-DQA1*06:01 \\nwere found to be markedly elevated compared to the control group, a significance \\nthat persisted even after applying the Bonferroni correction. Furthermore, the \\nrisk of NSAID allergy demonstrated a significant association with HLA-A*02:01 \\n(OR = 1.29, p < 0.001) and HLA-A*34:01 (OR = 9.90, p = 0.001), in comparison to \\ntheir respective counterparts. Notably, the genotype frequency of HLA-B*46:01 \\nexhibited a significant increase in the severe allergy group when compared with \\nthe mild allergy group.\\nCONCLUSIONS: We identified HLA genotypes linked to the onset and severity of \\nNSAID hypersensitivity. Our findings establish a basis for precision \\nprescription in future clinical applications.\\n\\nDOI: 10.3390/biomedicines11123273\\nPMCID: PMC10741656\\nPMID: 38137494\\n\\nConflict of interest statement: The authors declare that the research was \\nconducted in the absence of any commercial or financial relationship that could \\nbe construed as a potential conflict of interest. The authors have no relevant \\nfinancial or non-financial interests to disclose. The funders had no role in the \\ndesign of the study; in the collection, analyses, or interpretation of data; in \\nthe writing of the manuscript; or in the decision to publish the results.\\n\\n\\n3. JCI Insight. 2023 Dec 8;8(23):e171417. doi: 10.1172/jci.insight.171417.\\n\\nSingle-cell transcriptomics reveals variations in monocytes and Tregs between \\ngout flare and remission.\\n\\nYu H(1), Xue W(1), Yu H(1), Song Y(1), Liu X(1), Qin L(1), Wang S(1), Bao H(1), \\nGu H(1), Chen G(1), Zhao D(1), Tu Y(1), Cheng J(1), Wang L(1), Ai Z(2), Hu D(1), \\nWang L(1), Peng A(1).\\n\\nAuthor information:\\n(1)Center for Nephrology and Clinical Metabolomics and Division of Nephrology, \\nShanghai Tenth People's Hospital, and.\\n(2)Department of Medical Statistics, Tongji University School of Medicine, \\nShanghai, China.\\n\\nGout commonly manifests as a painful, self-limiting inflammatory arthritis. \\nNevertheless, the understanding of the inflammatory and immune responses \\nunderlying gout flares and remission remains ambiguous. Here, based on \\nsingle-cell RNA-Seq and an independent validation cohort, we identified the \\npotential mechanism of gout flare, which likely involves the upregulation of \\nHLA-DQA1+ nonclassical monocytes and is related to antigen processing and \\npresentation. Furthermore, Tregs also play an essential role in the suppressive \\ncapacity during gout remission. Cell communication analysis suggested the \\nexistence of altered crosstalk between monocytes and other T cell types, such as \\nTregs. Moreover, we observed the systemic upregulation of inflammatory and \\ncytokine genes, primarily in classical monocytes, during gout flares. All \\nmonocyte subtypes showed increased arachidonic acid metabolic activity along \\nwith upregulation of prostaglandin-endoperoxide synthase 2 (PTGS2). We also \\ndetected a decrease in blood arachidonic acid and an increase in leukotriene B4 \\nlevels during gout flares. In summary, our study illustrates the distinctive \\nimmune cell responses and systemic inflammation patterns that characterize the \\ntransition from gout flares to remission, and it suggests that blood monocyte \\nsubtypes and Tregs are potential intervention targets for preventing recurrent \\ngout attacks and progression.\\n\\nDOI: 10.1172/jci.insight.171417\\nPMID: 38063198 [Indexed for MEDLINE]\\n\\n\\n4. Arthritis Rheumatol. 2023 Dec 7. doi: 10.1002/art.42768. Online ahead of\\nprint.\\n\\nClinical features and immunogenetic risk factors associated with additional \\nautoantibodies in anti-transcriptional intermediary factor 1γ juvenile-onset \\ndermatomyositis.\\n\\nSherman MA(1), Yang Q(2), Gutierrez-Alamillo L(2), Pak K(1), Flegel WA(3), \\nMammen AL(1)(4)(5), Rider LG(#)(6), Casciola-Rosen LA(#)(2); Childhood Myositis \\nHeterogeneity Collaborative Study Group.\\n\\nCollaborators: Arabshahi B, Ballinger S, Bingham CA, Bohnsack JF, Carrasco R, \\nEberhardt BA, Edelheit BS, Farhadi PN, Finkel TH, Fuhlbrigge RC, Goldmuntz EA, \\nGottlieb BS, Griffin TA, Guirola R, Hannan W, Henrickson M, Hong S, Jones OY, \\nKingsbury DJ, Kishi T, Lindsley CB, Mamyrova G, McCarthy PL, Miller FW, Nativ S, \\nOral EA, Pachman LM, de la Pena W, Perez MD, Person DA, Pinal-Fernandez I, \\nSabbagh SE, Sarkar K, Schiffenbauer A, Schlefman A, Shaham B, Soep J, Sule S, \\nTargoff IN, Vogelgesang SA, Volochayev R, Wahezi D.\\n\\nAuthor information:\\n(1)Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and \\nSkin Diseases, National Institutes of Health, Bethesda, Maryland, USA.\\n(2)Division of Rheumatology, Johns Hopkins University School of Medicine, \\nBaltimore, Maryland, USA.\\n(3)Department of Transfusion Medicine, NIH Clinical Center, National Institutes \\nof Health, Bethesda, Maryland, USA.\\n(4)Department of Neurology, Johns Hopkins University School of Medicine, \\nBaltimore, Maryland, USA.\\n(5)Department of Medicine, Johns Hopkins University School of Medicine, \\nBaltimore, Maryland, USA.\\n(6)Environmental Autoimmunity Group, Clinical Research Branch, National \\nInstitute of Environmental Health Sciences, National Institutes of Health, \\nBethesda, Maryland, USA.\\n(#)Contributed equally\\n\\nOBJECTIVE: Novel autoantibody specificities including anti-CCAR1 were recently \\ndiscovered in adult patients with anti-TIF1γ-positive dermatomyositis (DM) and \\nwere associated with attenuated cancer emergence. The aims of the present study \\nwere to examine whether these autoantibodies occur in patients with \\njuvenile-onset dermatomyositis (JDM) and to determine their associated features.\\nMETHODS: Sera from 150 patients with anti-TIF1γ autoantibody-positive JDM in a \\ncross-sectional cohort and 90 juvenile healthy controls were assayed for \\nanti-CCAR1, anti-C1Z1, anti-IMMT, anti-TBL1XR1, and anti-Sp4 autoantibodies. \\nDemographics, myositis autoantibodies, clinical features, medications, outcomes, \\nand HLA-DRB1 and HLA-DQA1 alleles were compared between those with and without \\nthese autoantibodies.\\nRESULTS: Any one of the anti-TIF1γ-associated autoantibodies was present in 44 \\n(29%) patients overall, including 25 (17%) with anti-Sp4, 22 (15%) with \\nanti-TBL1XR1, 14 (9%) with anti-CCAR1, 2 (1%) with anti-C1Z1, and 2 (1%) with \\nanti-IMMT autoantibodies. These anti-TIF1γ-associated autoantibodies frequently \\nco-occurred. Patients with any of the anti-TIF1γ-associated autoantibodies had \\nless frequent falling (34% [15] vs 53% [56], p=0.032) and lower peak muscle \\nenzymes. None of the patients had cancer. Among White patients, HLA-DRB1*03 was \\nprotective against an anti-TIF1γ-associated autoantibody (OR 0.20, 95% CI \\n0.07-0.52).\\nCONCLUSION: Autoantibodies associated with anti-TIF1γ were found in isolation \\nand in combination among a subset of patients with JDM. Patients with these \\nautoantibodies had less severe muscle disease and were not enriched for \\nHLA-DRB1*03. Additional autoantibodies among anti-TIF1γ-positive patients with \\nJDM likely contribute to the heterogeneity of the anti-TIF1γ serologic subgroup. \\nThis article is protected by copyright. All rights reserved.\\n\\nThis article is protected by copyright. All rights reserved.\\n\\nDOI: 10.1002/art.42768\\nPMID: 38059274\\n\\n\\n5. Nat Genet. 2023 Dec;55(12):2255-2268. doi: 10.1038/s41588-023-01586-6. Epub\\n2023  Nov 30.\\n\\nMapping the dynamic genetic regulatory architecture of HLA genes at single-cell \\nresolution.\\n\\nKang JB(1)(2)(3)(4)(5), Shen AZ(1)(2)(3)(4)(5), Gurajala S(1)(2)(3)(4)(5), \\nNathan A(1)(2)(3)(4)(5), Rumker L(1)(2)(3)(4)(5), Aguiar VRC(4)(6), Valencia \\nC(1)(2)(3)(4)(5), Lagattuta KA(1)(2)(3)(4)(5), Zhang F(1)(2)(3)(4)(5)(7), \\nJonsson AH(5), Yazar S(8), Alquicira-Hernandez J(8), Khalili H(9), \\nAnanthakrishnan AN(9), Jagadeesh K(10), Dey K(10)(11)(12); Accelerating \\nMedicines Partnership Program: Rheumatoid Arthritis and Systemic Lupus \\nErythematosus (AMP RA/SLE) Network; Daly MJ(13)(14)(15)(16), Xavier \\nRJ(17)(18)(19), Donlin LT(20)(21), Anolik JH(22), Powell JE(8), Rao DA(5), \\nBrenner MB(5), Gutierrez-Arcelus M(4)(6), Luo Y(1)(2)(3)(4)(5)(23), Sakaue \\nS(1)(2)(3)(4)(5), Raychaudhuri S(24)(25)(26)(27)(28).\\n\\nCollaborators: Albrecht J, Apruzzese W, Banda N, Barnas JL, Bathon JM, Ben-Artzi \\nA, Boyce BF, Boyle DL, Bridges SL Jr, Bykerk VP, Campbell D, Carr HL, Ceponis A, \\nChicoine A, Cordle A, Curtis M, Deane KD, DiCarlo E, Dunn P, Filer A, Firestein \\nGS, Forbess L, Geraldino-Pardilla L, Goodman SM, Gravallese EM, Gregersen PK, \\nGuthridge JM, Holers VM, Horowitz D, Hughes LB, Ishigaki K, Ivashkiv LB, James \\nJA, Keras G, Korsunsky I, Lakhanpal A, Lederer JA, Lewis M, Li ZJ, Li Y, Liao \\nKP, Mandelin AM 2nd, Mantel I, Marks KE, Maybury M, McDavid A, McGeachy MJ, \\nMears J, Meednu N, Millard N, Moreland LW, Nayar S, Nerviani A, Orange DE, \\nPerlman H, Pitzalis C, Rangel-Moreno J, Raza K, Reshef Y, Ritchlin C, Rivellese \\nF, Robinson WH, Sahbudin I, Singaraju A, Seifert JA, Slowikowski K, Smith MH, \\nTabechian D, Scheel-Toellner D, Utz PJ, Watts GFM, Wei K, Weinand K, Weisenfeld \\nD, Weisman MH, Wyse A, Xiao Q, Zhu Z.\\n\\nAuthor information:\\n(1)Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.\\n(2)Division of Genetics, Department of Medicine, Brigham and Women's Hospital \\nand Harvard Medical School, Boston, MA, USA.\\n(3)Department of Biomedical Informatics, Harvard Medical School, Boston, MA, \\nUSA.\\n(4)Program in Medical and Population Genetics, Broad Institute of MIT and \\nHarvard, Cambridge, MA, USA.\\n(5)Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, \\nBrigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.\\n(6)Division of Immunology, Boston Children's Hospital, Harvard Medical School, \\nBoston, MA, USA.\\n(7)Division of Rheumatology and the Center for Health Artificial Intelligence, \\nUniversity of Colorado School of Medicine, Aurora, CO, USA.\\n(8)Garvan Institute of Medical Research, Sydney, New South Wales, Australia.\\n(9)Division of Gastroenterology, Massachusetts General Hospital and Harvard \\nMedical School, Boston, MA, USA.\\n(10)Harvard T. H. Chan School of Public Health, Boston, MA, USA.\\n(11)Computational and Systems Biology Program, Sloan Kettering Institute, \\nMemorial Sloan Kettering Cancer Center, New York, NY, USA.\\n(12)Physiology, Biophysics and Systems Biology Program, Weill Cornell Medicine, \\nNew York, NY, USA.\\n(13)Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General \\nHospital, Boston, MA, USA.\\n(14)The Stanley Center for Psychiatric Research, The Broad Institute of MIT and \\nHarvard, Cambridge, MA, USA.\\n(15)Institute for Molecular Medicine Finland (FIMM), University of Helsinki, \\nHelsinki, Finland.\\n(16)Analytic and Translational Genetics Unit, Department of Medicine, \\nMassachusetts General Hospital, Boston, MA, USA.\\n(17)Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, \\nUSA.\\n(18)Center for Computational and Integrative Biology, Massachusetts General \\nHospital and Harvard Medical School, Boston, MA, USA.\\n(19)Department of Molecular Biology, Massachusetts General Hospital and Harvard \\nMedical School, Boston, MA, USA.\\n(20)Hospital for Special Surgery, New York, NY, USA.\\n(21)Weill Cornell Medicine, New York, NY, USA.\\n(22)Department of Medicine, University of Rochester Medical Center, Rochester, \\nNY, USA.\\n(23)Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.\\n(24)Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA. \\nsoumya@broadinstitute.org.\\n(25)Division of Genetics, Department of Medicine, Brigham and Women's Hospital \\nand Harvard Medical School, Boston, MA, USA. soumya@broadinstitute.org.\\n(26)Department of Biomedical Informatics, Harvard Medical School, Boston, MA, \\nUSA. soumya@broadinstitute.org.\\n(27)Program in Medical and Population Genetics, Broad Institute of MIT and \\nHarvard, Cambridge, MA, USA. soumya@broadinstitute.org.\\n(28)Division of Rheumatology, Inflammation, and Immunity, Department of \\nMedicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, \\nUSA. soumya@broadinstitute.org.\\n\\nUpdate of\\n    medRxiv. 2023 Mar 20;:\\n\\nThe human leukocyte antigen (HLA) locus plays a critical role in complex traits \\nspanning autoimmune and infectious diseases, transplantation and cancer. While \\ncoding variation in HLA genes has been extensively documented, regulatory \\ngenetic variation modulating HLA expression levels has not been comprehensively \\ninvestigated. Here we mapped expression quantitative trait loci (eQTLs) for \\nclassical HLA genes across 1,073 individuals and 1,131,414 single cells from \\nthree tissues. To mitigate technical confounding, we developed scHLApers, a \\npipeline to accurately quantify single-cell HLA expression using personalized \\nreference genomes. We identified cell-type-specific cis-eQTLs for every \\nclassical HLA gene. Modeling eQTLs at single-cell resolution revealed that many \\neQTL effects are dynamic across cell states even within a cell type. HLA-DQ \\ngenes exhibit particularly cell-state-dependent effects within myeloid, B and T \\ncells. For example, a T cell HLA-DQA1 eQTL ( rs3104371 ) is strongest in \\ncytotoxic cells. Dynamic HLA regulation may underlie important interindividual \\nvariability in immune responses.\\n\\n© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.\\n\\nDOI: 10.1038/s41588-023-01586-6\\nPMID: 38036787 [Indexed for MEDLINE]\\n\\n\\n6. Inflamm Bowel Dis. 2023 Nov 29:izad273. doi: 10.1093/ibd/izad273. Online ahead\\n of print.\\n\\nHLA-DQA1*05 Not Associated With Ustekinumab Loss of Response and Antidrug \\nAntibodies in Ulcerative Colitis and Crohn's Disease Patients.\\n\\nColombel JF(1), Martín-Arranz MD(2), Brinkman B(3), Guan M(4), Hart A(4), Gasink \\nC(5).\\n\\nAuthor information:\\n(1)Icahn School of Medicine at Mt Sinai, New York, NY, USA.\\n(2)Gastroenterology Department, Hospital Universitario de La Paz, Institute for \\nHealth Research La Paz, Universidad Autónoma de Madrid, Madrid, Spain.\\n(3)Janssen Pharmaceutica, Beerse, Belgium.\\n(4)Janssen Research & Development, LLC, Spring House, PA, USA.\\n(5)Janssen Scientific Affairs, LLC, Horsham, PA, USA.\\n\\nPlain Language Summary: It is unknown if inflammatory bowel disease patients \\ncarrying the HLA-DQA1*05 allele have a greater risk of immunogenicity to \\nustekinumab. We observed that ustekinumab-treated patients carrying the allele \\ndid not have increased immunogenicity or reduced efficacy/serum ustekinumab \\nconcentrations vs noncarriers.\\n\\nDOI: 10.1093/ibd/izad273\\nPMID: 38029420\\n\\n\\n7. Sci Rep. 2023 Nov 27;13(1):20820. doi: 10.1038/s41598-023-47632-5.\\n\\nA web-based genome-wide association study reveals the susceptibility loci of \\ncommon adverse events following COVID-19 vaccination in the Japanese population.\\n\\nNogawa S(1), Kanamori H(2)(3), Tokuda K(2)(3), Kawafune K(1), Chijiiwa M(1), \\nSaito K(1), Takahashi S(4).\\n\\nAuthor information:\\n(1)Genequest Inc., Siba 5-29-11, Minato-ku, Tokyo, 108-0014, Japan.\\n(2)Department of Infectious Diseases, Internal Medicine, Tohoku University \\nGraduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.\\n(3)Division of Infection Control, Tohoku University Hospital, 1-1 Seiryo-machi, \\nAoba-ku, Sendai, 980-8574, Japan.\\n(4)Genequest Inc., Siba 5-29-11, Minato-ku, Tokyo, 108-0014, Japan. \\ntakahashi@genequest.jp.\\n\\nThe coronavirus disease 2019 (COVID-19) pandemic has spread rapidly worldwide. \\nTo prevent its spread, mRNA-based vaccines made by Pfizer/BioNTech (BNT162b1) \\nand Moderna (mRNA-1273) have been widely used, including in Japan. Various \\nadverse events have been reported following the COVID-19 mRNA vaccination, with \\ndifferences observed among individuals. However, analyses of the genetic \\nbackground associated with the susceptibility to side effects have been limited. \\nIn the present study, we performed genome-wide association studies (GWAS) for \\nself-reported adverse events of the COVID-19 mRNA vaccination in 4545 Japanese \\nindividuals and identified 14 associated loci. Among these, 6p21 was associated \\nwith 37.5\\xa0°C or higher fever, 38\\xa0°C or higher fever, and muscle pain. HLA allele \\nassociation analysis revealed that various HLA alleles were associated with the \\nadverse effects; HLA-DQA1*03:01 and HLA-A*11:01 were more reliably associated \\nwith the adverse effects. Our results may enable the preparation and management \\nof adverse effects by identifying the susceptibility to these adverse events. \\nFurthermore, we obtained valuable data that may lead to a better understanding \\nof the mechanisms of action of the COVID-19 mRNA vaccines.\\n\\n© 2023. The Author(s).\\n\\nDOI: 10.1038/s41598-023-47632-5\\nPMCID: PMC10682012\\nPMID: 38012279 [Indexed for MEDLINE]\\n\\nConflict of interest statement: S.N., K.K., and M.C. are employees of Genequest \\nInc.; K.S. and S.T. are board members of Genequest Inc.; H.K. and K.T. declare \\nno competing interests.\\n\\n\\n8. BMC Cancer. 2023 Nov 24;23(1):1141. doi: 10.1186/s12885-023-11579-7.\\n\\nMolecular subtyping based on immune cell marker genes predicts prognosis and \\ntherapeutic response in patients with lung adenocarcinoma.\\n\\nLiu ZT(#)(1), Shen JT(#)(1), Lei YJ(#)(1), Huang YC(1), Zhao GQ(1), Zheng CH(2), \\nWang X(1), Wang YT(1), Chen L(3), Li ZX(1), Li SZ(1), Liao J(1), Yu TD(4).\\n\\nAuthor information:\\n(1)Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming \\nMedical University, Kunming, China.\\n(2)Department of Ultrasound, The Third Affiliated Hospital of Kunming Medical \\nUniversity, Yunnan Cancer Hospital, Kunming, China.\\n(3)Department of PET/CT Center, Cancer Center of Yunnan Province, The Third \\nAffiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, \\nKunming, China.\\n(4)Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming \\nMedical University, Kunming, China. yutingdong@outlook.com.\\n(#)Contributed equally\\n\\nOBJECTIVE: Lung adenocarcinoma (LA) is one of the most common malignancies and \\nis responsible for the greatest number of tumor-related deaths. Our research \\naimed to explore the molecular subtype signatures of LA to clarify the \\ncorrelation among the immune microenvironment, clinical outcomes, and \\ntherapeutic response.\\nMETHODS: The LA immune cell marker genes (LICMGs) identified by single-cell RNA \\nsequencing (scRNA-seq) analysis were used to discriminate the molecular subtypes \\nand homologous immune and metabolic traits of GSE72094 LA cases. In addition, \\nthe model-building genes were identified from 1441 LICMGs by Cox-regression \\nanalysis, and a LA immune difference score (LIDscore) was developed to quantify \\nindividual differences in each patient, thereby predicting prognosis and \\nsusceptibility to immunotherapy and chemotherapy of LA patients.\\nRESULTS: Patients of the GSE72094 cohort were divided into two distinct \\nmolecular subtypes based on LICMGs: immune activating subtype (Cluster-C1) and \\nmetabolically activating subtype (cluster-C2). The two molecular subtypes have \\ndistinct characteristics regarding prognosis, clinicopathology, genomics, immune \\nmicroenvironment, and response to immunotherapy. Among the LICMGs, LGR4, GOLM1, \\nCYP24A1, SFTPB, COL1A1, HLA-DQA1, MS4A7, PPARG, and IL7R were enrolled to \\nconstruct a LIDscore model. Low-LIDscore patients had a higher survival rate due \\nto abundant immune cell infiltration, activated immunity, and lower genetic \\nvariation, but probably the higher levels of Treg cells in the immune \\nmicroenvironment lead to immune cell dysfunction and promote tumor immune \\nescape, thus decreasing the responsiveness to immunotherapy compared with that \\nof the high-LIDscore patients. Overall, high-LIDscore patients had a higher \\nresponsiveness to immunotherapy and a higher sensitivity to chemotherapy than \\nthe low-LIDscore group.\\nCONCLUSIONS: Molecular subtypes based on LICMGs provided a promising strategy \\nfor predicting patient prognosis, biological characteristics, and immune \\nmicroenvironment features. In addition, they helped identify the patients most \\nlikely to benefit from immunotherapy and chemotherapy.\\n\\n© 2023. The Author(s).\\n\\nDOI: 10.1186/s12885-023-11579-7\\nPMCID: PMC10668343\\nPMID: 38001428 [Indexed for MEDLINE]\\n\\nConflict of interest statement: The authors declare that they have no competing \\ninterests.\\n\\n\\n9. Immunogenetics. 2023 Nov 18. doi: 10.1007/s00251-023-01325-5. Online ahead of \\nprint.\\n\\nInvestigating associations between HLA DQA1\\u2009~\\u2009DQB1 haplotypes, H. pylori \\ninfection, metaplasia, and anti-CagA IgA seropositivity in a Turkish gastritis \\ncohort.\\n\\nColakogullari M(1), Karatas L(2), Tatar Z(2).\\n\\nAuthor information:\\n(1)Izmir Democracy University, Izmir, Turkey. \\nmukaddes.colakogullari@yahoo.co.uk.\\n(2)Izmir Democracy University, Izmir, Turkey.\\n\\nHelicobacter pylori was reported as an important cause of gastritis, and gastric \\nulcers and CagA oncoprotein-producing H. pylori subgroups were blamed to \\nincrease the severity of gastritis. Disparities were reported in that the \\npresence of serum anti-CagA IgA was not parallel with CagA-positive H. pylori \\ncohabitation. We hypothesized that the HLA-DQA1\\u2009~\\u2009DQB1 haplotypes in human \\npopulations include protective haplotypes that more effectively present \\nimmunogenic CagA peptides and susceptible haplotypes with an impaired capacity \\nto present CagA peptides. We recruited patients (n\\u2009=\\u2009201) admitted for \\ngastroendoscopy procedures and performed high-resolution HLA-DQA1 and DQB1 \\ntyping. Serum anti-CagA IgA levels were analyzed by ELISA (23.0% positive), and \\nH. pylori was classified as positive or negative in gastric mucosal tissue \\nslides (72.6% positive). The HLA DQA1*05:05 allele (29.1%) and HLA DQB1*03:01 \\nallele (32.8%) were found at the highest frequency among gastritis patients of \\nTurkish descent. In HLA DQA1*05:05\\u2009~\\u2009DQB1*03:01 double homozygous (7.3%) and \\nheterozygous (40.7%) haplotype carriers, the presence of anti-CagA IgA decreased \\ndramatically, the presence of H. pylori increased, and the presence of \\nmetaplasia followed a decreasing trend. The DQ protein encoded by HLA \\nDQA1*05:05-DQ*03:01 showed a low binding affinity to the CagA peptide when \\nbinding capacity was analyzed by the NetMHCIIPan 4.0 prediction method. In \\nconclusion, HLA DQA1\\u2009~\\u2009DQB1 polymorphisms are crucial as host defense mechanisms \\nagainst CagA H. pylori since antigen binding capacity plays a crucial role in \\nanti-CagA IgA production.\\n\\n© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, \\npart of Springer Nature.\\n\\nDOI: 10.1007/s00251-023-01325-5\\nPMID: 37979046\\n\\n\\n10. HLA. 2023 Nov 16. doi: 10.1111/tan.15291. Online ahead of print.\\n\\nIdentification of the novel HLA-DQA1*01:138 allele by next-generation \\nsequencing.\\n\\nLee JK(1), Bae GE(1), Lee S(1), Park JW(1), Kang ES(1).\\n\\nAuthor information:\\n(1)Department of Laboratory Medicine and Genetics, Samsung Medical Center, \\nSungkyunkwan University School of Medicine, Seoul, South Korea.\\n\\nHLA-DQA1*01:138 is identical to HLA-DQA1*01:03 except for a single nucleotide \\nsubstitution in exon 3.\\n\\n© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.\\n\\nDOI: 10.1111/tan.15291\\nPMID: 37971080\""
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pesquisa_ncbi(email,termo)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Como podemos observar, foram processados processados somente 10 resultados dos 2009 resultados encontrados. \n",
    "\n",
    "O resultado apresentado é um artigo intitulado de \"Gene expression in multiple sclerosis during pregnancy based on integrated \n",
    "bioinformatics analysis\", publicado em dezembro de 2003 na revista Multiple Sclerosis and Related Disorders. O estudo foi conduzido por 6 autores que se encontram listados acima em conjunto com informação relevante sobre os mesmos.\n",
    "\n",
    "No final do output podemos observar que tanto o DOI e o PMID são fornecidos. \n",
    "\n",
    "Podemos concluir que o output da função **pesquisa_ncbi** permite a extração de informações relevantes na análise dos genes a nível da análise de artigos científicos disponíveis em diversas bases de dados. "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Flexibilidade da função pesquisa_ncbi\n",
    "\n",
    "Como foi descrito anteriormente, é possível adaptar os parâmetros da função de forma a atingir os objetivos esperados. Desta forma, é possível:\n",
    "\n",
    "- **Manipular quantidade de resultados processados**\n",
    "\n",
    "Podemos manipular a quantidade de resultados apresentados modificando o número do parâmetro \"retmax\". Na função seguinte foi alterado o parâmetro \"retmax\" para \"1\" de modo a ser processo um único resultado."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Encontrados 2009 resultados em pubmed. Irá ser processado 1 resultado.\n",
      "\n",
      "1. Mult Scler Relat Disord. 2023 Dec 14;82:105373. doi: \n",
      "10.1016/j.msard.2023.105373. Online ahead of print.\n",
      "\n",
      "Gene expression in multiple sclerosis during pregnancy based on integrated \n",
      "bioinformatics analysis.\n",
      "\n",
      "Hernández-Preciado MR(1), Torres-Mendoza BM(2), Mireles-Ramírez MA(3), \n",
      "Kobayashi-Gutiérrez A(4), Sánchez-Rosales NA(3), Vázquez-Valls E(5), \n",
      "Marquez-Pedroza J(6).\n",
      "\n",
      "Author information:\n",
      "(1)High Specialty Medical Unit, Pediatric Hospital, Western National Medical \n",
      "Center of the Mexican Institute of Social Security, Guadalajara 44340, Mexico; \n",
      "Department of Philosophical and Methodological Disciplines, University Health \n",
      "Sciences Center, University of Guadalajara, Guadalajara 44340, Mexico.\n",
      "(2)Department of Philosophical and Methodological Disciplines, University Health \n",
      "Sciences Center, University of Guadalajara, Guadalajara 44340, Mexico; \n",
      "Neurosciences Division, Western Biomedical Research Center (IMSS), Guadalajara \n",
      "44340, Mexico.\n",
      "(3)High Specialty Medical Unit, Western National Medical Center of the Mexican \n",
      "Institute of Social Security, Guadalajara 44340, Mexico.\n",
      "(4)High Specialty Medical Unit, Western National Medical Center of the Mexican \n",
      "Institute of Social Security, Guadalajara 44340, Mexico; PhD in Psychology of \n",
      "Health, University Health Sciences Center, University of Guadalajara, \n",
      "Guadalajara 44340, Mexico.\n",
      "(5)Directorate of Generation of Professional Resources, Research, and \n",
      "Development, Secretary of Health, Guadalajara 44100, Mexico.\n",
      "(6)Neurosciences Division, Western Biomedical Research Center (IMSS), \n",
      "Guadalajara 44340, Mexico. Electronic address: jaz180688@gmail.com.\n",
      "\n",
      "BACKGROUND: The modulation of the activity disease in patients with Multiple \n",
      "Sclerosis (MS) that occurs during pregnancy is a helpful model which could \n",
      "provide insight into central disease mechanisms and facilitate treatment. \n",
      "Therefore, the aim of the study was to identify differentially expressed genes \n",
      "in-silico to perform biological function pathway enrichment analysis and \n",
      "protein-protein interaction from pregnant women with MS.\n",
      "METHODS: Transcriptome data were obtained from the Gene Expression Omnibus (GEO) \n",
      "database. We selected the microarray dataset GSE17449. The gene expression \n",
      "dataset contains the data of mononuclear cells from four different groups \n",
      "sought, including seven healthy women (H), four healthy pregnant women (HP), \n",
      "eight women with multiple sclerosis (WMS), and nine women nine months pregnant \n",
      "with multiple sclerosis (PMS). The GSEA software was employed for enrichment \n",
      "analysis, and the REACTOME database was used for biological pathways. The \n",
      "protein-protein interaction (PPI) network was plotted with STRING. The databases \n",
      "used to identify the connection of DEGs with different signaling pathways were \n",
      "KEGG and WIKIPATHWAYS.\n",
      "RESULTS: We identified 42 differentially expressed genes in pregnant women with \n",
      "MS. The significant pathways included IL-10 signaling pathway, ErbB2 activates, \n",
      "the hemoglobin complex (HBD, HBB, HBA1, AHSP, and HBA2), IL-17 signaling pathway \n",
      "(LCN2 and MMP9), antigen processing and presentation, and Th17 cell \n",
      "differentiation (HLA-DQA1), Rap1 signaling pathway (ID1), NOD-Like receptor \n",
      "signaling pathway (CAMP and DEFA4), PD-L1 Signaling, Interferon gamma signaling \n",
      "(MMP9 and ARG1), Neutrophil degranulation (CAMP, DEFA4, ELANE, CEACAM8, S100P, \n",
      "CHI3L1, AZU1, OLFM4, CRISP3, LTF, ARG1, PGLYRP1, and TCN1). In the WIKIPATHWAYS \n",
      "set, significance was found Vitamin B12 metabolism (TCN1, HBB, and HBA2), and \n",
      "IL-18 signaling pathway (S100P).\n",
      "CONCLUSION: This study can be used to understand several essential target genes \n",
      "and pathways identified in the present study, which may serve as feasible \n",
      "targets for MS therapies.\n",
      "\n",
      "Copyright © 2023 Elsevier B.V. All rights reserved.\n",
      "\n",
      "DOI: 10.1016/j.msard.2023.105373\n",
      "PMID: 38154347\n",
      "\n",
      "Conflict of interest statement: Declaration of Competing Interest The authors \n",
      "declare that they have no known competing financial interests or personal \n",
      "relationships that could have appeared to influence the work reported in this \n",
      "paper.\n",
      "Concluído.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'1. Mult Scler Relat Disord. 2023 Dec 14;82:105373. doi: \\n10.1016/j.msard.2023.105373. Online ahead of print.\\n\\nGene expression in multiple sclerosis during pregnancy based on integrated \\nbioinformatics analysis.\\n\\nHernández-Preciado MR(1), Torres-Mendoza BM(2), Mireles-Ramírez MA(3), \\nKobayashi-Gutiérrez A(4), Sánchez-Rosales NA(3), Vázquez-Valls E(5), \\nMarquez-Pedroza J(6).\\n\\nAuthor information:\\n(1)High Specialty Medical Unit, Pediatric Hospital, Western National Medical \\nCenter of the Mexican Institute of Social Security, Guadalajara 44340, Mexico; \\nDepartment of Philosophical and Methodological Disciplines, University Health \\nSciences Center, University of Guadalajara, Guadalajara 44340, Mexico.\\n(2)Department of Philosophical and Methodological Disciplines, University Health \\nSciences Center, University of Guadalajara, Guadalajara 44340, Mexico; \\nNeurosciences Division, Western Biomedical Research Center (IMSS), Guadalajara \\n44340, Mexico.\\n(3)High Specialty Medical Unit, Western National Medical Center of the Mexican \\nInstitute of Social Security, Guadalajara 44340, Mexico.\\n(4)High Specialty Medical Unit, Western National Medical Center of the Mexican \\nInstitute of Social Security, Guadalajara 44340, Mexico; PhD in Psychology of \\nHealth, University Health Sciences Center, University of Guadalajara, \\nGuadalajara 44340, Mexico.\\n(5)Directorate of Generation of Professional Resources, Research, and \\nDevelopment, Secretary of Health, Guadalajara 44100, Mexico.\\n(6)Neurosciences Division, Western Biomedical Research Center (IMSS), \\nGuadalajara 44340, Mexico. Electronic address: jaz180688@gmail.com.\\n\\nBACKGROUND: The modulation of the activity disease in patients with Multiple \\nSclerosis (MS) that occurs during pregnancy is a helpful model which could \\nprovide insight into central disease mechanisms and facilitate treatment. \\nTherefore, the aim of the study was to identify differentially expressed genes \\nin-silico to perform biological function pathway enrichment analysis and \\nprotein-protein interaction from pregnant women with MS.\\nMETHODS: Transcriptome data were obtained from the Gene Expression Omnibus (GEO) \\ndatabase. We selected the microarray dataset GSE17449. The gene expression \\ndataset contains the data of mononuclear cells from four different groups \\nsought, including seven healthy women (H), four healthy pregnant women (HP), \\neight women with multiple sclerosis (WMS), and nine women nine months pregnant \\nwith multiple sclerosis (PMS). The GSEA software was employed for enrichment \\nanalysis, and the REACTOME database was used for biological pathways. The \\nprotein-protein interaction (PPI) network was plotted with STRING. The databases \\nused to identify the connection of DEGs with different signaling pathways were \\nKEGG and WIKIPATHWAYS.\\nRESULTS: We identified 42 differentially expressed genes in pregnant women with \\nMS. The significant pathways included IL-10 signaling pathway, ErbB2 activates, \\nthe hemoglobin complex (HBD, HBB, HBA1, AHSP, and HBA2), IL-17 signaling pathway \\n(LCN2 and MMP9), antigen processing and presentation, and Th17 cell \\ndifferentiation (HLA-DQA1), Rap1 signaling pathway (ID1), NOD-Like receptor \\nsignaling pathway (CAMP and DEFA4), PD-L1 Signaling, Interferon gamma signaling \\n(MMP9 and ARG1), Neutrophil degranulation (CAMP, DEFA4, ELANE, CEACAM8, S100P, \\nCHI3L1, AZU1, OLFM4, CRISP3, LTF, ARG1, PGLYRP1, and TCN1). In the WIKIPATHWAYS \\nset, significance was found Vitamin B12 metabolism (TCN1, HBB, and HBA2), and \\nIL-18 signaling pathway (S100P).\\nCONCLUSION: This study can be used to understand several essential target genes \\nand pathways identified in the present study, which may serve as feasible \\ntargets for MS therapies.\\n\\nCopyright © 2023 Elsevier B.V. All rights reserved.\\n\\nDOI: 10.1016/j.msard.2023.105373\\nPMID: 38154347\\n\\nConflict of interest statement: Declaration of Competing Interest The authors \\ndeclare that they have no known competing financial interests or personal \\nrelationships that could have appeared to influence the work reported in this \\npaper.'"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pesquisa_ncbi(email,termo,retmax=1)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Podemos observar que, dos 2009 resultados obtidos, apenas 1 foi processado.\n",
    "\n",
    "Para além da alteração da quantidade de resultados processados é igualmente possível realizar as seguintes manipulações da função:\n",
    "\n",
    "-  **Manipular o display do output**\n",
    "\n",
    "-  **Manipulação da gravação do ficheiro**\n",
    "\n",
    "A manipulação do display do output é alcançada através da alteração do parâmetro \"display\" e o modo de gravação dos resultados processados é feita através da alteração do parâmetro \"save\"."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Encontrados 2009 resultados em pubmed. Irão ser processados 10 resultados.\n",
      "\n",
      "Ficheiro gravado.\n",
      "Concluído.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "\"1. Mult Scler Relat Disord. 2023 Dec 14;82:105373. doi: \\n10.1016/j.msard.2023.105373. Online ahead of print.\\n\\nGene expression in multiple sclerosis during pregnancy based on integrated \\nbioinformatics analysis.\\n\\nHernández-Preciado MR(1), Torres-Mendoza BM(2), Mireles-Ramírez MA(3), \\nKobayashi-Gutiérrez A(4), Sánchez-Rosales NA(3), Vázquez-Valls E(5), \\nMarquez-Pedroza J(6).\\n\\nAuthor information:\\n(1)High Specialty Medical Unit, Pediatric Hospital, Western National Medical \\nCenter of the Mexican Institute of Social Security, Guadalajara 44340, Mexico; \\nDepartment of Philosophical and Methodological Disciplines, University Health \\nSciences Center, University of Guadalajara, Guadalajara 44340, Mexico.\\n(2)Department of Philosophical and Methodological Disciplines, University Health \\nSciences Center, University of Guadalajara, Guadalajara 44340, Mexico; \\nNeurosciences Division, Western Biomedical Research Center (IMSS), Guadalajara \\n44340, Mexico.\\n(3)High Specialty Medical Unit, Western National Medical Center of the Mexican \\nInstitute of Social Security, Guadalajara 44340, Mexico.\\n(4)High Specialty Medical Unit, Western National Medical Center of the Mexican \\nInstitute of Social Security, Guadalajara 44340, Mexico; PhD in Psychology of \\nHealth, University Health Sciences Center, University of Guadalajara, \\nGuadalajara 44340, Mexico.\\n(5)Directorate of Generation of Professional Resources, Research, and \\nDevelopment, Secretary of Health, Guadalajara 44100, Mexico.\\n(6)Neurosciences Division, Western Biomedical Research Center (IMSS), \\nGuadalajara 44340, Mexico. Electronic address: jaz180688@gmail.com.\\n\\nBACKGROUND: The modulation of the activity disease in patients with Multiple \\nSclerosis (MS) that occurs during pregnancy is a helpful model which could \\nprovide insight into central disease mechanisms and facilitate treatment. \\nTherefore, the aim of the study was to identify differentially expressed genes \\nin-silico to perform biological function pathway enrichment analysis and \\nprotein-protein interaction from pregnant women with MS.\\nMETHODS: Transcriptome data were obtained from the Gene Expression Omnibus (GEO) \\ndatabase. We selected the microarray dataset GSE17449. The gene expression \\ndataset contains the data of mononuclear cells from four different groups \\nsought, including seven healthy women (H), four healthy pregnant women (HP), \\neight women with multiple sclerosis (WMS), and nine women nine months pregnant \\nwith multiple sclerosis (PMS). The GSEA software was employed for enrichment \\nanalysis, and the REACTOME database was used for biological pathways. The \\nprotein-protein interaction (PPI) network was plotted with STRING. The databases \\nused to identify the connection of DEGs with different signaling pathways were \\nKEGG and WIKIPATHWAYS.\\nRESULTS: We identified 42 differentially expressed genes in pregnant women with \\nMS. The significant pathways included IL-10 signaling pathway, ErbB2 activates, \\nthe hemoglobin complex (HBD, HBB, HBA1, AHSP, and HBA2), IL-17 signaling pathway \\n(LCN2 and MMP9), antigen processing and presentation, and Th17 cell \\ndifferentiation (HLA-DQA1), Rap1 signaling pathway (ID1), NOD-Like receptor \\nsignaling pathway (CAMP and DEFA4), PD-L1 Signaling, Interferon gamma signaling \\n(MMP9 and ARG1), Neutrophil degranulation (CAMP, DEFA4, ELANE, CEACAM8, S100P, \\nCHI3L1, AZU1, OLFM4, CRISP3, LTF, ARG1, PGLYRP1, and TCN1). In the WIKIPATHWAYS \\nset, significance was found Vitamin B12 metabolism (TCN1, HBB, and HBA2), and \\nIL-18 signaling pathway (S100P).\\nCONCLUSION: This study can be used to understand several essential target genes \\nand pathways identified in the present study, which may serve as feasible \\ntargets for MS therapies.\\n\\nCopyright © 2023 Elsevier B.V. All rights reserved.\\n\\nDOI: 10.1016/j.msard.2023.105373\\nPMID: 38154347\\n\\nConflict of interest statement: Declaration of Competing Interest The authors \\ndeclare that they have no known competing financial interests or personal \\nrelationships that could have appeared to influence the work reported in this \\npaper.\\n\\n\\n2. Biomedicines. 2023 Dec 11;11(12):3273. doi: 10.3390/biomedicines11123273.\\n\\nGenetic Susceptibility of HLA Alleles to Non-Steroidal Anti-Inflammatory Drug \\nHypersensitivity in the Taiwanese Population.\\n\\nChang SL(1)(2)(3)(4), Lai CH(2)(4)(5), Lin GC(6), Chen YM(2)(4)(6)(7)(8), Lee \\nMH(9), Hsu HS(3)(10), Chen IC(6).\\n\\nAuthor information:\\n(1)Department of Anesthesiology, Taichung Veterans General Hospital, Taichung \\n407219, Taiwan.\\n(2)Department of Postbaccalaureate Medicine, College of Medicine, National Chung \\nHsing University, Taichung 402202, Taiwan.\\n(3)Institute of Emergency and Critical Care Medicine, School of Medicine, \\nNational Yang Ming Chiao Tung University, Taipei 112304, Taiwan.\\n(4)School of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, \\nTaiwan.\\n(5)Department of Medicine and Cardiovascular Center, Taichung Veterans General \\nHospital, Taichung 407219, Taiwan.\\n(6)Department of Medical Research, Taichung Veterans General Hospital, Taichung \\n407219, Taiwan.\\n(7)Division of Allergy, Immunology and Rheumatology, Department of Medical \\nResearch, Taichung Veterans General Hospital, Taichung 407219, Taiwan.\\n(8)Institute of Biomedical Science and Rong Hsing Research Center for \\nTranslational Medicine, National Chung Hsing University, Taichung 402202, \\nTaiwan.\\n(9)Institute of Clinical Medicine, National Yang Ming Chiao Tung University, \\nTaipei 112304, Taiwan.\\n(10)Division of Thoracic Surgery, Department of Surgery, Taipei Veterans General \\nHospital, Taipei 112201, Taiwan.\\n\\nBACKGROUND: Human leukocyte antigen (HLA) genes are important in many immune \\nprocesses and contribute to many adverse drug reactions. Whether genetic \\nvariations in the HLA region are associated with non-steroid anti-inflammatory \\ndrug (NSAID) hypersensitivity remains uncertain. Therefore, the aim of our study \\nwas to identify HLA genetic variations in patients with NSAID hypersensitivity \\nin the Taiwanese population.\\nMETHODS: This hospital-based, retrospective case-control study enrolled 37,156 \\nparticipants with NSAID exposure from the Taiwan Precision Medicine Initiative \\n(TPMI), who were all genotyped and imputed to fine map HLA typing. Our study \\nassigned 1217 cases to the NSAID allergy group and 12,170 controls to a matched \\ngroup. Logistic regression analyses were utilized to explore associations \\nbetween HLA alleles and NSAID hypersensitivity.\\nRESULTS: Overall, 13,387 patients were genotyped for eight major HLA alleles. \\nAllele frequencies were different between the two groups. In the NSAID allergy \\ngroup, the genotype frequencies of HLA-A*02:01, HLA-A*34:01, and HLA-DQA1*06:01 \\nwere found to be markedly elevated compared to the control group, a significance \\nthat persisted even after applying the Bonferroni correction. Furthermore, the \\nrisk of NSAID allergy demonstrated a significant association with HLA-A*02:01 \\n(OR = 1.29, p < 0.001) and HLA-A*34:01 (OR = 9.90, p = 0.001), in comparison to \\ntheir respective counterparts. Notably, the genotype frequency of HLA-B*46:01 \\nexhibited a significant increase in the severe allergy group when compared with \\nthe mild allergy group.\\nCONCLUSIONS: We identified HLA genotypes linked to the onset and severity of \\nNSAID hypersensitivity. Our findings establish a basis for precision \\nprescription in future clinical applications.\\n\\nDOI: 10.3390/biomedicines11123273\\nPMCID: PMC10741656\\nPMID: 38137494\\n\\nConflict of interest statement: The authors declare that the research was \\nconducted in the absence of any commercial or financial relationship that could \\nbe construed as a potential conflict of interest. The authors have no relevant \\nfinancial or non-financial interests to disclose. The funders had no role in the \\ndesign of the study; in the collection, analyses, or interpretation of data; in \\nthe writing of the manuscript; or in the decision to publish the results.\\n\\n\\n3. JCI Insight. 2023 Dec 8;8(23):e171417. doi: 10.1172/jci.insight.171417.\\n\\nSingle-cell transcriptomics reveals variations in monocytes and Tregs between \\ngout flare and remission.\\n\\nYu H(1), Xue W(1), Yu H(1), Song Y(1), Liu X(1), Qin L(1), Wang S(1), Bao H(1), \\nGu H(1), Chen G(1), Zhao D(1), Tu Y(1), Cheng J(1), Wang L(1), Ai Z(2), Hu D(1), \\nWang L(1), Peng A(1).\\n\\nAuthor information:\\n(1)Center for Nephrology and Clinical Metabolomics and Division of Nephrology, \\nShanghai Tenth People's Hospital, and.\\n(2)Department of Medical Statistics, Tongji University School of Medicine, \\nShanghai, China.\\n\\nGout commonly manifests as a painful, self-limiting inflammatory arthritis. \\nNevertheless, the understanding of the inflammatory and immune responses \\nunderlying gout flares and remission remains ambiguous. Here, based on \\nsingle-cell RNA-Seq and an independent validation cohort, we identified the \\npotential mechanism of gout flare, which likely involves the upregulation of \\nHLA-DQA1+ nonclassical monocytes and is related to antigen processing and \\npresentation. Furthermore, Tregs also play an essential role in the suppressive \\ncapacity during gout remission. Cell communication analysis suggested the \\nexistence of altered crosstalk between monocytes and other T cell types, such as \\nTregs. Moreover, we observed the systemic upregulation of inflammatory and \\ncytokine genes, primarily in classical monocytes, during gout flares. All \\nmonocyte subtypes showed increased arachidonic acid metabolic activity along \\nwith upregulation of prostaglandin-endoperoxide synthase 2 (PTGS2). We also \\ndetected a decrease in blood arachidonic acid and an increase in leukotriene B4 \\nlevels during gout flares. In summary, our study illustrates the distinctive \\nimmune cell responses and systemic inflammation patterns that characterize the \\ntransition from gout flares to remission, and it suggests that blood monocyte \\nsubtypes and Tregs are potential intervention targets for preventing recurrent \\ngout attacks and progression.\\n\\nDOI: 10.1172/jci.insight.171417\\nPMID: 38063198 [Indexed for MEDLINE]\\n\\n\\n4. Arthritis Rheumatol. 2023 Dec 7. doi: 10.1002/art.42768. Online ahead of\\nprint.\\n\\nClinical features and immunogenetic risk factors associated with additional \\nautoantibodies in anti-transcriptional intermediary factor 1γ juvenile-onset \\ndermatomyositis.\\n\\nSherman MA(1), Yang Q(2), Gutierrez-Alamillo L(2), Pak K(1), Flegel WA(3), \\nMammen AL(1)(4)(5), Rider LG(#)(6), Casciola-Rosen LA(#)(2); Childhood Myositis \\nHeterogeneity Collaborative Study Group.\\n\\nCollaborators: Arabshahi B, Ballinger S, Bingham CA, Bohnsack JF, Carrasco R, \\nEberhardt BA, Edelheit BS, Farhadi PN, Finkel TH, Fuhlbrigge RC, Goldmuntz EA, \\nGottlieb BS, Griffin TA, Guirola R, Hannan W, Henrickson M, Hong S, Jones OY, \\nKingsbury DJ, Kishi T, Lindsley CB, Mamyrova G, McCarthy PL, Miller FW, Nativ S, \\nOral EA, Pachman LM, de la Pena W, Perez MD, Person DA, Pinal-Fernandez I, \\nSabbagh SE, Sarkar K, Schiffenbauer A, Schlefman A, Shaham B, Soep J, Sule S, \\nTargoff IN, Vogelgesang SA, Volochayev R, Wahezi D.\\n\\nAuthor information:\\n(1)Muscle Disease Unit, National Institute of Arthritis and Musculoskeletal and \\nSkin Diseases, National Institutes of Health, Bethesda, Maryland, USA.\\n(2)Division of Rheumatology, Johns Hopkins University School of Medicine, \\nBaltimore, Maryland, USA.\\n(3)Department of Transfusion Medicine, NIH Clinical Center, National Institutes \\nof Health, Bethesda, Maryland, USA.\\n(4)Department of Neurology, Johns Hopkins University School of Medicine, \\nBaltimore, Maryland, USA.\\n(5)Department of Medicine, Johns Hopkins University School of Medicine, \\nBaltimore, Maryland, USA.\\n(6)Environmental Autoimmunity Group, Clinical Research Branch, National \\nInstitute of Environmental Health Sciences, National Institutes of Health, \\nBethesda, Maryland, USA.\\n(#)Contributed equally\\n\\nOBJECTIVE: Novel autoantibody specificities including anti-CCAR1 were recently \\ndiscovered in adult patients with anti-TIF1γ-positive dermatomyositis (DM) and \\nwere associated with attenuated cancer emergence. The aims of the present study \\nwere to examine whether these autoantibodies occur in patients with \\njuvenile-onset dermatomyositis (JDM) and to determine their associated features.\\nMETHODS: Sera from 150 patients with anti-TIF1γ autoantibody-positive JDM in a \\ncross-sectional cohort and 90 juvenile healthy controls were assayed for \\nanti-CCAR1, anti-C1Z1, anti-IMMT, anti-TBL1XR1, and anti-Sp4 autoantibodies. \\nDemographics, myositis autoantibodies, clinical features, medications, outcomes, \\nand HLA-DRB1 and HLA-DQA1 alleles were compared between those with and without \\nthese autoantibodies.\\nRESULTS: Any one of the anti-TIF1γ-associated autoantibodies was present in 44 \\n(29%) patients overall, including 25 (17%) with anti-Sp4, 22 (15%) with \\nanti-TBL1XR1, 14 (9%) with anti-CCAR1, 2 (1%) with anti-C1Z1, and 2 (1%) with \\nanti-IMMT autoantibodies. These anti-TIF1γ-associated autoantibodies frequently \\nco-occurred. Patients with any of the anti-TIF1γ-associated autoantibodies had \\nless frequent falling (34% [15] vs 53% [56], p=0.032) and lower peak muscle \\nenzymes. None of the patients had cancer. Among White patients, HLA-DRB1*03 was \\nprotective against an anti-TIF1γ-associated autoantibody (OR 0.20, 95% CI \\n0.07-0.52).\\nCONCLUSION: Autoantibodies associated with anti-TIF1γ were found in isolation \\nand in combination among a subset of patients with JDM. Patients with these \\nautoantibodies had less severe muscle disease and were not enriched for \\nHLA-DRB1*03. Additional autoantibodies among anti-TIF1γ-positive patients with \\nJDM likely contribute to the heterogeneity of the anti-TIF1γ serologic subgroup. \\nThis article is protected by copyright. All rights reserved.\\n\\nThis article is protected by copyright. All rights reserved.\\n\\nDOI: 10.1002/art.42768\\nPMID: 38059274\\n\\n\\n5. Nat Genet. 2023 Dec;55(12):2255-2268. doi: 10.1038/s41588-023-01586-6. Epub\\n2023  Nov 30.\\n\\nMapping the dynamic genetic regulatory architecture of HLA genes at single-cell \\nresolution.\\n\\nKang JB(1)(2)(3)(4)(5), Shen AZ(1)(2)(3)(4)(5), Gurajala S(1)(2)(3)(4)(5), \\nNathan A(1)(2)(3)(4)(5), Rumker L(1)(2)(3)(4)(5), Aguiar VRC(4)(6), Valencia \\nC(1)(2)(3)(4)(5), Lagattuta KA(1)(2)(3)(4)(5), Zhang F(1)(2)(3)(4)(5)(7), \\nJonsson AH(5), Yazar S(8), Alquicira-Hernandez J(8), Khalili H(9), \\nAnanthakrishnan AN(9), Jagadeesh K(10), Dey K(10)(11)(12); Accelerating \\nMedicines Partnership Program: Rheumatoid Arthritis and Systemic Lupus \\nErythematosus (AMP RA/SLE) Network; Daly MJ(13)(14)(15)(16), Xavier \\nRJ(17)(18)(19), Donlin LT(20)(21), Anolik JH(22), Powell JE(8), Rao DA(5), \\nBrenner MB(5), Gutierrez-Arcelus M(4)(6), Luo Y(1)(2)(3)(4)(5)(23), Sakaue \\nS(1)(2)(3)(4)(5), Raychaudhuri S(24)(25)(26)(27)(28).\\n\\nCollaborators: Albrecht J, Apruzzese W, Banda N, Barnas JL, Bathon JM, Ben-Artzi \\nA, Boyce BF, Boyle DL, Bridges SL Jr, Bykerk VP, Campbell D, Carr HL, Ceponis A, \\nChicoine A, Cordle A, Curtis M, Deane KD, DiCarlo E, Dunn P, Filer A, Firestein \\nGS, Forbess L, Geraldino-Pardilla L, Goodman SM, Gravallese EM, Gregersen PK, \\nGuthridge JM, Holers VM, Horowitz D, Hughes LB, Ishigaki K, Ivashkiv LB, James \\nJA, Keras G, Korsunsky I, Lakhanpal A, Lederer JA, Lewis M, Li ZJ, Li Y, Liao \\nKP, Mandelin AM 2nd, Mantel I, Marks KE, Maybury M, McDavid A, McGeachy MJ, \\nMears J, Meednu N, Millard N, Moreland LW, Nayar S, Nerviani A, Orange DE, \\nPerlman H, Pitzalis C, Rangel-Moreno J, Raza K, Reshef Y, Ritchlin C, Rivellese \\nF, Robinson WH, Sahbudin I, Singaraju A, Seifert JA, Slowikowski K, Smith MH, \\nTabechian D, Scheel-Toellner D, Utz PJ, Watts GFM, Wei K, Weinand K, Weisenfeld \\nD, Weisman MH, Wyse A, Xiao Q, Zhu Z.\\n\\nAuthor information:\\n(1)Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA.\\n(2)Division of Genetics, Department of Medicine, Brigham and Women's Hospital \\nand Harvard Medical School, Boston, MA, USA.\\n(3)Department of Biomedical Informatics, Harvard Medical School, Boston, MA, \\nUSA.\\n(4)Program in Medical and Population Genetics, Broad Institute of MIT and \\nHarvard, Cambridge, MA, USA.\\n(5)Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, \\nBrigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.\\n(6)Division of Immunology, Boston Children's Hospital, Harvard Medical School, \\nBoston, MA, USA.\\n(7)Division of Rheumatology and the Center for Health Artificial Intelligence, \\nUniversity of Colorado School of Medicine, Aurora, CO, USA.\\n(8)Garvan Institute of Medical Research, Sydney, New South Wales, Australia.\\n(9)Division of Gastroenterology, Massachusetts General Hospital and Harvard \\nMedical School, Boston, MA, USA.\\n(10)Harvard T. H. Chan School of Public Health, Boston, MA, USA.\\n(11)Computational and Systems Biology Program, Sloan Kettering Institute, \\nMemorial Sloan Kettering Cancer Center, New York, NY, USA.\\n(12)Physiology, Biophysics and Systems Biology Program, Weill Cornell Medicine, \\nNew York, NY, USA.\\n(13)Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General \\nHospital, Boston, MA, USA.\\n(14)The Stanley Center for Psychiatric Research, The Broad Institute of MIT and \\nHarvard, Cambridge, MA, USA.\\n(15)Institute for Molecular Medicine Finland (FIMM), University of Helsinki, \\nHelsinki, Finland.\\n(16)Analytic and Translational Genetics Unit, Department of Medicine, \\nMassachusetts General Hospital, Boston, MA, USA.\\n(17)Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA, \\nUSA.\\n(18)Center for Computational and Integrative Biology, Massachusetts General \\nHospital and Harvard Medical School, Boston, MA, USA.\\n(19)Department of Molecular Biology, Massachusetts General Hospital and Harvard \\nMedical School, Boston, MA, USA.\\n(20)Hospital for Special Surgery, New York, NY, USA.\\n(21)Weill Cornell Medicine, New York, NY, USA.\\n(22)Department of Medicine, University of Rochester Medical Center, Rochester, \\nNY, USA.\\n(23)Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.\\n(24)Center for Data Sciences, Brigham and Women's Hospital, Boston, MA, USA. \\nsoumya@broadinstitute.org.\\n(25)Division of Genetics, Department of Medicine, Brigham and Women's Hospital \\nand Harvard Medical School, Boston, MA, USA. soumya@broadinstitute.org.\\n(26)Department of Biomedical Informatics, Harvard Medical School, Boston, MA, \\nUSA. soumya@broadinstitute.org.\\n(27)Program in Medical and Population Genetics, Broad Institute of MIT and \\nHarvard, Cambridge, MA, USA. soumya@broadinstitute.org.\\n(28)Division of Rheumatology, Inflammation, and Immunity, Department of \\nMedicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, \\nUSA. soumya@broadinstitute.org.\\n\\nUpdate of\\n    medRxiv. 2023 Mar 20;:\\n\\nThe human leukocyte antigen (HLA) locus plays a critical role in complex traits \\nspanning autoimmune and infectious diseases, transplantation and cancer. While \\ncoding variation in HLA genes has been extensively documented, regulatory \\ngenetic variation modulating HLA expression levels has not been comprehensively \\ninvestigated. Here we mapped expression quantitative trait loci (eQTLs) for \\nclassical HLA genes across 1,073 individuals and 1,131,414 single cells from \\nthree tissues. To mitigate technical confounding, we developed scHLApers, a \\npipeline to accurately quantify single-cell HLA expression using personalized \\nreference genomes. We identified cell-type-specific cis-eQTLs for every \\nclassical HLA gene. Modeling eQTLs at single-cell resolution revealed that many \\neQTL effects are dynamic across cell states even within a cell type. HLA-DQ \\ngenes exhibit particularly cell-state-dependent effects within myeloid, B and T \\ncells. For example, a T cell HLA-DQA1 eQTL ( rs3104371 ) is strongest in \\ncytotoxic cells. Dynamic HLA regulation may underlie important interindividual \\nvariability in immune responses.\\n\\n© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.\\n\\nDOI: 10.1038/s41588-023-01586-6\\nPMID: 38036787 [Indexed for MEDLINE]\\n\\n\\n6. Inflamm Bowel Dis. 2023 Nov 29:izad273. doi: 10.1093/ibd/izad273. Online ahead\\n of print.\\n\\nHLA-DQA1*05 Not Associated With Ustekinumab Loss of Response and Antidrug \\nAntibodies in Ulcerative Colitis and Crohn's Disease Patients.\\n\\nColombel JF(1), Martín-Arranz MD(2), Brinkman B(3), Guan M(4), Hart A(4), Gasink \\nC(5).\\n\\nAuthor information:\\n(1)Icahn School of Medicine at Mt Sinai, New York, NY, USA.\\n(2)Gastroenterology Department, Hospital Universitario de La Paz, Institute for \\nHealth Research La Paz, Universidad Autónoma de Madrid, Madrid, Spain.\\n(3)Janssen Pharmaceutica, Beerse, Belgium.\\n(4)Janssen Research & Development, LLC, Spring House, PA, USA.\\n(5)Janssen Scientific Affairs, LLC, Horsham, PA, USA.\\n\\nPlain Language Summary: It is unknown if inflammatory bowel disease patients \\ncarrying the HLA-DQA1*05 allele have a greater risk of immunogenicity to \\nustekinumab. We observed that ustekinumab-treated patients carrying the allele \\ndid not have increased immunogenicity or reduced efficacy/serum ustekinumab \\nconcentrations vs noncarriers.\\n\\nDOI: 10.1093/ibd/izad273\\nPMID: 38029420\\n\\n\\n7. Sci Rep. 2023 Nov 27;13(1):20820. doi: 10.1038/s41598-023-47632-5.\\n\\nA web-based genome-wide association study reveals the susceptibility loci of \\ncommon adverse events following COVID-19 vaccination in the Japanese population.\\n\\nNogawa S(1), Kanamori H(2)(3), Tokuda K(2)(3), Kawafune K(1), Chijiiwa M(1), \\nSaito K(1), Takahashi S(4).\\n\\nAuthor information:\\n(1)Genequest Inc., Siba 5-29-11, Minato-ku, Tokyo, 108-0014, Japan.\\n(2)Department of Infectious Diseases, Internal Medicine, Tohoku University \\nGraduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.\\n(3)Division of Infection Control, Tohoku University Hospital, 1-1 Seiryo-machi, \\nAoba-ku, Sendai, 980-8574, Japan.\\n(4)Genequest Inc., Siba 5-29-11, Minato-ku, Tokyo, 108-0014, Japan. \\ntakahashi@genequest.jp.\\n\\nThe coronavirus disease 2019 (COVID-19) pandemic has spread rapidly worldwide. \\nTo prevent its spread, mRNA-based vaccines made by Pfizer/BioNTech (BNT162b1) \\nand Moderna (mRNA-1273) have been widely used, including in Japan. Various \\nadverse events have been reported following the COVID-19 mRNA vaccination, with \\ndifferences observed among individuals. However, analyses of the genetic \\nbackground associated with the susceptibility to side effects have been limited. \\nIn the present study, we performed genome-wide association studies (GWAS) for \\nself-reported adverse events of the COVID-19 mRNA vaccination in 4545 Japanese \\nindividuals and identified 14 associated loci. Among these, 6p21 was associated \\nwith 37.5\\xa0°C or higher fever, 38\\xa0°C or higher fever, and muscle pain. HLA allele \\nassociation analysis revealed that various HLA alleles were associated with the \\nadverse effects; HLA-DQA1*03:01 and HLA-A*11:01 were more reliably associated \\nwith the adverse effects. Our results may enable the preparation and management \\nof adverse effects by identifying the susceptibility to these adverse events. \\nFurthermore, we obtained valuable data that may lead to a better understanding \\nof the mechanisms of action of the COVID-19 mRNA vaccines.\\n\\n© 2023. The Author(s).\\n\\nDOI: 10.1038/s41598-023-47632-5\\nPMCID: PMC10682012\\nPMID: 38012279 [Indexed for MEDLINE]\\n\\nConflict of interest statement: S.N., K.K., and M.C. are employees of Genequest \\nInc.; K.S. and S.T. are board members of Genequest Inc.; H.K. and K.T. declare \\nno competing interests.\\n\\n\\n8. BMC Cancer. 2023 Nov 24;23(1):1141. doi: 10.1186/s12885-023-11579-7.\\n\\nMolecular subtyping based on immune cell marker genes predicts prognosis and \\ntherapeutic response in patients with lung adenocarcinoma.\\n\\nLiu ZT(#)(1), Shen JT(#)(1), Lei YJ(#)(1), Huang YC(1), Zhao GQ(1), Zheng CH(2), \\nWang X(1), Wang YT(1), Chen L(3), Li ZX(1), Li SZ(1), Liao J(1), Yu TD(4).\\n\\nAuthor information:\\n(1)Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming \\nMedical University, Kunming, China.\\n(2)Department of Ultrasound, The Third Affiliated Hospital of Kunming Medical \\nUniversity, Yunnan Cancer Hospital, Kunming, China.\\n(3)Department of PET/CT Center, Cancer Center of Yunnan Province, The Third \\nAffiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, \\nKunming, China.\\n(4)Department of Thoracic Surgery, The Third Affiliated Hospital of Kunming \\nMedical University, Kunming, China. yutingdong@outlook.com.\\n(#)Contributed equally\\n\\nOBJECTIVE: Lung adenocarcinoma (LA) is one of the most common malignancies and \\nis responsible for the greatest number of tumor-related deaths. Our research \\naimed to explore the molecular subtype signatures of LA to clarify the \\ncorrelation among the immune microenvironment, clinical outcomes, and \\ntherapeutic response.\\nMETHODS: The LA immune cell marker genes (LICMGs) identified by single-cell RNA \\nsequencing (scRNA-seq) analysis were used to discriminate the molecular subtypes \\nand homologous immune and metabolic traits of GSE72094 LA cases. In addition, \\nthe model-building genes were identified from 1441 LICMGs by Cox-regression \\nanalysis, and a LA immune difference score (LIDscore) was developed to quantify \\nindividual differences in each patient, thereby predicting prognosis and \\nsusceptibility to immunotherapy and chemotherapy of LA patients.\\nRESULTS: Patients of the GSE72094 cohort were divided into two distinct \\nmolecular subtypes based on LICMGs: immune activating subtype (Cluster-C1) and \\nmetabolically activating subtype (cluster-C2). The two molecular subtypes have \\ndistinct characteristics regarding prognosis, clinicopathology, genomics, immune \\nmicroenvironment, and response to immunotherapy. Among the LICMGs, LGR4, GOLM1, \\nCYP24A1, SFTPB, COL1A1, HLA-DQA1, MS4A7, PPARG, and IL7R were enrolled to \\nconstruct a LIDscore model. Low-LIDscore patients had a higher survival rate due \\nto abundant immune cell infiltration, activated immunity, and lower genetic \\nvariation, but probably the higher levels of Treg cells in the immune \\nmicroenvironment lead to immune cell dysfunction and promote tumor immune \\nescape, thus decreasing the responsiveness to immunotherapy compared with that \\nof the high-LIDscore patients. Overall, high-LIDscore patients had a higher \\nresponsiveness to immunotherapy and a higher sensitivity to chemotherapy than \\nthe low-LIDscore group.\\nCONCLUSIONS: Molecular subtypes based on LICMGs provided a promising strategy \\nfor predicting patient prognosis, biological characteristics, and immune \\nmicroenvironment features. In addition, they helped identify the patients most \\nlikely to benefit from immunotherapy and chemotherapy.\\n\\n© 2023. The Author(s).\\n\\nDOI: 10.1186/s12885-023-11579-7\\nPMCID: PMC10668343\\nPMID: 38001428 [Indexed for MEDLINE]\\n\\nConflict of interest statement: The authors declare that they have no competing \\ninterests.\\n\\n\\n9. Immunogenetics. 2023 Nov 18. doi: 10.1007/s00251-023-01325-5. Online ahead of \\nprint.\\n\\nInvestigating associations between HLA DQA1\\u2009~\\u2009DQB1 haplotypes, H. pylori \\ninfection, metaplasia, and anti-CagA IgA seropositivity in a Turkish gastritis \\ncohort.\\n\\nColakogullari M(1), Karatas L(2), Tatar Z(2).\\n\\nAuthor information:\\n(1)Izmir Democracy University, Izmir, Turkey. \\nmukaddes.colakogullari@yahoo.co.uk.\\n(2)Izmir Democracy University, Izmir, Turkey.\\n\\nHelicobacter pylori was reported as an important cause of gastritis, and gastric \\nulcers and CagA oncoprotein-producing H. pylori subgroups were blamed to \\nincrease the severity of gastritis. Disparities were reported in that the \\npresence of serum anti-CagA IgA was not parallel with CagA-positive H. pylori \\ncohabitation. We hypothesized that the HLA-DQA1\\u2009~\\u2009DQB1 haplotypes in human \\npopulations include protective haplotypes that more effectively present \\nimmunogenic CagA peptides and susceptible haplotypes with an impaired capacity \\nto present CagA peptides. We recruited patients (n\\u2009=\\u2009201) admitted for \\ngastroendoscopy procedures and performed high-resolution HLA-DQA1 and DQB1 \\ntyping. Serum anti-CagA IgA levels were analyzed by ELISA (23.0% positive), and \\nH. pylori was classified as positive or negative in gastric mucosal tissue \\nslides (72.6% positive). The HLA DQA1*05:05 allele (29.1%) and HLA DQB1*03:01 \\nallele (32.8%) were found at the highest frequency among gastritis patients of \\nTurkish descent. In HLA DQA1*05:05\\u2009~\\u2009DQB1*03:01 double homozygous (7.3%) and \\nheterozygous (40.7%) haplotype carriers, the presence of anti-CagA IgA decreased \\ndramatically, the presence of H. pylori increased, and the presence of \\nmetaplasia followed a decreasing trend. The DQ protein encoded by HLA \\nDQA1*05:05-DQ*03:01 showed a low binding affinity to the CagA peptide when \\nbinding capacity was analyzed by the NetMHCIIPan 4.0 prediction method. In \\nconclusion, HLA DQA1\\u2009~\\u2009DQB1 polymorphisms are crucial as host defense mechanisms \\nagainst CagA H. pylori since antigen binding capacity plays a crucial role in \\nanti-CagA IgA production.\\n\\n© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, \\npart of Springer Nature.\\n\\nDOI: 10.1007/s00251-023-01325-5\\nPMID: 37979046\\n\\n\\n10. HLA. 2023 Nov 16. doi: 10.1111/tan.15291. Online ahead of print.\\n\\nIdentification of the novel HLA-DQA1*01:138 allele by next-generation \\nsequencing.\\n\\nLee JK(1), Bae GE(1), Lee S(1), Park JW(1), Kang ES(1).\\n\\nAuthor information:\\n(1)Department of Laboratory Medicine and Genetics, Samsung Medical Center, \\nSungkyunkwan University School of Medicine, Seoul, South Korea.\\n\\nHLA-DQA1*01:138 is identical to HLA-DQA1*01:03 except for a single nucleotide \\nsubstitution in exon 3.\\n\\n© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.\\n\\nDOI: 10.1111/tan.15291\\nPMID: 37971080\""
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Pesquisa com output, sem display e permitindo a gravação dos resultados processados\n",
    "pesquisa_ncbi(email,termo,save='y',display='n')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Como podemos observar pelo resultado apresentado, não ocorreu o display dos resultados e o ficheiro foi gravado.\n",
    "\n",
    "Também é possível realizar a seguinte manipulação da função:\n",
    "\n",
    "- **Manipular bases de dados onde a pesquisa é efetuada**\n",
    "\n",
    "O parâmetro \"db\" pode ser alterado de forma a alterar a base de dados onde a pesquisa é realizada. No seguinte exemplo podemos observar que a base de dados selecionada para efeitos de pesquisa dos resultados foi a \"nuccore\"."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Encontrados 1743 resultados em nuccore. Irão ser processados 10 resultados.\n",
      "\n",
      "LOCUS       OR913133                5683 bp    DNA     linear   PRI 25-DEC-2023\n",
      "DEFINITION  Homo sapiens MHC class II antigen (HLA-DQA1) gene,\n",
      "            HLA-DQA1*01:03:03extended allele, complete cds.\n",
      "ACCESSION   OR913133\n",
      "VERSION     OR913133.1\n",
      "KEYWORDS    .\n",
      "SOURCE      Homo sapiens (human)\n",
      "  ORGANISM  Homo sapiens\n",
      "            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\n",
      "            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\n",
      "            Catarrhini; Hominidae; Homo.\n",
      "REFERENCE   1  (bases 1 to 5683)\n",
      "  AUTHORS   Kouprie,N. Sr. and Bungener,L.B.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (07-DEC-2023) Transplant Immunologie Laboratory,\n",
      "            University Medical Center Groningen, Postbus 30.001, Groningen 9700\n",
      "            RB, Netherlands\n",
      "COMMENT     ##Assembly-Data-START##\n",
      "            Assembly Method       :: NGSengine v. 2.31.0.30527\n",
      "            Sequencing Technology :: Illumina\n",
      "            ##Assembly-Data-END##\n",
      "FEATURES             Location/Qualifiers\n",
      "     source          1..5683\n",
      "                     /organism=\"Homo sapiens\"\n",
      "                     /mol_type=\"genomic DNA\"\n",
      "                     /db_xref=\"taxon:9606\"\n",
      "     gene            1..5683\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:03:03extended\"\n",
      "     mRNA            join(1..347,4125..4373,4787..5068,5425..5683)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:03:03extended\"\n",
      "                     /product=\"MHC class II antigen\"\n",
      "     exon            1..347\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:03:03extended\"\n",
      "                     /number=1\n",
      "     5'UTR           1..265\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:03:03extended\"\n",
      "     CDS             join(266..347,4125..4373,4787..5068,5425..5579)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:03:03extended\"\n",
      "                     /codon_start=1\n",
      "                     /product=\"MHC class II antigen\"\n",
      "                     /protein_id=\"WQK80776.1\"\n",
      "                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASCGVNLYQFYGP\n",
      "                     SGQFTHEFDGDEQFYVDLEKKETAWRWPEFSKFGGFDPQGALRNMAVAKHNLNIMIKR\n",
      "                     YNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGHAVTEGVSE\n",
      "                     TSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDQPLLKHWEPEIPAPMSELTET\n",
      "                     VVCALGLSVGLVGIVVGTVFIIQGLRSVGASRHQGPL\"\n",
      "     intron          348..4124\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:03:03extended\"\n",
      "                     /number=1\n",
      "     exon            4125..4373\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:03:03extended\"\n",
      "                     /number=2\n",
      "     intron          4374..4786\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:03:03extended\"\n",
      "                     /number=2\n",
      "     exon            4787..5068\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:03:03extended\"\n",
      "                     /number=3\n",
      "     intron          5069..5424\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:03:03extended\"\n",
      "                     /number=3\n",
      "     exon            5425..5683\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:03:03extended\"\n",
      "                     /number=4\n",
      "     3'UTR           5580..5683\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:03:03extended\"\n",
      "ORIGIN      \n",
      "        1 gtcctccctt tattcataga acaattcctc aagtccactc tgagtagagg ctgcatcaca\n",
      "       61 aggggattgc cccgtctcct tccagggctc ttaatacaaa ctcttcaact agtaactgag\n",
      "      121 atgtcaccat aggggatttt tctaattggc caaaacctga cttggcaggg tttggtttgg\n",
      "      181 gtgtcttcag atttccttgt cttgaggtcc tcacaattac tctacagctc agaacaccaa\n",
      "      241 ctgctgaggc tgccttggga agaggatgat cctaaacaaa gctctgctgc tgggggccct\n",
      "      301 cgctctgacc accgtgatga gcccctgtgg aggtgaagac attgtgggtg agtgcatgag\n",
      "      361 tgagggatgt tctctggagc tgaaaaacag taaattgaag gaaaagagat aaagcgattt\n",
      "      421 gcagagaaac tgtagagatt tcctaagggc cctttcagta ttaagacaat taaaaattat\n",
      "      481 agctgttcct ccttcaggaa accagagccc caacctactc tttttgttat ctatgctgtt\n",
      "      541 gtgttcacta aggacgctat tctgtttata ttatattcag tgactacagc ctggaggtct\n",
      "      601 ctatgtcgtt ccatcatgat tgcctcaaaa attagtgagg tttccatcag tggataattt\n",
      "      661 tttattatta aaaatttatg aagtgtcatt ctcaaatttc cctgaacaac ttttgaagct\n",
      "      721 tttcggatgt ctccggtggt agatcttggg gtcattccat caattatgta ctctatagat\n",
      "      781 atttaaaatg ttgcccgttt ctttctctca gacttactca catttccaca tgggaactgg\n",
      "      841 cacaggtggg gagtgggtaa aggagtccag caggctgaat gccttcaaca gtcattttac\n",
      "      901 cacatggtcc tcacttactc tcagctgcct catatgtgtc acctcacaag taatcaaata\n",
      "      961 aaatgggcat gtggctaagt tttgtaaata gtgaaaacat gaatgtcaat tttttttaca\n",
      "     1021 tatttctatt acagatatag cttcacattt cttttcttta gcaaaataag ggatcatttt\n",
      "     1081 attttaaaat tgagaagtag aaaaaattgg taaaataaat cattttattc tcaaattatc\n",
      "     1141 aacccaaatt acctgttctt cacctcatct aataaagtcc tataaaaaga aaagtgggcc\n",
      "     1201 agacaaggtg gctcatgcct gtaatcccag cactttggga ggccgaggca ggaggatcat\n",
      "     1261 ttgagcctgg gagcttgaga ccagcctggg caacatagca agacctcatc tctacaaaaa\n",
      "     1321 aagaaaaata aaaattagcc aggcatggtg gtgtgtgcct gtggtgccag ctactcagaa\n",
      "     1381 ggctgccgtg ggaggaccac ttgagtccat gaggcggaag ctgcagtgag ccatgatggc\n",
      "     1441 accactacac tccagccagg gcaacagaga gagactctgt ctcaaaaaga aagaggaaag\n",
      "     1501 aaagcaagga accaaggaag gaaggaagga aggagaagga aggaaggaaa agaaaagaaa\n",
      "     1561 agggaaggga ggaaggaagg aaaaaagaaa gacggaaaga aaaaggaagg aaggaagaaa\n",
      "     1621 ggaagcacag attaattatt tggtctctta ctctcctctg cctttgtcgt ccatctcttt\n",
      "     1681 ccacctctct tgatgcattc ctttctcccc cttccctttc aggatccacc tctggctccc\n",
      "     1741 tgctccttta tagatatgga cagtgggttt gtaaagcaaa agttgaaaag tcagatagtt\n",
      "     1801 aaaaggggaa gtgaactgga aggtactcta aactttcaca actttattaa ccgtggctgc\n",
      "     1861 tcccattatg attttgttcg gcagtggaag tttcacctgc ttctccagag cacttggcat\n",
      "     1921 ctttgttcca aatttccttt cttcagcctc acaccagagt gccctggtca ggctcggctc\n",
      "     1981 atccattagg cactatgtgg gcagtgcagg ggaccctcca tactgtaaag ccacatgaga\n",
      "     2041 aggttttaac accttttaaa attagaaaaa taatggaata ttagagccta agaaaatgtt\n",
      "     2101 ttaactttta attcagccta gattatattg tctttatacc aattcagtca taaaatataa\n",
      "     2161 ttttccatat ttttatggag gaaggggccc atacaagcaa gaatgctcgg ggctcacatg\n",
      "     2221 tcagaatgca gccttggtca tgactgatcc tggcgtttgt atggttctgc tacctgtgtg\n",
      "     2281 cctgtccgtc ttccccaaaa tctgtgtggt cctcgaatat agcaactgtc attcaataca\n",
      "     2341 catgtttgag cacacagtga gctaagtttt aaggattcaa agatgaaaag tcatgctgtc\n",
      "     2401 ttccctgcag agggtgctca gattagtgat ggaaacagtg tggggtgcag gaaagcagaa\n",
      "     2461 ggccattgct gagcagggca gtggacccag cagaggctga aacaatacaa gtgacttggt\n",
      "     2521 tccaggtggg ccagcagggt gacgtcctct agcaaaattt ggcacccaag acaagtacca\n",
      "     2581 gaagaaaaga aagactgcat gtattccaca tatattcatg tttgaacaag gagtcaagat\n",
      "     2641 ttatggcaag gataaggagg ctttgttggt gacctgttaa gaccaaccag ggcagtcatg\n",
      "     2701 ctggataggg aagaaggtga gctggaagag gaacagacaa acttggacag ccagatgttg\n",
      "     2761 agatggaggg gttggaggtc ataatgtggt caaaacatgt tgatgagagg actcagctac\n",
      "     2821 aaagttgtta acttaagcag aaacctcaag gatggatttt agaatttctc caggaagtcc\n",
      "     2881 taaaagataa ttccttttca gggagaaaaa caacagacca ctgcaaagac cagggaacat\n",
      "     2941 gaaaggataa tgtagtttgg cttgcttggc agatactttt gaaggatgtt ggactgtaag\n",
      "     3001 gctgtcgata tcctcctcac agaacttact acagtacatt gtatctgttc ccttacctac\n",
      "     3061 ctgactcttc cactattcag tttgttcctt aatggtagac catgcctgat tggtgtttta\n",
      "     3121 cacatctccg gctatgtctg acacttgtgg atgctcagaa agtggggaag gaaggaaaga\n",
      "     3181 tacgatggta aaaggcttac acatgtcttg acaagaaagt ccagttcggc tcatttggct\n",
      "     3241 ggagtcgtac tgcatggctg ccattctgct ctggcatcct cagacaagca cactgcccat\n",
      "     3301 tagaggaaaa agtgtgaata taagtgttga gtcagaatgc tgtagacatt tagtaacctc\n",
      "     3361 cttcacagga aaaaaaaaag atggggggaa tgacagaaat ccaaaaacta gtagagcttc\n",
      "     3421 cacttttcat ttcagaagaa atcagttgct ctcctataag gaccattact attaacaaaa\n",
      "     3481 cagagacctt agaaggaggc attgtttatt tattatatat tttgtaatgt tattaccaat\n",
      "     3541 cttgttatac tctttcttat accctacaat tgttagcaga aattatttta aattaataag\n",
      "     3601 atcctgcatg cttttcctta aaaaaaaaaa aaagaaagaa agaaagatct ctgtgtagag\n",
      "     3661 tgtcctattc tgagccagtc ctgagaggaa aggaagtata atcaatttgt tattaaccga\n",
      "     3721 tgaaagaatt aagtgaaaga taaatctcag gaagcagagg gaagtaaacc taatctctga\n",
      "     3781 ctaagaaagc taaatactat gataactcat tcattccttc ttttgttcaa ttacattatt\n",
      "     3841 taatcataag tccatgacgt gccaggcact caggaaatag taaaaattgg acgtgcgata\n",
      "     3901 ttctgccctt gtgtagcgca cactagagtg ggaaagaaag tgcactttta actggacaac\n",
      "     3961 taccaacatg atgaggggag gaaacagggg ctggaaatgt ccacggactg tgccgaaaaa\n",
      "     4021 tgaagcccat aatatttgaa agtcagtttc ttccatcatt ttgtgtatta aggttctttc\n",
      "     4081 ttcccctgtt ctccgccttc ctgcttgtca tcttcactca tcagctgacc atgttgcctc\n",
      "     4141 ttgtggtgta aacttgtacc agttttacgg tccctctggc cagttcaccc atgaatttga\n",
      "     4201 tggagatgag cagttctacg tggacctgga gaagaaggag actgcctggc ggtggcctga\n",
      "     4261 gttcagcaaa tttggaggtt ttgacccgca gggtgcactg agaaacatgg ctgtggcaaa\n",
      "     4321 acacaacttg aacatcatga ttaaacgcta caactctacc gctgctacca atggtatgcg\n",
      "     4381 tccaccattc tgcctctctt tacttaagct atcccttcat accagggttc attattttct\n",
      "     4441 tcccaagagg tccccagatc ttcttatggc aattgctgaa attttatcat ctcccatctc\n",
      "     4501 taaaatcaca tattcccatg taatacaagg gtctttccat tatgcattca gcaaatcctt\n",
      "     4561 ctaggagagg tctcatcaac ctcctacttt attaaacatg cccacagaga gaagggcaca\n",
      "     4621 ggaataaagc agaggcaatg tgtcattgct cccaagcaga aggtaaataa gacctctttg\n",
      "     4681 actatcaggt ggtgaaatgc tggtaggagg gctcttccag gatgtaatgc agaacttcag\n",
      "     4741 ggcagagcta ttcacacttc acaccagtgc tgtttcctca ccacagaggt tcctgaggtc\n",
      "     4801 acagtgtttt ccaagtctcc cgtgacgctg ggtcagccca acaccctcat ctgtcttgtg\n",
      "     4861 gacaacatct ttcctcctgt ggtcaacatc acatggctga gcaatgggca cgcagtcaca\n",
      "     4921 gaaggtgttt ctgagaccag cttcctctcc aagagtgatc attccttctt caagatcagt\n",
      "     4981 tacctcacct tcctcccttc tgctgatgag atttatgact gcaaggtgga gcactggggc\n",
      "     5041 ctggaccagc ctcttctgaa acactggggt aaggatgagt ttcatcattt tttgattctt\n",
      "     5101 tcttgtctgt caggttcaga acttcctgcc ttttactcct atatccaaaa acttgttttc\n",
      "     5161 cacacttcat gggtttcttt tctgtctcac tttttttttt gaaagaataa agcaaaaaaa\n",
      "     5221 gcagagattt attgaaaatg aaagtacact ctacaggatg ggagtgggcc tgccacttca\n",
      "     5281 tggttttcta atgatagact tcactctcct ccctaagctg ggggccttga gtctttgtag\n",
      "     5341 agccaaccct gtaccccatc ccatcccaca cacatgcaca tgagcaaact ctgcattctg\n",
      "     5401 acctcaacaa cttcacttcc acagagcctg agattccagc ccctatgtca gagctcacag\n",
      "     5461 agactgtggt ctgtgccctg gggttgtctg tgggcctcgt gggcattgtg gtgggcactg\n",
      "     5521 tcttcatcat ccaaggcctg cgttcagttg gtgcttccag acaccaaggg cccttgtgaa\n",
      "     5581 tcccatcctg gaagggaagg taagattgag actggttaca gttgaagcgg cagtatgaaa\n",
      "     5641 ggaaggaaag tgggagggcg ttgtggacat gaatgtggtt taa\n",
      "//\n",
      "\n",
      "LOCUS       OR921180                5690 bp    DNA     linear   PRI 20-DEC-2023\n",
      "DEFINITION  Homo sapiens MHC class II antigen (HLA-DQA1) gene, HLA-DQA1*01NEW\n",
      "            allele, complete cds.\n",
      "ACCESSION   OR921180\n",
      "VERSION     OR921180.1\n",
      "KEYWORDS    .\n",
      "SOURCE      Homo sapiens (human)\n",
      "  ORGANISM  Homo sapiens\n",
      "            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\n",
      "            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\n",
      "            Catarrhini; Hominidae; Homo.\n",
      "REFERENCE   1  (bases 1 to 5690)\n",
      "  AUTHORS   Deghaide,N.H.S., Martins,G.V., Domeneghetti,M.S., Correa,A.P.B.,\n",
      "            Santos,V.T. and Donadi,E.A.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (07-DEC-2023) Laboratorio de HLA, Hemocentro de Ribeirao\n",
      "            Preto, Rua: Tenente Catao Roxo, Ribeirao Preto, SP 14051-140,\n",
      "            Brazil\n",
      "COMMENT     ##Assembly-Data-START##\n",
      "            Assembly Method       :: TypeStream Visual v. 3.0\n",
      "            Assembly Name         :: HLA-DQA1*01:NEW\n",
      "            Coverage              :: Full Gene\n",
      "            Sequencing Technology :: Illumina\n",
      "            ##Assembly-Data-END##\n",
      "FEATURES             Location/Qualifiers\n",
      "     source          1..5690\n",
      "                     /organism=\"Homo sapiens\"\n",
      "                     /mol_type=\"genomic DNA\"\n",
      "                     /db_xref=\"taxon:9606\"\n",
      "     gene            1..5690\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "     exon            1..345\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=1\n",
      "     5'UTR           1..263\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "     CDS             join(264..345,4123..4371,4785..5066,5423..5577)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /codon_start=1\n",
      "                     /product=\"MHC class II antigen\"\n",
      "                     /protein_id=\"WQB05986.1\"\n",
      "                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASCGVNLYQFYGP\n",
      "                     SGQYTHEFDGDEQFYVDLERKETAWRWPEFSKFGGFDPQGALRNMAVAKHNLNIMIKR\n",
      "                     YNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGQSVTEGVSE\n",
      "                     TSFLSKSDHSFFKISYLTFLPSAGEIYDCKVEHWGLDQPLLKHWEPEIPAPMSELTET\n",
      "                     VVCALGLSVGLMGIVVGTVFIIQGLRSVGASRHQGPL\"\n",
      "     exon            4123..4371\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=2\n",
      "     exon            4785..5066\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=3\n",
      "     exon            5423..5690\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=4\n",
      "     3'UTR           5578..5690\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "ORIGIN      \n",
      "        1 cctccgttta ttcatagaac aattcctcaa gtccactctg agtagaggct gcatcacaag\n",
      "       61 gggattgccc cgtctccttc cagggctctt aatacaaact cttcaactag taactgagat\n",
      "      121 gtcaccatag gggatttttc taattggcca aaacctgact tggcagggtt tggtttgggt\n",
      "      181 gtcttcagat ttccttgtct tgaggtcctc acaattactc tacagctcag aacaccaact\n",
      "      241 gctgaggctg ccttgggaag aggatgatcc taaacaaagc tctgctgctg ggggccctcg\n",
      "      301 ctctgaccac cgtgatgagc ccctgtggag gtgaagacat tgtgggtgag tgcatgagtg\n",
      "      361 agggatgttc tctggagctg aaaaacagta aattgaagga aaagagataa agcgatttgc\n",
      "      421 agagaaactg tagagatttc ctaagggccc tttcagtatt aagacaatta aaaattatag\n",
      "      481 ctgttcctcc ttcaggaaac cagagcccca acctactctt tttgttatgt atgcttttgt\n",
      "      541 gttcactaag gatgctattc tgtttatatt atattcagtg actacagcct ggaggtctct\n",
      "      601 atgtcgttcc gtcatgattg cctcaaaaat tagtgaggtt tccatcagtg gataattttt\n",
      "      661 tattattaaa aatttatgaa gtgtcattct caaatttccc tgaacaactt ttgaagcttt\n",
      "      721 tcggatgtct ccggtggtag atcttggggt cattccatca attatgtact ctatagatat\n",
      "      781 ttaaaatgtt gcccgtttct ttctctcaga cttactcaca tttccacatg ggaactggca\n",
      "      841 caggtgggga gtgggtaaag gagtccagca ggctgaatgc cttcaacaat cattttacca\n",
      "      901 catggtcctc acttactctc agctgcctca tatgtgtcac ctcacaagta atcaaataaa\n",
      "      961 atgggcatgt ggctaagctt tgtaaatagt gaaaacatga atgtcaattt tttttacata\n",
      "     1021 tttctattac agatatagct tcacatttct tttctttagc aaaataaggg atcattttat\n",
      "     1081 tttaaaattg agaagtagaa aaaattggta aaataaatca ttttattctc aaattatcaa\n",
      "     1141 cccaaattac ctgttcttca cctcatctaa taaagtccta taaaaagaaa agtgggccag\n",
      "     1201 acaaggtggc tcatgcctgt aatcccagca ctttgggagg ccgaggcagg aggatcattt\n",
      "     1261 gagcctggga gcttgagacc agcctgggca acatagcaag acctcatctc tacaaaaaaa\n",
      "     1321 gaaaaagaaa aattagccag gcatggtggt gtgtgcctgt ggtgccagct actcagaagg\n",
      "     1381 ctgccgtggg aggaccactt gagcccatga ggcggaagct gcagtgagcc atggtggcac\n",
      "     1441 cactacactc cagccagggc aacagagaga gacgctgtct caaaaagaaa gaggaaagaa\n",
      "     1501 agcgaggaag gaaggaagga aggaaggaag gagaaggaag gaaggaagga aaagaaaaga\n",
      "     1561 aaagggaagg gaggaaggaa ggaaaaaaga aagacagaaa gaaagaggaa ggaaggaaga\n",
      "     1621 aaggaagcac agattaatta tttggtctct tactctcctc tgcctttgtc gtccatctct\n",
      "     1681 ttccacctct cttgatgcat ccctttctcc ctcttccgtt tcaggagcca tctctggctc\n",
      "     1741 cctgctcctt tatagagatg gacagtgggt ttgtaaaaca aaagttgaaa agtcagatag\n",
      "     1801 ttaaaagggg aagtgaactg gaaggtactt taaactttca caactttatt aaccgtggct\n",
      "     1861 gctcccatta tgattttgtt cggcagtgga agtttcacct gcttctccag agcacttggc\n",
      "     1921 gtctttgttc caaatttcct ttcttcaacc tcacaccaga gtgccctggt caggcttggc\n",
      "     1981 tcattcatta ggcacaatgt gggcagtgca ggggaccctc catactgtaa agccacatga\n",
      "     2041 gaaggtttta actcctttta aaattagaaa aataatggaa tattagagcc taagaaaatg\n",
      "     2101 ttttaacttt taattcagcc tagattatat tgtctttata ccaattcagt cataaaatat\n",
      "     2161 aattttccat atttttgtgg aggaagaggc ccatacaagc aagaatgctc ggggctcaca\n",
      "     2221 tgtcagaatg cagccttggt catgactgat cctggccttc gtatggttct gctacctgtg\n",
      "     2281 tgcctgcccg tcttccccaa aatctatgtg gtcctcgaat atagcaactg tcattcaata\n",
      "     2341 cacatgtttg agcacacagt gagctaagtt ttaaggattc aaagatgaaa agtcatgctg\n",
      "     2401 tcttccctgc agagggtgct cagattagtg atggaaacag tatggggtgc aggaaagcag\n",
      "     2461 aaggccattg ctgagcaggg cagtggaccc agcagaggct gaaacaatac aagtgacttg\n",
      "     2521 gttccaggtg ggccagcagg gtgacgtcct ctagcaaaat ttggcaccca agacaagtac\n",
      "     2581 cagaagaaaa gaaagactgc atgtattcca catatattca tgtttgaaca aggagtcaag\n",
      "     2641 atttatggca aggataagga ggctttgttg gtgacctgtt aagaccaacc agggcagtca\n",
      "     2701 tgctggatag ggaagaaggt gagctggaag aggaacagac aacttggaca gccagatgtt\n",
      "     2761 gagacggagg ggttggaggt cataatgtgg tcaaaaacat gttgatgaga ggactcagct\n",
      "     2821 acaaagttgt taacttaagc agaaacctca aggatggatt ttagaatttc tccaggaagt\n",
      "     2881 cctaaaagat aattccattt cagggagaaa aacaacagac cactgcaaag accagggaac\n",
      "     2941 atgaaaggat aatgtagttt gtcttgcttg gcagatactt ttgaaggatg ttggactgta\n",
      "     3001 aggctgtcga tatcctcctc agagaactta ctacagtaca ttgtatctgt tcccttacct\n",
      "     3061 acctgactct tccactattc agtttgttcc ttaatggtag accatgcctg attggtgttt\n",
      "     3121 tacacatctc cggctatgtc tgacacttgt ggatgctcag aaagtgggga aggaaggaaa\n",
      "     3181 gatacgatgg taaaaggctt acacatgtct tgacaaaaaa gtccagtttg gctcatttgg\n",
      "     3241 ctggagtcgt actgcatggc tgccattctg ctctggcatc ctcagacaag cacactgccc\n",
      "     3301 attagaggaa agagtgtgat ataagtgttg agtcagaatg ctgtagacat ttagtaacct\n",
      "     3361 ccttcacagg aaaaaaaaaa aaaggtgggg ggaatgacag aaatccaaaa actagtagag\n",
      "     3421 cttccacttt tcatttcaga agaaatcagt tgctctcctc taaggaccac tactattaac\n",
      "     3481 aaaacagaga ccttagaagg aggcattgtt tatttattat atattttgta atgttattac\n",
      "     3541 caatcttgtt atactctttc ttatacccta caattgttag cagaaattat tttaaattaa\n",
      "     3601 taagatcctg catgcttttc ctttaaaaaa aaaaaaaaag aaagatctct gtgtagagtg\n",
      "     3661 tcctattctg agccagtcct gagaggaaag gaagtataat caatttgtta ttaaccaatg\n",
      "     3721 aaagaattaa gtgaaagata aatctcagga agcagaggga agtaaaccta atttctgact\n",
      "     3781 aagaaagcta aatactatga taactcattc attccttctt ttgttcaatt acattattta\n",
      "     3841 atcataagtc catgacgtgc caggcactca ggaaatagta aaaattggac atgcgatatt\n",
      "     3901 ctgcccttgt gtagcgcaca ctagagtggg aaagaaagtg cacttttaac tggacaacta\n",
      "     3961 ccaacatgaa gaggggagga agcaggggct ggaaatgtcc acagactgtg ccaaaaaatg\n",
      "     4021 aagcccataa tatttgaaag tcaggttctt ccatcatttt gtgtattaag gttctttctt\n",
      "     4081 cctctgttct ccgccttcct gcttgtcatc ttcactcatc agctgaccac gttgcctctt\n",
      "     4141 gtggtgtaaa cttgtaccag ttttacggtc cctctggcca gtacacccat gaatttgatg\n",
      "     4201 gagatgagca gttctacgtg gacctggaga ggaaggagac tgcctggcgg tggcctgagt\n",
      "     4261 tcagcaaatt tggaggtttt gacccgcagg gtgcactgag aaacatggct gtggcaaaac\n",
      "     4321 acaacttgaa catcatgatt aaacgctaca actctaccgc tgctaccaat ggtatgcgtc\n",
      "     4381 caccattctg cctctcttta cttaagctat ccctccatac cagggttcat tattttcttc\n",
      "     4441 ccaagaggtc cccagatctt gttatggcaa ttgctgaaat tttatcatct cccatctcta\n",
      "     4501 aaatcacata ttcccatgta atacaagggt ctttccatta tgcattcagc aaatccttct\n",
      "     4561 aggagaggtc tcatcaacct cctactttat taaacatgcc cacagagaga agggcacagg\n",
      "     4621 aataaagcag aggcaatgtg tcgttgctcc caagcagaag gtaaataaga cctctttgac\n",
      "     4681 tatcaggtgg tgaaatgctg gtaggagggc tcttccagga tgtaatgcag aacttcaggg\n",
      "     4741 cagagctatt cacacttcac accagtgctg tttcctcacc acagaggttc ctgaggtcac\n",
      "     4801 agtgttttcc aagtctcccg tgacactggg tcagcccaac accctcattt gtcttgtgga\n",
      "     4861 caacatcttt cctcctgtgg tcaacatcac atggctgagc aatgggcagt cagtcacaga\n",
      "     4921 aggtgtttct gagaccagct tcctctccaa gagtgatcat tccttcttca agatcagtta\n",
      "     4981 cctcaccttc ctcccttctg ctggtgagat ttatgactgc aaggtggagc actggggcct\n",
      "     5041 ggaccagcct cttctgaaac actggggtaa ggatgagttt catcattttt tgattctttc\n",
      "     5101 ttgtctgtca agttcagaac ttcctgcctt ttactcctat atccaaaaac ttgttttcca\n",
      "     5161 cacttcatgg gtttcttttc tgtctctctt ttttttttga aagaataaag caaaaaaagc\n",
      "     5221 agagatttat tgaaaatgaa agtacactct acaggatggg agtgggcctg ccacttcatg\n",
      "     5281 gttttctaat gatagacttc actcttctcc ctaagcctgg ggccttgagt ctttgcagag\n",
      "     5341 ccaaccctct accccatccc atcccacaca catgcacatg agcacactct gcattctgac\n",
      "     5401 ctcaacaact tcacttccac agagcctgag attccagccc ctatgtcaga gctcacagag\n",
      "     5461 actgtggtct gtgccctggg gttgtctgtg ggcctcatgg gcattgtggt gggcactgtc\n",
      "     5521 ttcatcatcc aaggcctgcg ttcagttggt gcttccagac accaagggcc attgtgaatc\n",
      "     5581 ccatcctgga agggaaggta agattgagac tggttacagt tgaagcggca gtatgaaagg\n",
      "     5641 aaggaaagtg ggagggcgtt gtggacatga atgtggttga aagttgtagg\n",
      "//\n",
      "\n",
      "LOCUS       OR909722                1068 bp    DNA     linear   PRI 20-DEC-2023\n",
      "DEFINITION  Homo sapiens MHC class II antigen (HLA-DQA1) gene,\n",
      "            HLA-DQA1*01:02:NEW allele, complete cds.\n",
      "ACCESSION   OR909722\n",
      "VERSION     OR909722.1\n",
      "KEYWORDS    .\n",
      "SOURCE      Homo sapiens (human)\n",
      "  ORGANISM  Homo sapiens\n",
      "            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\n",
      "            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\n",
      "            Catarrhini; Hominidae; Homo.\n",
      "REFERENCE   1  (bases 1 to 1068)\n",
      "  AUTHORS   Cargou,M., Andreani,M., Galluccio,T., Ralazamahaleo,M. and\n",
      "            Visentin,J.\n",
      "  TITLE     Characterization of the novel HLA-DQA1*01:02:NEW allele by\n",
      "            sequencing-based typing\n",
      "  JOURNAL   Unpublished\n",
      "REFERENCE   2  (bases 1 to 1068)\n",
      "  AUTHORS   Cargou,M., Andreani,M., Galluccio,T., Ralazamahaleo,M. and\n",
      "            Visentin,J.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (05-DEC-2023) laboratoire d'Immunologie et\n",
      "            d'Immunogenetique, CHU Bordeaux, Place Amelie Raba Leon, Bordeaux,\n",
      "            Gironde 33076, France\n",
      "COMMENT     ##Assembly-Data-START##\n",
      "            Assembly Method       :: TypeStream Visual v. v3.0\n",
      "            Sequencing Technology :: Illumina\n",
      "            ##Assembly-Data-END##\n",
      "FEATURES             Location/Qualifiers\n",
      "     source          1..1068\n",
      "                     /organism=\"Homo sapiens\"\n",
      "                     /mol_type=\"genomic DNA\"\n",
      "                     /db_xref=\"taxon:9606\"\n",
      "     gene            <1..>1068\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:02:NEW\"\n",
      "     mRNA            join(<1..82,183..431,532..813,914..>1068)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:02:NEW\"\n",
      "                     /product=\"MHC class II antigen\"\n",
      "     CDS             join(1..82,183..431,532..813,914..1068)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01:02:NEW\"\n",
      "                     /codon_start=1\n",
      "                     /product=\"MHC class II antigen\"\n",
      "                     /protein_id=\"WQB05981.1\"\n",
      "                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASCGVNLYQFYGP\n",
      "                     SGQYTHEFDGDEQFYVDLERKETAWRWPEFSKFGGFDPQGALRNMAVAKHNLNIMIKR\n",
      "                     YNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGQSVTEGVSE\n",
      "                     TSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDQPLLKHWEPEIPAPMSELTET\n",
      "                     VVCALGLSVGLMGIVVGTVFIIQGLRSVGASRHQGPL\"\n",
      "     gap             83..182\n",
      "                     /estimated_length=unknown\n",
      "     gap             432..531\n",
      "                     /estimated_length=unknown\n",
      "     gap             814..913\n",
      "                     /estimated_length=unknown\n",
      "ORIGIN      \n",
      "        1 atgatcctaa acaaagctct gctgctgggg gccctcgctc tgaccaccgt gatgagcccc\n",
      "       61 tgtggaggtg aagacattgt ggnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn\n",
      "      121 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn\n",
      "      181 nnctgaccac gttgcctctt gtggtgtaaa cttgtaccag ttttacggtc cctctggcca\n",
      "      241 gtacacccat gaatttgatg gagatgagca gttctacgtg gacctggaga ggaaggagac\n",
      "      301 tgcctggcgg tggcctgagt tcagcaaatt tggaggtttt gacccgcagg gtgcactgag\n",
      "      361 aaacatggct gtggcaaaac acaacttgaa catcatgatt aaacgctaca actctaccgc\n",
      "      421 tgctaccaat gnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn\n",
      "      481 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn naggttcctg\n",
      "      541 aggtcacagt gttttccaag tctcccgtga cactgggtca gcccaacacc ctcatttgtc\n",
      "      601 ttgtggacaa catctttcct cctgtggtca acatcacatg gctgagcaat gggcagtcag\n",
      "      661 tcacagaagg tgtttctgag accagcttcc tctccaagag tgatcattcc ttcttcaaga\n",
      "      721 tcagttacct caccttcctc ccttctgctg atgagattta tgactgcaaa gtggagcact\n",
      "      781 ggggcctgga ccagcctctt ctgaaacact gggnnnnnnn nnnnnnnnnn nnnnnnnnnn\n",
      "      841 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn\n",
      "      901 nnnnnnnnnn nnnagcctga gattccagcc cctatgtcag agctcacaga gactgtggtc\n",
      "      961 tgtgccctgg ggttgtctgt gggcctcatg ggcattgtgg tgggcactgt cttcatcatc\n",
      "     1021 caaggcctgc gttcagttgg tgcttccaga caccaagggc cattgtga\n",
      "//\n",
      "\n",
      "LOCUS       OR879057                5107 bp    DNA     linear   PRI 12-DEC-2023\n",
      "DEFINITION  Homo sapiens MHC class II antigen (HLA-DQA1) gene,\n",
      "            HLA-DQA1-DQA1*02:01:01:01v1var allele, exons 1 through 3 and\n",
      "            partial cds.\n",
      "ACCESSION   OR879057\n",
      "VERSION     OR879057.1\n",
      "KEYWORDS    .\n",
      "SOURCE      Homo sapiens (human)\n",
      "  ORGANISM  Homo sapiens\n",
      "            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\n",
      "            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\n",
      "            Catarrhini; Hominidae; Homo.\n",
      "REFERENCE   1  (bases 1 to 5107)\n",
      "  AUTHORS   Marin Rubio,L.A. Sr.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (29-NOV-2023) Inmunologia, Hospital Universitario de\n",
      "            Albacete, Hermanos Falco, 37, Albacete, Albacete 02006, Spain\n",
      "COMMENT     ##Assembly-Data-START##\n",
      "            Assembly Method       :: NGSengine v. 2.31.0\n",
      "            Sequencing Technology :: Illumina\n",
      "            ##Assembly-Data-END##\n",
      "FEATURES             Location/Qualifiers\n",
      "     source          1..5107\n",
      "                     /organism=\"Homo sapiens\"\n",
      "                     /mol_type=\"genomic DNA\"\n",
      "                     /db_xref=\"taxon:9606\"\n",
      "     gene            <1..>5107\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"DQA1*02:01:01:01v1var\"\n",
      "     mRNA            join(<1..350,4045..4290,4703..>4984)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"DQA1*02:01:01:01v1var\"\n",
      "                     /product=\"MHC class II antigen\"\n",
      "     exon            <1..350\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"DQA1*02:01:01:01v1var\"\n",
      "                     /number=1\n",
      "     5'UTR           <1..268\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"DQA1*02:01:01:01v1var\"\n",
      "     CDS             join(269..350,4045..4290,4703..>4984)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"DQA1*02:01:01:01v1var\"\n",
      "                     /note=\"DQ alpha chain\"\n",
      "                     /codon_start=1\n",
      "                     /product=\"MHC class II antigen\"\n",
      "                     /protein_id=\"WPT07520.1\"\n",
      "                     /translation=\"MILNKALMLGALALTTVMSPCGGEDIVADHVASYGVNLYQSYGP\n",
      "                     SGQFTHEFDGDEEFYVDLERKETVWKLPLFHRLRFDPQFALTNIAVLKHNLNILIKRS\n",
      "                     NSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGHSVTEGVSET\n",
      "                     SFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDEPLLKHW\"\n",
      "     exon            4045..4290\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"DQA1*02:01:01:01v1var\"\n",
      "                     /number=2\n",
      "     exon            4703..4984\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"DQA1*02:01:01:01v1var\"\n",
      "                     /number=3\n",
      "ORIGIN      \n",
      "        1 gtcttccctc tcttcataga acaattcctc aagtccactc tgagtagagg ctgcatcaca\n",
      "       61 acaaggggat tgccctgtct ccttccaggg ctcttaatag aaactcttca actagtaact\n",
      "      121 gagatgtcac catgggggat ttttctaatt ggccaaaacc tgacttggca gggtttggtt\n",
      "      181 tgggtgtctt cagatttcct tgtcttgagg tcctcacaat tactctacag ctcagaacag\n",
      "      241 caactgctga ggctgccttg ggaagaagat gatcctaaac aaagctctga tgctgggggc\n",
      "      301 cctggccctg accaccgtga tgagcccttg tggaggtgaa gacattgtgg gtgagtgcgt\n",
      "      361 gagtgaggaa tgttctctgg agctgaaaaa cagtaaattg aaggaaaaga gagaaagcga\n",
      "      421 tttgcagaga aattgtagag atttcctaag acccctttca gtattaagag aattaaaaat\n",
      "      481 tatagctgtt cctccttcag gaaaccagag ccccaaccta ctctttttgt tatgtatgct\n",
      "      541 tttgtgttca ctaaggatgc tattctgttt atattatatt cagtgactac agcctggagg\n",
      "      601 tctctatgtc attccatcat gattgcctca aaaattagtg aggtttccat cagtggataa\n",
      "      661 ttttttatta ttaaaaatgt atgaagtgtc attctcaaat ttccctgaac aacttttgaa\n",
      "      721 gattttcgga tgtctcctgt agtagatctt ggggtcgttc catcaattat atactctata\n",
      "      781 gatattaaaa aagttgcccg tttctttctc tcagacttac tcacatttcc acatgggaac\n",
      "      841 tggcacaggt ggggagtagg taaaggagtc cagcaggctg aatgccttca acaatcattt\n",
      "      901 taccacatgg tcctcactta ctctcagctg cctcatatgt gtcacctcac aaataatcaa\n",
      "      961 ataaaatggg catgtagcta agctttgtaa atagtgaaaa catggatgtc aattgttttt\n",
      "     1021 acatatttct attacaggta tagcttcaca tttcttttct ttagcaaaat aagggatcct\n",
      "     1081 tttagtttaa aattgagaag tagaaaaaat tggtaaatta aatcatttta ttctcaaatt\n",
      "     1141 atcaacccaa attacctgtt cttcacctca tctaataaag tcctataaaa agaaaagtgg\n",
      "     1201 gccagacatg gtggctcatg cctgtaatcc cagcactttg ggaggccgaa gcaggaggat\n",
      "     1261 catttgagcc tgggagtttg agaccagcct gggcaacaca gcaagacctc atctctacca\n",
      "     1321 aaaaataaaa taaaaattag ccaggcatgg tagtgcatgc ctgtggtgcc agctactcag\n",
      "     1381 aaggctgcag tgggaggagc acttgagtcc aggaggtgga agctgcagtg agccatgatg\n",
      "     1441 gcaccactac actccagcca gggcaacaga gagagaccct gtctcaaaaa gaaagcggaa\n",
      "     1501 agaaagagag aaaggaagga aagaaggaaa gaaggaagca aggaaggaga aagggaaggg\n",
      "     1561 aagaaagaag aaagaaagaa agaaaacaga aggaaggaag cacagattaa ttatttggtc\n",
      "     1621 tcttagtctc ctctgccttt gtcgtccatc tcttcccacc tctcttcatg cattcctttc\n",
      "     1681 tccctcttcc ctttcaggat ccatctctga ctccctgctc ctttatagag atggacatga\n",
      "     1741 gtttgtaaaa caaaagttga aaagtcagat agttaaaagg ggaagtaaac tggaaggtac\n",
      "     1801 tctaaacttt cacaacctta ttaaccgtgg cagctcccat tctgattttg ttcagcagtg\n",
      "     1861 gaagtttcac cctctcctcc agagcgcttg gcttctttgt tccaaatttc ctttcttcag\n",
      "     1921 cctcacacca gagtgccctg gtcaggctca gctcatccat taggcacaat gtgggcagtg\n",
      "     1981 caggggaacc tccatactgt aaagccacat gagaatgttt taactccttt taaaattata\n",
      "     2041 aaaaaatgaa attgtagagc ctaagaaaat gttttaactt ttaattcagc ctatattata\n",
      "     2101 ttgtctttat accaattcag tcataaaata taattttcca tatttttatg gaggaaggcg\n",
      "     2161 tccacacaag caagagtgct tggggctcac atgtcagaac gcatccctga tcatggctga\n",
      "     2221 tcctgacctt cgtgtggttc tgctaactat gtgcctgtca gtcttcccca aaatctatgt\n",
      "     2281 ggtcctcaaa tataacaact gtcattcaat acacatgttt gagcacccag tgagctaagt\n",
      "     2341 tttaaggatt caaagatgaa aagtcatgct gtctcccctg cagagggtgc tcagactagt\n",
      "     2401 gatggaaaca gtatgggatg aaagaaagca gaaggccatt gctgagcagg cagtggactc\n",
      "     2461 agcagaggct gaaactatac aagtgacttg gttccagctg ggccagcagg ataaccagac\n",
      "     2521 gaaaagaagg attgcatata ttccatatat atttatgttt gaacaaagag tcaaggttta\n",
      "     2581 ttgcaaggat aaggaggctt tgttggtggc ctgttaagac catccagcgt ggtcatactg\n",
      "     2641 gatagggaag aaggtgagct ggaagaggga tagacaaact tggatggcca gatgttgaga\n",
      "     2701 tggaggagct ggaggtcata acgtggtcaa aaacatgttg atgagaggac ttagctacaa\n",
      "     2761 agttgttaac ttaagcagaa acctcaagga ttgattttat gatttctcca ggaagtccta\n",
      "     2821 aaagataatt tcatttcagg gaggaaaaca acagaccact gcaaagacca ggaacatgaa\n",
      "     2881 aggataatgt agtttggttt gcttggcaga tacttgtgaa agatgttgga ctgtaaggct\n",
      "     2941 gtcaatatcc tcctcgcaga acttactaca gtacattgta tctgctccct tacctacctg\n",
      "     3001 actctcccac tattcagttt gttccttaat ggtagaccat gcctgattgg tgttttacac\n",
      "     3061 ttcccctgct atgtctgata cttgtggatg ctcagaaagt ggggaaggaa ggaaagatac\n",
      "     3121 gatggtaaaa ggcttacaca tgtcttgacc agaatgttca gtttggctca tttggctgga\n",
      "     3181 gtcatactgc atggctgcca ttctgctctg gcatcctcag agaagcacac tgcccattag\n",
      "     3241 aggaaaaagg gtgaatataa atgttgagtc agaacactgc agacatttag taacctcctt\n",
      "     3301 cagaggaaaa aaagggtggg gggaatgaca gaaatccaaa aactagtaga gcttccactt\n",
      "     3361 tttcatttca gaagaaatca gttactctcc tctaaggacc attactatta acaaaacaga\n",
      "     3421 gaccttagaa ggaagcatta tttatttatc atatattttg taatgttatt accgttcttg\n",
      "     3481 ttatactctt tcttataccc taccattgtt agcagaaatt attttaaatt aataagatcc\n",
      "     3541 tgcatgcttt tcctttttct aaaaaaagaa agatctctgt gtagaatgtc ctgttctgag\n",
      "     3601 ccagtcctga gaggaaagga agtataatca atttgttatt aactgatgaa agaattaagt\n",
      "     3661 gaaagataaa ccttaggaag cagagggaag ttaatctatg actaagaaag ttaagtactc\n",
      "     3721 tgataactca ttcattcctt cttctgttca tttacattat ttaatcacaa gtccatgatg\n",
      "     3781 tgccaggcac tcaggaaata gtgaaaatcg gacacgcgat attctgccct tgtgtagcac\n",
      "     3841 acactgtagt gggaaagaaa gtgcactttt aactggacaa ctatcaacac gaagagggga\n",
      "     3901 ggaagcaggg gctggaaatg tccacagact ttgccaaaga caaagcccat aatatttgaa\n",
      "     3961 agtcagtttc ttccatcatt ttgtgtatta aggtttttta ttctcctgtt ctctgccttc\n",
      "     4021 ctgcttgtca tcttcactca tcagctgacc acgttgcctc ttacggtgta aacttgtacc\n",
      "     4081 agtcttacgg tccctctggc cagttcaccc atgaatttga tggagacgag gagttctatg\n",
      "     4141 tggacctgga gaggaaggag actgtctgga agttgcctct gttccacaga cttagatttg\n",
      "     4201 acccgcaatt tgcactgaca aacatcgctg tgctaaaaca taacttgaac atcctgatta\n",
      "     4261 aacgctccaa ctctaccgct gctaccaatg gtatgtgtcc accattctgc ctttctttac\n",
      "     4321 tgatctatcc ctttatacca agtttcatta ttttctttcc aagaggtccc cagatcttct\n",
      "     4381 catggcaatt gctgaaattt tatcatttct catctctaaa atcacatatc cccatgtaat\n",
      "     4441 acaagggtct ttccattatg cattcattaa atcattctag gagaggtctc atcaacctcc\n",
      "     4501 tactttatta aacatgccca cagagagaag ggcacaggag taaagcagag gcaatgtgtc\n",
      "     4561 attgctccca agtagaaggt aaataaggcc tctttgacca gcaggagagg aaatgctggt\n",
      "     4621 aggaagactc ttccaggatg taatgcagaa gctcagggca gagctattca cacttcacac\n",
      "     4681 cagtgctgtt tcctcaccat agaggttcct gaggtcacag tgttttccaa gtctcccgtg\n",
      "     4741 acactgggtc agcccaacac cctcatctgt cttgtggaca acatctttcc tcctgtggtc\n",
      "     4801 aacatcacct ggctgagcaa tgggcactca gtcacagaag gtgtttctga gaccagcttc\n",
      "     4861 ctctccaaga gtgatcattc cttcttcaag atcagttacc tcaccttcct cccttctgct\n",
      "     4921 gatgagattt atgactgcaa ggtggagcac tggggcctgg atgagcctct tctgaaacac\n",
      "     4981 tggggtaagg atgagtttca ccattttttg atgctttctt gtctgtcaag ttcagaactt\n",
      "     5041 cctgcctttt actctatgtc ccaaaacttg ttttccacac ttcatgagtt tcttttatct\n",
      "     5101 ttttttt\n",
      "//\n",
      "\n",
      "LOCUS       OR880478                5653 bp    DNA     linear   PRI 12-DEC-2023\n",
      "DEFINITION  Homo sapiens isolate N-23-20246-A-03-00 MHC class II antigen\n",
      "            (HLA-DQA1) gene, HLA-DQA1*01NEW allele, complete cds.\n",
      "ACCESSION   OR880478\n",
      "VERSION     OR880478.1\n",
      "KEYWORDS    .\n",
      "SOURCE      Homo sapiens (human)\n",
      "  ORGANISM  Homo sapiens\n",
      "            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\n",
      "            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\n",
      "            Catarrhini; Hominidae; Homo.\n",
      "REFERENCE   1  (bases 1 to 5653)\n",
      "  AUTHORS   Velickovic,M.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (28-NOV-2023) New South Wales Transplantation and\n",
      "            Immunogenetics Services Pathology and Clinical Governance,\n",
      "            Australian Red Cross Lifeblood, 17 O'Riordan Street Alexandria NSW\n",
      "            2015, Sydney, NSW 2060, Australia\n",
      "COMMENT     ##Assembly-Data-START##\n",
      "            Assembly Method       :: TSV v. 3.0.0.27232; created on 1/02/2023\n",
      "            Sequencing Technology :: Illumina\n",
      "            ##Assembly-Data-END##\n",
      "FEATURES             Location/Qualifiers\n",
      "     source          1..5653\n",
      "                     /organism=\"Homo sapiens\"\n",
      "                     /mol_type=\"genomic DNA\"\n",
      "                     /isolate=\"N-23-20246-A-03-00\"\n",
      "                     /db_xref=\"taxon:9606\"\n",
      "     gene            1..5653\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "     mRNA            join(1..349,4120..4368,4782..5063,5420..5653)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /product=\"MHC class II antigen\"\n",
      "     exon            1..349\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=1\n",
      "     5'UTR           1..267\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "     CDS             join(268..349,4120..4368,4782..5063,5420..5574)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /codon_start=1\n",
      "                     /product=\"MHC class II antigen\"\n",
      "                     /protein_id=\"WPS91253.1\"\n",
      "                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASCGVNLYQFYGP\n",
      "                     SGQFTHEFDGDEQFYVDLEKKETAWRWPEFSKFGGFDPQGALRNMAVAKHNLNIMIKR\n",
      "                     YNSTAATNEVPEVTVFSKSPVTLCQPNTLICLVDNIFPPVVNITWLSNGHAVTEGVSE\n",
      "                     TSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDQPLLKHWEPEIPAPMSELTET\n",
      "                     VVCALGLSVGLVGIVVGTVFIIQGLRSVGASRHQGPL\"\n",
      "     intron          350..4119\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=1\n",
      "     exon            4120..4368\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=2\n",
      "     intron          4369..4781\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=2\n",
      "     exon            4782..5063\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=3\n",
      "     intron          5064..5419\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=3\n",
      "     exon            5420..5653\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=4\n",
      "     3'UTR           5575..5653\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "ORIGIN      \n",
      "        1 atgtcctccc tttattcata gaacaattcc tcaagtccac tctgagtaga ggctgcatca\n",
      "       61 caaggggatt gccccgtctc cttccagggc tcttaataca aactcttcaa ctagtaactg\n",
      "      121 agatgtcacc ataggggatt tttctaattg gccaaaacct gacttggcag ggtttggttt\n",
      "      181 gggtgtcttc agatttcctt gtcttgaggt cctcacaatt actctacagc tcagaacacc\n",
      "      241 aactgctgag gctgccttgg gaagaggatg atcctaaaca aagctctgct gctgggggcc\n",
      "      301 ctcgctctga ccaccgtgat gagcccctgt ggaggtgaag acattgtggg tgagtgcatg\n",
      "      361 agtgagggat gttctctgga gctgaaaaac agtaaattga aggaaaagag ataaagcgat\n",
      "      421 ttgcagagaa actgtagaga tttcctaagg gccctttcag tattaagaca attaaaaatt\n",
      "      481 atagctgttc ctccttcagg aaaccagagc cccaacctac tctttttgtt atctatgctg\n",
      "      541 ttgtgttcac taaggacgct attctgttta tattatattc agtgactacg gcctggaggt\n",
      "      601 ctctatgtcg ttccatcatg attgcctcaa aaattagtga ggtttccatc agtggataat\n",
      "      661 tttttattat taaaaattta tgaagtgtca ttctcaaatt tccctgaaca acttttgaag\n",
      "      721 cttttcggat gtctccggtg gtagatcttg gggtcattcc atcaattatg tactctatag\n",
      "      781 atatttaaaa tgttgcccgt ttctttctct cagacttact cacatttcca catgggaact\n",
      "      841 ggcacaggtg gggagtgggt aaaggagtcc agcaggctga atgccttcaa caatcatttt\n",
      "      901 accacatggt cctcacttac tctcagctgc ctcatatgtg tcacctcaca agtaatcaaa\n",
      "      961 taaaatgggc atgtggctaa gctttgtaaa tagtgaaaac atgaatgtca atttttttta\n",
      "     1021 catatttcta ttacagatat agcttcacat ttcttttctt tagcaaaata agggatcatt\n",
      "     1081 ttattttaaa attgagaagt agaaaaaatt ggtaaaataa atcattttat tctcaaatta\n",
      "     1141 tcaacccaaa ttacctgttc ttcacctcat ctaataaagt cctataaaaa gaaaagtggg\n",
      "     1201 ccagacaagg tggctcatgc ctgtaatccc agcactttgg gaggccgagg caggaggatc\n",
      "     1261 atttgagcct gggagcttga gaccagcctg ggcaacatag caagacctca tctctacaaa\n",
      "     1321 aaaagaaaaa gaaaaattag ccaggcatgg tggtgtgtgc ctgtggtgcc agctactcag\n",
      "     1381 aaggctgccg tgggaggacc acttgagtcc atgaggcgga agctgcagtg agccatgatg\n",
      "     1441 gcaccactac actccagcca gggcaacaga gagagacgct gtctcaaaaa gaaagaggaa\n",
      "     1501 agaaagcgag gaaggaagga aggaaggaga aggaaggaag gaaggaaaag aaaagaaaag\n",
      "     1561 ggaagggagg aaggaaggaa aaaagaaaga cagaaagaaa gaggaaggaa ggaaggaagg\n",
      "     1621 aagcacagat taattatttg gtctcttact ctcctctgcc tttgtcgtcc atctctttcc\n",
      "     1681 acctctcttc atgcatccct ttctccctct tccctttcag gatccatctc tggctccctg\n",
      "     1741 ctcctttata gagatggaca gtgggtttgt aaaacaaaag ttgaaaagtc agatagttaa\n",
      "     1801 aaggggaagt gaactggaag gtactttaaa ctttcacaac tttattaacc gtggctgctc\n",
      "     1861 ccattatgat tttgttcggc agtggaagtt tcacctgctt ctccagagca cttggcgtct\n",
      "     1921 ttgttccaaa tttcctttct tcaacctcac accagagtgc cctggtcagg cttggctcat\n",
      "     1981 tcattaggca caatgtgggc agtgcagggg accctccata ctgtaaagcc acatgagaag\n",
      "     2041 gttttaactc gttttaaaat tagaaaaata atggaatatt agagcctaag aaaatgtttt\n",
      "     2101 aacttttaat tcagcctaga ttatattgtc tttataccaa ttcagtcata aaatataatt\n",
      "     2161 ttccatattt ttgtggagga agaggcccat acaagcaaga atgctcgggg ctcacatgtc\n",
      "     2221 agaatgcagc cttggtcatg actgatcctg gccttcgtat ggttctgcta cctgtgtgcc\n",
      "     2281 tgcccgtctt ccccaaaatc tatgtggtcc tcgaatatag caactgtcat tcaatacaca\n",
      "     2341 tgtttgagca cacagtgagc taagttttaa ggattcaaag atgaaaagtc atgctgtctt\n",
      "     2401 ccctgcagag ggtgctcaga ttagtgatgg aaacagtatg gggtgcagga aagcagaagg\n",
      "     2461 ccattgctga gcaggtcagt ggacccagca gaggctgaaa caatacaagt gacttggttc\n",
      "     2521 caggtgggcc agcagggtga cgtcctctag caaaatttgg cacccaagac aagtaccaga\n",
      "     2581 agaaaagaaa gactgcatgt attccacata tattcatgtt tgaacaagga gtcaagattt\n",
      "     2641 atggcaagga taaggaggct ttgttggtga cctgttaaga ccaaccaggg cagtcatgct\n",
      "     2701 ggatagggaa gaaggtgagc tggaagagga acagacaact tggacagcca gatgttgaga\n",
      "     2761 cggaggggtt ggaggtcata atgtggtcaa aaacatgttg atgagaggac tcagctacaa\n",
      "     2821 agttgttaac ttaagcagaa acctcaagga tggattttag aatttctcca ggaagtccta\n",
      "     2881 aaagataatt ccatttcagg gagaaaaaca acagaccact gcaaagacca gggaacatga\n",
      "     2941 aaggataatg tagtttgtct tgcttggcag atacttttga aggatgttgg actgtaaggc\n",
      "     3001 tgtcgatatc ctcctcagag aacttactac agtacattgt atctgttccc ttacctacct\n",
      "     3061 gactcttcca ctattcagtt tgttccttaa tagtagacca tgcctgattg gtgttttaca\n",
      "     3121 catctccggc tatgtctgac acttgtggat gctcagaaag tggggaagga aggaaagata\n",
      "     3181 cgatggtaaa aggcttacac atgtcttgac aaaaaagtcc agtttggctc atttggctgg\n",
      "     3241 agtcgtactg catggctgcc attctgctct ggcatcctca gacaagcaca ctgcccatta\n",
      "     3301 gaggaaaaag tgtgatataa gtgttgagtc agaatgctgt agacatttag taatctcctt\n",
      "     3361 cacaggaaaa aaaaaaaaaa ggtgggggga atgacagaaa tccaaaaact agtagagctt\n",
      "     3421 ccacttttca tttcagaaga aatcagttgc tctcctctaa ggaccattac tattaacaaa\n",
      "     3481 acagagacct tagaaggagg cattgtttat ttattatata ttttgtaatg ttattaccaa\n",
      "     3541 tcttgttata ctctttctta taccctacaa ttgttagcag aaattatttt aaattaataa\n",
      "     3601 gatcctgcat gcttttcctt taaaaaaaaa aaaaaagaaa gatctctgtg tagagtgtcc\n",
      "     3661 tattctgagc cagtcctgag aggaaaggaa gtataatcaa tttgttatta accaatgaaa\n",
      "     3721 gaattaagtg aaagataaat ctcaggaagc agagggaagt aaacctaatt tctgactaag\n",
      "     3781 aaagctaaat actatgataa ctcattcatt ccttcttttg ttcaattaca ttatttaatc\n",
      "     3841 ataagtccat gacatgccag gcactcagga aatagtaaaa attggacatg cgatattctg\n",
      "     3901 cccttgtgta gcgcacacta gagtgggaaa gaaagtgcac ttttaactgg acaactacca\n",
      "     3961 acatgatgag gggaggaaac aggggctgga aatgtccacg gactgtgccg aaaaatgaag\n",
      "     4021 cccataatat ttgaaagtca gtttcttcca tcattttgtg tattaaggtt ctttcttccc\n",
      "     4081 ctgttctccg ccttcctgct tgtcatcttc actcatcagc tgaccatgtt gcctcttgtg\n",
      "     4141 gtgtaaactt gtaccagttt tacggtccct ctggccagtt cacccatgaa tttgatggag\n",
      "     4201 atgagcagtt ctacgtggac ctggagaaga aggagactgc ctggcggtgg cctgagttca\n",
      "     4261 gcaaatttgg aggttttgac ccgcagggtg cactgagaaa catggctgtg gcaaaacaca\n",
      "     4321 acttgaacat catgattaaa cgctacaact ctaccgctgc taccaatggt atgcgtccac\n",
      "     4381 cattctgcct ctctttactt aagctatccc ttcataccag ggttcattat tttcttccca\n",
      "     4441 agaggtcccc agatcttctt atggcaattg ctgaaatttt atcatctccc atctctaaaa\n",
      "     4501 tcacatattc ccatgtaata caagggtctt tccattatgc attcagcaaa tccttctagg\n",
      "     4561 agaggtctca tcaacctcct actttattaa acatgcccac agagagaagg gcacaggaat\n",
      "     4621 aaagcagagg caatgtgtca ttgctcccaa gcagaaggta aataagacct ctttgactat\n",
      "     4681 caggtggtga aatgctggta ggagggctct tccaggatgt aatgcagaac ttcagggcag\n",
      "     4741 agctattcac acttcacacc agtgctgttt cctcaccaca gaggttcctg aggtcacagt\n",
      "     4801 gttttccaag tctcccgtga cactgtgtca gcccaacacc ctcatctgtc ttgtggacaa\n",
      "     4861 catctttcct cctgtggtca acatcacatg gctgagcaat gggcacgcag tcacagaagg\n",
      "     4921 tgtttctgag accagcttcc tctccaagag tgatcattcc ttcttcaaga tcagttacct\n",
      "     4981 caccttcctc ccttctgctg atgagattta tgactgcaag gtggagcact ggggcctgga\n",
      "     5041 ccagcctctt ctgaaacact ggggtaagga tgagtttcat cattttttga ttctttcttg\n",
      "     5101 tctgtcaggt tcagaacttc ctgcctttta ctcctatatc caaaaacttg ttttccacac\n",
      "     5161 ttcatgggtt tcttttctgt ctcacttttt tttttgaaag aataaagcaa aaaaagcaga\n",
      "     5221 gatttattga aaatgaaagt acactctaca ggatgggagt gggcctgcca cttcatggtt\n",
      "     5281 ttctaatgat agacttcact ctcctcccta agctgggggc cttgagtctt tgtagagcca\n",
      "     5341 accctgtacc ccatcccatc ccacacacat gcacatgagc aaactctgca ttctgacctc\n",
      "     5401 aacaacttca cttccacaga gcctgagatt ccagccccta tgtcagagct cacagagact\n",
      "     5461 gtggtctgtg ccctggggtt gtctgtgggc ctcgtgggca ttgtggtggg cactgtcttc\n",
      "     5521 atcatccaag gcctgcgttc agttggtgct tccagacacc aagggccctt gtgaatccca\n",
      "     5581 tcctggaagg gaaggtaaga ttgagactgg ttacagttga agcggcagta tgaaaggaag\n",
      "     5641 gaaagtggga ggg\n",
      "//\n",
      "\n",
      "LOCUS       OR880477                5730 bp    DNA     linear   PRI 12-DEC-2023\n",
      "DEFINITION  Homo sapiens isolate N-23-17675-A-02-00 MHC class II antigen\n",
      "            (HLA-DQA1) gene, HLA-DQA1*04NEW allele, complete cds.\n",
      "ACCESSION   OR880477\n",
      "VERSION     OR880477.1\n",
      "KEYWORDS    .\n",
      "SOURCE      Homo sapiens (human)\n",
      "  ORGANISM  Homo sapiens\n",
      "            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\n",
      "            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\n",
      "            Catarrhini; Hominidae; Homo.\n",
      "REFERENCE   1  (bases 1 to 5730)\n",
      "  AUTHORS   Velickovic,M.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (27-NOV-2023) New South Wales Transplantation and\n",
      "            Immunogenetics Services Pathology and Clinical Governance,\n",
      "            Australian Red Cross Lifeblood, 17 O'Riordan Street Alexandria NSW\n",
      "            2015, Sydney, NSW 2060, Australia\n",
      "COMMENT     ##Assembly-Data-START##\n",
      "            Assembly Method       :: TSV v. 3.0.0.27232; created on 1/02/2023\n",
      "            Sequencing Technology :: Illumina\n",
      "            ##Assembly-Data-END##\n",
      "FEATURES             Location/Qualifiers\n",
      "     source          1..5730\n",
      "                     /organism=\"Homo sapiens\"\n",
      "                     /mol_type=\"genomic DNA\"\n",
      "                     /isolate=\"N-23-17675-A-02-00\"\n",
      "                     /db_xref=\"taxon:9606\"\n",
      "     gene            1..5730\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*04NEW\"\n",
      "     mRNA            join(1..341,4199..4444,4857..5138,5502..5730)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*04NEW\"\n",
      "                     /product=\"MHC class II antigen\"\n",
      "     exon            1..341\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*04NEW\"\n",
      "                     /number=1\n",
      "     5'UTR           1..259\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*04NEW\"\n",
      "     CDS             join(260..341,4199..4444,4857..5138,5502..5656)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*04NEW\"\n",
      "                     /codon_start=1\n",
      "                     /product=\"MHC class II antigen\"\n",
      "                     /protein_id=\"WPS91252.1\"\n",
      "                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASYGVNLYQSYGP\n",
      "                     SGQYTHEFDGDEQFYVDLGRKETVWCLPVLRQFRFDPQFALTNIAVTKHNLNILIKRS\n",
      "                     NSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGHSVTEGVSET\n",
      "                     SFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDEPLLKHWEPEIPAPMSELTETV\n",
      "                     VCTLGLSVGLVGIVVGTVFIIRGLRSVGASRHQGPL\"\n",
      "     intron          342..4198\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*04NEW\"\n",
      "                     /number=1\n",
      "     exon            4199..4444\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*04NEW\"\n",
      "                     /number=2\n",
      "     intron          4445..4856\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*04NEW\"\n",
      "                     /number=2\n",
      "     exon            4857..5138\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*04NEW\"\n",
      "                     /number=3\n",
      "     intron          5139..5501\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*04NEW\"\n",
      "                     /number=3\n",
      "     exon            5502..5730\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*04NEW\"\n",
      "                     /number=4\n",
      "     3'UTR           5657..5730\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*04NEW\"\n",
      "ORIGIN      \n",
      "        1 ctattcatag aatatttcct caagtccact ctgagtggag gctgcgtcac aaccagggga\n",
      "       61 tttccctgtc tccttccagg gctcttaata caaactcttc aactagtaac tgaggtgtca\n",
      "      121 tcatagggga gttttctaat tagccaaaac ctgacctggc agggtttggt ttgggtgtct\n",
      "      181 tcagatttgc ttgtctcgag gtcctcacaa ttgctctaca gctcagagca gcaactgctg\n",
      "      241 aggctgcctt gggaagagga tgatcctaaa caaagctctg ctgctggggg cccttgccct\n",
      "      301 gaccaccgtg atgagcccct gtggaggtga agacattgtg ggtgagtgca tgagtgaggg\n",
      "      361 atgttctctg gagctggaag agaggaaatc gaagaaaaga gagaaagcga ttttgcagag\n",
      "      421 aaattgtaga gatttcctaa gggccccttc agtattaaga gatttaaaaa ttacggctgt\n",
      "      481 ttctccttca ggaaaccaga gtcccaacct actctttttg ttatctatgc tgttggcgtt\n",
      "      541 cactaaggat gctattctgt ttatattgta ttcagtcact acagcctgga ggtctctatg\n",
      "      601 tcattccatc atgactgcct caaaaattgg tgaggtttcc atcagtcgat aattttttat\n",
      "      661 tattaaaaat ttgtgaagta tcattctcaa atttccctga acaacttttg aagcttttcg\n",
      "      721 gatgtctcct gtagtagacc ttggggtaaa tgattccatc aattatatac tctatagata\n",
      "      781 ttaagaaaga tgcccttttc tttctctcag acttacttac atttccacat gggaactggc\n",
      "      841 acaggtgggg agtgggtaaa ggagtccagc aggctgaatg ccttcaacaa tcattttacc\n",
      "      901 acatggtcct cacttactct cagctgcctc atttgtgtca cctcacaaat aatcaaataa\n",
      "      961 aatgggcatg tagttaagct ttgtaaatag tgaaaacatg aatgtcaatt ttatttttac\n",
      "     1021 atatttccat tataggagta gcttcacatt tcttttcttt agcaaaataa ggaatccttt\n",
      "     1081 tattttaaaa ttgagaattt atagtagaaa aacttgctaa attaaatcat tttgttctca\n",
      "     1141 aattatcaac ccaaattacc tgttgttcac ctcatctaat gaagtcctat aaaaagaaaa\n",
      "     1201 gtgggttaga catggtggct catgcctgta atcccagcac tttgggaggc tgaggcagga\n",
      "     1261 ggatcctttg agcccaggag ttcgagacca gcctgggcaa catagcaaga cctcatctct\n",
      "     1321 acaaaaaata aaaattagcc aggtgtggtg gtgcgtgcct gggtgccagc tactcagaag\n",
      "     1381 gctgcaatgg gaggactgct tgagtccagg aggcggaagc tgcagtgagc catgatggca\n",
      "     1441 ccactacact ccagccaggg caacagagag agaccctgtc ccaaaaagaa agaggaaaga\n",
      "     1501 aagagagaaa ggaaggaaag aaagaaagaa ggaagtaagg aaggaaagaa ggaaggaagg\n",
      "     1561 gagaagggga agggaaggga aggaaggaag gaaaggaaag ggaagggagg aaagaaggaa\n",
      "     1621 ggaaaaaaga aaaagaaaga aagtagaaag gaagaaagaa gaaagaaaga agaaagaaag\n",
      "     1681 gaaagaaaag agggaaggaa agaaagaaga aggaaggaag cacagattaa ttattaatta\n",
      "     1741 tttggtctct cttagtctcc tctgtctttg ttgtccatct cttcctaccc ctcttcatgc\n",
      "     1801 attcctttct ccctcttccc tttcaggatc catctctgac tccctgcttc tttatatgga\n",
      "     1861 cagtgggttt gtaaaacaaa agttgaaaaa tcagatagtt aaaaggtgaa gtgaactgga\n",
      "     1921 aggtctaaac ttccacaacc ttattaacca tggctgctcc cattctgatt ttgttcggca\n",
      "     1981 gtggaagttc cacctgcttc tccagagcac ttggcttctt tgttccaaat ttcctttctt\n",
      "     2041 caacctcaca ccagagtgcc ctggtcaggc tcggctcatc cattaggcac aacgtgggca\n",
      "     2101 atgcagagaa ccctccatac tgtaaagcca catgagaatg ttttaactcc ttttaagatt\n",
      "     2161 agaaaaaaat gaaatttcag agcccaagaa aatgttttaa ttcagcctag attgtattgt\n",
      "     2221 ctttatacca attcagtcat aaaatacaat tttccatatt tttatggagg aaggggccca\n",
      "     2281 caaaagcaag agtgcttagg gctcacatgt cagaacgcag ccctggtcat ggctgatcct\n",
      "     2341 ggccttcgta tgattctgct agtgtgcctg tccgtcttcc ccagaatcta tgtggtcctc\n",
      "     2401 aaatatagca actgtaattc aaaacacgtt tgagcacaca gtaagctaag ttttaaggat\n",
      "     2461 tcaaagacga aaagtcatgc tgtcttccct gcagagggtg ctcagactag tgatggaaac\n",
      "     2521 agtatgggat gcaggaaagc agaaggccat tgctgagcag ggcagtggac tcagcagagg\n",
      "     2581 ctgaaactat acaaatgact tggttccagc tgggccagca gggtgacatc ctccagcaaa\n",
      "     2641 actcggcacc caagacaagt cccagatgaa aagaaggatt gctttgtgtt tgataaggag\n",
      "     2701 tcaaggttta ttgcaaggat aagaaggctt tgttggtggc ctgttaagac catccagggc\n",
      "     2761 agtcatactg gataaggagg aaggtgagct ggaagaggaa cagacaaaca gccagatatt\n",
      "     2821 gagatggaag aggtggaggt cataacgtgg taaaaaatat gttgatgaga ggacttagct\n",
      "     2881 acaaagttgt taacttaagc ataaaccgca aggatgaatt ttaggatttc tccaggaagt\n",
      "     2941 cctaaaagat aatttcattt cagggagaaa aacaacaaac cactgcaaag accaggcaac\n",
      "     3001 acgaaaggat aatgtagttt tgtttgcttg gcagatactt atgaaagatg ttggactgta\n",
      "     3061 aggctgttga tagcctcctc acagaacgtg ctacagtaca ttgtatctac tcccttacct\n",
      "     3121 acctgactct tccactgttc agtttgtttc ttaatggtag accatgcctg attggtgttt\n",
      "     3181 tacacatccc ctgctatgtc tgacacttgt gaatgctcag aaagtgggga aggaaggaaa\n",
      "     3241 gatacaacag taaaaggctt acacgtcttg acaagaatgt ccagttcggc tcatttggct\n",
      "     3301 ggagccatat cgcatggctg ccattctgct ctggcatcct cagacaagca cactgcccat\n",
      "     3361 tagaggaaaa agggtttaat ttagctgagt cctcaagtga atataagtgt taagtcagaa\n",
      "     3421 cactgtagac atttagtaac ctccttcaga ggaaaaaaaa aaaaggtggg gggaaatgac\n",
      "     3481 agaaatccaa aaactagtag agcttccatt cttcatttca gaagaaatca gttgctctcc\n",
      "     3541 tctaaggatc attactatta acaaaacaga gaccttgaag gaggcattgt ttatttatta\n",
      "     3601 tatattttgt aatgttatta ccattcttgt tatactcttt cttataccct acaattgtta\n",
      "     3661 gcaaacatta ttttaaatta ataagatcct gcatgctttt ccttttttaa aaaaaagaaa\n",
      "     3721 gacctctgtg tagagtgtcc tgttctgagc cagtcctgag aggaaagaaa gtacaatcag\n",
      "     3781 tttgttatta actgatgaaa gaattaagtg aaagatgaat cttaggaagc agagggaagt\n",
      "     3841 aaacctagtc tctgactaag aaagctaaat accataataa ctcattcatt ccttcttttg\n",
      "     3901 ttcaattaca gtatttaatc gtaagtccat gatgtgccag gcactcagga aatagtaaaa\n",
      "     3961 actggacatg tgatattctg cccttgtgta gcacacatta tagtgggaaa gaaagcgcaa\n",
      "     4021 ttttaaccgg acaactacca acactaagag cggaggaagc aggggctgga aatgtccaca\n",
      "     4081 ggctgtgcca aagatgaagc tcgtaatatt tgaaagtcag tttcttccat cattttgtgt\n",
      "     4141 attaaggttc tttcttcccc tgttctccac cttcttgctt gtcatcttca ctcatcagct\n",
      "     4201 gaccatgttg cctcttatgg tgtaaacttg taccagtctt acggtccctc tggccagtac\n",
      "     4261 acccatgaat ttgatggaga cgagcagttc tacgtggacc tggggaggaa ggagactgtc\n",
      "     4321 tggtgtttgc ctgttctcag acaatttaga tttgacccgc aatttgcact gacaaacatc\n",
      "     4381 gctgtgacaa aacacaactt gaacatcctg attaaacgct ccaactctac tgctgctacc\n",
      "     4441 aatggtatgt gtccacaatt ctgcccctct ttactgatct atcccttcat accaagtttc\n",
      "     4501 attattttac ttccaagagg tccccagatc ttctcatggc aattgctgaa attctatcac\n",
      "     4561 ttcccatctc taaaatcaca tattcccatg taatacaagg gtctttccat tatccattca\n",
      "     4621 ttaaatcctt ctaggagagg tctcatcaac ctcctacttt attaaacatg cccacagaga\n",
      "     4681 gaagggcata ggaataaagc agaggcaatg tgtcgttgct cccaagcaga aggtaaataa\n",
      "     4741 gacctctttg actatcaggt ggtgaaatgc tggtaggagg gctcttccag gatgtaatgc\n",
      "     4801 agaagctcat ggcagagcta ttcacacttc acatcagtgc tgtttcctca ccacagaggt\n",
      "     4861 tcctgaggtc acagtgtttt ccaagtctcc cgtgacgctg ggtcagccca acaccctcat\n",
      "     4921 ctgtcttgtg gacaacatct ttcctcctgt ggtcaacatc acatggctga gcaatgggca\n",
      "     4981 ctcagtcaca gaaggtgttt ctgagaccag cttcctctcc aagagtgatc attccttctt\n",
      "     5041 caagatcagt tacctcacct tcctcccttc tgctgatgag atttatgact gcaaggtgga\n",
      "     5101 gcactggggc ctggacgagc ctcttctgaa acactggggt aaggatgagt tccaccactt\n",
      "     5161 tttgatgctt tcttgtctgt caagttcaga acttcctgcc ttttactcct atatcccaaa\n",
      "     5221 acttgttttt cacacttcat gggtttcttt ctttcttttg aaagaataaa gcaacaaaag\n",
      "     5281 caaagattta ttgaaaatga aagtacactt cacagggtgg gaacgggcct gagcataggg\n",
      "     5341 gctcaagagc cacttcatgg gtttctaatg atagacttca ctctcctccc taagctgagg\n",
      "     5401 accttgagtc tttgcagagc caaccctcca ccccatccca tcccacacac atgcacatga\n",
      "     5461 gcacactctg ctttctgacc tcaacgactt catatccaca gagcctgaga ttccagcccc\n",
      "     5521 tatgtcagag ctcacagaga ctgtggtctg caccctggga ttgtctgtgg gcctcgtggg\n",
      "     5581 cattgtggtg ggcactgtct tcatcatccg aggcctgcgt tcagttggtg cttccagaca\n",
      "     5641 ccaagggccc ttgtgaatcc catcctggaa gggaaggtaa gattgagatt tgttagagct\n",
      "     5701 gaatccgcag tatgagagga aggaaagtgg\n",
      "//\n",
      "\n",
      "LOCUS       OR880476                5633 bp    DNA     linear   PRI 12-DEC-2023\n",
      "DEFINITION  Homo sapiens isolate N-23-11753-B-02-00 MHC class II antigen\n",
      "            (HLA-DQA1) gene, HLA-DQA1*01NEW allele, complete cds.\n",
      "ACCESSION   OR880476\n",
      "VERSION     OR880476.1\n",
      "KEYWORDS    .\n",
      "SOURCE      Homo sapiens (human)\n",
      "  ORGANISM  Homo sapiens\n",
      "            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\n",
      "            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\n",
      "            Catarrhini; Hominidae; Homo.\n",
      "REFERENCE   1  (bases 1 to 5633)\n",
      "  AUTHORS   Velickovic,M.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (27-NOV-2023) New South Wales Transplantation and\n",
      "            Immunogenetics Services Pathology and Clinical Governance,\n",
      "            Australian Red Cross Lifeblood, 17 O'Riordan Street Alexandria NSW\n",
      "            2015, Sydney, NSW 2060, Australia\n",
      "COMMENT     ##Assembly-Data-START##\n",
      "            Assembly Method       :: TSV v. 3.0.0.27232; created on 1/02/2023\n",
      "            Sequencing Technology :: Illumina\n",
      "            ##Assembly-Data-END##\n",
      "FEATURES             Location/Qualifiers\n",
      "     source          1..5633\n",
      "                     /organism=\"Homo sapiens\"\n",
      "                     /mol_type=\"genomic DNA\"\n",
      "                     /isolate=\"N-23-11753-B-02-00\"\n",
      "                     /db_xref=\"taxon:9606\"\n",
      "     gene            1..5633\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "     mRNA            join(1..322,4093..4341,4755..5036,5393..5633)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /product=\"MHC class II antigen\"\n",
      "     exon            1..322\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=1\n",
      "     5'UTR           1..240\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "     CDS             join(241..322,4093..4341,4755..5036,5393..5547)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /codon_start=1\n",
      "                     /product=\"MHC class II antigen\"\n",
      "                     /protein_id=\"WPS91251.1\"\n",
      "                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASCGVNLYQFYGP\n",
      "                     SGQFTHEFDGDEQFYVDLEKKETAWRWPEFSKFGGFDPQGALRNMAVAKHNLNIMIKR\n",
      "                     YNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGHSVTEGVSE\n",
      "                     TSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDQPLLKHWEPEIPAPMSELTET\n",
      "                     VVCALGLSVGLVGIVVGTVFIIQGLRSVGASRHQGPL\"\n",
      "     intron          323..4092\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=1\n",
      "     exon            4093..4341\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=2\n",
      "     intron          4342..4754\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=2\n",
      "     exon            4755..5036\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=3\n",
      "     intron          5037..5392\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=3\n",
      "     exon            5393..5633\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=4\n",
      "     3'UTR           5548..5633\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "ORIGIN      \n",
      "        1 tcctcaagtc cactctgagt agaggctgca tcacaagggg attgccccgt ctccttccag\n",
      "       61 ggctcttaat acaaactctt caactagtaa ctgagatgtc accatagggg atttttctaa\n",
      "      121 ttggccaaaa cctgacttgg cagggtttgg tttgggtgtc ttcagatttc cttgtcttga\n",
      "      181 ggtcctcaca attactctac agctcagaac accaactgct gaggctgcct tgggaagagg\n",
      "      241 atgatcctaa acaaagctct gctgctgggg gccctcgctc tgaccaccgt gatgagcccc\n",
      "      301 tgtggaggtg aagacattgt gggtgagtgc atgagtgagg gatgttctct ggagctgaaa\n",
      "      361 aacagtaaat tgaaggaaaa gagataaagc gatttgcaga gaaactgtag agatttccta\n",
      "      421 agggcccttt cagtattaag acaattaaaa attatagctg ttcctccttc aggaaaccag\n",
      "      481 agccccaacc tactcttttt gttatctatg ctgttgtgtt cactaaggac gctattctgt\n",
      "      541 ttatattata ttcagtgact acggcctgga ggtctctatg tcgttccatc atgattgcct\n",
      "      601 caaaaattag tgaggtttcc atcagtggat aattttttat tattaaaaat ttatgaagtg\n",
      "      661 tcattctcaa atttccctga acaacttttg aagcttttcg gatgtctccg gtggtagatc\n",
      "      721 ttggggtcat tccatcaatt atgtactcta tagatattta aaatgttgcc cgtttctttc\n",
      "      781 tctcagactt actcacattt ccacatggga actggcacag gtggggagtg ggtaaaggag\n",
      "      841 tccagcaggc tgaatgcctt caacaatcat tttaccacat ggtcctcact tactctcagc\n",
      "      901 tgcctcatat gtgtcacctc acaagtaatc aaataaaatg ggcatgtggc taagctttgt\n",
      "      961 aaatagtgaa aacatgaatg tcaatttttt ttacatattt ctattacaga tatagcttca\n",
      "     1021 catttctttt ctttagcaaa ataagggatc attttatttt aaaattgaga agtagaaaaa\n",
      "     1081 attggtaaaa taaatcattt tattctcaaa ttatcaaccc aaattacctg ttcttcacct\n",
      "     1141 catctaataa agtcctataa aaagaaaagt gggccagaca aggtggctca tgcctgtaat\n",
      "     1201 cccagcactt tgggaggccg aggcaggagg atcatttgag cctgggagct tgagaccagc\n",
      "     1261 ctgggcaaca tagcaagacc tcatctctac aaaaaaagaa aaagaaaaat tagccaggca\n",
      "     1321 tggtggtgtg tgcctgtggt gccagctact cagaaggctg ccgtgggagg accacttgag\n",
      "     1381 tccatgaggc ggaagctgca gtgagccatg atggcaccac tacactccag ccagggcaac\n",
      "     1441 agagagagac gctgtctcaa aaagaaagag gaaagaaagc gaggaaggaa ggaaggaagg\n",
      "     1501 agaaggaagg aaggaaggaa aagaaaagaa aagggaaggg aggaaggaag gaaaaaagaa\n",
      "     1561 agacagaaag aaagaggaag gaaggaagga aggaagcaca gattaattat ttggtctctt\n",
      "     1621 actctcctct gcctttgtcg tccatctctt tccacctctc ttcatgcatc cctttctccc\n",
      "     1681 tcttcccttt caggatccat ctctggctcc ctgctccttt atagagatgg acagtgggtt\n",
      "     1741 tgtaaaacaa aagttgaaaa gtcagatagt taaaagggga agtgaactgg aaggtacttt\n",
      "     1801 aaactttcac aactttatta accgtggctg ctcccattat gattttgttc ggcagtggaa\n",
      "     1861 gtttcacctg cttctccaga gcacttggcg tctttgttcc aaatttcctt tcttcaacct\n",
      "     1921 cacaccagag tgccctggtc aggcttggct cattcattag gcacaatgtg ggcagtgcag\n",
      "     1981 gggaccctcc atactgtaaa gccacatgag aaggttttaa ctcgttttaa aattagaaaa\n",
      "     2041 ataatggaat attagagcct aagaaaatgt tttaactttt aattcagcct agattatatt\n",
      "     2101 gtctttatac caattcagtc ataaaatata attttccata tttttgtgga ggaagaggcc\n",
      "     2161 catacaagca agaatgctcg gggctcacat gtcagaatgc agccttggtc atgactgatc\n",
      "     2221 ctggccttcg tatggttctg ctacctgtgt gcctgcccgt cttccccaaa atctatgtgg\n",
      "     2281 tcctcgaata tagcaactgt cattcaatac acatgtttga gcacacagtg agctaagttt\n",
      "     2341 taaggattca aagatgaaaa gtcatgctgt cttccctgca gagggtgctc agattagtga\n",
      "     2401 tggaaacagt atggggtgca ggaaagcaga aggccattgc tgagcaggtc agtggaccca\n",
      "     2461 gcagaggctg aaacaataca agtgacttgg ttccaggtgg gccagcaggg tgacgtcctc\n",
      "     2521 tagcaaaatt tggcacccaa gacaagtacc agaagaaaag aaagactgca tgtattccac\n",
      "     2581 atatattcat gtttgaacaa ggagtcaaga tttatggcaa ggataaggag gctttgttgg\n",
      "     2641 tgacctgtta agaccaacca gggcagtcat gctggatagg gaagaaggtg agctggaaga\n",
      "     2701 ggaacagaca acttggacag ccagatgttg agacggaggg gttggaggtc ataatgtggt\n",
      "     2761 caaaaacatg ttgatgagag gactcagcta caaagttgtt aacttaagca gaaacctcaa\n",
      "     2821 ggatggattt tagaatttct ccaggaagtc ctaaaagata attccatttc agggagaaaa\n",
      "     2881 acaacagacc actgcaaaga ccagggaaca tgaaaggata atgtagtttg tcttgcttgg\n",
      "     2941 cagatacttt tgaaggatgt tggactgtaa ggctgtcgat atcctcctca gagaacttac\n",
      "     3001 tacagtacat tgtatctgtt cccttaccta cctgactctt ccactattca gtttgttcct\n",
      "     3061 taatagtaga ccatgcctga ttggtgtttt acacatctcc ggctatgtct gacacttgtg\n",
      "     3121 gatgctcaga aagtggggaa ggaaggaaag atacgatggt aaaaggctta cacatgtctt\n",
      "     3181 gacaaaaaag tccagtttgg ctcatttggc tggagtcgta ctgcatggct gccattctgc\n",
      "     3241 tctggcatcc tcagacaagc acactgccca ttagaggaaa aagtgtgata taagtgttga\n",
      "     3301 gtcagaatgc tgtagacatt tagtaatctc cttcacagga aaaaaaaaaa aaaggtgggg\n",
      "     3361 ggaatgacag aaatccaaaa actagtagag cttccacttt tcatttcaga agaaatcagt\n",
      "     3421 tgctctcctc taaggaccat tactattaac aaaacagaga ccttagaagg aggcattgtt\n",
      "     3481 tatttattat atattttgta atgttattac caatcttgtt atactctttc ttatacccta\n",
      "     3541 caattgttag cagaaattat tttaaattaa taagatcctg catgcttttc ctttaaaaaa\n",
      "     3601 aaaaaaaaag aaagatctct gtgtagagtg tcctattctg agccagtcct gagaggaaag\n",
      "     3661 gaagtataat caatttgtta ttaaccaatg aaagaattaa gtgaaagata aatctcagga\n",
      "     3721 agcagaggga agtaaaccta atttctgact aagaaagcta aatactatga taactcattc\n",
      "     3781 attccttctt ttgttcaatt acattattta atcataagtc catgacatgc caggcactca\n",
      "     3841 ggaaatagta aaaattggac atgcgatatt ctgcccttgt gtagcgcaca ctagagtggg\n",
      "     3901 aaagaaagtg cacttttaac tggacaacta ccaacatgat gaggggagga aacaggggct\n",
      "     3961 ggaaatgtcc acggactgtg ccgaaaaatg aagcccataa tatttgaaag tcagtttctt\n",
      "     4021 ccatcatttt gtgtattaag gttctttctt cccctgttct ccgccttcct gcttgtcatc\n",
      "     4081 ttcactcatc agctgaccat gttgcctctt gtggtgtaaa cttgtaccag ttttacggtc\n",
      "     4141 cctctggcca gttcacccat gaatttgatg gagatgagca gttctacgtg gacctggaga\n",
      "     4201 agaaggagac tgcctggcgg tggcctgagt tcagcaaatt tggaggtttt gacccgcagg\n",
      "     4261 gtgcactgag aaacatggct gtggcaaaac acaacttgaa catcatgatt aaacgctaca\n",
      "     4321 actctaccgc tgctaccaat ggtatgcgtc caccattctg cctctcttta cttaagctat\n",
      "     4381 cccttcatac cagggttcat tattttcttc ccaagaggtc cccagatctt cttatggcaa\n",
      "     4441 ttgctgaaat tttatcatct cccatctcta aaatcacata ttcccatgta atacaagggt\n",
      "     4501 ctttccatta tgcattcagc aaatccttct aggagaggtc tcatcaacct cctactttat\n",
      "     4561 taaacatgcc cacagagaga agggcacagg aataaagcag aggcaatgtg tcattgctcc\n",
      "     4621 caagcagaag gtaaataaga cctctttgac tatcaggtgg tgaaatgctg gtaggagggc\n",
      "     4681 tcttccagga tgtaatgcag aacttcaggg cagagctatt cacacttcac accagtgctg\n",
      "     4741 tttcctcacc acagaggttc ctgaggtcac agtgttttcc aagtctcccg tgacactggg\n",
      "     4801 tcagcccaac accctcatct gtcttgtgga caacatcttt cctcctgtgg tcaacatcac\n",
      "     4861 atggctgagc aatgggcact cagtcacaga aggtgtttct gagaccagct tcctctccaa\n",
      "     4921 gagtgatcat tccttcttca agatcagtta cctcaccttc ctcccttctg ctgatgagat\n",
      "     4981 ttatgactgc aaggtggagc actggggcct ggaccagcct cttctgaaac actggggtaa\n",
      "     5041 ggatgagttt catcattttt tgattctttc ttgtctgtca ggttcagaac ttcctgcctt\n",
      "     5101 ttactcctat atccaaaaac ttgttttcca cacttcatgg gtttcttttc tgtctcactt\n",
      "     5161 ttttttttga aagaataaag caaaaaaagc agagatttat tgaaaatgaa agtacactct\n",
      "     5221 acaggatggg agtgggcctg ccacttcatg gttttctaat gatagacttc actctcctcc\n",
      "     5281 ctaagctggg ggccttgagt ctttgtagag ccaaccctgt accccatccc atcccacaca\n",
      "     5341 catgcacatg agcaaactct gcattctgac ctcaacaact tcacttccac agagcctgag\n",
      "     5401 attccagccc ctatgtcaga gctcacagag actgtggtct gtgccctggg gttgtctgtg\n",
      "     5461 ggcctcgtgg gcattgtggt gggcactgtc ttcatcatcc aaggcctgcg ttcagttggt\n",
      "     5521 gcttccagac accaagggcc cttgtgaatc ccatcctgga agggaaggta agattgagac\n",
      "     5581 tggttacagt tgaagcggca gtatgaaagg aaggaaagtg ggagggcgtt gtg\n",
      "//\n",
      "\n",
      "LOCUS       OR880475                5589 bp    DNA     linear   PRI 12-DEC-2023\n",
      "DEFINITION  Homo sapiens isolate N-23-3542-B-02-00 MHC class II antigen\n",
      "            (HLA-DQA1) gene, HLA-DQA1*03NEW allele, complete cds.\n",
      "ACCESSION   OR880475\n",
      "VERSION     OR880475.1\n",
      "KEYWORDS    .\n",
      "SOURCE      Homo sapiens (human)\n",
      "  ORGANISM  Homo sapiens\n",
      "            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\n",
      "            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\n",
      "            Catarrhini; Hominidae; Homo.\n",
      "REFERENCE   1  (bases 1 to 5589)\n",
      "  AUTHORS   Velickovic,M.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (27-NOV-2023) New South Wales Transplantation and\n",
      "            Immunogenetics Services Pathology and Clinical Governance,\n",
      "            Australian Red Cross Lifeblood, 17 O'Riordan Street Alexandria NSW\n",
      "            2015, Sydney, NSW 2060, Australia\n",
      "COMMENT     ##Assembly-Data-START##\n",
      "            Assembly Method       :: TSV v. 3.0.0.27232; created on 1/02/2023\n",
      "            Sequencing Technology :: Illumina\n",
      "            ##Assembly-Data-END##\n",
      "FEATURES             Location/Qualifiers\n",
      "     source          1..5589\n",
      "                     /organism=\"Homo sapiens\"\n",
      "                     /mol_type=\"genomic DNA\"\n",
      "                     /isolate=\"N-23-3542-B-02-00\"\n",
      "                     /db_xref=\"taxon:9606\"\n",
      "     gene            1..5589\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*03NEW\"\n",
      "     mRNA            join(1..342,4040..4288,4734..5015,5363..5589)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*03NEW\"\n",
      "                     /product=\"MHC class II antigen\"\n",
      "     exon            1..342\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*03NEW\"\n",
      "                     /number=1\n",
      "     5'UTR           1..260\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*03NEW\"\n",
      "     CDS             join(261..342,4040..4288,4734..5015,5363..5517)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*03NEW\"\n",
      "                     /codon_start=1\n",
      "                     /product=\"MHC class II antigen\"\n",
      "                     /protein_id=\"WPS91250.1\"\n",
      "                     /translation=\"MILNKALMLGALALTTVMSPCGGEDIVADHVASYGVNLYQSYGP\n",
      "                     SGQYSHEFDGDEEFYVDLERKETVWQLPLFRRFRRFDPQFALTNIAVLKHNLNIVIKR\n",
      "                     SNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGHSVTEGVSE\n",
      "                     TSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDEPLLKHWEPEIPTPMSELTET\n",
      "                     VVCALGLSVGLVGIVVGTVLIIRGLRSVGASRHQEPL\"\n",
      "     intron          343..4039\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*03NEW\"\n",
      "                     /number=1\n",
      "     exon            4040..4288\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*03NEW\"\n",
      "                     /number=2\n",
      "     intron          4289..4733\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*03NEW\"\n",
      "                     /number=2\n",
      "     exon            4734..5015\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*03NEW\"\n",
      "                     /number=3\n",
      "     intron          5016..5362\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*03NEW\"\n",
      "                     /number=3\n",
      "     exon            5363..5589\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*03NEW\"\n",
      "                     /number=4\n",
      "     3'UTR           5518..5589\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*03NEW\"\n",
      "ORIGIN      \n",
      "        1 tctgttcata gaacaattcc tcaagtccac tctgagtaga ggctgcatca caacaagggg\n",
      "       61 attgccctgt ctccttccag ggctcttaat acaaactctt cagctagtaa ctgagatgtc\n",
      "      121 accatggggg atttttctaa ttggccaaaa cctgacctgg cagggtttgg tttgggtgtc\n",
      "      181 ttcagatttc cttgtcttga ggccctcaca attgctctac agctcagaac agcaactgct\n",
      "      241 gaggctgcct tgggaagagg atgatcctaa acaaagctct gatgctgggg gccctcgccc\n",
      "      301 tgaccaccgt gatgagccct tgtggaggtg aagacattgt gggtgagtgc atgagtgagg\n",
      "      361 aatgttctct ggagctgaaa aacagtaaat tgaaggaaaa gagagaaagc gatttgcaga\n",
      "      421 gaaattgtag agatttccta agaccccttt cagtattaag agaattaaaa attatagctg\n",
      "      481 ttcctccttc aggaaaccag agccccaacc tactcttttt gttatgtatg cttttgtgtt\n",
      "      541 cactaaggat gctattctgt ttatattata ttcagtgaca acagcctgga ggtctctatg\n",
      "      601 tcgttccgtc atgattgcct caaaaattag tgaagtttcc atcagtggat aattttttat\n",
      "      661 tattaaaaat gtatgaagtg tcattctcaa atttccctga acaacttttg aagcttttcg\n",
      "      721 tatgtctcct gtagtagatc ttggggtcgt tccatcaatt atatactcta tagatattaa\n",
      "      781 aaaagttgcc cgtttctttc tctcagactt actcacattt ccacatggga actggcacag\n",
      "      841 gtggggagtg ggtaaaggag tccagcaggc tgaatgcctt caacaatcat tttaccacat\n",
      "      901 ggtcctcact tactctcagc tgcctcatat gtgtcacctc acaaataatc aaataaaatg\n",
      "      961 ggcatgtagc taagctttgt aaatagtgaa aacatggatg tcaattgttt ttacatattt\n",
      "     1021 ctattacagg tatagcttca catttttctt tagcaaaata agggatcctt ttagtttaaa\n",
      "     1081 attgagaagt agaaaaaatt ggtaaattaa atcattttat tctcaaatta tcaacccaaa\n",
      "     1141 ttacctgttc ttcacctcat ctaataaagt cctataaaaa gaaaagtggg ccagacatgg\n",
      "     1201 tggctcatgc ctgtaatccc agcactttgg gaggccgaag caggaggatc atttgagcct\n",
      "     1261 gggagtttga gaccagcctg ggcaacatag caagacctca tctctaccaa aaaataaaat\n",
      "     1321 aaaaattagc caggtgtggt ggtgcatgcc tgtggtgcca gctactcaga aggctgcagt\n",
      "     1381 gggaggagca cttgagtcca ggaggtggaa gctgcagtga gccatgatgg caccactaca\n",
      "     1441 ctccagccag ggcaacagag agagactctg tctcaaaaag aaagaggaaa gaaagagaga\n",
      "     1501 aaggaaggaa agaaggaaag aaggaaggaa ggaaggagaa agggaaggga ggaaggaaaa\n",
      "     1561 aagaaagaaa gaaagaaaac ggaaggaagg aagcacagat taattatttg gtctctttgt\n",
      "     1621 ctcctctgcc tttgtcgtcc atctcttccc acctctcttc atgcattcct ttctccctct\n",
      "     1681 tccctttcag gatccatctc tgactccctg ctcctttata gagatggaca gtgagtttgt\n",
      "     1741 aaaacaaaag ttgaaaagtc agatagttaa aaggggaagt gaactggaag gtactctaaa\n",
      "     1801 ctttcacaac cttattaacc atggctgctc ccattctgat tttgttcagc agtggaagtt\n",
      "     1861 tcacccgctc ctccagagcg cttggcttct ttgttccaaa tttcctttct tcaacctcac\n",
      "     1921 accagagtgc cctggtcagg ctcagctcat ccattaggca caatgtgggc agtgcagggg\n",
      "     1981 accctccaga ctgtaaagcc acatgagaat gttttaactc cttttaaaat tataaaaaaa\n",
      "     2041 tgaaattgta gagcctaaga aaatgtttta acttttaatt cagcctagat tatattgtct\n",
      "     2101 ttataccaat tcagtcataa aatatagttt tccatatttt tatggaggaa ggcgtccaca\n",
      "     2161 caagcaagag tgcttggggc tcacatgtca gaacgcaacc ctgatcatgg ctgatcctgg\n",
      "     2221 ccttcgtgtg gttctgctaa ctatgtgcct gtcagtcttc cccaaaatct atgtggtcct\n",
      "     2281 caaatataac aactgtcatt caatacacat gtttgagcac ccagtgagct aagttttaag\n",
      "     2341 gattcaaaga tgaaaagtca tgctgtctcc tctgcaaagg gtgctcagac tagtgatgga\n",
      "     2401 aacagtatgg gatgaaagaa agcagaaggc cattgctgag caggcagtgg actcagcaga\n",
      "     2461 ggctgaaact atacaagtga cttggttcca gctgggccag caggataacc agatgaaaag\n",
      "     2521 aaggattgca tatattccat atatatttat gtttgaacaa agagtcaagg tttattgcaa\n",
      "     2581 ggataaggag gttttgttgg tggcctgtta agaccatcca gggtggtcat actggatagg\n",
      "     2641 gaagaaggtg agctggaaga ggaacagaca aacttggatg gccagatgtt gagatggagg\n",
      "     2701 agatggaggt cataacgtgg tcaaaaacat gttgatgaga ggacttagct acaaagttgt\n",
      "     2761 taacttaagc agaaacctca aggattgatt ttatgatttc tccaggaagt cctaaaagtt\n",
      "     2821 aatttcattt cagggagaaa aacaacagac cactgcaaag accaggaaca tgaaaggata\n",
      "     2881 atgtagtttg gtttgcttgg cagatacttg tgaaagatgt tggactgtaa ggctgtcaat\n",
      "     2941 atcctcctcg cagaacttac tacagtacat tgtatctgct cccttaccta cctgactctc\n",
      "     3001 ccactattca gtttgttcct taatggtaga ccatgcctga tcggtgtttt acacatcccc\n",
      "     3061 tgctatgtct gatacttgtg gatgctcaga aagtggggaa ggaaggaaag atacgatggt\n",
      "     3121 aaaaggctta cacatgtctt gagcagaatg ttcagtttgg ctcatttggc tggagtcata\n",
      "     3181 ctgcatggct gccattctgc tctggcatcc tcagagaagc acactgccca ttaaaggaaa\n",
      "     3241 aagggtgaat acaaatgttg agtcagaaca ctgcagacat ttagtaacct ccttcagagg\n",
      "     3301 aaaaaaaaag gtggggggaa tgacagaaat ccaaaaacta gtagagcttc cactttttca\n",
      "     3361 tttcagaaga aatcagttac tctcctctaa ggaccattac tattaacaaa acagagacct\n",
      "     3421 tagaaggaag cattatttac ttatcatata ttttgtaatg ttattaccct tcttgttata\n",
      "     3481 ctctttctta taccctacca ttgttagcag aaattatttt aaattaataa gatcctgcat\n",
      "     3541 gcttttcctt tttctaaaaa aagaaagatc tctgtgtaga atgtcctgtt ctgagccagt\n",
      "     3601 cctgagagga aaggaagtat aatcaatttg ttattaactg atgaaagaat taagtgaaag\n",
      "     3661 ataaacctta ggaagcagag ggaagttaat ctatgactaa gaaagttaag tactctgata\n",
      "     3721 actcattcat tccttctttt gttcatttac attatttaat cacaagtcta tgatgtgcca\n",
      "     3781 ggcactcagg aaatagtgaa aattggacac gcgatattct gcccttgtgt agcacacacc\n",
      "     3841 gtagtgggaa agaaagtgca cttttaaccg gacaactatc aacacgaaga ggggaggaag\n",
      "     3901 caggggctgg aaatgtccac agactttgcc aaagacaaag cccataatat ctgaaagtca\n",
      "     3961 gtttcttcca tcattttgtg tattaaggtt ctttattccc ctgttctctg ccttcctgct\n",
      "     4021 tgtcatcttc actcatcagc tgaccatgtt gcctcttacg gtgtaaactt gtaccagtct\n",
      "     4081 tatggtccct ctgggcagta cagccatgaa tttgatggag acgaggagtt ctatgtggac\n",
      "     4141 ctggagagga aggagactgt ctggcagttg cctctgttcc gcagatttag aagatttgac\n",
      "     4201 ccgcaatttg cactgacaaa catcgctgtg ctaaaacata acttgaacat cgtgattaaa\n",
      "     4261 cgctccaact ctaccgctgc taccaatggt atgtgtccac cattctgcct ttctttactg\n",
      "     4321 atttatccct ttataccaag tttcattatt ttctttccaa gaggtcccca gatcttctca\n",
      "     4381 tggcaattgc tgaaatttta tcatttctca tctctaaaat cacatattcc aatgtaatac\n",
      "     4441 aagggtcttt ccattatgca ttcattaaat ccttctagga gaggtctcat caaccttcta\n",
      "     4501 ctttattaaa catgcccaca gagagaaggg cacaggagta aagcagaggc aatgtgtcgt\n",
      "     4561 tgctcccaaa tgtgtcgtta caatgtgtcg ttgcttaccc aaagaggtaa ataaggcctc\n",
      "     4621 tttgaccagc aggagaggaa atgctggtag gaagactctt ccaggatgta atgcagaaga\n",
      "     4681 agctcagggc agagctattc acactttaca ccagtgctgt ttcctcacca tagaggttcc\n",
      "     4741 tgaggtcaca gtgttttcca agtctcccgt gacactgggt cagcccaaca ccctcatctg\n",
      "     4801 tcttgtggac aacatctttc ctcctgtggt caacatcacc tggctgagca atgggcactc\n",
      "     4861 agtcacagaa ggtgtttctg agaccagctt cctctccaag agtgatcatt ccttcttcaa\n",
      "     4921 gatcagttac ctcaccttcc tcccttctgc tgatgagatt tatgactgca aggtggagca\n",
      "     4981 ctggggcctg gatgagcctc ttctgaaaca ctggggtaag gatgagtttc accatttttt\n",
      "     5041 gatgctttct tgtctgtcaa gttcagaact tcctgccttt tactctatat cccaaaactt\n",
      "     5101 gttttccaca cttcatgagt ttcttttgtc ttttttttga aagaattaag caacaaaagc\n",
      "     5161 acagatttat taaaaaagaa agtacactcc acagggtggg agcaggcctg ccacttcatg\n",
      "     5221 ggtttctaat aacagacttc actctcctcc ctaagctggg ggccttgagt ctttgcagag\n",
      "     5281 ccaaccctct accccatccc atcccacaca catgcacatg agcaaactct gcattctgac\n",
      "     5341 ctcaacaact tcacttccac agagcctgag attccaacac ctatgtcaga gctcacagag\n",
      "     5401 actgtggtct gcgccctggg gttgtctgtg ggcctcgtgg gcattgtggt ggggaccgtc\n",
      "     5461 ttgatcatcc gaggcctgcg ttcagttggt gcttccagac accaagagcc cttgtgaatc\n",
      "     5521 ccatcctgaa aaggaaggta agattgagat ttgttagagc tgaagctgca ggaaggaaag\n",
      "     5581 tgggaggag\n",
      "//\n",
      "\n",
      "LOCUS       OR880474                5622 bp    DNA     linear   PRI 12-DEC-2023\n",
      "DEFINITION  Homo sapiens isolate N-23-2330-A-02-00 MHC class II antigen\n",
      "            (HLA-DQA1) gene, HLA-DQA1*01NEW allele, complete cds.\n",
      "ACCESSION   OR880474\n",
      "VERSION     OR880474.1\n",
      "KEYWORDS    .\n",
      "SOURCE      Homo sapiens (human)\n",
      "  ORGANISM  Homo sapiens\n",
      "            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\n",
      "            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\n",
      "            Catarrhini; Hominidae; Homo.\n",
      "REFERENCE   1  (bases 1 to 5622)\n",
      "  AUTHORS   Velickovic,M.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (27-NOV-2023) New South Wales Transplantation and\n",
      "            Immunogenetics Services Pathology and Clinical Governance,\n",
      "            Australian Red Cross Lifeblood, 17 O'Riordan Street Alexandria NSW\n",
      "            2015, Sydney, NSW 2060, Australia\n",
      "COMMENT     ##Assembly-Data-START##\n",
      "            Assembly Method       :: TSV v. 3.0.0.27232; created on 1/02/2023\n",
      "            Sequencing Technology :: Illumina\n",
      "            ##Assembly-Data-END##\n",
      "FEATURES             Location/Qualifiers\n",
      "     source          1..5622\n",
      "                     /organism=\"Homo sapiens\"\n",
      "                     /mol_type=\"genomic DNA\"\n",
      "                     /isolate=\"N-23-2330-A-02-00\"\n",
      "                     /db_xref=\"taxon:9606\"\n",
      "     gene            1..5622\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "     mRNA            join(1..339,4109..4357,4771..5052,5409..5622)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /product=\"MHC class II antigen\"\n",
      "     exon            1..339\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=1\n",
      "     5'UTR           1..257\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "     CDS             join(258..339,4109..4357,4771..5052,5409..5563)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /codon_start=1\n",
      "                     /product=\"MHC class II antigen\"\n",
      "                     /protein_id=\"WPS91249.1\"\n",
      "                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASCGVNLYQFYGP\n",
      "                     SGQYTHEFDGDEQFYVDLERKETAWRWPEFSKFGGFDPQGALRNMAVAKHNLNIMIKR\n",
      "                     YNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGQSITEGVSE\n",
      "                     TSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDQPLLKHWEPEIPAPMSELTET\n",
      "                     VVCALGLSVGLMGIVVGTVFIIQGLRSVGASRHQGPL\"\n",
      "     intron          340..4108\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=1\n",
      "     exon            4109..4357\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=2\n",
      "     intron          4358..4770\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=2\n",
      "     exon            4771..5052\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=3\n",
      "     intron          5053..5408\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=3\n",
      "     exon            5409..5622\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "                     /number=4\n",
      "     3'UTR           5564..5622\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*01NEW\"\n",
      "ORIGIN      \n",
      "        1 tttattcata gaacaattcc tcaagtccac tctgagtaga ggctgcatca caaggggatt\n",
      "       61 gccccgtctc cttccagggc tcttaataca aactcttcaa ctagtaactg agatgtcacc\n",
      "      121 ataggggatt tttctaattg gccaaaacct gacttggcag ggtttggttt gggtgtcttc\n",
      "      181 agatttcctt gtcttgaggt cctcacaatt actctacagc tcagaacacc aactgctgag\n",
      "      241 gctgccttgg gaagaggatg atcctaaaca aagctctgct gctgggggcc ctcgctctga\n",
      "      301 ccaccgtgat gagcccctgt ggaggtgaag acattgtggg tgagtgcatg agtgagggat\n",
      "      361 gttctctgga gctgaaaaac agtaaattga aggaaaagag ataaagcgat ttgcagagaa\n",
      "      421 actgtagaga tttcctaagg gccctttcag tattaagaca attaaaaatt atagctgttc\n",
      "      481 ctccttcagg aaaccagagc cccaacctac tctttttgtt atctatgctg ttgtgttcac\n",
      "      541 taaggacgct attctgttta tattatattc agtgactacg gcctggaggt ctctatgtcg\n",
      "      601 ttccatcatg attgcctcaa aaattagtga ggtttccatc agtggataat tttttattat\n",
      "      661 taaaaattta tgaagtgtca ttctcaaatt tccctgaaca acttttgaag cttttcggat\n",
      "      721 gtctccggtg gtagatcttg gggtcattcc atcaattatg tactctatag atatttaaaa\n",
      "      781 tgttgcccgt ttctttctct cagacttact cacatttcca catgggaact ggcacaggtg\n",
      "      841 gggagtgggt aaaggagtcc agcaggctga atgccttcaa caatcatttt accacatggt\n",
      "      901 cctcacttac tctcagctgc ctcatatgtg tcacctcaca agtaatcaaa taaaatgggc\n",
      "      961 atgtggctaa gctttgtaaa tagtgaaaac atgaatgtca atttttttta catatttcta\n",
      "     1021 ttacagatat agcttcacat ttcttttctt tagcaaaata agggatcatt ttattttaaa\n",
      "     1081 attgagaagt agaaaaaatt ggtaaaataa atcattttat tctcaaatta tcaacccaaa\n",
      "     1141 ttacctgttc ttcacctcat ctaataaagt cctataaaaa gaaaagtggg ccagacaagg\n",
      "     1201 tggctcatgc ctgtaatccc agcactttgg gaggccgagg caggaggatc atttgagcct\n",
      "     1261 gggagcttga gaccagcctg ggcaacatag caagacctca tctctacaaa aaaagaaaaa\n",
      "     1321 taaaaattag ccaggcatgg tggtgtgtgc ctgtggtgcc agctactcag aaggctgccg\n",
      "     1381 tgggaggacc acttgagtcc atgaggcgga agctgcagtg agccatggtg gcaccactac\n",
      "     1441 actccagcca gggcaacaga gagaggcgct gtctcaaaaa gaaagaggaa agaaagcgag\n",
      "     1501 gaaggaagga aggaaggaga aggaaggaag gaaggaaaag aaaagaaaag ggaagggagg\n",
      "     1561 aaggaaggga aaaagaaaga cagaaagaaa gaggaaggaa ggaagaaagg aagcacagat\n",
      "     1621 taattatttg gtctcttact ctcctctgcc tttgtcgtcc atctctttcc acctctcttc\n",
      "     1681 atgcatccct ttctccctct tccctttcag gatccatctc tgactccctg ctcctttata\n",
      "     1741 gagatggaca gtgggtttgt aaaacaaaag ttgaaaagtc agatagttaa aaggggaagt\n",
      "     1801 gaactggaag gtactttaaa ctttcacaac tttattaacc gtggctgctc ccattatgat\n",
      "     1861 tttgttcggc agtggaagtt tcacctgctt ctccagagcg cttggcgtct ttgttccaaa\n",
      "     1921 tttcctttct tcaacctcac accagagtgc cctggtcagg cttggctcat tcattaggca\n",
      "     1981 caatgtgggc agtgcagggg accctccata ctgtaaagcc acatgagaag gttttaactc\n",
      "     2041 cttttaaaat tagaaaaata atggaatatt agagcctaag aaaatgtttt aacttttaat\n",
      "     2101 tcagcctaga ttatattgtc tttataccaa ttcagtcata aaatataatt ttccatattt\n",
      "     2161 ttgtggagga agaggcccat acaagcaaga atgctcgggg ctcacatgtc agaatgcagc\n",
      "     2221 cttggtcatg actgatcctg gccttcgtat ggttctgcta cctgtgtgcc tgcccgtctt\n",
      "     2281 ccccaaaatc tatgtggtcc tcgaatatag caactgtcat tcaatacaca tgtttgagca\n",
      "     2341 cacagtgagc taagttttaa ggattcaaag atgaaaagtc atgctgtctt ccctgcagag\n",
      "     2401 ggtgctcaga ttagtgatgg aaacagtatg gggtgcagga aagcagaagg ccattgctga\n",
      "     2461 gcagggcagt ggacccagca gaggctgaaa caatacaagt gacttggttc caggtgggcc\n",
      "     2521 agcagggtga cgtcctctag caaaatttgg cacccaagac aagtaccaga agaaaagaaa\n",
      "     2581 gactgcatgt attccacata tattcatgtt tgaacaagga gtcaagattt atggcaagga\n",
      "     2641 taaggaggct ttgttggtga cctgttaaga ccaaccaggg cagtcatgct ggatagggaa\n",
      "     2701 gaaggtgagc tggaagagga acagacaact tggacagcca gatgttgaga cggaggggtt\n",
      "     2761 ggaggtcata atgtggtcaa aaacatgttg atgagaggac tcagctacaa agttgttaac\n",
      "     2821 ttaagcagaa acctcaagga tggattttag aatttctcca ggaagtccta aaagataatt\n",
      "     2881 ccatttcagg gagaaaaaca acagaccact gcaaagacca gggaacatga aaggataatg\n",
      "     2941 tagtttgtct tgcttggcag atacttttga aggatgttgg actgtaaggc tgtcgatatc\n",
      "     3001 ctcctcagag aacttactac agtacattgt atctgttccc ttacctacct gactcttcca\n",
      "     3061 ctattcagtt tgttccttaa tagtagacca tgcctgattg gtgttttaca catctccggc\n",
      "     3121 tatgtctgac acttgtggat gctcagaaag tggggaagga aggaaagata cgatggtaaa\n",
      "     3181 aggcttacac atgtcttgac aaaaaagtcc agtttggctc atttggctgg agtcgtactg\n",
      "     3241 catggctgcc attctgctct ggcatcctca gacaagcaca ctgcccatta gaggaaaaag\n",
      "     3301 tgtgatataa gtgttgagtc agaatgctgt agacatttag taatctcctt cacaggaaaa\n",
      "     3361 aaaaaaaaaa ggtgggggga atgacagaaa tccaaaaact agtagagctt ccacttttca\n",
      "     3421 tttcagaaga aatcagttgc tctcctctaa ggaccattac tattaacaaa acagagacct\n",
      "     3481 tagaaggagg cattgtttat ttattatata ttttgtaatg ttattaccaa tcttgttata\n",
      "     3541 ctctttctta taccctacaa ttgttagcag aaattatttt aaattaataa gatcctgcat\n",
      "     3601 gcttttcctt taaaaaaaaa aaaaagaaag atctctgtgt agagtgtcct attctgagcc\n",
      "     3661 agtcctgaga ggaaaggaag tataatcaat ttgttattaa ccaatgaaag aattaagtga\n",
      "     3721 aagataaatc tcaggaagca gagggaagta aacctaattt ctgactaaga aagctaaata\n",
      "     3781 ctatgataac tcattcattc cttcttttgt tcaattacat tatttaatca taagtccatg\n",
      "     3841 acatgccagg cactcaggaa atagtaaaaa ttggacatgc gatattctgc ccttgtgtag\n",
      "     3901 cgcacactag agtgggaaag aaagtgcact tttaactgga caactaccaa catgaagagg\n",
      "     3961 ggaggaagca ggggctggaa atgtccacag actgtgccaa aaaatgaagc ccataatatt\n",
      "     4021 tgaaagtcag tttcttccat cattttgtgt attaaggttc tttcttcccc tgttctccgc\n",
      "     4081 cttcctgctt gtcatcttca ctcatcagct gaccacgttg cctcttgtgg tgtaaacttg\n",
      "     4141 taccagtttt acggtccctc tggccagtac acccatgaat ttgatggaga tgagcagttc\n",
      "     4201 tacgtggacc tggagaggaa ggagactgcc tggcggtggc ctgagttcag caaatttgga\n",
      "     4261 ggttttgacc cgcagggtgc actgagaaac atggctgtgg caaaacacaa cttgaacatc\n",
      "     4321 atgattaaac gctacaactc taccgctgct accaatggta tgcgtccacc attctgcctc\n",
      "     4381 tctttactta agttatccct ccataccagg gttcattatt ttcttcccaa gaggtcccca\n",
      "     4441 gatcttctta tggcaattgc tgaaatttta tcatctccca tctctaaaat cacatattcc\n",
      "     4501 catgtaatac aagggtcttt ccattatgca ttcagcaaat ccttctagga gaggtctcat\n",
      "     4561 caacctccta ctttattaaa catgcccaca gagagaaggg cacaggaata aagcagaggc\n",
      "     4621 aatgtgtcgt tgctcccaag cagaaggtaa ataagacctc tttgactatc aggtggtgaa\n",
      "     4681 atgctggtag gagggctctt ccaggatgta atgcagaact tcagggcaga gctattcaca\n",
      "     4741 cttcacacca gtgctgtttc ctcaccacag aggttcctga ggtcacagtg ttttccaagt\n",
      "     4801 ctcccgtgac actgggtcag cccaacaccc tcatttgtct tgtggacaac atctttcctc\n",
      "     4861 ctgtggtcaa catcacatgg ctgagcaatg ggcagtcaat cacagaaggt gtttctgaga\n",
      "     4921 ccagcttcct ctccaagagt gatcattcct tcttcaagat cagttacctc accttcctcc\n",
      "     4981 cttctgctga tgagatttat gactgcaagg tggagcactg gggcctggac cagcctcttc\n",
      "     5041 tgaaacactg gggtaaggat gagtttcatc attttttgat tctttcttgt ctgtcaagtt\n",
      "     5101 cagaacttcc tgccttttac tcctatatcc aaaaacttgt tttccacact tcatgggttt\n",
      "     5161 cttttctgtc tctctttttt ttttgaaaga ataaagcaaa aaaagcagag atttattgaa\n",
      "     5221 aatgaaagta cactctacag gatgggagtg ggcctgccac ttcatggttt tctaatgata\n",
      "     5281 gacttcactc ttctccctaa gcctggggcc ttgagtcttt gcagagccaa ccctctaccc\n",
      "     5341 catcccatcc cacacacatg cacatgagca cactctgcat tctgacctca acaacttcac\n",
      "     5401 ttccacagag cctgagattc cagcccctat gtcagagctc acagagactg tggtctgtgc\n",
      "     5461 cctggggttg tctgtgggcc tcatgggcat tgtggtgggc actgtcttca tcatccaagg\n",
      "     5521 cctgcgttca gttggtgctt ccagacacca agggccattg tgaatcccat cctggaaggg\n",
      "     5581 aaggtaagat tgagactggt tacagttgaa gcggcagtat ga\n",
      "//\n",
      "\n",
      "LOCUS       OR880473                5755 bp    DNA     linear   PRI 12-DEC-2023\n",
      "DEFINITION  Homo sapiens isolate N-23-1374-A-02-00 MHC class II antigen\n",
      "            (HLA-DQA1) gene, HLA-DQA1*05NEW allele, complete cds.\n",
      "ACCESSION   OR880473\n",
      "VERSION     OR880473.1\n",
      "KEYWORDS    .\n",
      "SOURCE      Homo sapiens (human)\n",
      "  ORGANISM  Homo sapiens\n",
      "            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\n",
      "            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\n",
      "            Catarrhini; Hominidae; Homo.\n",
      "REFERENCE   1  (bases 1 to 5755)\n",
      "  AUTHORS   Velickovic,M.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (27-NOV-2023) New South Wales Transplantation and\n",
      "            Immunogenetics Services Pathology and Clinical Governance,\n",
      "            Australian Red Cross Lifeblood, 17 O'Riordan Street Alexandria NSW\n",
      "            2015, Sydney, NSW 2060, Australia\n",
      "COMMENT     ##Assembly-Data-START##\n",
      "            Assembly Method       :: TSV v. 3.0.0.27232; created on 1/02/2023\n",
      "            Sequencing Technology :: Illumina\n",
      "            ##Assembly-Data-END##\n",
      "FEATURES             Location/Qualifiers\n",
      "     source          1..5755\n",
      "                     /organism=\"Homo sapiens\"\n",
      "                     /mol_type=\"genomic DNA\"\n",
      "                     /isolate=\"N-23-1374-A-02-00\"\n",
      "                     /db_xref=\"taxon:9606\"\n",
      "     gene            1..5755\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*05NEW\"\n",
      "     mRNA            join(1..342,4162..4407,4820..5101,5539..5755)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*05NEW\"\n",
      "                     /product=\"MHC class II antigen\"\n",
      "     exon            1..342\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*05NEW\"\n",
      "                     /number=1\n",
      "     5'UTR           1..260\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*05NEW\"\n",
      "     CDS             join(261..342,4162..4407,4820..5101,5539..5693)\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*05NEW\"\n",
      "                     /codon_start=1\n",
      "                     /product=\"MHC class II antigen\"\n",
      "                     /protein_id=\"WPS91248.1\"\n",
      "                     /translation=\"MILNKALMLGTLALTTVMSPCGGEDIVADHVASYGVNLYQSYGP\n",
      "                     SGQYTHEFDGDEQFYVDLGRKETVWCLPVLRQFRFDPQFALTNIAVLKHNLNSLIKRS\n",
      "                     NSTAATNEVPEVTVFSKSPVTLGQPNILICLADNIFPPVVNITWLSNGHSVTEGVSET\n",
      "                     SFLSKSDHSFFKISYLTLLPSAEESYDCKVEHWGLDKPLLKHWEPEIPAPMSELTETV\n",
      "                     VCALGLSVGLVGIVVGTVFIIRGLRSVGASRHQGPL\"\n",
      "     intron          343..4161\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*05NEW\"\n",
      "                     /number=1\n",
      "     exon            4162..4407\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*05NEW\"\n",
      "                     /number=2\n",
      "     intron          4408..4819\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*05NEW\"\n",
      "                     /number=2\n",
      "     exon            4820..5101\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*05NEW\"\n",
      "                     /number=3\n",
      "     intron          5102..5538\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*05NEW\"\n",
      "                     /number=3\n",
      "     exon            5539..5755\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*05NEW\"\n",
      "                     /number=4\n",
      "     3'UTR           5694..5755\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "                     /allele=\"HLA-DQA1*05NEW\"\n",
      "ORIGIN      \n",
      "        1 tctattcaca gaacatttcc tcaagtccac tctgagtgga ggctgcatca caacaagggg\n",
      "       61 attgccctgt ctccttccag ggctcttaat acaaactctt caactagtaa ctgaggtgtc\n",
      "      121 atcatagggg atttttctaa ttagccaaaa cctgacttgg cagggtttgg tttgggtgtc\n",
      "      181 ttcagattgc cttgtctcga ggtcctcaca attgctctac aactcagaac agcaactgct\n",
      "      241 aaggctgcct tgggaagagg atgatcctaa acaaagctct gatgctgggg acccttgccc\n",
      "      301 tgaccaccgt gatgagcccc tgtggaggtg aagacattgt gggtgagtgt atgagtgagg\n",
      "      361 gatgttctct ggagctggaa gagaggaaat tgaagcaaaa gagagaaagc gatttgcaga\n",
      "      421 gaaattgtag agatttccta agggtccctt cagtattaag agatttaaaa attatggctg\n",
      "      481 ttcctccttc aggaaaccag agtcccaacc tactcttttt gttatctatg ctgttggcgt\n",
      "      541 tcactaagga tgctattctg tttatattgt attcagtgac tatagcctgg aggtctctat\n",
      "      601 gtcattccat catgattgcc tcaaaaatta gtgaggtttc catcaatgga taatttttta\n",
      "      661 ttattaaaaa tttgtgaagt atcattctca aatttccctg aacaactttt gaagcttttc\n",
      "      721 ggatgtctcc tgtagtagcg cttggggtaa atgattccat caattatata ctctatagat\n",
      "      781 attaagaaag atgccctttt ctttctctca gacttactaa catttccacg tgggaactgg\n",
      "      841 cacaggtggg gagtgggtaa aggagtccag caggctgaat gccttcaaca atcattttac\n",
      "      901 cacatggtcc tcacttactc tcagctgcct catatgtgtc acctcacaaa taatcaaata\n",
      "      961 aaatgggcat gtagctaagc tttgtaaata gtgaaaacat gaatgtcaat tttattttta\n",
      "     1021 catatttcta ttataggtat agcttcacat ttcttttctt ttgcaaaata aggaatcctt\n",
      "     1081 ttattttaaa attgagaatt tatagtagaa aaacttggta aattaaatca ttttattctc\n",
      "     1141 aaattatcaa cccaaattac ctgttcttca actcatctaa tgaagtccta taaaaagaaa\n",
      "     1201 agtgggccag acatggtggc tcatgcctgt aatcccagca ctttgggagg ccgaggcagg\n",
      "     1261 aggatccttt gagcccagga gttgagacca gcctgggcaa catagcaaga cctcatctct\n",
      "     1321 acaaaaaata aaaattagcc aggtgtggtg gtgcatgcct gtggtgccag ctactcagaa\n",
      "     1381 ggctgcagtg ggaggactgc ttgagtccag gaggcggaag ctgcagtgag ccatgatggc\n",
      "     1441 accactacac tccagccagg gcaacagaga gaaactctgt ctcagaaaga aaaaggaaag\n",
      "     1501 aaagagagaa aggaaggaaa gaaagaaaga aggaaggaag gaaggaagaa ggggaaggga\n",
      "     1561 agggaaggaa gggaaggaaa gggaagggag gaaagaagga aggaaaaaag aaaaagaaag\n",
      "     1621 aaaaaagaaa gaaaaagaaa gaaagaaaga aaagagggaa ggaaagaaag aaaaaggaag\n",
      "     1681 gaaggaagca cagattaatt attaatcatt tggtctctct tagtcttctc tgtctttgtc\n",
      "     1741 atccatctat ttccacctct cttcatgcat tcctttctcc ctcttccctt tcaggatcca\n",
      "     1801 tctctgactc cctgcttctt tatatggaca gtggggtttg taaaacaaaa gttgaaaaat\n",
      "     1861 cagatagtta aaaggtgaag tgaactggaa ggtctaaact tccacaacct tattaaccat\n",
      "     1921 ggctgctccc attctgattt tgttcgacgg tggaagtttc acctccttct ccagagcact\n",
      "     1981 tggcttcttt gttccaaatt tcctttcttc aacctcacac cagagtgccc tggtcaggct\n",
      "     2041 cggctcatcc attaggcaca acatgggcaa tgcagagaac cctccatact gtaaagccac\n",
      "     2101 atgagaatgt tttaactcct tttaagatta gaaaaaaatg aaatttcaga gcctaagaaa\n",
      "     2161 atgttttaat tcagcctaga ttgtattgtc tttataccaa ttcagtcata aaatacaatt\n",
      "     2221 ttccatattt tcatggagga aggggcccac aaaagcaaga gtgctcaggg ctcacatgtc\n",
      "     2281 agaatgcagc cctggtcatg gctgatcctg gccttcttat gattctgcta gtgtgcctgt\n",
      "     2341 ccgtcttccc caaaatctat gtcgtcctca aatatagcaa ctgtaattca aaacacgttt\n",
      "     2401 gagcacacag taagctaagt tttaaggatt caaagatgaa aagtcatgct gtcttccctg\n",
      "     2461 cagagggtgc tcagactagt gatggaaacg gtatgggatg caggaaagca gaaggccatt\n",
      "     2521 gctgaccagg gcagtggact cagcagaggc tgaaactata caaatgactt ggttccagct\n",
      "     2581 gggccagcag ggtgacatcc tccagcaaaa ctcggcaccc aagacaagtc ccagatgaaa\n",
      "     2641 agaaggattg ctttgtgttt gataaggagt caaggtttat tgcaaggata aggctttgtt\n",
      "     2701 ggtggcctgt taagacaatc cagggcagtc atactggata aggaagaagg tgagctggaa\n",
      "     2761 gaggaacaga caaacagcca gatattgagg tggaggagct ggaggtcata acgtggtcaa\n",
      "     2821 aaacatgtcg atgagaggac ttagctacaa agttgttaac ttaagcagaa acctcaagga\n",
      "     2881 tgaattttag gatttctcca ggaagtccta aaagataatt tcatttcagg gagaaaaaca\n",
      "     2941 acaaaccact ggaaagacca gggaacatga aaggataatg tagtttggtt tgcttggcag\n",
      "     3001 atacttatga aggatgttgg actgtaaggc tgttgatagc ctcctcacag aacatgctac\n",
      "     3061 agtacattgt atctgctccc ttacctacct gactcttcca ctcttcagtt tgttccttaa\n",
      "     3121 tggtagacca tgcctgattg gtgttttaca catcccctgc tatgtctgac acttgtggat\n",
      "     3181 gctcagaaag tggggaagga aggaaagata caacggtaaa aggcttacac gtcttgacag\n",
      "     3241 gaatgtccag ttcggctcat ttggctggag ccacattgca cggctgccat tctgctctgg\n",
      "     3301 catcctcaga caagcacact gcccattaga ggaaaaaggg tttaatttac ctgagtcctc\n",
      "     3361 aagtgaatat aagtgttaag tcagaacact gtagacattt agtaacctcc ttcagaggaa\n",
      "     3421 aaaaaaaggt ggggggaaat gacagaaatc caaaaactag tagagcttcc actcttcatt\n",
      "     3481 tcagaagaaa tcagttgctc tcctctaagg accattacta ttaacaaaac agagaccttg\n",
      "     3541 aaggaggcat tgtttattta ttatatattt tgtaatgtta ttaccattct tgttatacta\n",
      "     3601 ttccttatac cctacaattg ttagcagaca ttattttaaa ttaataagat cctgcatgct\n",
      "     3661 tttctttttt taaaaaaaag aaagacctct gtgtagagtg tcctgttctg agccagtcct\n",
      "     3721 gagaggaaag aaaatacaat cagtttgtta ttaactgagg aaagaattaa gtgaaagatg\n",
      "     3781 aatcttagga agcagaagga agtaaaccta atctctgact aagaaagcta aataccataa\n",
      "     3841 taactcattc attccttctt ttgtttaatt acattattta atcataagtc cgtgatgtgc\n",
      "     3901 caggcactca ggaaatagta aaaactggac atgtgatatt ctgcccttgt gtagcgcaca\n",
      "     3961 ttatagtggg aaagaaagcg caattttaac cggacaacta ccaacaataa gagcggagga\n",
      "     4021 agcaggggtt ggaaatgtcc acaggctgtg ccaaagatga agcccgtaat atttgaaagt\n",
      "     4081 cagtttcttt catcattttg tgtattaagg ttctttcttc ccctgttctc caccttcctg\n",
      "     4141 cttgtcatct tcactcatca gctgaccacg tcgcctctta tggtgtaaac ttgtaccagt\n",
      "     4201 cttacggtcc ctctggccag tacacccatg aatttgatgg agatgagcag ttctacgtgg\n",
      "     4261 acctggggag gaaggagact gtctggtgtt tgcctgttct cagacaattt agatttgacc\n",
      "     4321 cgcaatttgc actgacaaac atcgctgtcc taaaacataa cttgaacagt ctgattaaac\n",
      "     4381 gctccaactc taccgctgct accaatggta tgtgtcaaca attctgcccc tctttactga\n",
      "     4441 tttatccctt cataccaagt ttcattattt tatttccaag aggtccccag atcttctcat\n",
      "     4501 ggcaattgct gaaattttat catctcccat ctctaaaatc acatattccc atgtaataca\n",
      "     4561 agggtctttc cattatccat tcattaaatc cttctcggag aggtctcatc aacctcctac\n",
      "     4621 tttattaaac atgcccacag agagaagggc acaggaataa agcggaggca atgtgtcgtt\n",
      "     4681 gctcccaagc agaaggtaaa taagacctct ttgactatca ggtggtgaaa tgctggtagg\n",
      "     4741 agggctcttc caggatgtaa tgcagaagct catggcagag ctattcacac ttcacatcag\n",
      "     4801 tgctgtttcc tcaccacaga ggttcctgag gtcacagtgt tttccaagtc tcccgtgaca\n",
      "     4861 ctgggtcagc ccaacatcct catctgtctt gcggacaaca tctttcctcc tgtggtcaac\n",
      "     4921 atcacatggc tgagcaatgg gcactcagtc acagaaggtg tttctgagac cagcttcctc\n",
      "     4981 tccaagagtg atcattcctt cttcaagatc agttacctca ccctcctccc ttctgctgag\n",
      "     5041 gagagttatg actgcaaggt ggagcactgg ggactggaca agcctcttct gaaacactgg\n",
      "     5101 ggtaaggatg agttccacca ctttttgatg ctttcttgtc tgtcaagttc agaacttcct\n",
      "     5161 gccttttact cctatatccc aaaacttgtt ttccacactt catgggtttc tttctttctt\n",
      "     5221 tctttctttc tttctttctt tctttctttc tttctttctt tctttctttc tttctttctt\n",
      "     5281 tctttctttc ttttttgaaa gaataaagca acaaaagcaa agatttattg aaaatgaaag\n",
      "     5341 tacacttcac atggtgggag cgggcctgag cataggggct caagagccac ttcatgggtt\n",
      "     5401 tctaatgata gacttcactc tcctccctaa gctggggacc ttgagtcttt gcagagccaa\n",
      "     5461 ccctccaccc catcccatcc cacacacatg cacatgagca cactctgctt tctgacctca\n",
      "     5521 acgacttcat atccacagag cctgagattc cagcccctat gtcagagctc acagagactg\n",
      "     5581 tggtctgcgc cctggggttg tctgtgggcc tcgtgggcat tgtggtgggc actgtcttca\n",
      "     5641 tcatccgagg cctgcgttca gttggtgctt ccagacacca agggcccttg tgaatcccat\n",
      "     5701 cctggaatgg aaggtaagat tgagatttgt tagagctgaa tccgcagtat gagag\n",
      "//\n",
      "\n",
      "\n",
      "Concluído.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'LOCUS       OR913133                5683 bp    DNA     linear   PRI 25-DEC-2023\\nDEFINITION  Homo sapiens MHC class II antigen (HLA-DQA1) gene,\\n            HLA-DQA1*01:03:03extended allele, complete cds.\\nACCESSION   OR913133\\nVERSION     OR913133.1\\nKEYWORDS    .\\nSOURCE      Homo sapiens (human)\\n  ORGANISM  Homo sapiens\\n            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\\n            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\\n            Catarrhini; Hominidae; Homo.\\nREFERENCE   1  (bases 1 to 5683)\\n  AUTHORS   Kouprie,N. Sr. and Bungener,L.B.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (07-DEC-2023) Transplant Immunologie Laboratory,\\n            University Medical Center Groningen, Postbus 30.001, Groningen 9700\\n            RB, Netherlands\\nCOMMENT     ##Assembly-Data-START##\\n            Assembly Method       :: NGSengine v. 2.31.0.30527\\n            Sequencing Technology :: Illumina\\n            ##Assembly-Data-END##\\nFEATURES             Location/Qualifiers\\n     source          1..5683\\n                     /organism=\"Homo sapiens\"\\n                     /mol_type=\"genomic DNA\"\\n                     /db_xref=\"taxon:9606\"\\n     gene            1..5683\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:03:03extended\"\\n     mRNA            join(1..347,4125..4373,4787..5068,5425..5683)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:03:03extended\"\\n                     /product=\"MHC class II antigen\"\\n     exon            1..347\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:03:03extended\"\\n                     /number=1\\n     5\\'UTR           1..265\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:03:03extended\"\\n     CDS             join(266..347,4125..4373,4787..5068,5425..5579)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:03:03extended\"\\n                     /codon_start=1\\n                     /product=\"MHC class II antigen\"\\n                     /protein_id=\"WQK80776.1\"\\n                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASCGVNLYQFYGP\\n                     SGQFTHEFDGDEQFYVDLEKKETAWRWPEFSKFGGFDPQGALRNMAVAKHNLNIMIKR\\n                     YNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGHAVTEGVSE\\n                     TSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDQPLLKHWEPEIPAPMSELTET\\n                     VVCALGLSVGLVGIVVGTVFIIQGLRSVGASRHQGPL\"\\n     intron          348..4124\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:03:03extended\"\\n                     /number=1\\n     exon            4125..4373\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:03:03extended\"\\n                     /number=2\\n     intron          4374..4786\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:03:03extended\"\\n                     /number=2\\n     exon            4787..5068\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:03:03extended\"\\n                     /number=3\\n     intron          5069..5424\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:03:03extended\"\\n                     /number=3\\n     exon            5425..5683\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:03:03extended\"\\n                     /number=4\\n     3\\'UTR           5580..5683\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:03:03extended\"\\nORIGIN      \\n        1 gtcctccctt tattcataga acaattcctc aagtccactc tgagtagagg ctgcatcaca\\n       61 aggggattgc cccgtctcct tccagggctc ttaatacaaa ctcttcaact agtaactgag\\n      121 atgtcaccat aggggatttt tctaattggc caaaacctga cttggcaggg tttggtttgg\\n      181 gtgtcttcag atttccttgt cttgaggtcc tcacaattac tctacagctc agaacaccaa\\n      241 ctgctgaggc tgccttggga agaggatgat cctaaacaaa gctctgctgc tgggggccct\\n      301 cgctctgacc accgtgatga gcccctgtgg aggtgaagac attgtgggtg agtgcatgag\\n      361 tgagggatgt tctctggagc tgaaaaacag taaattgaag gaaaagagat aaagcgattt\\n      421 gcagagaaac tgtagagatt tcctaagggc cctttcagta ttaagacaat taaaaattat\\n      481 agctgttcct ccttcaggaa accagagccc caacctactc tttttgttat ctatgctgtt\\n      541 gtgttcacta aggacgctat tctgtttata ttatattcag tgactacagc ctggaggtct\\n      601 ctatgtcgtt ccatcatgat tgcctcaaaa attagtgagg tttccatcag tggataattt\\n      661 tttattatta aaaatttatg aagtgtcatt ctcaaatttc cctgaacaac ttttgaagct\\n      721 tttcggatgt ctccggtggt agatcttggg gtcattccat caattatgta ctctatagat\\n      781 atttaaaatg ttgcccgttt ctttctctca gacttactca catttccaca tgggaactgg\\n      841 cacaggtggg gagtgggtaa aggagtccag caggctgaat gccttcaaca gtcattttac\\n      901 cacatggtcc tcacttactc tcagctgcct catatgtgtc acctcacaag taatcaaata\\n      961 aaatgggcat gtggctaagt tttgtaaata gtgaaaacat gaatgtcaat tttttttaca\\n     1021 tatttctatt acagatatag cttcacattt cttttcttta gcaaaataag ggatcatttt\\n     1081 attttaaaat tgagaagtag aaaaaattgg taaaataaat cattttattc tcaaattatc\\n     1141 aacccaaatt acctgttctt cacctcatct aataaagtcc tataaaaaga aaagtgggcc\\n     1201 agacaaggtg gctcatgcct gtaatcccag cactttggga ggccgaggca ggaggatcat\\n     1261 ttgagcctgg gagcttgaga ccagcctggg caacatagca agacctcatc tctacaaaaa\\n     1321 aagaaaaata aaaattagcc aggcatggtg gtgtgtgcct gtggtgccag ctactcagaa\\n     1381 ggctgccgtg ggaggaccac ttgagtccat gaggcggaag ctgcagtgag ccatgatggc\\n     1441 accactacac tccagccagg gcaacagaga gagactctgt ctcaaaaaga aagaggaaag\\n     1501 aaagcaagga accaaggaag gaaggaagga aggagaagga aggaaggaaa agaaaagaaa\\n     1561 agggaaggga ggaaggaagg aaaaaagaaa gacggaaaga aaaaggaagg aaggaagaaa\\n     1621 ggaagcacag attaattatt tggtctctta ctctcctctg cctttgtcgt ccatctcttt\\n     1681 ccacctctct tgatgcattc ctttctcccc cttccctttc aggatccacc tctggctccc\\n     1741 tgctccttta tagatatgga cagtgggttt gtaaagcaaa agttgaaaag tcagatagtt\\n     1801 aaaaggggaa gtgaactgga aggtactcta aactttcaca actttattaa ccgtggctgc\\n     1861 tcccattatg attttgttcg gcagtggaag tttcacctgc ttctccagag cacttggcat\\n     1921 ctttgttcca aatttccttt cttcagcctc acaccagagt gccctggtca ggctcggctc\\n     1981 atccattagg cactatgtgg gcagtgcagg ggaccctcca tactgtaaag ccacatgaga\\n     2041 aggttttaac accttttaaa attagaaaaa taatggaata ttagagccta agaaaatgtt\\n     2101 ttaactttta attcagccta gattatattg tctttatacc aattcagtca taaaatataa\\n     2161 ttttccatat ttttatggag gaaggggccc atacaagcaa gaatgctcgg ggctcacatg\\n     2221 tcagaatgca gccttggtca tgactgatcc tggcgtttgt atggttctgc tacctgtgtg\\n     2281 cctgtccgtc ttccccaaaa tctgtgtggt cctcgaatat agcaactgtc attcaataca\\n     2341 catgtttgag cacacagtga gctaagtttt aaggattcaa agatgaaaag tcatgctgtc\\n     2401 ttccctgcag agggtgctca gattagtgat ggaaacagtg tggggtgcag gaaagcagaa\\n     2461 ggccattgct gagcagggca gtggacccag cagaggctga aacaatacaa gtgacttggt\\n     2521 tccaggtggg ccagcagggt gacgtcctct agcaaaattt ggcacccaag acaagtacca\\n     2581 gaagaaaaga aagactgcat gtattccaca tatattcatg tttgaacaag gagtcaagat\\n     2641 ttatggcaag gataaggagg ctttgttggt gacctgttaa gaccaaccag ggcagtcatg\\n     2701 ctggataggg aagaaggtga gctggaagag gaacagacaa acttggacag ccagatgttg\\n     2761 agatggaggg gttggaggtc ataatgtggt caaaacatgt tgatgagagg actcagctac\\n     2821 aaagttgtta acttaagcag aaacctcaag gatggatttt agaatttctc caggaagtcc\\n     2881 taaaagataa ttccttttca gggagaaaaa caacagacca ctgcaaagac cagggaacat\\n     2941 gaaaggataa tgtagtttgg cttgcttggc agatactttt gaaggatgtt ggactgtaag\\n     3001 gctgtcgata tcctcctcac agaacttact acagtacatt gtatctgttc ccttacctac\\n     3061 ctgactcttc cactattcag tttgttcctt aatggtagac catgcctgat tggtgtttta\\n     3121 cacatctccg gctatgtctg acacttgtgg atgctcagaa agtggggaag gaaggaaaga\\n     3181 tacgatggta aaaggcttac acatgtcttg acaagaaagt ccagttcggc tcatttggct\\n     3241 ggagtcgtac tgcatggctg ccattctgct ctggcatcct cagacaagca cactgcccat\\n     3301 tagaggaaaa agtgtgaata taagtgttga gtcagaatgc tgtagacatt tagtaacctc\\n     3361 cttcacagga aaaaaaaaag atggggggaa tgacagaaat ccaaaaacta gtagagcttc\\n     3421 cacttttcat ttcagaagaa atcagttgct ctcctataag gaccattact attaacaaaa\\n     3481 cagagacctt agaaggaggc attgtttatt tattatatat tttgtaatgt tattaccaat\\n     3541 cttgttatac tctttcttat accctacaat tgttagcaga aattatttta aattaataag\\n     3601 atcctgcatg cttttcctta aaaaaaaaaa aaagaaagaa agaaagatct ctgtgtagag\\n     3661 tgtcctattc tgagccagtc ctgagaggaa aggaagtata atcaatttgt tattaaccga\\n     3721 tgaaagaatt aagtgaaaga taaatctcag gaagcagagg gaagtaaacc taatctctga\\n     3781 ctaagaaagc taaatactat gataactcat tcattccttc ttttgttcaa ttacattatt\\n     3841 taatcataag tccatgacgt gccaggcact caggaaatag taaaaattgg acgtgcgata\\n     3901 ttctgccctt gtgtagcgca cactagagtg ggaaagaaag tgcactttta actggacaac\\n     3961 taccaacatg atgaggggag gaaacagggg ctggaaatgt ccacggactg tgccgaaaaa\\n     4021 tgaagcccat aatatttgaa agtcagtttc ttccatcatt ttgtgtatta aggttctttc\\n     4081 ttcccctgtt ctccgccttc ctgcttgtca tcttcactca tcagctgacc atgttgcctc\\n     4141 ttgtggtgta aacttgtacc agttttacgg tccctctggc cagttcaccc atgaatttga\\n     4201 tggagatgag cagttctacg tggacctgga gaagaaggag actgcctggc ggtggcctga\\n     4261 gttcagcaaa tttggaggtt ttgacccgca gggtgcactg agaaacatgg ctgtggcaaa\\n     4321 acacaacttg aacatcatga ttaaacgcta caactctacc gctgctacca atggtatgcg\\n     4381 tccaccattc tgcctctctt tacttaagct atcccttcat accagggttc attattttct\\n     4441 tcccaagagg tccccagatc ttcttatggc aattgctgaa attttatcat ctcccatctc\\n     4501 taaaatcaca tattcccatg taatacaagg gtctttccat tatgcattca gcaaatcctt\\n     4561 ctaggagagg tctcatcaac ctcctacttt attaaacatg cccacagaga gaagggcaca\\n     4621 ggaataaagc agaggcaatg tgtcattgct cccaagcaga aggtaaataa gacctctttg\\n     4681 actatcaggt ggtgaaatgc tggtaggagg gctcttccag gatgtaatgc agaacttcag\\n     4741 ggcagagcta ttcacacttc acaccagtgc tgtttcctca ccacagaggt tcctgaggtc\\n     4801 acagtgtttt ccaagtctcc cgtgacgctg ggtcagccca acaccctcat ctgtcttgtg\\n     4861 gacaacatct ttcctcctgt ggtcaacatc acatggctga gcaatgggca cgcagtcaca\\n     4921 gaaggtgttt ctgagaccag cttcctctcc aagagtgatc attccttctt caagatcagt\\n     4981 tacctcacct tcctcccttc tgctgatgag atttatgact gcaaggtgga gcactggggc\\n     5041 ctggaccagc ctcttctgaa acactggggt aaggatgagt ttcatcattt tttgattctt\\n     5101 tcttgtctgt caggttcaga acttcctgcc ttttactcct atatccaaaa acttgttttc\\n     5161 cacacttcat gggtttcttt tctgtctcac tttttttttt gaaagaataa agcaaaaaaa\\n     5221 gcagagattt attgaaaatg aaagtacact ctacaggatg ggagtgggcc tgccacttca\\n     5281 tggttttcta atgatagact tcactctcct ccctaagctg ggggccttga gtctttgtag\\n     5341 agccaaccct gtaccccatc ccatcccaca cacatgcaca tgagcaaact ctgcattctg\\n     5401 acctcaacaa cttcacttcc acagagcctg agattccagc ccctatgtca gagctcacag\\n     5461 agactgtggt ctgtgccctg gggttgtctg tgggcctcgt gggcattgtg gtgggcactg\\n     5521 tcttcatcat ccaaggcctg cgttcagttg gtgcttccag acaccaaggg cccttgtgaa\\n     5581 tcccatcctg gaagggaagg taagattgag actggttaca gttgaagcgg cagtatgaaa\\n     5641 ggaaggaaag tgggagggcg ttgtggacat gaatgtggtt taa\\n//\\n\\nLOCUS       OR921180                5690 bp    DNA     linear   PRI 20-DEC-2023\\nDEFINITION  Homo sapiens MHC class II antigen (HLA-DQA1) gene, HLA-DQA1*01NEW\\n            allele, complete cds.\\nACCESSION   OR921180\\nVERSION     OR921180.1\\nKEYWORDS    .\\nSOURCE      Homo sapiens (human)\\n  ORGANISM  Homo sapiens\\n            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\\n            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\\n            Catarrhini; Hominidae; Homo.\\nREFERENCE   1  (bases 1 to 5690)\\n  AUTHORS   Deghaide,N.H.S., Martins,G.V., Domeneghetti,M.S., Correa,A.P.B.,\\n            Santos,V.T. and Donadi,E.A.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (07-DEC-2023) Laboratorio de HLA, Hemocentro de Ribeirao\\n            Preto, Rua: Tenente Catao Roxo, Ribeirao Preto, SP 14051-140,\\n            Brazil\\nCOMMENT     ##Assembly-Data-START##\\n            Assembly Method       :: TypeStream Visual v. 3.0\\n            Assembly Name         :: HLA-DQA1*01:NEW\\n            Coverage              :: Full Gene\\n            Sequencing Technology :: Illumina\\n            ##Assembly-Data-END##\\nFEATURES             Location/Qualifiers\\n     source          1..5690\\n                     /organism=\"Homo sapiens\"\\n                     /mol_type=\"genomic DNA\"\\n                     /db_xref=\"taxon:9606\"\\n     gene            1..5690\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n     exon            1..345\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=1\\n     5\\'UTR           1..263\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n     CDS             join(264..345,4123..4371,4785..5066,5423..5577)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /codon_start=1\\n                     /product=\"MHC class II antigen\"\\n                     /protein_id=\"WQB05986.1\"\\n                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASCGVNLYQFYGP\\n                     SGQYTHEFDGDEQFYVDLERKETAWRWPEFSKFGGFDPQGALRNMAVAKHNLNIMIKR\\n                     YNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGQSVTEGVSE\\n                     TSFLSKSDHSFFKISYLTFLPSAGEIYDCKVEHWGLDQPLLKHWEPEIPAPMSELTET\\n                     VVCALGLSVGLMGIVVGTVFIIQGLRSVGASRHQGPL\"\\n     exon            4123..4371\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=2\\n     exon            4785..5066\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=3\\n     exon            5423..5690\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=4\\n     3\\'UTR           5578..5690\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\nORIGIN      \\n        1 cctccgttta ttcatagaac aattcctcaa gtccactctg agtagaggct gcatcacaag\\n       61 gggattgccc cgtctccttc cagggctctt aatacaaact cttcaactag taactgagat\\n      121 gtcaccatag gggatttttc taattggcca aaacctgact tggcagggtt tggtttgggt\\n      181 gtcttcagat ttccttgtct tgaggtcctc acaattactc tacagctcag aacaccaact\\n      241 gctgaggctg ccttgggaag aggatgatcc taaacaaagc tctgctgctg ggggccctcg\\n      301 ctctgaccac cgtgatgagc ccctgtggag gtgaagacat tgtgggtgag tgcatgagtg\\n      361 agggatgttc tctggagctg aaaaacagta aattgaagga aaagagataa agcgatttgc\\n      421 agagaaactg tagagatttc ctaagggccc tttcagtatt aagacaatta aaaattatag\\n      481 ctgttcctcc ttcaggaaac cagagcccca acctactctt tttgttatgt atgcttttgt\\n      541 gttcactaag gatgctattc tgtttatatt atattcagtg actacagcct ggaggtctct\\n      601 atgtcgttcc gtcatgattg cctcaaaaat tagtgaggtt tccatcagtg gataattttt\\n      661 tattattaaa aatttatgaa gtgtcattct caaatttccc tgaacaactt ttgaagcttt\\n      721 tcggatgtct ccggtggtag atcttggggt cattccatca attatgtact ctatagatat\\n      781 ttaaaatgtt gcccgtttct ttctctcaga cttactcaca tttccacatg ggaactggca\\n      841 caggtgggga gtgggtaaag gagtccagca ggctgaatgc cttcaacaat cattttacca\\n      901 catggtcctc acttactctc agctgcctca tatgtgtcac ctcacaagta atcaaataaa\\n      961 atgggcatgt ggctaagctt tgtaaatagt gaaaacatga atgtcaattt tttttacata\\n     1021 tttctattac agatatagct tcacatttct tttctttagc aaaataaggg atcattttat\\n     1081 tttaaaattg agaagtagaa aaaattggta aaataaatca ttttattctc aaattatcaa\\n     1141 cccaaattac ctgttcttca cctcatctaa taaagtccta taaaaagaaa agtgggccag\\n     1201 acaaggtggc tcatgcctgt aatcccagca ctttgggagg ccgaggcagg aggatcattt\\n     1261 gagcctggga gcttgagacc agcctgggca acatagcaag acctcatctc tacaaaaaaa\\n     1321 gaaaaagaaa aattagccag gcatggtggt gtgtgcctgt ggtgccagct actcagaagg\\n     1381 ctgccgtggg aggaccactt gagcccatga ggcggaagct gcagtgagcc atggtggcac\\n     1441 cactacactc cagccagggc aacagagaga gacgctgtct caaaaagaaa gaggaaagaa\\n     1501 agcgaggaag gaaggaagga aggaaggaag gagaaggaag gaaggaagga aaagaaaaga\\n     1561 aaagggaagg gaggaaggaa ggaaaaaaga aagacagaaa gaaagaggaa ggaaggaaga\\n     1621 aaggaagcac agattaatta tttggtctct tactctcctc tgcctttgtc gtccatctct\\n     1681 ttccacctct cttgatgcat ccctttctcc ctcttccgtt tcaggagcca tctctggctc\\n     1741 cctgctcctt tatagagatg gacagtgggt ttgtaaaaca aaagttgaaa agtcagatag\\n     1801 ttaaaagggg aagtgaactg gaaggtactt taaactttca caactttatt aaccgtggct\\n     1861 gctcccatta tgattttgtt cggcagtgga agtttcacct gcttctccag agcacttggc\\n     1921 gtctttgttc caaatttcct ttcttcaacc tcacaccaga gtgccctggt caggcttggc\\n     1981 tcattcatta ggcacaatgt gggcagtgca ggggaccctc catactgtaa agccacatga\\n     2041 gaaggtttta actcctttta aaattagaaa aataatggaa tattagagcc taagaaaatg\\n     2101 ttttaacttt taattcagcc tagattatat tgtctttata ccaattcagt cataaaatat\\n     2161 aattttccat atttttgtgg aggaagaggc ccatacaagc aagaatgctc ggggctcaca\\n     2221 tgtcagaatg cagccttggt catgactgat cctggccttc gtatggttct gctacctgtg\\n     2281 tgcctgcccg tcttccccaa aatctatgtg gtcctcgaat atagcaactg tcattcaata\\n     2341 cacatgtttg agcacacagt gagctaagtt ttaaggattc aaagatgaaa agtcatgctg\\n     2401 tcttccctgc agagggtgct cagattagtg atggaaacag tatggggtgc aggaaagcag\\n     2461 aaggccattg ctgagcaggg cagtggaccc agcagaggct gaaacaatac aagtgacttg\\n     2521 gttccaggtg ggccagcagg gtgacgtcct ctagcaaaat ttggcaccca agacaagtac\\n     2581 cagaagaaaa gaaagactgc atgtattcca catatattca tgtttgaaca aggagtcaag\\n     2641 atttatggca aggataagga ggctttgttg gtgacctgtt aagaccaacc agggcagtca\\n     2701 tgctggatag ggaagaaggt gagctggaag aggaacagac aacttggaca gccagatgtt\\n     2761 gagacggagg ggttggaggt cataatgtgg tcaaaaacat gttgatgaga ggactcagct\\n     2821 acaaagttgt taacttaagc agaaacctca aggatggatt ttagaatttc tccaggaagt\\n     2881 cctaaaagat aattccattt cagggagaaa aacaacagac cactgcaaag accagggaac\\n     2941 atgaaaggat aatgtagttt gtcttgcttg gcagatactt ttgaaggatg ttggactgta\\n     3001 aggctgtcga tatcctcctc agagaactta ctacagtaca ttgtatctgt tcccttacct\\n     3061 acctgactct tccactattc agtttgttcc ttaatggtag accatgcctg attggtgttt\\n     3121 tacacatctc cggctatgtc tgacacttgt ggatgctcag aaagtgggga aggaaggaaa\\n     3181 gatacgatgg taaaaggctt acacatgtct tgacaaaaaa gtccagtttg gctcatttgg\\n     3241 ctggagtcgt actgcatggc tgccattctg ctctggcatc ctcagacaag cacactgccc\\n     3301 attagaggaa agagtgtgat ataagtgttg agtcagaatg ctgtagacat ttagtaacct\\n     3361 ccttcacagg aaaaaaaaaa aaaggtgggg ggaatgacag aaatccaaaa actagtagag\\n     3421 cttccacttt tcatttcaga agaaatcagt tgctctcctc taaggaccac tactattaac\\n     3481 aaaacagaga ccttagaagg aggcattgtt tatttattat atattttgta atgttattac\\n     3541 caatcttgtt atactctttc ttatacccta caattgttag cagaaattat tttaaattaa\\n     3601 taagatcctg catgcttttc ctttaaaaaa aaaaaaaaag aaagatctct gtgtagagtg\\n     3661 tcctattctg agccagtcct gagaggaaag gaagtataat caatttgtta ttaaccaatg\\n     3721 aaagaattaa gtgaaagata aatctcagga agcagaggga agtaaaccta atttctgact\\n     3781 aagaaagcta aatactatga taactcattc attccttctt ttgttcaatt acattattta\\n     3841 atcataagtc catgacgtgc caggcactca ggaaatagta aaaattggac atgcgatatt\\n     3901 ctgcccttgt gtagcgcaca ctagagtggg aaagaaagtg cacttttaac tggacaacta\\n     3961 ccaacatgaa gaggggagga agcaggggct ggaaatgtcc acagactgtg ccaaaaaatg\\n     4021 aagcccataa tatttgaaag tcaggttctt ccatcatttt gtgtattaag gttctttctt\\n     4081 cctctgttct ccgccttcct gcttgtcatc ttcactcatc agctgaccac gttgcctctt\\n     4141 gtggtgtaaa cttgtaccag ttttacggtc cctctggcca gtacacccat gaatttgatg\\n     4201 gagatgagca gttctacgtg gacctggaga ggaaggagac tgcctggcgg tggcctgagt\\n     4261 tcagcaaatt tggaggtttt gacccgcagg gtgcactgag aaacatggct gtggcaaaac\\n     4321 acaacttgaa catcatgatt aaacgctaca actctaccgc tgctaccaat ggtatgcgtc\\n     4381 caccattctg cctctcttta cttaagctat ccctccatac cagggttcat tattttcttc\\n     4441 ccaagaggtc cccagatctt gttatggcaa ttgctgaaat tttatcatct cccatctcta\\n     4501 aaatcacata ttcccatgta atacaagggt ctttccatta tgcattcagc aaatccttct\\n     4561 aggagaggtc tcatcaacct cctactttat taaacatgcc cacagagaga agggcacagg\\n     4621 aataaagcag aggcaatgtg tcgttgctcc caagcagaag gtaaataaga cctctttgac\\n     4681 tatcaggtgg tgaaatgctg gtaggagggc tcttccagga tgtaatgcag aacttcaggg\\n     4741 cagagctatt cacacttcac accagtgctg tttcctcacc acagaggttc ctgaggtcac\\n     4801 agtgttttcc aagtctcccg tgacactggg tcagcccaac accctcattt gtcttgtgga\\n     4861 caacatcttt cctcctgtgg tcaacatcac atggctgagc aatgggcagt cagtcacaga\\n     4921 aggtgtttct gagaccagct tcctctccaa gagtgatcat tccttcttca agatcagtta\\n     4981 cctcaccttc ctcccttctg ctggtgagat ttatgactgc aaggtggagc actggggcct\\n     5041 ggaccagcct cttctgaaac actggggtaa ggatgagttt catcattttt tgattctttc\\n     5101 ttgtctgtca agttcagaac ttcctgcctt ttactcctat atccaaaaac ttgttttcca\\n     5161 cacttcatgg gtttcttttc tgtctctctt ttttttttga aagaataaag caaaaaaagc\\n     5221 agagatttat tgaaaatgaa agtacactct acaggatggg agtgggcctg ccacttcatg\\n     5281 gttttctaat gatagacttc actcttctcc ctaagcctgg ggccttgagt ctttgcagag\\n     5341 ccaaccctct accccatccc atcccacaca catgcacatg agcacactct gcattctgac\\n     5401 ctcaacaact tcacttccac agagcctgag attccagccc ctatgtcaga gctcacagag\\n     5461 actgtggtct gtgccctggg gttgtctgtg ggcctcatgg gcattgtggt gggcactgtc\\n     5521 ttcatcatcc aaggcctgcg ttcagttggt gcttccagac accaagggcc attgtgaatc\\n     5581 ccatcctgga agggaaggta agattgagac tggttacagt tgaagcggca gtatgaaagg\\n     5641 aaggaaagtg ggagggcgtt gtggacatga atgtggttga aagttgtagg\\n//\\n\\nLOCUS       OR909722                1068 bp    DNA     linear   PRI 20-DEC-2023\\nDEFINITION  Homo sapiens MHC class II antigen (HLA-DQA1) gene,\\n            HLA-DQA1*01:02:NEW allele, complete cds.\\nACCESSION   OR909722\\nVERSION     OR909722.1\\nKEYWORDS    .\\nSOURCE      Homo sapiens (human)\\n  ORGANISM  Homo sapiens\\n            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\\n            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\\n            Catarrhini; Hominidae; Homo.\\nREFERENCE   1  (bases 1 to 1068)\\n  AUTHORS   Cargou,M., Andreani,M., Galluccio,T., Ralazamahaleo,M. and\\n            Visentin,J.\\n  TITLE     Characterization of the novel HLA-DQA1*01:02:NEW allele by\\n            sequencing-based typing\\n  JOURNAL   Unpublished\\nREFERENCE   2  (bases 1 to 1068)\\n  AUTHORS   Cargou,M., Andreani,M., Galluccio,T., Ralazamahaleo,M. and\\n            Visentin,J.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (05-DEC-2023) laboratoire d\\'Immunologie et\\n            d\\'Immunogenetique, CHU Bordeaux, Place Amelie Raba Leon, Bordeaux,\\n            Gironde 33076, France\\nCOMMENT     ##Assembly-Data-START##\\n            Assembly Method       :: TypeStream Visual v. v3.0\\n            Sequencing Technology :: Illumina\\n            ##Assembly-Data-END##\\nFEATURES             Location/Qualifiers\\n     source          1..1068\\n                     /organism=\"Homo sapiens\"\\n                     /mol_type=\"genomic DNA\"\\n                     /db_xref=\"taxon:9606\"\\n     gene            <1..>1068\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:02:NEW\"\\n     mRNA            join(<1..82,183..431,532..813,914..>1068)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:02:NEW\"\\n                     /product=\"MHC class II antigen\"\\n     CDS             join(1..82,183..431,532..813,914..1068)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01:02:NEW\"\\n                     /codon_start=1\\n                     /product=\"MHC class II antigen\"\\n                     /protein_id=\"WQB05981.1\"\\n                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASCGVNLYQFYGP\\n                     SGQYTHEFDGDEQFYVDLERKETAWRWPEFSKFGGFDPQGALRNMAVAKHNLNIMIKR\\n                     YNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGQSVTEGVSE\\n                     TSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDQPLLKHWEPEIPAPMSELTET\\n                     VVCALGLSVGLMGIVVGTVFIIQGLRSVGASRHQGPL\"\\n     gap             83..182\\n                     /estimated_length=unknown\\n     gap             432..531\\n                     /estimated_length=unknown\\n     gap             814..913\\n                     /estimated_length=unknown\\nORIGIN      \\n        1 atgatcctaa acaaagctct gctgctgggg gccctcgctc tgaccaccgt gatgagcccc\\n       61 tgtggaggtg aagacattgt ggnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn\\n      121 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn\\n      181 nnctgaccac gttgcctctt gtggtgtaaa cttgtaccag ttttacggtc cctctggcca\\n      241 gtacacccat gaatttgatg gagatgagca gttctacgtg gacctggaga ggaaggagac\\n      301 tgcctggcgg tggcctgagt tcagcaaatt tggaggtttt gacccgcagg gtgcactgag\\n      361 aaacatggct gtggcaaaac acaacttgaa catcatgatt aaacgctaca actctaccgc\\n      421 tgctaccaat gnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn\\n      481 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn naggttcctg\\n      541 aggtcacagt gttttccaag tctcccgtga cactgggtca gcccaacacc ctcatttgtc\\n      601 ttgtggacaa catctttcct cctgtggtca acatcacatg gctgagcaat gggcagtcag\\n      661 tcacagaagg tgtttctgag accagcttcc tctccaagag tgatcattcc ttcttcaaga\\n      721 tcagttacct caccttcctc ccttctgctg atgagattta tgactgcaaa gtggagcact\\n      781 ggggcctgga ccagcctctt ctgaaacact gggnnnnnnn nnnnnnnnnn nnnnnnnnnn\\n      841 nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn nnnnnnnnnn\\n      901 nnnnnnnnnn nnnagcctga gattccagcc cctatgtcag agctcacaga gactgtggtc\\n      961 tgtgccctgg ggttgtctgt gggcctcatg ggcattgtgg tgggcactgt cttcatcatc\\n     1021 caaggcctgc gttcagttgg tgcttccaga caccaagggc cattgtga\\n//\\n\\nLOCUS       OR879057                5107 bp    DNA     linear   PRI 12-DEC-2023\\nDEFINITION  Homo sapiens MHC class II antigen (HLA-DQA1) gene,\\n            HLA-DQA1-DQA1*02:01:01:01v1var allele, exons 1 through 3 and\\n            partial cds.\\nACCESSION   OR879057\\nVERSION     OR879057.1\\nKEYWORDS    .\\nSOURCE      Homo sapiens (human)\\n  ORGANISM  Homo sapiens\\n            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\\n            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\\n            Catarrhini; Hominidae; Homo.\\nREFERENCE   1  (bases 1 to 5107)\\n  AUTHORS   Marin Rubio,L.A. Sr.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (29-NOV-2023) Inmunologia, Hospital Universitario de\\n            Albacete, Hermanos Falco, 37, Albacete, Albacete 02006, Spain\\nCOMMENT     ##Assembly-Data-START##\\n            Assembly Method       :: NGSengine v. 2.31.0\\n            Sequencing Technology :: Illumina\\n            ##Assembly-Data-END##\\nFEATURES             Location/Qualifiers\\n     source          1..5107\\n                     /organism=\"Homo sapiens\"\\n                     /mol_type=\"genomic DNA\"\\n                     /db_xref=\"taxon:9606\"\\n     gene            <1..>5107\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"DQA1*02:01:01:01v1var\"\\n     mRNA            join(<1..350,4045..4290,4703..>4984)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"DQA1*02:01:01:01v1var\"\\n                     /product=\"MHC class II antigen\"\\n     exon            <1..350\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"DQA1*02:01:01:01v1var\"\\n                     /number=1\\n     5\\'UTR           <1..268\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"DQA1*02:01:01:01v1var\"\\n     CDS             join(269..350,4045..4290,4703..>4984)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"DQA1*02:01:01:01v1var\"\\n                     /note=\"DQ alpha chain\"\\n                     /codon_start=1\\n                     /product=\"MHC class II antigen\"\\n                     /protein_id=\"WPT07520.1\"\\n                     /translation=\"MILNKALMLGALALTTVMSPCGGEDIVADHVASYGVNLYQSYGP\\n                     SGQFTHEFDGDEEFYVDLERKETVWKLPLFHRLRFDPQFALTNIAVLKHNLNILIKRS\\n                     NSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGHSVTEGVSET\\n                     SFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDEPLLKHW\"\\n     exon            4045..4290\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"DQA1*02:01:01:01v1var\"\\n                     /number=2\\n     exon            4703..4984\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"DQA1*02:01:01:01v1var\"\\n                     /number=3\\nORIGIN      \\n        1 gtcttccctc tcttcataga acaattcctc aagtccactc tgagtagagg ctgcatcaca\\n       61 acaaggggat tgccctgtct ccttccaggg ctcttaatag aaactcttca actagtaact\\n      121 gagatgtcac catgggggat ttttctaatt ggccaaaacc tgacttggca gggtttggtt\\n      181 tgggtgtctt cagatttcct tgtcttgagg tcctcacaat tactctacag ctcagaacag\\n      241 caactgctga ggctgccttg ggaagaagat gatcctaaac aaagctctga tgctgggggc\\n      301 cctggccctg accaccgtga tgagcccttg tggaggtgaa gacattgtgg gtgagtgcgt\\n      361 gagtgaggaa tgttctctgg agctgaaaaa cagtaaattg aaggaaaaga gagaaagcga\\n      421 tttgcagaga aattgtagag atttcctaag acccctttca gtattaagag aattaaaaat\\n      481 tatagctgtt cctccttcag gaaaccagag ccccaaccta ctctttttgt tatgtatgct\\n      541 tttgtgttca ctaaggatgc tattctgttt atattatatt cagtgactac agcctggagg\\n      601 tctctatgtc attccatcat gattgcctca aaaattagtg aggtttccat cagtggataa\\n      661 ttttttatta ttaaaaatgt atgaagtgtc attctcaaat ttccctgaac aacttttgaa\\n      721 gattttcgga tgtctcctgt agtagatctt ggggtcgttc catcaattat atactctata\\n      781 gatattaaaa aagttgcccg tttctttctc tcagacttac tcacatttcc acatgggaac\\n      841 tggcacaggt ggggagtagg taaaggagtc cagcaggctg aatgccttca acaatcattt\\n      901 taccacatgg tcctcactta ctctcagctg cctcatatgt gtcacctcac aaataatcaa\\n      961 ataaaatggg catgtagcta agctttgtaa atagtgaaaa catggatgtc aattgttttt\\n     1021 acatatttct attacaggta tagcttcaca tttcttttct ttagcaaaat aagggatcct\\n     1081 tttagtttaa aattgagaag tagaaaaaat tggtaaatta aatcatttta ttctcaaatt\\n     1141 atcaacccaa attacctgtt cttcacctca tctaataaag tcctataaaa agaaaagtgg\\n     1201 gccagacatg gtggctcatg cctgtaatcc cagcactttg ggaggccgaa gcaggaggat\\n     1261 catttgagcc tgggagtttg agaccagcct gggcaacaca gcaagacctc atctctacca\\n     1321 aaaaataaaa taaaaattag ccaggcatgg tagtgcatgc ctgtggtgcc agctactcag\\n     1381 aaggctgcag tgggaggagc acttgagtcc aggaggtgga agctgcagtg agccatgatg\\n     1441 gcaccactac actccagcca gggcaacaga gagagaccct gtctcaaaaa gaaagcggaa\\n     1501 agaaagagag aaaggaagga aagaaggaaa gaaggaagca aggaaggaga aagggaaggg\\n     1561 aagaaagaag aaagaaagaa agaaaacaga aggaaggaag cacagattaa ttatttggtc\\n     1621 tcttagtctc ctctgccttt gtcgtccatc tcttcccacc tctcttcatg cattcctttc\\n     1681 tccctcttcc ctttcaggat ccatctctga ctccctgctc ctttatagag atggacatga\\n     1741 gtttgtaaaa caaaagttga aaagtcagat agttaaaagg ggaagtaaac tggaaggtac\\n     1801 tctaaacttt cacaacctta ttaaccgtgg cagctcccat tctgattttg ttcagcagtg\\n     1861 gaagtttcac cctctcctcc agagcgcttg gcttctttgt tccaaatttc ctttcttcag\\n     1921 cctcacacca gagtgccctg gtcaggctca gctcatccat taggcacaat gtgggcagtg\\n     1981 caggggaacc tccatactgt aaagccacat gagaatgttt taactccttt taaaattata\\n     2041 aaaaaatgaa attgtagagc ctaagaaaat gttttaactt ttaattcagc ctatattata\\n     2101 ttgtctttat accaattcag tcataaaata taattttcca tatttttatg gaggaaggcg\\n     2161 tccacacaag caagagtgct tggggctcac atgtcagaac gcatccctga tcatggctga\\n     2221 tcctgacctt cgtgtggttc tgctaactat gtgcctgtca gtcttcccca aaatctatgt\\n     2281 ggtcctcaaa tataacaact gtcattcaat acacatgttt gagcacccag tgagctaagt\\n     2341 tttaaggatt caaagatgaa aagtcatgct gtctcccctg cagagggtgc tcagactagt\\n     2401 gatggaaaca gtatgggatg aaagaaagca gaaggccatt gctgagcagg cagtggactc\\n     2461 agcagaggct gaaactatac aagtgacttg gttccagctg ggccagcagg ataaccagac\\n     2521 gaaaagaagg attgcatata ttccatatat atttatgttt gaacaaagag tcaaggttta\\n     2581 ttgcaaggat aaggaggctt tgttggtggc ctgttaagac catccagcgt ggtcatactg\\n     2641 gatagggaag aaggtgagct ggaagaggga tagacaaact tggatggcca gatgttgaga\\n     2701 tggaggagct ggaggtcata acgtggtcaa aaacatgttg atgagaggac ttagctacaa\\n     2761 agttgttaac ttaagcagaa acctcaagga ttgattttat gatttctcca ggaagtccta\\n     2821 aaagataatt tcatttcagg gaggaaaaca acagaccact gcaaagacca ggaacatgaa\\n     2881 aggataatgt agtttggttt gcttggcaga tacttgtgaa agatgttgga ctgtaaggct\\n     2941 gtcaatatcc tcctcgcaga acttactaca gtacattgta tctgctccct tacctacctg\\n     3001 actctcccac tattcagttt gttccttaat ggtagaccat gcctgattgg tgttttacac\\n     3061 ttcccctgct atgtctgata cttgtggatg ctcagaaagt ggggaaggaa ggaaagatac\\n     3121 gatggtaaaa ggcttacaca tgtcttgacc agaatgttca gtttggctca tttggctgga\\n     3181 gtcatactgc atggctgcca ttctgctctg gcatcctcag agaagcacac tgcccattag\\n     3241 aggaaaaagg gtgaatataa atgttgagtc agaacactgc agacatttag taacctcctt\\n     3301 cagaggaaaa aaagggtggg gggaatgaca gaaatccaaa aactagtaga gcttccactt\\n     3361 tttcatttca gaagaaatca gttactctcc tctaaggacc attactatta acaaaacaga\\n     3421 gaccttagaa ggaagcatta tttatttatc atatattttg taatgttatt accgttcttg\\n     3481 ttatactctt tcttataccc taccattgtt agcagaaatt attttaaatt aataagatcc\\n     3541 tgcatgcttt tcctttttct aaaaaaagaa agatctctgt gtagaatgtc ctgttctgag\\n     3601 ccagtcctga gaggaaagga agtataatca atttgttatt aactgatgaa agaattaagt\\n     3661 gaaagataaa ccttaggaag cagagggaag ttaatctatg actaagaaag ttaagtactc\\n     3721 tgataactca ttcattcctt cttctgttca tttacattat ttaatcacaa gtccatgatg\\n     3781 tgccaggcac tcaggaaata gtgaaaatcg gacacgcgat attctgccct tgtgtagcac\\n     3841 acactgtagt gggaaagaaa gtgcactttt aactggacaa ctatcaacac gaagagggga\\n     3901 ggaagcaggg gctggaaatg tccacagact ttgccaaaga caaagcccat aatatttgaa\\n     3961 agtcagtttc ttccatcatt ttgtgtatta aggtttttta ttctcctgtt ctctgccttc\\n     4021 ctgcttgtca tcttcactca tcagctgacc acgttgcctc ttacggtgta aacttgtacc\\n     4081 agtcttacgg tccctctggc cagttcaccc atgaatttga tggagacgag gagttctatg\\n     4141 tggacctgga gaggaaggag actgtctgga agttgcctct gttccacaga cttagatttg\\n     4201 acccgcaatt tgcactgaca aacatcgctg tgctaaaaca taacttgaac atcctgatta\\n     4261 aacgctccaa ctctaccgct gctaccaatg gtatgtgtcc accattctgc ctttctttac\\n     4321 tgatctatcc ctttatacca agtttcatta ttttctttcc aagaggtccc cagatcttct\\n     4381 catggcaatt gctgaaattt tatcatttct catctctaaa atcacatatc cccatgtaat\\n     4441 acaagggtct ttccattatg cattcattaa atcattctag gagaggtctc atcaacctcc\\n     4501 tactttatta aacatgccca cagagagaag ggcacaggag taaagcagag gcaatgtgtc\\n     4561 attgctccca agtagaaggt aaataaggcc tctttgacca gcaggagagg aaatgctggt\\n     4621 aggaagactc ttccaggatg taatgcagaa gctcagggca gagctattca cacttcacac\\n     4681 cagtgctgtt tcctcaccat agaggttcct gaggtcacag tgttttccaa gtctcccgtg\\n     4741 acactgggtc agcccaacac cctcatctgt cttgtggaca acatctttcc tcctgtggtc\\n     4801 aacatcacct ggctgagcaa tgggcactca gtcacagaag gtgtttctga gaccagcttc\\n     4861 ctctccaaga gtgatcattc cttcttcaag atcagttacc tcaccttcct cccttctgct\\n     4921 gatgagattt atgactgcaa ggtggagcac tggggcctgg atgagcctct tctgaaacac\\n     4981 tggggtaagg atgagtttca ccattttttg atgctttctt gtctgtcaag ttcagaactt\\n     5041 cctgcctttt actctatgtc ccaaaacttg ttttccacac ttcatgagtt tcttttatct\\n     5101 ttttttt\\n//\\n\\nLOCUS       OR880478                5653 bp    DNA     linear   PRI 12-DEC-2023\\nDEFINITION  Homo sapiens isolate N-23-20246-A-03-00 MHC class II antigen\\n            (HLA-DQA1) gene, HLA-DQA1*01NEW allele, complete cds.\\nACCESSION   OR880478\\nVERSION     OR880478.1\\nKEYWORDS    .\\nSOURCE      Homo sapiens (human)\\n  ORGANISM  Homo sapiens\\n            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\\n            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\\n            Catarrhini; Hominidae; Homo.\\nREFERENCE   1  (bases 1 to 5653)\\n  AUTHORS   Velickovic,M.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (28-NOV-2023) New South Wales Transplantation and\\n            Immunogenetics Services Pathology and Clinical Governance,\\n            Australian Red Cross Lifeblood, 17 O\\'Riordan Street Alexandria NSW\\n            2015, Sydney, NSW 2060, Australia\\nCOMMENT     ##Assembly-Data-START##\\n            Assembly Method       :: TSV v. 3.0.0.27232; created on 1/02/2023\\n            Sequencing Technology :: Illumina\\n            ##Assembly-Data-END##\\nFEATURES             Location/Qualifiers\\n     source          1..5653\\n                     /organism=\"Homo sapiens\"\\n                     /mol_type=\"genomic DNA\"\\n                     /isolate=\"N-23-20246-A-03-00\"\\n                     /db_xref=\"taxon:9606\"\\n     gene            1..5653\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n     mRNA            join(1..349,4120..4368,4782..5063,5420..5653)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /product=\"MHC class II antigen\"\\n     exon            1..349\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=1\\n     5\\'UTR           1..267\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n     CDS             join(268..349,4120..4368,4782..5063,5420..5574)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /codon_start=1\\n                     /product=\"MHC class II antigen\"\\n                     /protein_id=\"WPS91253.1\"\\n                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASCGVNLYQFYGP\\n                     SGQFTHEFDGDEQFYVDLEKKETAWRWPEFSKFGGFDPQGALRNMAVAKHNLNIMIKR\\n                     YNSTAATNEVPEVTVFSKSPVTLCQPNTLICLVDNIFPPVVNITWLSNGHAVTEGVSE\\n                     TSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDQPLLKHWEPEIPAPMSELTET\\n                     VVCALGLSVGLVGIVVGTVFIIQGLRSVGASRHQGPL\"\\n     intron          350..4119\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=1\\n     exon            4120..4368\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=2\\n     intron          4369..4781\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=2\\n     exon            4782..5063\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=3\\n     intron          5064..5419\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=3\\n     exon            5420..5653\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=4\\n     3\\'UTR           5575..5653\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\nORIGIN      \\n        1 atgtcctccc tttattcata gaacaattcc tcaagtccac tctgagtaga ggctgcatca\\n       61 caaggggatt gccccgtctc cttccagggc tcttaataca aactcttcaa ctagtaactg\\n      121 agatgtcacc ataggggatt tttctaattg gccaaaacct gacttggcag ggtttggttt\\n      181 gggtgtcttc agatttcctt gtcttgaggt cctcacaatt actctacagc tcagaacacc\\n      241 aactgctgag gctgccttgg gaagaggatg atcctaaaca aagctctgct gctgggggcc\\n      301 ctcgctctga ccaccgtgat gagcccctgt ggaggtgaag acattgtggg tgagtgcatg\\n      361 agtgagggat gttctctgga gctgaaaaac agtaaattga aggaaaagag ataaagcgat\\n      421 ttgcagagaa actgtagaga tttcctaagg gccctttcag tattaagaca attaaaaatt\\n      481 atagctgttc ctccttcagg aaaccagagc cccaacctac tctttttgtt atctatgctg\\n      541 ttgtgttcac taaggacgct attctgttta tattatattc agtgactacg gcctggaggt\\n      601 ctctatgtcg ttccatcatg attgcctcaa aaattagtga ggtttccatc agtggataat\\n      661 tttttattat taaaaattta tgaagtgtca ttctcaaatt tccctgaaca acttttgaag\\n      721 cttttcggat gtctccggtg gtagatcttg gggtcattcc atcaattatg tactctatag\\n      781 atatttaaaa tgttgcccgt ttctttctct cagacttact cacatttcca catgggaact\\n      841 ggcacaggtg gggagtgggt aaaggagtcc agcaggctga atgccttcaa caatcatttt\\n      901 accacatggt cctcacttac tctcagctgc ctcatatgtg tcacctcaca agtaatcaaa\\n      961 taaaatgggc atgtggctaa gctttgtaaa tagtgaaaac atgaatgtca atttttttta\\n     1021 catatttcta ttacagatat agcttcacat ttcttttctt tagcaaaata agggatcatt\\n     1081 ttattttaaa attgagaagt agaaaaaatt ggtaaaataa atcattttat tctcaaatta\\n     1141 tcaacccaaa ttacctgttc ttcacctcat ctaataaagt cctataaaaa gaaaagtggg\\n     1201 ccagacaagg tggctcatgc ctgtaatccc agcactttgg gaggccgagg caggaggatc\\n     1261 atttgagcct gggagcttga gaccagcctg ggcaacatag caagacctca tctctacaaa\\n     1321 aaaagaaaaa gaaaaattag ccaggcatgg tggtgtgtgc ctgtggtgcc agctactcag\\n     1381 aaggctgccg tgggaggacc acttgagtcc atgaggcgga agctgcagtg agccatgatg\\n     1441 gcaccactac actccagcca gggcaacaga gagagacgct gtctcaaaaa gaaagaggaa\\n     1501 agaaagcgag gaaggaagga aggaaggaga aggaaggaag gaaggaaaag aaaagaaaag\\n     1561 ggaagggagg aaggaaggaa aaaagaaaga cagaaagaaa gaggaaggaa ggaaggaagg\\n     1621 aagcacagat taattatttg gtctcttact ctcctctgcc tttgtcgtcc atctctttcc\\n     1681 acctctcttc atgcatccct ttctccctct tccctttcag gatccatctc tggctccctg\\n     1741 ctcctttata gagatggaca gtgggtttgt aaaacaaaag ttgaaaagtc agatagttaa\\n     1801 aaggggaagt gaactggaag gtactttaaa ctttcacaac tttattaacc gtggctgctc\\n     1861 ccattatgat tttgttcggc agtggaagtt tcacctgctt ctccagagca cttggcgtct\\n     1921 ttgttccaaa tttcctttct tcaacctcac accagagtgc cctggtcagg cttggctcat\\n     1981 tcattaggca caatgtgggc agtgcagggg accctccata ctgtaaagcc acatgagaag\\n     2041 gttttaactc gttttaaaat tagaaaaata atggaatatt agagcctaag aaaatgtttt\\n     2101 aacttttaat tcagcctaga ttatattgtc tttataccaa ttcagtcata aaatataatt\\n     2161 ttccatattt ttgtggagga agaggcccat acaagcaaga atgctcgggg ctcacatgtc\\n     2221 agaatgcagc cttggtcatg actgatcctg gccttcgtat ggttctgcta cctgtgtgcc\\n     2281 tgcccgtctt ccccaaaatc tatgtggtcc tcgaatatag caactgtcat tcaatacaca\\n     2341 tgtttgagca cacagtgagc taagttttaa ggattcaaag atgaaaagtc atgctgtctt\\n     2401 ccctgcagag ggtgctcaga ttagtgatgg aaacagtatg gggtgcagga aagcagaagg\\n     2461 ccattgctga gcaggtcagt ggacccagca gaggctgaaa caatacaagt gacttggttc\\n     2521 caggtgggcc agcagggtga cgtcctctag caaaatttgg cacccaagac aagtaccaga\\n     2581 agaaaagaaa gactgcatgt attccacata tattcatgtt tgaacaagga gtcaagattt\\n     2641 atggcaagga taaggaggct ttgttggtga cctgttaaga ccaaccaggg cagtcatgct\\n     2701 ggatagggaa gaaggtgagc tggaagagga acagacaact tggacagcca gatgttgaga\\n     2761 cggaggggtt ggaggtcata atgtggtcaa aaacatgttg atgagaggac tcagctacaa\\n     2821 agttgttaac ttaagcagaa acctcaagga tggattttag aatttctcca ggaagtccta\\n     2881 aaagataatt ccatttcagg gagaaaaaca acagaccact gcaaagacca gggaacatga\\n     2941 aaggataatg tagtttgtct tgcttggcag atacttttga aggatgttgg actgtaaggc\\n     3001 tgtcgatatc ctcctcagag aacttactac agtacattgt atctgttccc ttacctacct\\n     3061 gactcttcca ctattcagtt tgttccttaa tagtagacca tgcctgattg gtgttttaca\\n     3121 catctccggc tatgtctgac acttgtggat gctcagaaag tggggaagga aggaaagata\\n     3181 cgatggtaaa aggcttacac atgtcttgac aaaaaagtcc agtttggctc atttggctgg\\n     3241 agtcgtactg catggctgcc attctgctct ggcatcctca gacaagcaca ctgcccatta\\n     3301 gaggaaaaag tgtgatataa gtgttgagtc agaatgctgt agacatttag taatctcctt\\n     3361 cacaggaaaa aaaaaaaaaa ggtgggggga atgacagaaa tccaaaaact agtagagctt\\n     3421 ccacttttca tttcagaaga aatcagttgc tctcctctaa ggaccattac tattaacaaa\\n     3481 acagagacct tagaaggagg cattgtttat ttattatata ttttgtaatg ttattaccaa\\n     3541 tcttgttata ctctttctta taccctacaa ttgttagcag aaattatttt aaattaataa\\n     3601 gatcctgcat gcttttcctt taaaaaaaaa aaaaaagaaa gatctctgtg tagagtgtcc\\n     3661 tattctgagc cagtcctgag aggaaaggaa gtataatcaa tttgttatta accaatgaaa\\n     3721 gaattaagtg aaagataaat ctcaggaagc agagggaagt aaacctaatt tctgactaag\\n     3781 aaagctaaat actatgataa ctcattcatt ccttcttttg ttcaattaca ttatttaatc\\n     3841 ataagtccat gacatgccag gcactcagga aatagtaaaa attggacatg cgatattctg\\n     3901 cccttgtgta gcgcacacta gagtgggaaa gaaagtgcac ttttaactgg acaactacca\\n     3961 acatgatgag gggaggaaac aggggctgga aatgtccacg gactgtgccg aaaaatgaag\\n     4021 cccataatat ttgaaagtca gtttcttcca tcattttgtg tattaaggtt ctttcttccc\\n     4081 ctgttctccg ccttcctgct tgtcatcttc actcatcagc tgaccatgtt gcctcttgtg\\n     4141 gtgtaaactt gtaccagttt tacggtccct ctggccagtt cacccatgaa tttgatggag\\n     4201 atgagcagtt ctacgtggac ctggagaaga aggagactgc ctggcggtgg cctgagttca\\n     4261 gcaaatttgg aggttttgac ccgcagggtg cactgagaaa catggctgtg gcaaaacaca\\n     4321 acttgaacat catgattaaa cgctacaact ctaccgctgc taccaatggt atgcgtccac\\n     4381 cattctgcct ctctttactt aagctatccc ttcataccag ggttcattat tttcttccca\\n     4441 agaggtcccc agatcttctt atggcaattg ctgaaatttt atcatctccc atctctaaaa\\n     4501 tcacatattc ccatgtaata caagggtctt tccattatgc attcagcaaa tccttctagg\\n     4561 agaggtctca tcaacctcct actttattaa acatgcccac agagagaagg gcacaggaat\\n     4621 aaagcagagg caatgtgtca ttgctcccaa gcagaaggta aataagacct ctttgactat\\n     4681 caggtggtga aatgctggta ggagggctct tccaggatgt aatgcagaac ttcagggcag\\n     4741 agctattcac acttcacacc agtgctgttt cctcaccaca gaggttcctg aggtcacagt\\n     4801 gttttccaag tctcccgtga cactgtgtca gcccaacacc ctcatctgtc ttgtggacaa\\n     4861 catctttcct cctgtggtca acatcacatg gctgagcaat gggcacgcag tcacagaagg\\n     4921 tgtttctgag accagcttcc tctccaagag tgatcattcc ttcttcaaga tcagttacct\\n     4981 caccttcctc ccttctgctg atgagattta tgactgcaag gtggagcact ggggcctgga\\n     5041 ccagcctctt ctgaaacact ggggtaagga tgagtttcat cattttttga ttctttcttg\\n     5101 tctgtcaggt tcagaacttc ctgcctttta ctcctatatc caaaaacttg ttttccacac\\n     5161 ttcatgggtt tcttttctgt ctcacttttt tttttgaaag aataaagcaa aaaaagcaga\\n     5221 gatttattga aaatgaaagt acactctaca ggatgggagt gggcctgcca cttcatggtt\\n     5281 ttctaatgat agacttcact ctcctcccta agctgggggc cttgagtctt tgtagagcca\\n     5341 accctgtacc ccatcccatc ccacacacat gcacatgagc aaactctgca ttctgacctc\\n     5401 aacaacttca cttccacaga gcctgagatt ccagccccta tgtcagagct cacagagact\\n     5461 gtggtctgtg ccctggggtt gtctgtgggc ctcgtgggca ttgtggtggg cactgtcttc\\n     5521 atcatccaag gcctgcgttc agttggtgct tccagacacc aagggccctt gtgaatccca\\n     5581 tcctggaagg gaaggtaaga ttgagactgg ttacagttga agcggcagta tgaaaggaag\\n     5641 gaaagtggga ggg\\n//\\n\\nLOCUS       OR880477                5730 bp    DNA     linear   PRI 12-DEC-2023\\nDEFINITION  Homo sapiens isolate N-23-17675-A-02-00 MHC class II antigen\\n            (HLA-DQA1) gene, HLA-DQA1*04NEW allele, complete cds.\\nACCESSION   OR880477\\nVERSION     OR880477.1\\nKEYWORDS    .\\nSOURCE      Homo sapiens (human)\\n  ORGANISM  Homo sapiens\\n            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\\n            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\\n            Catarrhini; Hominidae; Homo.\\nREFERENCE   1  (bases 1 to 5730)\\n  AUTHORS   Velickovic,M.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (27-NOV-2023) New South Wales Transplantation and\\n            Immunogenetics Services Pathology and Clinical Governance,\\n            Australian Red Cross Lifeblood, 17 O\\'Riordan Street Alexandria NSW\\n            2015, Sydney, NSW 2060, Australia\\nCOMMENT     ##Assembly-Data-START##\\n            Assembly Method       :: TSV v. 3.0.0.27232; created on 1/02/2023\\n            Sequencing Technology :: Illumina\\n            ##Assembly-Data-END##\\nFEATURES             Location/Qualifiers\\n     source          1..5730\\n                     /organism=\"Homo sapiens\"\\n                     /mol_type=\"genomic DNA\"\\n                     /isolate=\"N-23-17675-A-02-00\"\\n                     /db_xref=\"taxon:9606\"\\n     gene            1..5730\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*04NEW\"\\n     mRNA            join(1..341,4199..4444,4857..5138,5502..5730)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*04NEW\"\\n                     /product=\"MHC class II antigen\"\\n     exon            1..341\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*04NEW\"\\n                     /number=1\\n     5\\'UTR           1..259\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*04NEW\"\\n     CDS             join(260..341,4199..4444,4857..5138,5502..5656)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*04NEW\"\\n                     /codon_start=1\\n                     /product=\"MHC class II antigen\"\\n                     /protein_id=\"WPS91252.1\"\\n                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASYGVNLYQSYGP\\n                     SGQYTHEFDGDEQFYVDLGRKETVWCLPVLRQFRFDPQFALTNIAVTKHNLNILIKRS\\n                     NSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGHSVTEGVSET\\n                     SFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDEPLLKHWEPEIPAPMSELTETV\\n                     VCTLGLSVGLVGIVVGTVFIIRGLRSVGASRHQGPL\"\\n     intron          342..4198\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*04NEW\"\\n                     /number=1\\n     exon            4199..4444\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*04NEW\"\\n                     /number=2\\n     intron          4445..4856\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*04NEW\"\\n                     /number=2\\n     exon            4857..5138\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*04NEW\"\\n                     /number=3\\n     intron          5139..5501\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*04NEW\"\\n                     /number=3\\n     exon            5502..5730\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*04NEW\"\\n                     /number=4\\n     3\\'UTR           5657..5730\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*04NEW\"\\nORIGIN      \\n        1 ctattcatag aatatttcct caagtccact ctgagtggag gctgcgtcac aaccagggga\\n       61 tttccctgtc tccttccagg gctcttaata caaactcttc aactagtaac tgaggtgtca\\n      121 tcatagggga gttttctaat tagccaaaac ctgacctggc agggtttggt ttgggtgtct\\n      181 tcagatttgc ttgtctcgag gtcctcacaa ttgctctaca gctcagagca gcaactgctg\\n      241 aggctgcctt gggaagagga tgatcctaaa caaagctctg ctgctggggg cccttgccct\\n      301 gaccaccgtg atgagcccct gtggaggtga agacattgtg ggtgagtgca tgagtgaggg\\n      361 atgttctctg gagctggaag agaggaaatc gaagaaaaga gagaaagcga ttttgcagag\\n      421 aaattgtaga gatttcctaa gggccccttc agtattaaga gatttaaaaa ttacggctgt\\n      481 ttctccttca ggaaaccaga gtcccaacct actctttttg ttatctatgc tgttggcgtt\\n      541 cactaaggat gctattctgt ttatattgta ttcagtcact acagcctgga ggtctctatg\\n      601 tcattccatc atgactgcct caaaaattgg tgaggtttcc atcagtcgat aattttttat\\n      661 tattaaaaat ttgtgaagta tcattctcaa atttccctga acaacttttg aagcttttcg\\n      721 gatgtctcct gtagtagacc ttggggtaaa tgattccatc aattatatac tctatagata\\n      781 ttaagaaaga tgcccttttc tttctctcag acttacttac atttccacat gggaactggc\\n      841 acaggtgggg agtgggtaaa ggagtccagc aggctgaatg ccttcaacaa tcattttacc\\n      901 acatggtcct cacttactct cagctgcctc atttgtgtca cctcacaaat aatcaaataa\\n      961 aatgggcatg tagttaagct ttgtaaatag tgaaaacatg aatgtcaatt ttatttttac\\n     1021 atatttccat tataggagta gcttcacatt tcttttcttt agcaaaataa ggaatccttt\\n     1081 tattttaaaa ttgagaattt atagtagaaa aacttgctaa attaaatcat tttgttctca\\n     1141 aattatcaac ccaaattacc tgttgttcac ctcatctaat gaagtcctat aaaaagaaaa\\n     1201 gtgggttaga catggtggct catgcctgta atcccagcac tttgggaggc tgaggcagga\\n     1261 ggatcctttg agcccaggag ttcgagacca gcctgggcaa catagcaaga cctcatctct\\n     1321 acaaaaaata aaaattagcc aggtgtggtg gtgcgtgcct gggtgccagc tactcagaag\\n     1381 gctgcaatgg gaggactgct tgagtccagg aggcggaagc tgcagtgagc catgatggca\\n     1441 ccactacact ccagccaggg caacagagag agaccctgtc ccaaaaagaa agaggaaaga\\n     1501 aagagagaaa ggaaggaaag aaagaaagaa ggaagtaagg aaggaaagaa ggaaggaagg\\n     1561 gagaagggga agggaaggga aggaaggaag gaaaggaaag ggaagggagg aaagaaggaa\\n     1621 ggaaaaaaga aaaagaaaga aagtagaaag gaagaaagaa gaaagaaaga agaaagaaag\\n     1681 gaaagaaaag agggaaggaa agaaagaaga aggaaggaag cacagattaa ttattaatta\\n     1741 tttggtctct cttagtctcc tctgtctttg ttgtccatct cttcctaccc ctcttcatgc\\n     1801 attcctttct ccctcttccc tttcaggatc catctctgac tccctgcttc tttatatgga\\n     1861 cagtgggttt gtaaaacaaa agttgaaaaa tcagatagtt aaaaggtgaa gtgaactgga\\n     1921 aggtctaaac ttccacaacc ttattaacca tggctgctcc cattctgatt ttgttcggca\\n     1981 gtggaagttc cacctgcttc tccagagcac ttggcttctt tgttccaaat ttcctttctt\\n     2041 caacctcaca ccagagtgcc ctggtcaggc tcggctcatc cattaggcac aacgtgggca\\n     2101 atgcagagaa ccctccatac tgtaaagcca catgagaatg ttttaactcc ttttaagatt\\n     2161 agaaaaaaat gaaatttcag agcccaagaa aatgttttaa ttcagcctag attgtattgt\\n     2221 ctttatacca attcagtcat aaaatacaat tttccatatt tttatggagg aaggggccca\\n     2281 caaaagcaag agtgcttagg gctcacatgt cagaacgcag ccctggtcat ggctgatcct\\n     2341 ggccttcgta tgattctgct agtgtgcctg tccgtcttcc ccagaatcta tgtggtcctc\\n     2401 aaatatagca actgtaattc aaaacacgtt tgagcacaca gtaagctaag ttttaaggat\\n     2461 tcaaagacga aaagtcatgc tgtcttccct gcagagggtg ctcagactag tgatggaaac\\n     2521 agtatgggat gcaggaaagc agaaggccat tgctgagcag ggcagtggac tcagcagagg\\n     2581 ctgaaactat acaaatgact tggttccagc tgggccagca gggtgacatc ctccagcaaa\\n     2641 actcggcacc caagacaagt cccagatgaa aagaaggatt gctttgtgtt tgataaggag\\n     2701 tcaaggttta ttgcaaggat aagaaggctt tgttggtggc ctgttaagac catccagggc\\n     2761 agtcatactg gataaggagg aaggtgagct ggaagaggaa cagacaaaca gccagatatt\\n     2821 gagatggaag aggtggaggt cataacgtgg taaaaaatat gttgatgaga ggacttagct\\n     2881 acaaagttgt taacttaagc ataaaccgca aggatgaatt ttaggatttc tccaggaagt\\n     2941 cctaaaagat aatttcattt cagggagaaa aacaacaaac cactgcaaag accaggcaac\\n     3001 acgaaaggat aatgtagttt tgtttgcttg gcagatactt atgaaagatg ttggactgta\\n     3061 aggctgttga tagcctcctc acagaacgtg ctacagtaca ttgtatctac tcccttacct\\n     3121 acctgactct tccactgttc agtttgtttc ttaatggtag accatgcctg attggtgttt\\n     3181 tacacatccc ctgctatgtc tgacacttgt gaatgctcag aaagtgggga aggaaggaaa\\n     3241 gatacaacag taaaaggctt acacgtcttg acaagaatgt ccagttcggc tcatttggct\\n     3301 ggagccatat cgcatggctg ccattctgct ctggcatcct cagacaagca cactgcccat\\n     3361 tagaggaaaa agggtttaat ttagctgagt cctcaagtga atataagtgt taagtcagaa\\n     3421 cactgtagac atttagtaac ctccttcaga ggaaaaaaaa aaaaggtggg gggaaatgac\\n     3481 agaaatccaa aaactagtag agcttccatt cttcatttca gaagaaatca gttgctctcc\\n     3541 tctaaggatc attactatta acaaaacaga gaccttgaag gaggcattgt ttatttatta\\n     3601 tatattttgt aatgttatta ccattcttgt tatactcttt cttataccct acaattgtta\\n     3661 gcaaacatta ttttaaatta ataagatcct gcatgctttt ccttttttaa aaaaaagaaa\\n     3721 gacctctgtg tagagtgtcc tgttctgagc cagtcctgag aggaaagaaa gtacaatcag\\n     3781 tttgttatta actgatgaaa gaattaagtg aaagatgaat cttaggaagc agagggaagt\\n     3841 aaacctagtc tctgactaag aaagctaaat accataataa ctcattcatt ccttcttttg\\n     3901 ttcaattaca gtatttaatc gtaagtccat gatgtgccag gcactcagga aatagtaaaa\\n     3961 actggacatg tgatattctg cccttgtgta gcacacatta tagtgggaaa gaaagcgcaa\\n     4021 ttttaaccgg acaactacca acactaagag cggaggaagc aggggctgga aatgtccaca\\n     4081 ggctgtgcca aagatgaagc tcgtaatatt tgaaagtcag tttcttccat cattttgtgt\\n     4141 attaaggttc tttcttcccc tgttctccac cttcttgctt gtcatcttca ctcatcagct\\n     4201 gaccatgttg cctcttatgg tgtaaacttg taccagtctt acggtccctc tggccagtac\\n     4261 acccatgaat ttgatggaga cgagcagttc tacgtggacc tggggaggaa ggagactgtc\\n     4321 tggtgtttgc ctgttctcag acaatttaga tttgacccgc aatttgcact gacaaacatc\\n     4381 gctgtgacaa aacacaactt gaacatcctg attaaacgct ccaactctac tgctgctacc\\n     4441 aatggtatgt gtccacaatt ctgcccctct ttactgatct atcccttcat accaagtttc\\n     4501 attattttac ttccaagagg tccccagatc ttctcatggc aattgctgaa attctatcac\\n     4561 ttcccatctc taaaatcaca tattcccatg taatacaagg gtctttccat tatccattca\\n     4621 ttaaatcctt ctaggagagg tctcatcaac ctcctacttt attaaacatg cccacagaga\\n     4681 gaagggcata ggaataaagc agaggcaatg tgtcgttgct cccaagcaga aggtaaataa\\n     4741 gacctctttg actatcaggt ggtgaaatgc tggtaggagg gctcttccag gatgtaatgc\\n     4801 agaagctcat ggcagagcta ttcacacttc acatcagtgc tgtttcctca ccacagaggt\\n     4861 tcctgaggtc acagtgtttt ccaagtctcc cgtgacgctg ggtcagccca acaccctcat\\n     4921 ctgtcttgtg gacaacatct ttcctcctgt ggtcaacatc acatggctga gcaatgggca\\n     4981 ctcagtcaca gaaggtgttt ctgagaccag cttcctctcc aagagtgatc attccttctt\\n     5041 caagatcagt tacctcacct tcctcccttc tgctgatgag atttatgact gcaaggtgga\\n     5101 gcactggggc ctggacgagc ctcttctgaa acactggggt aaggatgagt tccaccactt\\n     5161 tttgatgctt tcttgtctgt caagttcaga acttcctgcc ttttactcct atatcccaaa\\n     5221 acttgttttt cacacttcat gggtttcttt ctttcttttg aaagaataaa gcaacaaaag\\n     5281 caaagattta ttgaaaatga aagtacactt cacagggtgg gaacgggcct gagcataggg\\n     5341 gctcaagagc cacttcatgg gtttctaatg atagacttca ctctcctccc taagctgagg\\n     5401 accttgagtc tttgcagagc caaccctcca ccccatccca tcccacacac atgcacatga\\n     5461 gcacactctg ctttctgacc tcaacgactt catatccaca gagcctgaga ttccagcccc\\n     5521 tatgtcagag ctcacagaga ctgtggtctg caccctggga ttgtctgtgg gcctcgtggg\\n     5581 cattgtggtg ggcactgtct tcatcatccg aggcctgcgt tcagttggtg cttccagaca\\n     5641 ccaagggccc ttgtgaatcc catcctggaa gggaaggtaa gattgagatt tgttagagct\\n     5701 gaatccgcag tatgagagga aggaaagtgg\\n//\\n\\nLOCUS       OR880476                5633 bp    DNA     linear   PRI 12-DEC-2023\\nDEFINITION  Homo sapiens isolate N-23-11753-B-02-00 MHC class II antigen\\n            (HLA-DQA1) gene, HLA-DQA1*01NEW allele, complete cds.\\nACCESSION   OR880476\\nVERSION     OR880476.1\\nKEYWORDS    .\\nSOURCE      Homo sapiens (human)\\n  ORGANISM  Homo sapiens\\n            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\\n            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\\n            Catarrhini; Hominidae; Homo.\\nREFERENCE   1  (bases 1 to 5633)\\n  AUTHORS   Velickovic,M.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (27-NOV-2023) New South Wales Transplantation and\\n            Immunogenetics Services Pathology and Clinical Governance,\\n            Australian Red Cross Lifeblood, 17 O\\'Riordan Street Alexandria NSW\\n            2015, Sydney, NSW 2060, Australia\\nCOMMENT     ##Assembly-Data-START##\\n            Assembly Method       :: TSV v. 3.0.0.27232; created on 1/02/2023\\n            Sequencing Technology :: Illumina\\n            ##Assembly-Data-END##\\nFEATURES             Location/Qualifiers\\n     source          1..5633\\n                     /organism=\"Homo sapiens\"\\n                     /mol_type=\"genomic DNA\"\\n                     /isolate=\"N-23-11753-B-02-00\"\\n                     /db_xref=\"taxon:9606\"\\n     gene            1..5633\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n     mRNA            join(1..322,4093..4341,4755..5036,5393..5633)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /product=\"MHC class II antigen\"\\n     exon            1..322\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=1\\n     5\\'UTR           1..240\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n     CDS             join(241..322,4093..4341,4755..5036,5393..5547)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /codon_start=1\\n                     /product=\"MHC class II antigen\"\\n                     /protein_id=\"WPS91251.1\"\\n                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASCGVNLYQFYGP\\n                     SGQFTHEFDGDEQFYVDLEKKETAWRWPEFSKFGGFDPQGALRNMAVAKHNLNIMIKR\\n                     YNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGHSVTEGVSE\\n                     TSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDQPLLKHWEPEIPAPMSELTET\\n                     VVCALGLSVGLVGIVVGTVFIIQGLRSVGASRHQGPL\"\\n     intron          323..4092\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=1\\n     exon            4093..4341\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=2\\n     intron          4342..4754\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=2\\n     exon            4755..5036\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=3\\n     intron          5037..5392\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=3\\n     exon            5393..5633\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=4\\n     3\\'UTR           5548..5633\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\nORIGIN      \\n        1 tcctcaagtc cactctgagt agaggctgca tcacaagggg attgccccgt ctccttccag\\n       61 ggctcttaat acaaactctt caactagtaa ctgagatgtc accatagggg atttttctaa\\n      121 ttggccaaaa cctgacttgg cagggtttgg tttgggtgtc ttcagatttc cttgtcttga\\n      181 ggtcctcaca attactctac agctcagaac accaactgct gaggctgcct tgggaagagg\\n      241 atgatcctaa acaaagctct gctgctgggg gccctcgctc tgaccaccgt gatgagcccc\\n      301 tgtggaggtg aagacattgt gggtgagtgc atgagtgagg gatgttctct ggagctgaaa\\n      361 aacagtaaat tgaaggaaaa gagataaagc gatttgcaga gaaactgtag agatttccta\\n      421 agggcccttt cagtattaag acaattaaaa attatagctg ttcctccttc aggaaaccag\\n      481 agccccaacc tactcttttt gttatctatg ctgttgtgtt cactaaggac gctattctgt\\n      541 ttatattata ttcagtgact acggcctgga ggtctctatg tcgttccatc atgattgcct\\n      601 caaaaattag tgaggtttcc atcagtggat aattttttat tattaaaaat ttatgaagtg\\n      661 tcattctcaa atttccctga acaacttttg aagcttttcg gatgtctccg gtggtagatc\\n      721 ttggggtcat tccatcaatt atgtactcta tagatattta aaatgttgcc cgtttctttc\\n      781 tctcagactt actcacattt ccacatggga actggcacag gtggggagtg ggtaaaggag\\n      841 tccagcaggc tgaatgcctt caacaatcat tttaccacat ggtcctcact tactctcagc\\n      901 tgcctcatat gtgtcacctc acaagtaatc aaataaaatg ggcatgtggc taagctttgt\\n      961 aaatagtgaa aacatgaatg tcaatttttt ttacatattt ctattacaga tatagcttca\\n     1021 catttctttt ctttagcaaa ataagggatc attttatttt aaaattgaga agtagaaaaa\\n     1081 attggtaaaa taaatcattt tattctcaaa ttatcaaccc aaattacctg ttcttcacct\\n     1141 catctaataa agtcctataa aaagaaaagt gggccagaca aggtggctca tgcctgtaat\\n     1201 cccagcactt tgggaggccg aggcaggagg atcatttgag cctgggagct tgagaccagc\\n     1261 ctgggcaaca tagcaagacc tcatctctac aaaaaaagaa aaagaaaaat tagccaggca\\n     1321 tggtggtgtg tgcctgtggt gccagctact cagaaggctg ccgtgggagg accacttgag\\n     1381 tccatgaggc ggaagctgca gtgagccatg atggcaccac tacactccag ccagggcaac\\n     1441 agagagagac gctgtctcaa aaagaaagag gaaagaaagc gaggaaggaa ggaaggaagg\\n     1501 agaaggaagg aaggaaggaa aagaaaagaa aagggaaggg aggaaggaag gaaaaaagaa\\n     1561 agacagaaag aaagaggaag gaaggaagga aggaagcaca gattaattat ttggtctctt\\n     1621 actctcctct gcctttgtcg tccatctctt tccacctctc ttcatgcatc cctttctccc\\n     1681 tcttcccttt caggatccat ctctggctcc ctgctccttt atagagatgg acagtgggtt\\n     1741 tgtaaaacaa aagttgaaaa gtcagatagt taaaagggga agtgaactgg aaggtacttt\\n     1801 aaactttcac aactttatta accgtggctg ctcccattat gattttgttc ggcagtggaa\\n     1861 gtttcacctg cttctccaga gcacttggcg tctttgttcc aaatttcctt tcttcaacct\\n     1921 cacaccagag tgccctggtc aggcttggct cattcattag gcacaatgtg ggcagtgcag\\n     1981 gggaccctcc atactgtaaa gccacatgag aaggttttaa ctcgttttaa aattagaaaa\\n     2041 ataatggaat attagagcct aagaaaatgt tttaactttt aattcagcct agattatatt\\n     2101 gtctttatac caattcagtc ataaaatata attttccata tttttgtgga ggaagaggcc\\n     2161 catacaagca agaatgctcg gggctcacat gtcagaatgc agccttggtc atgactgatc\\n     2221 ctggccttcg tatggttctg ctacctgtgt gcctgcccgt cttccccaaa atctatgtgg\\n     2281 tcctcgaata tagcaactgt cattcaatac acatgtttga gcacacagtg agctaagttt\\n     2341 taaggattca aagatgaaaa gtcatgctgt cttccctgca gagggtgctc agattagtga\\n     2401 tggaaacagt atggggtgca ggaaagcaga aggccattgc tgagcaggtc agtggaccca\\n     2461 gcagaggctg aaacaataca agtgacttgg ttccaggtgg gccagcaggg tgacgtcctc\\n     2521 tagcaaaatt tggcacccaa gacaagtacc agaagaaaag aaagactgca tgtattccac\\n     2581 atatattcat gtttgaacaa ggagtcaaga tttatggcaa ggataaggag gctttgttgg\\n     2641 tgacctgtta agaccaacca gggcagtcat gctggatagg gaagaaggtg agctggaaga\\n     2701 ggaacagaca acttggacag ccagatgttg agacggaggg gttggaggtc ataatgtggt\\n     2761 caaaaacatg ttgatgagag gactcagcta caaagttgtt aacttaagca gaaacctcaa\\n     2821 ggatggattt tagaatttct ccaggaagtc ctaaaagata attccatttc agggagaaaa\\n     2881 acaacagacc actgcaaaga ccagggaaca tgaaaggata atgtagtttg tcttgcttgg\\n     2941 cagatacttt tgaaggatgt tggactgtaa ggctgtcgat atcctcctca gagaacttac\\n     3001 tacagtacat tgtatctgtt cccttaccta cctgactctt ccactattca gtttgttcct\\n     3061 taatagtaga ccatgcctga ttggtgtttt acacatctcc ggctatgtct gacacttgtg\\n     3121 gatgctcaga aagtggggaa ggaaggaaag atacgatggt aaaaggctta cacatgtctt\\n     3181 gacaaaaaag tccagtttgg ctcatttggc tggagtcgta ctgcatggct gccattctgc\\n     3241 tctggcatcc tcagacaagc acactgccca ttagaggaaa aagtgtgata taagtgttga\\n     3301 gtcagaatgc tgtagacatt tagtaatctc cttcacagga aaaaaaaaaa aaaggtgggg\\n     3361 ggaatgacag aaatccaaaa actagtagag cttccacttt tcatttcaga agaaatcagt\\n     3421 tgctctcctc taaggaccat tactattaac aaaacagaga ccttagaagg aggcattgtt\\n     3481 tatttattat atattttgta atgttattac caatcttgtt atactctttc ttatacccta\\n     3541 caattgttag cagaaattat tttaaattaa taagatcctg catgcttttc ctttaaaaaa\\n     3601 aaaaaaaaag aaagatctct gtgtagagtg tcctattctg agccagtcct gagaggaaag\\n     3661 gaagtataat caatttgtta ttaaccaatg aaagaattaa gtgaaagata aatctcagga\\n     3721 agcagaggga agtaaaccta atttctgact aagaaagcta aatactatga taactcattc\\n     3781 attccttctt ttgttcaatt acattattta atcataagtc catgacatgc caggcactca\\n     3841 ggaaatagta aaaattggac atgcgatatt ctgcccttgt gtagcgcaca ctagagtggg\\n     3901 aaagaaagtg cacttttaac tggacaacta ccaacatgat gaggggagga aacaggggct\\n     3961 ggaaatgtcc acggactgtg ccgaaaaatg aagcccataa tatttgaaag tcagtttctt\\n     4021 ccatcatttt gtgtattaag gttctttctt cccctgttct ccgccttcct gcttgtcatc\\n     4081 ttcactcatc agctgaccat gttgcctctt gtggtgtaaa cttgtaccag ttttacggtc\\n     4141 cctctggcca gttcacccat gaatttgatg gagatgagca gttctacgtg gacctggaga\\n     4201 agaaggagac tgcctggcgg tggcctgagt tcagcaaatt tggaggtttt gacccgcagg\\n     4261 gtgcactgag aaacatggct gtggcaaaac acaacttgaa catcatgatt aaacgctaca\\n     4321 actctaccgc tgctaccaat ggtatgcgtc caccattctg cctctcttta cttaagctat\\n     4381 cccttcatac cagggttcat tattttcttc ccaagaggtc cccagatctt cttatggcaa\\n     4441 ttgctgaaat tttatcatct cccatctcta aaatcacata ttcccatgta atacaagggt\\n     4501 ctttccatta tgcattcagc aaatccttct aggagaggtc tcatcaacct cctactttat\\n     4561 taaacatgcc cacagagaga agggcacagg aataaagcag aggcaatgtg tcattgctcc\\n     4621 caagcagaag gtaaataaga cctctttgac tatcaggtgg tgaaatgctg gtaggagggc\\n     4681 tcttccagga tgtaatgcag aacttcaggg cagagctatt cacacttcac accagtgctg\\n     4741 tttcctcacc acagaggttc ctgaggtcac agtgttttcc aagtctcccg tgacactggg\\n     4801 tcagcccaac accctcatct gtcttgtgga caacatcttt cctcctgtgg tcaacatcac\\n     4861 atggctgagc aatgggcact cagtcacaga aggtgtttct gagaccagct tcctctccaa\\n     4921 gagtgatcat tccttcttca agatcagtta cctcaccttc ctcccttctg ctgatgagat\\n     4981 ttatgactgc aaggtggagc actggggcct ggaccagcct cttctgaaac actggggtaa\\n     5041 ggatgagttt catcattttt tgattctttc ttgtctgtca ggttcagaac ttcctgcctt\\n     5101 ttactcctat atccaaaaac ttgttttcca cacttcatgg gtttcttttc tgtctcactt\\n     5161 ttttttttga aagaataaag caaaaaaagc agagatttat tgaaaatgaa agtacactct\\n     5221 acaggatggg agtgggcctg ccacttcatg gttttctaat gatagacttc actctcctcc\\n     5281 ctaagctggg ggccttgagt ctttgtagag ccaaccctgt accccatccc atcccacaca\\n     5341 catgcacatg agcaaactct gcattctgac ctcaacaact tcacttccac agagcctgag\\n     5401 attccagccc ctatgtcaga gctcacagag actgtggtct gtgccctggg gttgtctgtg\\n     5461 ggcctcgtgg gcattgtggt gggcactgtc ttcatcatcc aaggcctgcg ttcagttggt\\n     5521 gcttccagac accaagggcc cttgtgaatc ccatcctgga agggaaggta agattgagac\\n     5581 tggttacagt tgaagcggca gtatgaaagg aaggaaagtg ggagggcgtt gtg\\n//\\n\\nLOCUS       OR880475                5589 bp    DNA     linear   PRI 12-DEC-2023\\nDEFINITION  Homo sapiens isolate N-23-3542-B-02-00 MHC class II antigen\\n            (HLA-DQA1) gene, HLA-DQA1*03NEW allele, complete cds.\\nACCESSION   OR880475\\nVERSION     OR880475.1\\nKEYWORDS    .\\nSOURCE      Homo sapiens (human)\\n  ORGANISM  Homo sapiens\\n            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\\n            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\\n            Catarrhini; Hominidae; Homo.\\nREFERENCE   1  (bases 1 to 5589)\\n  AUTHORS   Velickovic,M.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (27-NOV-2023) New South Wales Transplantation and\\n            Immunogenetics Services Pathology and Clinical Governance,\\n            Australian Red Cross Lifeblood, 17 O\\'Riordan Street Alexandria NSW\\n            2015, Sydney, NSW 2060, Australia\\nCOMMENT     ##Assembly-Data-START##\\n            Assembly Method       :: TSV v. 3.0.0.27232; created on 1/02/2023\\n            Sequencing Technology :: Illumina\\n            ##Assembly-Data-END##\\nFEATURES             Location/Qualifiers\\n     source          1..5589\\n                     /organism=\"Homo sapiens\"\\n                     /mol_type=\"genomic DNA\"\\n                     /isolate=\"N-23-3542-B-02-00\"\\n                     /db_xref=\"taxon:9606\"\\n     gene            1..5589\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*03NEW\"\\n     mRNA            join(1..342,4040..4288,4734..5015,5363..5589)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*03NEW\"\\n                     /product=\"MHC class II antigen\"\\n     exon            1..342\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*03NEW\"\\n                     /number=1\\n     5\\'UTR           1..260\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*03NEW\"\\n     CDS             join(261..342,4040..4288,4734..5015,5363..5517)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*03NEW\"\\n                     /codon_start=1\\n                     /product=\"MHC class II antigen\"\\n                     /protein_id=\"WPS91250.1\"\\n                     /translation=\"MILNKALMLGALALTTVMSPCGGEDIVADHVASYGVNLYQSYGP\\n                     SGQYSHEFDGDEEFYVDLERKETVWQLPLFRRFRRFDPQFALTNIAVLKHNLNIVIKR\\n                     SNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGHSVTEGVSE\\n                     TSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDEPLLKHWEPEIPTPMSELTET\\n                     VVCALGLSVGLVGIVVGTVLIIRGLRSVGASRHQEPL\"\\n     intron          343..4039\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*03NEW\"\\n                     /number=1\\n     exon            4040..4288\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*03NEW\"\\n                     /number=2\\n     intron          4289..4733\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*03NEW\"\\n                     /number=2\\n     exon            4734..5015\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*03NEW\"\\n                     /number=3\\n     intron          5016..5362\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*03NEW\"\\n                     /number=3\\n     exon            5363..5589\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*03NEW\"\\n                     /number=4\\n     3\\'UTR           5518..5589\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*03NEW\"\\nORIGIN      \\n        1 tctgttcata gaacaattcc tcaagtccac tctgagtaga ggctgcatca caacaagggg\\n       61 attgccctgt ctccttccag ggctcttaat acaaactctt cagctagtaa ctgagatgtc\\n      121 accatggggg atttttctaa ttggccaaaa cctgacctgg cagggtttgg tttgggtgtc\\n      181 ttcagatttc cttgtcttga ggccctcaca attgctctac agctcagaac agcaactgct\\n      241 gaggctgcct tgggaagagg atgatcctaa acaaagctct gatgctgggg gccctcgccc\\n      301 tgaccaccgt gatgagccct tgtggaggtg aagacattgt gggtgagtgc atgagtgagg\\n      361 aatgttctct ggagctgaaa aacagtaaat tgaaggaaaa gagagaaagc gatttgcaga\\n      421 gaaattgtag agatttccta agaccccttt cagtattaag agaattaaaa attatagctg\\n      481 ttcctccttc aggaaaccag agccccaacc tactcttttt gttatgtatg cttttgtgtt\\n      541 cactaaggat gctattctgt ttatattata ttcagtgaca acagcctgga ggtctctatg\\n      601 tcgttccgtc atgattgcct caaaaattag tgaagtttcc atcagtggat aattttttat\\n      661 tattaaaaat gtatgaagtg tcattctcaa atttccctga acaacttttg aagcttttcg\\n      721 tatgtctcct gtagtagatc ttggggtcgt tccatcaatt atatactcta tagatattaa\\n      781 aaaagttgcc cgtttctttc tctcagactt actcacattt ccacatggga actggcacag\\n      841 gtggggagtg ggtaaaggag tccagcaggc tgaatgcctt caacaatcat tttaccacat\\n      901 ggtcctcact tactctcagc tgcctcatat gtgtcacctc acaaataatc aaataaaatg\\n      961 ggcatgtagc taagctttgt aaatagtgaa aacatggatg tcaattgttt ttacatattt\\n     1021 ctattacagg tatagcttca catttttctt tagcaaaata agggatcctt ttagtttaaa\\n     1081 attgagaagt agaaaaaatt ggtaaattaa atcattttat tctcaaatta tcaacccaaa\\n     1141 ttacctgttc ttcacctcat ctaataaagt cctataaaaa gaaaagtggg ccagacatgg\\n     1201 tggctcatgc ctgtaatccc agcactttgg gaggccgaag caggaggatc atttgagcct\\n     1261 gggagtttga gaccagcctg ggcaacatag caagacctca tctctaccaa aaaataaaat\\n     1321 aaaaattagc caggtgtggt ggtgcatgcc tgtggtgcca gctactcaga aggctgcagt\\n     1381 gggaggagca cttgagtcca ggaggtggaa gctgcagtga gccatgatgg caccactaca\\n     1441 ctccagccag ggcaacagag agagactctg tctcaaaaag aaagaggaaa gaaagagaga\\n     1501 aaggaaggaa agaaggaaag aaggaaggaa ggaaggagaa agggaaggga ggaaggaaaa\\n     1561 aagaaagaaa gaaagaaaac ggaaggaagg aagcacagat taattatttg gtctctttgt\\n     1621 ctcctctgcc tttgtcgtcc atctcttccc acctctcttc atgcattcct ttctccctct\\n     1681 tccctttcag gatccatctc tgactccctg ctcctttata gagatggaca gtgagtttgt\\n     1741 aaaacaaaag ttgaaaagtc agatagttaa aaggggaagt gaactggaag gtactctaaa\\n     1801 ctttcacaac cttattaacc atggctgctc ccattctgat tttgttcagc agtggaagtt\\n     1861 tcacccgctc ctccagagcg cttggcttct ttgttccaaa tttcctttct tcaacctcac\\n     1921 accagagtgc cctggtcagg ctcagctcat ccattaggca caatgtgggc agtgcagggg\\n     1981 accctccaga ctgtaaagcc acatgagaat gttttaactc cttttaaaat tataaaaaaa\\n     2041 tgaaattgta gagcctaaga aaatgtttta acttttaatt cagcctagat tatattgtct\\n     2101 ttataccaat tcagtcataa aatatagttt tccatatttt tatggaggaa ggcgtccaca\\n     2161 caagcaagag tgcttggggc tcacatgtca gaacgcaacc ctgatcatgg ctgatcctgg\\n     2221 ccttcgtgtg gttctgctaa ctatgtgcct gtcagtcttc cccaaaatct atgtggtcct\\n     2281 caaatataac aactgtcatt caatacacat gtttgagcac ccagtgagct aagttttaag\\n     2341 gattcaaaga tgaaaagtca tgctgtctcc tctgcaaagg gtgctcagac tagtgatgga\\n     2401 aacagtatgg gatgaaagaa agcagaaggc cattgctgag caggcagtgg actcagcaga\\n     2461 ggctgaaact atacaagtga cttggttcca gctgggccag caggataacc agatgaaaag\\n     2521 aaggattgca tatattccat atatatttat gtttgaacaa agagtcaagg tttattgcaa\\n     2581 ggataaggag gttttgttgg tggcctgtta agaccatcca gggtggtcat actggatagg\\n     2641 gaagaaggtg agctggaaga ggaacagaca aacttggatg gccagatgtt gagatggagg\\n     2701 agatggaggt cataacgtgg tcaaaaacat gttgatgaga ggacttagct acaaagttgt\\n     2761 taacttaagc agaaacctca aggattgatt ttatgatttc tccaggaagt cctaaaagtt\\n     2821 aatttcattt cagggagaaa aacaacagac cactgcaaag accaggaaca tgaaaggata\\n     2881 atgtagtttg gtttgcttgg cagatacttg tgaaagatgt tggactgtaa ggctgtcaat\\n     2941 atcctcctcg cagaacttac tacagtacat tgtatctgct cccttaccta cctgactctc\\n     3001 ccactattca gtttgttcct taatggtaga ccatgcctga tcggtgtttt acacatcccc\\n     3061 tgctatgtct gatacttgtg gatgctcaga aagtggggaa ggaaggaaag atacgatggt\\n     3121 aaaaggctta cacatgtctt gagcagaatg ttcagtttgg ctcatttggc tggagtcata\\n     3181 ctgcatggct gccattctgc tctggcatcc tcagagaagc acactgccca ttaaaggaaa\\n     3241 aagggtgaat acaaatgttg agtcagaaca ctgcagacat ttagtaacct ccttcagagg\\n     3301 aaaaaaaaag gtggggggaa tgacagaaat ccaaaaacta gtagagcttc cactttttca\\n     3361 tttcagaaga aatcagttac tctcctctaa ggaccattac tattaacaaa acagagacct\\n     3421 tagaaggaag cattatttac ttatcatata ttttgtaatg ttattaccct tcttgttata\\n     3481 ctctttctta taccctacca ttgttagcag aaattatttt aaattaataa gatcctgcat\\n     3541 gcttttcctt tttctaaaaa aagaaagatc tctgtgtaga atgtcctgtt ctgagccagt\\n     3601 cctgagagga aaggaagtat aatcaatttg ttattaactg atgaaagaat taagtgaaag\\n     3661 ataaacctta ggaagcagag ggaagttaat ctatgactaa gaaagttaag tactctgata\\n     3721 actcattcat tccttctttt gttcatttac attatttaat cacaagtcta tgatgtgcca\\n     3781 ggcactcagg aaatagtgaa aattggacac gcgatattct gcccttgtgt agcacacacc\\n     3841 gtagtgggaa agaaagtgca cttttaaccg gacaactatc aacacgaaga ggggaggaag\\n     3901 caggggctgg aaatgtccac agactttgcc aaagacaaag cccataatat ctgaaagtca\\n     3961 gtttcttcca tcattttgtg tattaaggtt ctttattccc ctgttctctg ccttcctgct\\n     4021 tgtcatcttc actcatcagc tgaccatgtt gcctcttacg gtgtaaactt gtaccagtct\\n     4081 tatggtccct ctgggcagta cagccatgaa tttgatggag acgaggagtt ctatgtggac\\n     4141 ctggagagga aggagactgt ctggcagttg cctctgttcc gcagatttag aagatttgac\\n     4201 ccgcaatttg cactgacaaa catcgctgtg ctaaaacata acttgaacat cgtgattaaa\\n     4261 cgctccaact ctaccgctgc taccaatggt atgtgtccac cattctgcct ttctttactg\\n     4321 atttatccct ttataccaag tttcattatt ttctttccaa gaggtcccca gatcttctca\\n     4381 tggcaattgc tgaaatttta tcatttctca tctctaaaat cacatattcc aatgtaatac\\n     4441 aagggtcttt ccattatgca ttcattaaat ccttctagga gaggtctcat caaccttcta\\n     4501 ctttattaaa catgcccaca gagagaaggg cacaggagta aagcagaggc aatgtgtcgt\\n     4561 tgctcccaaa tgtgtcgtta caatgtgtcg ttgcttaccc aaagaggtaa ataaggcctc\\n     4621 tttgaccagc aggagaggaa atgctggtag gaagactctt ccaggatgta atgcagaaga\\n     4681 agctcagggc agagctattc acactttaca ccagtgctgt ttcctcacca tagaggttcc\\n     4741 tgaggtcaca gtgttttcca agtctcccgt gacactgggt cagcccaaca ccctcatctg\\n     4801 tcttgtggac aacatctttc ctcctgtggt caacatcacc tggctgagca atgggcactc\\n     4861 agtcacagaa ggtgtttctg agaccagctt cctctccaag agtgatcatt ccttcttcaa\\n     4921 gatcagttac ctcaccttcc tcccttctgc tgatgagatt tatgactgca aggtggagca\\n     4981 ctggggcctg gatgagcctc ttctgaaaca ctggggtaag gatgagtttc accatttttt\\n     5041 gatgctttct tgtctgtcaa gttcagaact tcctgccttt tactctatat cccaaaactt\\n     5101 gttttccaca cttcatgagt ttcttttgtc ttttttttga aagaattaag caacaaaagc\\n     5161 acagatttat taaaaaagaa agtacactcc acagggtggg agcaggcctg ccacttcatg\\n     5221 ggtttctaat aacagacttc actctcctcc ctaagctggg ggccttgagt ctttgcagag\\n     5281 ccaaccctct accccatccc atcccacaca catgcacatg agcaaactct gcattctgac\\n     5341 ctcaacaact tcacttccac agagcctgag attccaacac ctatgtcaga gctcacagag\\n     5401 actgtggtct gcgccctggg gttgtctgtg ggcctcgtgg gcattgtggt ggggaccgtc\\n     5461 ttgatcatcc gaggcctgcg ttcagttggt gcttccagac accaagagcc cttgtgaatc\\n     5521 ccatcctgaa aaggaaggta agattgagat ttgttagagc tgaagctgca ggaaggaaag\\n     5581 tgggaggag\\n//\\n\\nLOCUS       OR880474                5622 bp    DNA     linear   PRI 12-DEC-2023\\nDEFINITION  Homo sapiens isolate N-23-2330-A-02-00 MHC class II antigen\\n            (HLA-DQA1) gene, HLA-DQA1*01NEW allele, complete cds.\\nACCESSION   OR880474\\nVERSION     OR880474.1\\nKEYWORDS    .\\nSOURCE      Homo sapiens (human)\\n  ORGANISM  Homo sapiens\\n            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\\n            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\\n            Catarrhini; Hominidae; Homo.\\nREFERENCE   1  (bases 1 to 5622)\\n  AUTHORS   Velickovic,M.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (27-NOV-2023) New South Wales Transplantation and\\n            Immunogenetics Services Pathology and Clinical Governance,\\n            Australian Red Cross Lifeblood, 17 O\\'Riordan Street Alexandria NSW\\n            2015, Sydney, NSW 2060, Australia\\nCOMMENT     ##Assembly-Data-START##\\n            Assembly Method       :: TSV v. 3.0.0.27232; created on 1/02/2023\\n            Sequencing Technology :: Illumina\\n            ##Assembly-Data-END##\\nFEATURES             Location/Qualifiers\\n     source          1..5622\\n                     /organism=\"Homo sapiens\"\\n                     /mol_type=\"genomic DNA\"\\n                     /isolate=\"N-23-2330-A-02-00\"\\n                     /db_xref=\"taxon:9606\"\\n     gene            1..5622\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n     mRNA            join(1..339,4109..4357,4771..5052,5409..5622)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /product=\"MHC class II antigen\"\\n     exon            1..339\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=1\\n     5\\'UTR           1..257\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n     CDS             join(258..339,4109..4357,4771..5052,5409..5563)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /codon_start=1\\n                     /product=\"MHC class II antigen\"\\n                     /protein_id=\"WPS91249.1\"\\n                     /translation=\"MILNKALLLGALALTTVMSPCGGEDIVADHVASCGVNLYQFYGP\\n                     SGQYTHEFDGDEQFYVDLERKETAWRWPEFSKFGGFDPQGALRNMAVAKHNLNIMIKR\\n                     YNSTAATNEVPEVTVFSKSPVTLGQPNTLICLVDNIFPPVVNITWLSNGQSITEGVSE\\n                     TSFLSKSDHSFFKISYLTFLPSADEIYDCKVEHWGLDQPLLKHWEPEIPAPMSELTET\\n                     VVCALGLSVGLMGIVVGTVFIIQGLRSVGASRHQGPL\"\\n     intron          340..4108\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=1\\n     exon            4109..4357\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=2\\n     intron          4358..4770\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=2\\n     exon            4771..5052\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=3\\n     intron          5053..5408\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=3\\n     exon            5409..5622\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\n                     /number=4\\n     3\\'UTR           5564..5622\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*01NEW\"\\nORIGIN      \\n        1 tttattcata gaacaattcc tcaagtccac tctgagtaga ggctgcatca caaggggatt\\n       61 gccccgtctc cttccagggc tcttaataca aactcttcaa ctagtaactg agatgtcacc\\n      121 ataggggatt tttctaattg gccaaaacct gacttggcag ggtttggttt gggtgtcttc\\n      181 agatttcctt gtcttgaggt cctcacaatt actctacagc tcagaacacc aactgctgag\\n      241 gctgccttgg gaagaggatg atcctaaaca aagctctgct gctgggggcc ctcgctctga\\n      301 ccaccgtgat gagcccctgt ggaggtgaag acattgtggg tgagtgcatg agtgagggat\\n      361 gttctctgga gctgaaaaac agtaaattga aggaaaagag ataaagcgat ttgcagagaa\\n      421 actgtagaga tttcctaagg gccctttcag tattaagaca attaaaaatt atagctgttc\\n      481 ctccttcagg aaaccagagc cccaacctac tctttttgtt atctatgctg ttgtgttcac\\n      541 taaggacgct attctgttta tattatattc agtgactacg gcctggaggt ctctatgtcg\\n      601 ttccatcatg attgcctcaa aaattagtga ggtttccatc agtggataat tttttattat\\n      661 taaaaattta tgaagtgtca ttctcaaatt tccctgaaca acttttgaag cttttcggat\\n      721 gtctccggtg gtagatcttg gggtcattcc atcaattatg tactctatag atatttaaaa\\n      781 tgttgcccgt ttctttctct cagacttact cacatttcca catgggaact ggcacaggtg\\n      841 gggagtgggt aaaggagtcc agcaggctga atgccttcaa caatcatttt accacatggt\\n      901 cctcacttac tctcagctgc ctcatatgtg tcacctcaca agtaatcaaa taaaatgggc\\n      961 atgtggctaa gctttgtaaa tagtgaaaac atgaatgtca atttttttta catatttcta\\n     1021 ttacagatat agcttcacat ttcttttctt tagcaaaata agggatcatt ttattttaaa\\n     1081 attgagaagt agaaaaaatt ggtaaaataa atcattttat tctcaaatta tcaacccaaa\\n     1141 ttacctgttc ttcacctcat ctaataaagt cctataaaaa gaaaagtggg ccagacaagg\\n     1201 tggctcatgc ctgtaatccc agcactttgg gaggccgagg caggaggatc atttgagcct\\n     1261 gggagcttga gaccagcctg ggcaacatag caagacctca tctctacaaa aaaagaaaaa\\n     1321 taaaaattag ccaggcatgg tggtgtgtgc ctgtggtgcc agctactcag aaggctgccg\\n     1381 tgggaggacc acttgagtcc atgaggcgga agctgcagtg agccatggtg gcaccactac\\n     1441 actccagcca gggcaacaga gagaggcgct gtctcaaaaa gaaagaggaa agaaagcgag\\n     1501 gaaggaagga aggaaggaga aggaaggaag gaaggaaaag aaaagaaaag ggaagggagg\\n     1561 aaggaaggga aaaagaaaga cagaaagaaa gaggaaggaa ggaagaaagg aagcacagat\\n     1621 taattatttg gtctcttact ctcctctgcc tttgtcgtcc atctctttcc acctctcttc\\n     1681 atgcatccct ttctccctct tccctttcag gatccatctc tgactccctg ctcctttata\\n     1741 gagatggaca gtgggtttgt aaaacaaaag ttgaaaagtc agatagttaa aaggggaagt\\n     1801 gaactggaag gtactttaaa ctttcacaac tttattaacc gtggctgctc ccattatgat\\n     1861 tttgttcggc agtggaagtt tcacctgctt ctccagagcg cttggcgtct ttgttccaaa\\n     1921 tttcctttct tcaacctcac accagagtgc cctggtcagg cttggctcat tcattaggca\\n     1981 caatgtgggc agtgcagggg accctccata ctgtaaagcc acatgagaag gttttaactc\\n     2041 cttttaaaat tagaaaaata atggaatatt agagcctaag aaaatgtttt aacttttaat\\n     2101 tcagcctaga ttatattgtc tttataccaa ttcagtcata aaatataatt ttccatattt\\n     2161 ttgtggagga agaggcccat acaagcaaga atgctcgggg ctcacatgtc agaatgcagc\\n     2221 cttggtcatg actgatcctg gccttcgtat ggttctgcta cctgtgtgcc tgcccgtctt\\n     2281 ccccaaaatc tatgtggtcc tcgaatatag caactgtcat tcaatacaca tgtttgagca\\n     2341 cacagtgagc taagttttaa ggattcaaag atgaaaagtc atgctgtctt ccctgcagag\\n     2401 ggtgctcaga ttagtgatgg aaacagtatg gggtgcagga aagcagaagg ccattgctga\\n     2461 gcagggcagt ggacccagca gaggctgaaa caatacaagt gacttggttc caggtgggcc\\n     2521 agcagggtga cgtcctctag caaaatttgg cacccaagac aagtaccaga agaaaagaaa\\n     2581 gactgcatgt attccacata tattcatgtt tgaacaagga gtcaagattt atggcaagga\\n     2641 taaggaggct ttgttggtga cctgttaaga ccaaccaggg cagtcatgct ggatagggaa\\n     2701 gaaggtgagc tggaagagga acagacaact tggacagcca gatgttgaga cggaggggtt\\n     2761 ggaggtcata atgtggtcaa aaacatgttg atgagaggac tcagctacaa agttgttaac\\n     2821 ttaagcagaa acctcaagga tggattttag aatttctcca ggaagtccta aaagataatt\\n     2881 ccatttcagg gagaaaaaca acagaccact gcaaagacca gggaacatga aaggataatg\\n     2941 tagtttgtct tgcttggcag atacttttga aggatgttgg actgtaaggc tgtcgatatc\\n     3001 ctcctcagag aacttactac agtacattgt atctgttccc ttacctacct gactcttcca\\n     3061 ctattcagtt tgttccttaa tagtagacca tgcctgattg gtgttttaca catctccggc\\n     3121 tatgtctgac acttgtggat gctcagaaag tggggaagga aggaaagata cgatggtaaa\\n     3181 aggcttacac atgtcttgac aaaaaagtcc agtttggctc atttggctgg agtcgtactg\\n     3241 catggctgcc attctgctct ggcatcctca gacaagcaca ctgcccatta gaggaaaaag\\n     3301 tgtgatataa gtgttgagtc agaatgctgt agacatttag taatctcctt cacaggaaaa\\n     3361 aaaaaaaaaa ggtgggggga atgacagaaa tccaaaaact agtagagctt ccacttttca\\n     3421 tttcagaaga aatcagttgc tctcctctaa ggaccattac tattaacaaa acagagacct\\n     3481 tagaaggagg cattgtttat ttattatata ttttgtaatg ttattaccaa tcttgttata\\n     3541 ctctttctta taccctacaa ttgttagcag aaattatttt aaattaataa gatcctgcat\\n     3601 gcttttcctt taaaaaaaaa aaaaagaaag atctctgtgt agagtgtcct attctgagcc\\n     3661 agtcctgaga ggaaaggaag tataatcaat ttgttattaa ccaatgaaag aattaagtga\\n     3721 aagataaatc tcaggaagca gagggaagta aacctaattt ctgactaaga aagctaaata\\n     3781 ctatgataac tcattcattc cttcttttgt tcaattacat tatttaatca taagtccatg\\n     3841 acatgccagg cactcaggaa atagtaaaaa ttggacatgc gatattctgc ccttgtgtag\\n     3901 cgcacactag agtgggaaag aaagtgcact tttaactgga caactaccaa catgaagagg\\n     3961 ggaggaagca ggggctggaa atgtccacag actgtgccaa aaaatgaagc ccataatatt\\n     4021 tgaaagtcag tttcttccat cattttgtgt attaaggttc tttcttcccc tgttctccgc\\n     4081 cttcctgctt gtcatcttca ctcatcagct gaccacgttg cctcttgtgg tgtaaacttg\\n     4141 taccagtttt acggtccctc tggccagtac acccatgaat ttgatggaga tgagcagttc\\n     4201 tacgtggacc tggagaggaa ggagactgcc tggcggtggc ctgagttcag caaatttgga\\n     4261 ggttttgacc cgcagggtgc actgagaaac atggctgtgg caaaacacaa cttgaacatc\\n     4321 atgattaaac gctacaactc taccgctgct accaatggta tgcgtccacc attctgcctc\\n     4381 tctttactta agttatccct ccataccagg gttcattatt ttcttcccaa gaggtcccca\\n     4441 gatcttctta tggcaattgc tgaaatttta tcatctccca tctctaaaat cacatattcc\\n     4501 catgtaatac aagggtcttt ccattatgca ttcagcaaat ccttctagga gaggtctcat\\n     4561 caacctccta ctttattaaa catgcccaca gagagaaggg cacaggaata aagcagaggc\\n     4621 aatgtgtcgt tgctcccaag cagaaggtaa ataagacctc tttgactatc aggtggtgaa\\n     4681 atgctggtag gagggctctt ccaggatgta atgcagaact tcagggcaga gctattcaca\\n     4741 cttcacacca gtgctgtttc ctcaccacag aggttcctga ggtcacagtg ttttccaagt\\n     4801 ctcccgtgac actgggtcag cccaacaccc tcatttgtct tgtggacaac atctttcctc\\n     4861 ctgtggtcaa catcacatgg ctgagcaatg ggcagtcaat cacagaaggt gtttctgaga\\n     4921 ccagcttcct ctccaagagt gatcattcct tcttcaagat cagttacctc accttcctcc\\n     4981 cttctgctga tgagatttat gactgcaagg tggagcactg gggcctggac cagcctcttc\\n     5041 tgaaacactg gggtaaggat gagtttcatc attttttgat tctttcttgt ctgtcaagtt\\n     5101 cagaacttcc tgccttttac tcctatatcc aaaaacttgt tttccacact tcatgggttt\\n     5161 cttttctgtc tctctttttt ttttgaaaga ataaagcaaa aaaagcagag atttattgaa\\n     5221 aatgaaagta cactctacag gatgggagtg ggcctgccac ttcatggttt tctaatgata\\n     5281 gacttcactc ttctccctaa gcctggggcc ttgagtcttt gcagagccaa ccctctaccc\\n     5341 catcccatcc cacacacatg cacatgagca cactctgcat tctgacctca acaacttcac\\n     5401 ttccacagag cctgagattc cagcccctat gtcagagctc acagagactg tggtctgtgc\\n     5461 cctggggttg tctgtgggcc tcatgggcat tgtggtgggc actgtcttca tcatccaagg\\n     5521 cctgcgttca gttggtgctt ccagacacca agggccattg tgaatcccat cctggaaggg\\n     5581 aaggtaagat tgagactggt tacagttgaa gcggcagtat ga\\n//\\n\\nLOCUS       OR880473                5755 bp    DNA     linear   PRI 12-DEC-2023\\nDEFINITION  Homo sapiens isolate N-23-1374-A-02-00 MHC class II antigen\\n            (HLA-DQA1) gene, HLA-DQA1*05NEW allele, complete cds.\\nACCESSION   OR880473\\nVERSION     OR880473.1\\nKEYWORDS    .\\nSOURCE      Homo sapiens (human)\\n  ORGANISM  Homo sapiens\\n            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\\n            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\\n            Catarrhini; Hominidae; Homo.\\nREFERENCE   1  (bases 1 to 5755)\\n  AUTHORS   Velickovic,M.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (27-NOV-2023) New South Wales Transplantation and\\n            Immunogenetics Services Pathology and Clinical Governance,\\n            Australian Red Cross Lifeblood, 17 O\\'Riordan Street Alexandria NSW\\n            2015, Sydney, NSW 2060, Australia\\nCOMMENT     ##Assembly-Data-START##\\n            Assembly Method       :: TSV v. 3.0.0.27232; created on 1/02/2023\\n            Sequencing Technology :: Illumina\\n            ##Assembly-Data-END##\\nFEATURES             Location/Qualifiers\\n     source          1..5755\\n                     /organism=\"Homo sapiens\"\\n                     /mol_type=\"genomic DNA\"\\n                     /isolate=\"N-23-1374-A-02-00\"\\n                     /db_xref=\"taxon:9606\"\\n     gene            1..5755\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*05NEW\"\\n     mRNA            join(1..342,4162..4407,4820..5101,5539..5755)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*05NEW\"\\n                     /product=\"MHC class II antigen\"\\n     exon            1..342\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*05NEW\"\\n                     /number=1\\n     5\\'UTR           1..260\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*05NEW\"\\n     CDS             join(261..342,4162..4407,4820..5101,5539..5693)\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*05NEW\"\\n                     /codon_start=1\\n                     /product=\"MHC class II antigen\"\\n                     /protein_id=\"WPS91248.1\"\\n                     /translation=\"MILNKALMLGTLALTTVMSPCGGEDIVADHVASYGVNLYQSYGP\\n                     SGQYTHEFDGDEQFYVDLGRKETVWCLPVLRQFRFDPQFALTNIAVLKHNLNSLIKRS\\n                     NSTAATNEVPEVTVFSKSPVTLGQPNILICLADNIFPPVVNITWLSNGHSVTEGVSET\\n                     SFLSKSDHSFFKISYLTLLPSAEESYDCKVEHWGLDKPLLKHWEPEIPAPMSELTETV\\n                     VCALGLSVGLVGIVVGTVFIIRGLRSVGASRHQGPL\"\\n     intron          343..4161\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*05NEW\"\\n                     /number=1\\n     exon            4162..4407\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*05NEW\"\\n                     /number=2\\n     intron          4408..4819\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*05NEW\"\\n                     /number=2\\n     exon            4820..5101\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*05NEW\"\\n                     /number=3\\n     intron          5102..5538\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*05NEW\"\\n                     /number=3\\n     exon            5539..5755\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*05NEW\"\\n                     /number=4\\n     3\\'UTR           5694..5755\\n                     /gene=\"HLA-DQA1\"\\n                     /allele=\"HLA-DQA1*05NEW\"\\nORIGIN      \\n        1 tctattcaca gaacatttcc tcaagtccac tctgagtgga ggctgcatca caacaagggg\\n       61 attgccctgt ctccttccag ggctcttaat acaaactctt caactagtaa ctgaggtgtc\\n      121 atcatagggg atttttctaa ttagccaaaa cctgacttgg cagggtttgg tttgggtgtc\\n      181 ttcagattgc cttgtctcga ggtcctcaca attgctctac aactcagaac agcaactgct\\n      241 aaggctgcct tgggaagagg atgatcctaa acaaagctct gatgctgggg acccttgccc\\n      301 tgaccaccgt gatgagcccc tgtggaggtg aagacattgt gggtgagtgt atgagtgagg\\n      361 gatgttctct ggagctggaa gagaggaaat tgaagcaaaa gagagaaagc gatttgcaga\\n      421 gaaattgtag agatttccta agggtccctt cagtattaag agatttaaaa attatggctg\\n      481 ttcctccttc aggaaaccag agtcccaacc tactcttttt gttatctatg ctgttggcgt\\n      541 tcactaagga tgctattctg tttatattgt attcagtgac tatagcctgg aggtctctat\\n      601 gtcattccat catgattgcc tcaaaaatta gtgaggtttc catcaatgga taatttttta\\n      661 ttattaaaaa tttgtgaagt atcattctca aatttccctg aacaactttt gaagcttttc\\n      721 ggatgtctcc tgtagtagcg cttggggtaa atgattccat caattatata ctctatagat\\n      781 attaagaaag atgccctttt ctttctctca gacttactaa catttccacg tgggaactgg\\n      841 cacaggtggg gagtgggtaa aggagtccag caggctgaat gccttcaaca atcattttac\\n      901 cacatggtcc tcacttactc tcagctgcct catatgtgtc acctcacaaa taatcaaata\\n      961 aaatgggcat gtagctaagc tttgtaaata gtgaaaacat gaatgtcaat tttattttta\\n     1021 catatttcta ttataggtat agcttcacat ttcttttctt ttgcaaaata aggaatcctt\\n     1081 ttattttaaa attgagaatt tatagtagaa aaacttggta aattaaatca ttttattctc\\n     1141 aaattatcaa cccaaattac ctgttcttca actcatctaa tgaagtccta taaaaagaaa\\n     1201 agtgggccag acatggtggc tcatgcctgt aatcccagca ctttgggagg ccgaggcagg\\n     1261 aggatccttt gagcccagga gttgagacca gcctgggcaa catagcaaga cctcatctct\\n     1321 acaaaaaata aaaattagcc aggtgtggtg gtgcatgcct gtggtgccag ctactcagaa\\n     1381 ggctgcagtg ggaggactgc ttgagtccag gaggcggaag ctgcagtgag ccatgatggc\\n     1441 accactacac tccagccagg gcaacagaga gaaactctgt ctcagaaaga aaaaggaaag\\n     1501 aaagagagaa aggaaggaaa gaaagaaaga aggaaggaag gaaggaagaa ggggaaggga\\n     1561 agggaaggaa gggaaggaaa gggaagggag gaaagaagga aggaaaaaag aaaaagaaag\\n     1621 aaaaaagaaa gaaaaagaaa gaaagaaaga aaagagggaa ggaaagaaag aaaaaggaag\\n     1681 gaaggaagca cagattaatt attaatcatt tggtctctct tagtcttctc tgtctttgtc\\n     1741 atccatctat ttccacctct cttcatgcat tcctttctcc ctcttccctt tcaggatcca\\n     1801 tctctgactc cctgcttctt tatatggaca gtggggtttg taaaacaaaa gttgaaaaat\\n     1861 cagatagtta aaaggtgaag tgaactggaa ggtctaaact tccacaacct tattaaccat\\n     1921 ggctgctccc attctgattt tgttcgacgg tggaagtttc acctccttct ccagagcact\\n     1981 tggcttcttt gttccaaatt tcctttcttc aacctcacac cagagtgccc tggtcaggct\\n     2041 cggctcatcc attaggcaca acatgggcaa tgcagagaac cctccatact gtaaagccac\\n     2101 atgagaatgt tttaactcct tttaagatta gaaaaaaatg aaatttcaga gcctaagaaa\\n     2161 atgttttaat tcagcctaga ttgtattgtc tttataccaa ttcagtcata aaatacaatt\\n     2221 ttccatattt tcatggagga aggggcccac aaaagcaaga gtgctcaggg ctcacatgtc\\n     2281 agaatgcagc cctggtcatg gctgatcctg gccttcttat gattctgcta gtgtgcctgt\\n     2341 ccgtcttccc caaaatctat gtcgtcctca aatatagcaa ctgtaattca aaacacgttt\\n     2401 gagcacacag taagctaagt tttaaggatt caaagatgaa aagtcatgct gtcttccctg\\n     2461 cagagggtgc tcagactagt gatggaaacg gtatgggatg caggaaagca gaaggccatt\\n     2521 gctgaccagg gcagtggact cagcagaggc tgaaactata caaatgactt ggttccagct\\n     2581 gggccagcag ggtgacatcc tccagcaaaa ctcggcaccc aagacaagtc ccagatgaaa\\n     2641 agaaggattg ctttgtgttt gataaggagt caaggtttat tgcaaggata aggctttgtt\\n     2701 ggtggcctgt taagacaatc cagggcagtc atactggata aggaagaagg tgagctggaa\\n     2761 gaggaacaga caaacagcca gatattgagg tggaggagct ggaggtcata acgtggtcaa\\n     2821 aaacatgtcg atgagaggac ttagctacaa agttgttaac ttaagcagaa acctcaagga\\n     2881 tgaattttag gatttctcca ggaagtccta aaagataatt tcatttcagg gagaaaaaca\\n     2941 acaaaccact ggaaagacca gggaacatga aaggataatg tagtttggtt tgcttggcag\\n     3001 atacttatga aggatgttgg actgtaaggc tgttgatagc ctcctcacag aacatgctac\\n     3061 agtacattgt atctgctccc ttacctacct gactcttcca ctcttcagtt tgttccttaa\\n     3121 tggtagacca tgcctgattg gtgttttaca catcccctgc tatgtctgac acttgtggat\\n     3181 gctcagaaag tggggaagga aggaaagata caacggtaaa aggcttacac gtcttgacag\\n     3241 gaatgtccag ttcggctcat ttggctggag ccacattgca cggctgccat tctgctctgg\\n     3301 catcctcaga caagcacact gcccattaga ggaaaaaggg tttaatttac ctgagtcctc\\n     3361 aagtgaatat aagtgttaag tcagaacact gtagacattt agtaacctcc ttcagaggaa\\n     3421 aaaaaaaggt ggggggaaat gacagaaatc caaaaactag tagagcttcc actcttcatt\\n     3481 tcagaagaaa tcagttgctc tcctctaagg accattacta ttaacaaaac agagaccttg\\n     3541 aaggaggcat tgtttattta ttatatattt tgtaatgtta ttaccattct tgttatacta\\n     3601 ttccttatac cctacaattg ttagcagaca ttattttaaa ttaataagat cctgcatgct\\n     3661 tttctttttt taaaaaaaag aaagacctct gtgtagagtg tcctgttctg agccagtcct\\n     3721 gagaggaaag aaaatacaat cagtttgtta ttaactgagg aaagaattaa gtgaaagatg\\n     3781 aatcttagga agcagaagga agtaaaccta atctctgact aagaaagcta aataccataa\\n     3841 taactcattc attccttctt ttgtttaatt acattattta atcataagtc cgtgatgtgc\\n     3901 caggcactca ggaaatagta aaaactggac atgtgatatt ctgcccttgt gtagcgcaca\\n     3961 ttatagtggg aaagaaagcg caattttaac cggacaacta ccaacaataa gagcggagga\\n     4021 agcaggggtt ggaaatgtcc acaggctgtg ccaaagatga agcccgtaat atttgaaagt\\n     4081 cagtttcttt catcattttg tgtattaagg ttctttcttc ccctgttctc caccttcctg\\n     4141 cttgtcatct tcactcatca gctgaccacg tcgcctctta tggtgtaaac ttgtaccagt\\n     4201 cttacggtcc ctctggccag tacacccatg aatttgatgg agatgagcag ttctacgtgg\\n     4261 acctggggag gaaggagact gtctggtgtt tgcctgttct cagacaattt agatttgacc\\n     4321 cgcaatttgc actgacaaac atcgctgtcc taaaacataa cttgaacagt ctgattaaac\\n     4381 gctccaactc taccgctgct accaatggta tgtgtcaaca attctgcccc tctttactga\\n     4441 tttatccctt cataccaagt ttcattattt tatttccaag aggtccccag atcttctcat\\n     4501 ggcaattgct gaaattttat catctcccat ctctaaaatc acatattccc atgtaataca\\n     4561 agggtctttc cattatccat tcattaaatc cttctcggag aggtctcatc aacctcctac\\n     4621 tttattaaac atgcccacag agagaagggc acaggaataa agcggaggca atgtgtcgtt\\n     4681 gctcccaagc agaaggtaaa taagacctct ttgactatca ggtggtgaaa tgctggtagg\\n     4741 agggctcttc caggatgtaa tgcagaagct catggcagag ctattcacac ttcacatcag\\n     4801 tgctgtttcc tcaccacaga ggttcctgag gtcacagtgt tttccaagtc tcccgtgaca\\n     4861 ctgggtcagc ccaacatcct catctgtctt gcggacaaca tctttcctcc tgtggtcaac\\n     4921 atcacatggc tgagcaatgg gcactcagtc acagaaggtg tttctgagac cagcttcctc\\n     4981 tccaagagtg atcattcctt cttcaagatc agttacctca ccctcctccc ttctgctgag\\n     5041 gagagttatg actgcaaggt ggagcactgg ggactggaca agcctcttct gaaacactgg\\n     5101 ggtaaggatg agttccacca ctttttgatg ctttcttgtc tgtcaagttc agaacttcct\\n     5161 gccttttact cctatatccc aaaacttgtt ttccacactt catgggtttc tttctttctt\\n     5221 tctttctttc tttctttctt tctttctttc tttctttctt tctttctttc tttctttctt\\n     5281 tctttctttc ttttttgaaa gaataaagca acaaaagcaa agatttattg aaaatgaaag\\n     5341 tacacttcac atggtgggag cgggcctgag cataggggct caagagccac ttcatgggtt\\n     5401 tctaatgata gacttcactc tcctccctaa gctggggacc ttgagtcttt gcagagccaa\\n     5461 ccctccaccc catcccatcc cacacacatg cacatgagca cactctgctt tctgacctca\\n     5521 acgacttcat atccacagag cctgagattc cagcccctat gtcagagctc acagagactg\\n     5581 tggtctgcgc cctggggttg tctgtgggcc tcgtgggcat tgtggtgggc actgtcttca\\n     5641 tcatccgagg cctgcgttca gttggtgctt ccagacacca agggcccttg tgaatcccat\\n     5701 cctggaatgg aaggtaagat tgagatttgt tagagctgaa tccgcagtat gagag\\n//\\n\\n'"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Pesquisa em base de dados de nucleotide/protein/gene\n",
    "pesquisa_ncbi(email,termo,db='nuccore')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "A execução da função pesquisa_ncbi para a base de dados 'nuccore' resultou na identificação de 1743 entradas relacionadas. Destas, foram processados os primeiros 10 resultados.\n",
    "\n",
    "O primeiro resultado apresentado é o registo com o Accession Number OR913133.1, correspondente a um alelo do gene do antígeno de classe II do MHC em Homo sapiens (HLA-DQA1).\n",
    "\n",
    "O output dos resultados da pesquisa na base de dados \"nuccore\" foi em formato \"genbank\". Nos resultados são incorporados detalhes característicos desse tipo de formato incluindo a origem da sequência, características e a própria sequência, sendo essas informações enriquecedoras no que toca ao aprofundamento da análise do gene em questão. \n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Transferência do ficheiro correspondente ao gene de interesse"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "De forma a realizar a transferência do ficheiro correspondente ao gene de interesse, em primeiro lugar, foi efetuada uma pesquisa na base de dados \"gene\" de forma a identificar o ID do gene de interesse. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Encontrados 189 resultados em gene. Irão ser processados 100 resultados.\n",
      "\n",
      "\n",
      "1. HLA-DRB1\n",
      "Official Symbol: HLA-DRB1 and Name: major histocompatibility complex, class II, DR beta 1 [Homo sapiens (human)]\n",
      "Other Aliases: DRB1, HLA-DR1B, HLA-DRB, SS1\n",
      "Other Designations: major histocompatibility complex, class II, DR beta 1 precursor; HLA class II histocompatibility antigen, DR-1 beta chain; MHC class II HLA-DR beta 1 chain; human leucocyte antigen DRB1; lymphocyte antigen DRB1\n",
      "Chromosome: 6; Location: 6p21.32\n",
      "Annotation: Chromosome 6 NC_000006.12 (32578775..32589848, complement)\n",
      "MIM: 142857\n",
      "ID: 3123\n",
      "\n",
      "2. env\n",
      "Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1]\n",
      "Other Aliases: HIV1gp8\n",
      "Other Designations: Envelope surface glycoprotein gp160, precursor; Envelope surface glycoprotein gp120; Envelope transmembrane domain; hypothetical protein\n",
      "Annotation:  NC_001802.1 (5771..8341)\n",
      "ID: 155971\n",
      "\n",
      "3. TERT\n",
      "Official Symbol: TERT and Name: telomerase reverse transcriptase [Homo sapiens (human)]\n",
      "Other Aliases: CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT\n",
      "Other Designations: telomerase reverse transcriptase; telomerase catalytic subunit; telomerase-associated protein 2\n",
      "Chromosome: 5; Location: 5p15.33\n",
      "Annotation: Chromosome 5 NC_000005.10 (1253167..1295068, complement)\n",
      "MIM: 187270\n",
      "ID: 7015\n",
      "\n",
      "4. HLA-B\n",
      "Official Symbol: HLA-B and Name: major histocompatibility complex, class I, B [Homo sapiens (human)]\n",
      "Other Aliases: AS, B-4901, HLAB\n",
      "Other Designations: major histocompatibility complex, class I, B; HLA class I antigen HLA-B; HLA class I histocompatibility antigen, B alpha chain; MHC HLA-B cell surface glycoprotein; MHC HLA-B transmembrane glycoprotein; MHC class 1 antigen; MHC class I antigen HLA-B alpha chain; MHC class I antigen HLA-B heavy chain; MHC class I antigen SHCHA; MHC class I molecule; leukocyte antigen class I-B\n",
      "Chromosome: 6; Location: 6p21.33\n",
      "Annotation: Chromosome 6 NC_000006.12 (31353875..31357179, complement)\n",
      "MIM: 142830\n",
      "ID: 3106\n",
      "\n",
      "5. HLA-A\n",
      "Official Symbol: HLA-A and Name: major histocompatibility complex, class I, A [Homo sapiens (human)]\n",
      "Other Aliases: HLAA\n",
      "Other Designations: HLA class I histocompatibility antigen, A alpha chain; HLA class I histocompatibility antigen, A-1 alpha chain; MHC class I antigen HLA-A heavy chain; leukocyte antigen class I-A\n",
      "Chromosome: 6; Location: 6p22.1\n",
      "Annotation: Chromosome 6 NC_000006.12 (29942532..29945870)\n",
      "MIM: 142800\n",
      "ID: 3105\n",
      "\n",
      "6. HLA-DQB1\n",
      "Official Symbol: HLA-DQB1 and Name: major histocompatibility complex, class II, DQ beta 1 [Homo sapiens (human)]\n",
      "Other Aliases: CELIAC1, HLA-DQB, IDDM1\n",
      "Other Designations: HLA class II histocompatibility antigen, DQ beta 1 chain; MHC class II DQ beta chain; MHC class II HLA-DQ beta glycoprotein; MHC class II antigen DQB1; MHC class II antigen HLA-DQ-beta-1\n",
      "Chromosome: 6; Location: 6p21.32\n",
      "Annotation: Chromosome 6 NC_000006.12 (32659467..32666657, complement)\n",
      "MIM: 604305\n",
      "ID: 3119\n",
      "\n",
      "7. tat\n",
      "Tat [Human immunodeficiency virus 1]\n",
      "Other Aliases: HIV1gp5\n",
      "Other Designations: Tat\n",
      "Annotation:  NC_001802.1 (5377..7970)\n",
      "ID: 155871\n",
      "\n",
      "8. gag\n",
      "Pr55(Gag) [Human immunodeficiency virus 1]\n",
      "Other Aliases: HIV1gp2\n",
      "Other Designations: Pr55(Gag); capsid; matrix; nucleocapsid; p1; p2; p6\n",
      "Annotation:  NC_001802.1 (336..1838)\n",
      "ID: 155030\n",
      "\n",
      "9. HLA-C\n",
      "Official Symbol: HLA-C and Name: major histocompatibility complex, class I, C [Homo sapiens (human)]\n",
      "Other Aliases: D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1\n",
      "Other Designations: HLA class I histocompatibility antigen, C alpha chain; HLA-C antigen; MHC class I antigen heavy chain HLA-C; human leukocyte antigen-C alpha chain; major histocompatibility antigen HLA-C\n",
      "Chromosome: 6; Location: 6p21.33\n",
      "Annotation: Chromosome 6 NC_000006.12 (31268749..31272092, complement)\n",
      "MIM: 142840\n",
      "ID: 3107\n",
      "\n",
      "10. CD14\n",
      "Official Symbol: CD14 and Name: CD14 molecule [Homo sapiens (human)]\n",
      "Other Designations: monocyte differentiation antigen CD14; myeloid cell-specific leucine-rich glycoprotein\n",
      "Chromosome: 5; Location: 5q31.3\n",
      "Annotation: Chromosome 5 NC_000005.10 (140631732..140633701, complement)\n",
      "MIM: 158120\n",
      "ID: 929\n",
      "\n",
      "11. POU5F1\n",
      "Official Symbol: POU5F1 and Name: POU class 5 homeobox 1 [Homo sapiens (human)]\n",
      "Other Aliases: OCT3, OCT4, OTF-3, OTF3, OTF4, Oct-3, Oct-4, Oct3/4\n",
      "Other Designations: POU domain, class 5, transcription factor 1; POU domain transcription factor OCT4; POU-type homeodomain-containing DNA-binding protein; octamer-binding protein 3; octamer-binding protein 4; octamer-binding transcription factor 3\n",
      "Chromosome: 6; Location: 6p21.33\n",
      "Annotation: Chromosome 6 NC_000006.12 (31164337..31170682, complement)\n",
      "MIM: 164177\n",
      "ID: 5460\n",
      "\n",
      "12. LPA\n",
      "Official Symbol: LPA and Name: lipoprotein(a) [Homo sapiens (human)]\n",
      "Other Aliases: AK38, APOA, LP\n",
      "Other Designations: apolipoprotein(a); antiangiogenic AK38 protein; apo(a); lipoprotein, Lp(a); lp(a)\n",
      "Chromosome: 6; Location: 6q25.3-q26\n",
      "Annotation: Chromosome 6 NC_000006.12 (160531482..160664275, complement)\n",
      "MIM: 152200\n",
      "ID: 4018\n",
      "\n",
      "13. HLA-DQA1\n",
      "Official Symbol: HLA-DQA1 and Name: major histocompatibility complex, class II, DQ alpha 1 [Homo sapiens (human)]\n",
      "Other Aliases: CELIAC1, DQ-A1, DQA1, HLA-DQA*, HLA-DQB1, HLA-DQA1\n",
      "Other Designations: HLA class II histocompatibility antigen, DQ alpha 1 chain; DC-1 alpha chain; DC-alpha; HLA class II histocompatibility antigen DQ alpha chain; HLA-DCA; MHC HLA-DQ alpha; MHC class II DQ alpha chain; MHC class II DQA1; MHC class II HLA-DQ-alpha-1; MHC class II antigen DQA1; MHC class II protein\n",
      "Chromosome: 6; Location: 6p21.32\n",
      "Annotation: Chromosome 6 NC_000006.12 (32637406..32655272)\n",
      "MIM: 146880\n",
      "ID: 3117\n",
      "\n",
      "14. nef\n",
      "Nef [Human immunodeficiency virus 1]\n",
      "Other Aliases: HIV1gp9\n",
      "Other Designations: Nef\n",
      "Annotation:  NC_001802.1 (8343..8963)\n",
      "ID: 156110\n",
      "\n",
      "15. STIM1\n",
      "Official Symbol: STIM1 and Name: stromal interaction molecule 1 [Homo sapiens (human)]\n",
      "Other Aliases: D11S4896E, GOK, IMD10, STRMK, TAM, TAM1\n",
      "Other Designations: stromal interaction molecule 1\n",
      "Chromosome: 11; Location: 11p15.4\n",
      "Annotation: Chromosome 11 NC_000011.10 (3854604..4093210)\n",
      "MIM: 605921\n",
      "ID: 6786\n",
      "\n",
      "16. HLA-DPB1\n",
      "Official Symbol: HLA-DPB1 and Name: major histocompatibility complex, class II, DP beta 1 [Homo sapiens (human)]\n",
      "Other Aliases: DPB1, HLA-DP, HLA-DP1B, HLA-DPB\n",
      "Other Designations: HLA class II histocompatibility antigen, DP beta 1 chain; HLA class II histocompatibility antigen, DP(W4) beta chain; HLA-DP histocompatibility type, beta-1 subunit; MHC HLA DPB1; MHC class II HLA-DP-beta-1; MHC class II antigen DPB1\n",
      "Chromosome: 6; Location: 6p21.32\n",
      "Annotation: Chromosome 6 NC_000006.12 (33075990..33089696)\n",
      "MIM: 142858\n",
      "ID: 3115\n",
      "\n",
      "17. CTCF\n",
      "Official Symbol: CTCF and Name: CCCTC-binding factor [Homo sapiens (human)]\n",
      "Other Aliases: CFAP108, FAP108, MRD21\n",
      "Other Designations: transcriptional repressor CTCF; 11 zinc finger transcriptional repressor; 11-zinc finger protein; CCCTC-binding factor (zinc finger protein); CTCFL paralog\n",
      "Chromosome: 16; Location: 16q22.1\n",
      "Annotation: Chromosome 16 NC_000016.10 (67562526..67639185)\n",
      "MIM: 604167\n",
      "ID: 10664\n",
      "\n",
      "18. SCARB1\n",
      "Official Symbol: SCARB1 and Name: scavenger receptor class B member 1 [Homo sapiens (human)]\n",
      "Other Aliases: CD36L1, CLA-1, CLA1, HDLCQ6, HDLQTL6, SR-BI, SRB1\n",
      "Other Designations: scavenger receptor class B member 1; CD36 and LIMPII analogous 1; CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 1; scavenger receptor class B type III\n",
      "Chromosome: 12; Location: 12q24.31\n",
      "Annotation: Chromosome 12 NC_000012.12 (124776856..124863864, complement)\n",
      "MIM: 601040\n",
      "ID: 949\n",
      "\n",
      "19. IKBKG\n",
      "Official Symbol: IKBKG and Name: inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [Homo sapiens (human)]\n",
      "Other Aliases: AMCBX1, EDAID1, FIP-3, FIP3, Fip3p, IKK-gamma, IKKAP1, IKKG, IMD33, IP, IP1, IP2, IPD2, NEMO, SAIDX, ZC2HC9\n",
      "Other Designations: NF-kappa-B essential modulator; 14.7K (adenovirus E3 protein) interacting protein 3; I-kappa-B kinase subunit gamma; NF-kappa-B essential modifier; ikB kinase subunit gamma; ikB kinase-associated protein 1; incontinentia pigmenti; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; inhibitor of nuclear factor kappa B kinase subunit gamma\n",
      "Chromosome: X; Location: Xq28\n",
      "Annotation: Chromosome X NC_000023.11 (154541238..154565046)\n",
      "MIM: 300248\n",
      "ID: 8517\n",
      "\n",
      "20. vpu\n",
      "Vpu [Human immunodeficiency virus 1]\n",
      "Other Aliases: HIV1gp7\n",
      "Other Designations: Vpu\n",
      "Annotation:  NC_001802.1 (5608..5856)\n",
      "ID: 155945\n",
      "\n",
      "21. ERN1\n",
      "Official Symbol: ERN1 and Name: endoplasmic reticulum to nucleus signaling 1 [Homo sapiens (human)]\n",
      "Other Aliases: IRE1, IRE1P, IRE1a, hIRE1p\n",
      "Other Designations: serine/threonine-protein kinase/endoribonuclease IRE1; ER to nucleus signalling 1; inositol-requiring 1; inositol-requiring enzyme 1; inositol-requiring protein 1; ire1-alpha; protein kinase/endoribonuclease\n",
      "Chromosome: 17; Location: 17q23.3\n",
      "Annotation: Chromosome 17 NC_000017.11 (64039142..64130144, complement)\n",
      "MIM: 604033\n",
      "ID: 2081\n",
      "\n",
      "22. HLA-DRA\n",
      "Official Symbol: HLA-DRA and Name: major histocompatibility complex, class II, DR alpha [Homo sapiens (human)]\n",
      "Other Aliases: HLA-DRA1\n",
      "Other Designations: HLA class II histocompatibility antigen, DR alpha chain; MHC class II antigen DRA; histocompatibility antigen HLA-DR alpha\n",
      "Chromosome: 6; Location: 6p21.32\n",
      "Annotation: Chromosome 6 NC_000006.12 (32439887..32445046)\n",
      "MIM: 142860\n",
      "ID: 3122\n",
      "\n",
      "23. EHMT2\n",
      "Official Symbol: EHMT2 and Name: euchromatic histone lysine methyltransferase 2 [Homo sapiens (human)]\n",
      "Other Aliases: BAT8, C6orf30, G9A, GAT8, KMT1C, NG36\n",
      "Other Designations: histone-lysine N-methyltransferase EHMT2; G9A histone methyltransferase; H3-K9-HMTase 3; HLA-B associated transcript 8; ankyrin repeat-containing protein; euchromatic histone-lysine N-methyltransferase 2; histone H3-K9 methyltransferase 3; histone-lysine N-methyltransferase, H3 lysine-9 specific 3; lysine N-methyltransferase 1C\n",
      "Chromosome: 6; Location: 6p21.33\n",
      "Annotation: Chromosome 6 NC_000006.12 (31879759..31897698, complement)\n",
      "MIM: 604599\n",
      "ID: 10919\n",
      "\n",
      "24. EIF2AK3\n",
      "Official Symbol: EIF2AK3 and Name: eukaryotic translation initiation factor 2 alpha kinase 3 [Homo sapiens (human)]\n",
      "Other Aliases: PEK, PERK, WRS\n",
      "Other Designations: eukaryotic translation initiation factor 2-alpha kinase 3; PKR-like ER kinase; PRKR-like endoplasmic reticulum kinase; pancreatic EIF2-alpha kinase; pancreatic eIF-2alpha kinase\n",
      "Chromosome: 2; Location: 2p11.2\n",
      "Annotation: Chromosome 2 NC_000002.12 (88556741..88628145, complement)\n",
      "MIM: 604032\n",
      "ID: 9451\n",
      "\n",
      "25. TNFRSF10A\n",
      "Official Symbol: TNFRSF10A and Name: TNF receptor superfamily member 10a [Homo sapiens (human)]\n",
      "Other Aliases: APO2, CD261, DR4, TRAILR-1, TRAILR1\n",
      "Other Designations: tumor necrosis factor receptor superfamily member 10A; TNF-related apoptosis-inducing ligand receptor 1; TRAIL receptor 1; TRAIL-R1; cytotoxic TRAIL receptor; death receptor 4; tumor necrosis factor receptor superfamily, member 10a\n",
      "Chromosome: 8; Location: 8p21.3\n",
      "Annotation: Chromosome 8 NC_000008.11 (23190452..23225102, complement)\n",
      "MIM: 603611\n",
      "ID: 8797\n",
      "\n",
      "26. PON2\n",
      "Official Symbol: PON2 and Name: paraoxonase 2 [Homo sapiens (human)]\n",
      "Other Designations: serum paraoxonase/arylesterase 2; A-esterase 2; PON 2; aromatic esterase 2; arylesterase 2; paraoxonase nirs; serum aryldialkylphosphatase 2\n",
      "Chromosome: 7; Location: 7q21.3\n",
      "Annotation: Chromosome 7 NC_000007.14 (95404862..95435028, complement)\n",
      "MIM: 602447\n",
      "ID: 5445\n",
      "\n",
      "27. CSNK2B\n",
      "Official Symbol: CSNK2B and Name: casein kinase 2 beta [Homo sapiens (human)]\n",
      "Other Aliases: CK2B, CK2N, CSK2B, Ckb1, Ckb2, G5A, POBINDS\n",
      "Other Designations: casein kinase II subunit beta; CK II beta; CSNK2B-LY6G5B-1072; CSNK2B-LY6G5B-1103; CSNK2B-LY6G5B-532; CSNK2B-LY6G5B-560; CSNK2B-LY6G5B-562; Casein kinase II beta subunit; alternative name: G5a, phosvitin; casein kinase 2, beta polypeptide; phosvitin; protein G5a\n",
      "Chromosome: 6; Location: 6p21.33\n",
      "Annotation: Chromosome 6 NC_000006.12 (31666080..31670067)\n",
      "MIM: 115441\n",
      "ID: 1460\n",
      "\n",
      "28. CANX\n",
      "Official Symbol: CANX and Name: calnexin [Homo sapiens (human)]\n",
      "Other Aliases: CNX, IP90, P90\n",
      "Other Designations: calnexin; epididymis secretory sperm binding protein; major histocompatibility complex class I antigen-binding protein p88\n",
      "Chromosome: 5; Location: 5q35.3\n",
      "Annotation: Chromosome 5 NC_000005.10 (179678656..179731641)\n",
      "MIM: 114217\n",
      "ID: 821\n",
      "\n",
      "29. ATF6\n",
      "Official Symbol: ATF6 and Name: activating transcription factor 6 [Homo sapiens (human)]\n",
      "Other Aliases: ACHM7A, ATP6alpha, ATF6\n",
      "Other Designations: cyclic AMP-dependent transcription factor ATF-6 alpha; cAMP-dependent transcription factor ATF-6 alpha\n",
      "Chromosome: 1; Location: 1q23.3\n",
      "Annotation: Chromosome 1 NC_000001.11 (161766320..161964070)\n",
      "MIM: 605537\n",
      "ID: 22926\n",
      "\n",
      "30. SCNN1A\n",
      "Official Symbol: SCNN1A and Name: sodium channel epithelial 1 subunit alpha [Homo sapiens (human)]\n",
      "Other Aliases: BESC2, ENaCa, ENaCalpha, LIDLS3, PHA1B1, SCNEA, SCNN1\n",
      "Other Designations: amiloride-sensitive sodium channel subunit alpha; alpha ENaC-2; alpha-ENaC; alpha-NaCH; amiloride-sensitive epithelial sodium channel alpha subunit; amiloride-sensitive sodium channel subunit alpha 2; epithelial Na(+) channel subunit alpha; nasal epithelial sodium channel alpha subunit; nonvoltage-gated sodium channel 1 subunit alpha; sodium channel epithelial 1 alpha subunit; sodium channel, non voltage gated 1 alpha subunit; sodium channel, non-voltage-gated 1 alpha; sodium channel, nonvoltage-gated 1 alpha\n",
      "Chromosome: 12; Location: 12p13.31\n",
      "Annotation: Chromosome 12 NC_000012.12 (6346847..6377359, complement)\n",
      "MIM: 600228\n",
      "ID: 6337\n",
      "\n",
      "31. CD74\n",
      "Official Symbol: CD74 and Name: CD74 molecule [Homo sapiens (human)]\n",
      "Other Aliases: CLIP, DHLAG, HLADG, II, Ia-GAMMA, p33\n",
      "Other Designations: HLA class II histocompatibility antigen gamma chain; CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); CD74 molecule, major histocompatibility complex, class II invariant chain; HLA-DR antigens-associated invariant chain; HLA-DR-gamma; Ia-associated invariant chain; MHC HLA-DR gamma chain; class II MHC-associated invariant chain peptide; gamma chain of class II antigens\n",
      "Chromosome: 5; Location: 5q33.1\n",
      "Annotation: Chromosome 5 NC_000005.10 (150401639..150412910, complement)\n",
      "MIM: 142790\n",
      "ID: 972\n",
      "\n",
      "32. GPT\n",
      "Official Symbol: GPT and Name: glutamic--pyruvic transaminase [Homo sapiens (human)]\n",
      "Other Aliases: AAT1, ALT, ALT11, SGPT, GPT\n",
      "Other Designations: alanine aminotransferase 1; alanine aminotransferase; alanine transaminase; glutamate pyruvate transaminase 1; glutamic--pyruvic transaminase 1; glutamic-alanine transaminase 1; glutamic-pyruvate transaminase (alanine aminotransferase)\n",
      "Chromosome: 8; Location: 8q24.3\n",
      "Annotation: Chromosome 8 NC_000008.11 (144503068..144507172)\n",
      "MIM: 138200\n",
      "ID: 2875\n",
      "\n",
      "33. CCL17\n",
      "Official Symbol: CCL17 and Name: C-C motif chemokine ligand 17 [Homo sapiens (human)]\n",
      "Other Aliases: A-152E5.3, ABCD-2, SCYA17, TARC\n",
      "Other Designations: C-C motif chemokine 17; CC chemokine TARC; T cell-directed CC chemokine; chemokine (C-C motif) ligand 17; small inducible cytokine subfamily A (Cys-Cys), member 17; small-inducible cytokine A17; thymus and activation-regulated chemokine\n",
      "Chromosome: 16; Location: 16q21\n",
      "Annotation: Chromosome 16 NC_000016.10 (57396093..57416063)\n",
      "MIM: 601520\n",
      "ID: 6361\n",
      "\n",
      "34. HCRT\n",
      "Official Symbol: HCRT and Name: hypocretin neuropeptide precursor [Homo sapiens (human)]\n",
      "Other Aliases: NRCLP1, OX, PPOX\n",
      "Other Designations: hypocretin neuropeptide precursor; hypocretin (orexin) neuropeptide; orexin; prepro-orexin; preprohypocretin\n",
      "Chromosome: 17; Location: 17q21.2\n",
      "Annotation: Chromosome 17 NC_000017.11 (42184060..42185452, complement)\n",
      "MIM: 602358\n",
      "ID: 3060\n",
      "\n",
      "35. TAP2\n",
      "Official Symbol: TAP2 and Name: transporter 2, ATP binding cassette subfamily B member [Homo sapiens (human)]\n",
      "Other Aliases: ABC18, ABCB3, APT2, D6S217E, PSF-2, PSF2, RING11\n",
      "Other Designations: antigen peptide transporter 2; ABC transporter, MHC 2; ATP-binding cassette, sub-family B (MDR/TAP), member 3; peptide supply factor 2; peptide transporter PSF2; peptide transporter involved in antigen processing 2; really interesting new gene 11 protein; transporter 2, ABC (ATP binding cassette); transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)\n",
      "Chromosome: 6; Location: 6p21.32\n",
      "Annotation: Chromosome 6 NC_000006.12 (32821831..32838739, complement)\n",
      "MIM: 170261\n",
      "ID: 6891\n",
      "\n",
      "36. GALT\n",
      "Official Symbol: GALT and Name: galactose-1-phosphate uridylyltransferase [Homo sapiens (human)]\n",
      "Other Designations: galactose-1-phosphate uridylyltransferase; UDP-glucose--hexose-1-phosphate uridylyltransferase; gal-1-P uridylyltransferase; galactose-1-phosphate uridyl transferase\n",
      "Chromosome: 9; Location: 9p13.3\n",
      "Annotation: Chromosome 9 NC_000009.12 (34646675..34651035)\n",
      "MIM: 606999\n",
      "ID: 2592\n",
      "\n",
      "37. EDA\n",
      "Official Symbol: EDA and Name: ectodysplasin A [Homo sapiens (human)]\n",
      "Other Aliases: ECTD1, ED1, ED1-A1, ED1-A2-A1, EDA-A2, EDA1, EDA2, HED, HED1, ODT1, STHAGX1, TNLG7C, XHED, XLHED, EDA\n",
      "Other Designations: ectodysplasin-A; X-linked anhidroitic ectodermal dysplasia protein; oligodontia 1; tumor necrosis factor ligand 7C\n",
      "Chromosome: X; Location: Xq13.1\n",
      "Annotation: Chromosome X NC_000023.11 (69616113..70039472)\n",
      "MIM: 300451\n",
      "ID: 1896\n",
      "\n",
      "38. APOBEC3A\n",
      "Official Symbol: APOBEC3A and Name: apolipoprotein B mRNA editing enzyme catalytic subunit 3A [Homo sapiens (human)]\n",
      "Other Aliases: A3A, ARP3, PHRBN, bK150C2.1\n",
      "Other Designations: DNA dC-&gt;dU-editing enzyme APOBEC-3A; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A; phorbolin-1; probable DNA dC-&gt;dU-editing enzyme APOBEC-3A\n",
      "Chromosome: 22; Location: 22q13.1\n",
      "Annotation: Chromosome 22 NC_000022.11 (38957609..38963184)\n",
      "MIM: 607109\n",
      "ID: 200315\n",
      "\n",
      "39. HLA-DRB5\n",
      "Official Symbol: HLA-DRB5 and Name: major histocompatibility complex, class II, DR beta 5 [Homo sapiens (human)]\n",
      "Other Aliases: DRB5*, HLA-DRB5\n",
      "Other Designations: major histocompatibility complex, class II, DR beta 5; DR beta-5; HLA class II histocompatibility antigen, DR-5 beta chain; MHC class II antigen DRB5\n",
      "Chromosome: 6; Location: 6p21.32\n",
      "Annotation: Chromosome 6 NC_000006.12 (32517353..32530287, complement)\n",
      "MIM: 604776\n",
      "ID: 3127\n",
      "\n",
      "40. HLA-DRB3\n",
      "Official Symbol: HLA-DRB3 and Name: major histocompatibility complex, class II, DR beta 3 [Homo sapiens (human)]\n",
      "Other Aliases: DRB3, HLA-DPB1, HLA-DR1B, HLA-DR3B*, HLA-DRB3\n",
      "Other Designations: major histocompatibility complex, class II, DR beta 3; HLA DRB3; HLA class II histocompatibility antigen, DR beta 3 chain; MHC class II DR beta chain; MHC class II HLA-DR beta 3 chain; MHC class II antigen DR beta 3 chain; MHC class II antigen DRB3; MHC class II protein; human leucocyte antigen DRB3; major histocompatibility complex, class II, DRB3\n",
      "Chromosome: 6; Location: 6p21.3\n",
      "MIM: 612735\n",
      "ID: 3125\n",
      "\n",
      "41. ROR2\n",
      "Official Symbol: ROR2 and Name: receptor tyrosine kinase like orphan receptor 2 [Homo sapiens (human)]\n",
      "Other Aliases: BDB, BDB1, NTRKR2\n",
      "Other Designations: tyrosine-protein kinase transmembrane receptor ROR2; neurotrophic tyrosine kinase receptor-related 2\n",
      "Chromosome: 9; Location: 9q22.31\n",
      "Annotation: Chromosome 9 NC_000009.12 (91722601..91950228, complement)\n",
      "MIM: 602337\n",
      "ID: 4920\n",
      "\n",
      "42. HLA-DRB4\n",
      "Official Symbol: HLA-DRB4 and Name: major histocompatibility complex, class II, DR beta 4 [Homo sapiens (human)]\n",
      "Other Aliases: DR4, DRB4, HLA-DR4B, HLA-DRB*, HLA-DRB4\n",
      "Other Designations: major histocompatibility complex, class II, DR beta 4; HLA class II histocompatibility antigen, DR beta 4 chain; MHC class II antigen DRB4\n",
      "Chromosome: 6; Location: 6p21.3\n",
      "ID: 3126\n",
      "\n",
      "43. ATP6AP2\n",
      "Official Symbol: ATP6AP2 and Name: ATPase H+ transporting accessory protein 2 [Homo sapiens (human)]\n",
      "Other Aliases: APT6M8-9, ATP6IP2, ATP6M8-9, CDG2R, ELDF10, HT028, M8-9, MRXE, MRXSH, MSTP009, PRR, RENR, XMRE, XPDS\n",
      "Other Designations: renin receptor; ATPase H(+)-transporting lysosomal-interacting protein 2; ATPase, H+ transporting, lysosomal (vacuolar proton pump) membrane sector associated protein M8-9; ATPase, H+ transporting, lysosomal accessory protein 2; ATPase, H+ transporting, lysosomal interacting protein 2; ER-localized type I transmembrane adapter; ER-localized type I transmembrane adaptor; N14F; V-ATPase M8.9 subunit; embryonic liver differentiation factor 10; prorenin receptor; renin/prorenin receptor; vacuolar ATP synthase membrane sector-associated protein M8-9; vacuolar proton ATP synthase membrane sector associated protein M8-9\n",
      "Chromosome: X; Location: Xp11.4\n",
      "Annotation: Chromosome X NC_000023.11 (40580970..40606848)\n",
      "MIM: 300556\n",
      "ID: 10159\n",
      "\n",
      "44. CDK7\n",
      "Official Symbol: CDK7 and Name: cyclin dependent kinase 7 [Homo sapiens (human)]\n",
      "Other Aliases: CAK, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15\n",
      "Other Designations: cyclin-dependent kinase 7; 39 KDa protein kinase; CDK-activating kinase 1; TFIIH basal transcription factor complex kinase subunit; cell division protein kinase 7; cyclin-dependent kinase 7 (MO15 homolog, Xenopus laevis, cdk-activating kinase); homolog of Xenopus MO15 Cdk-activating kinase; kinase subunit of CAK; serine/threonine kinase stk1; serine/threonine protein kinase 1; serine/threonine protein kinase MO15\n",
      "Chromosome: 5; Location: 5q13.2\n",
      "Annotation: Chromosome 5 NC_000005.10 (69234795..69277430)\n",
      "MIM: 601955\n",
      "ID: 1022\n",
      "\n",
      "45. EXT1\n",
      "Official Symbol: EXT1 and Name: exostosin glycosyltransferase 1 [Homo sapiens (human)]\n",
      "Other Aliases: EXT, LGCR, LGS, TRPS2, TTV\n",
      "Other Designations: exostosin-1; Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N- acetylglucosaminyltransferase; Langer-Giedion syndrome chromosome region; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase; exostoses (multiple) 1; glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase; multiple exostoses protein 1; putative tumor suppressor protein EXT1\n",
      "Chromosome: 8; Location: 8q24.11\n",
      "Annotation: Chromosome 8 NC_000008.11 (117794490..118111826, complement)\n",
      "MIM: 608177\n",
      "ID: 2131\n",
      "\n",
      "46. ATP13A2\n",
      "Official Symbol: ATP13A2 and Name: ATPase cation transporting 13A2 [Homo sapiens (human)]\n",
      "Other Aliases: CLN12, HSA9947, KRPPD, PARK9, SPG78\n",
      "Other Designations: polyamine-transporting ATPase 13A2; ATPase 13A2; ATPase type 13A2; cation-transporting ATPase 13A2; probable cation-transporting ATPase 13A2\n",
      "Chromosome: 1; Location: 1p36.13\n",
      "Annotation: Chromosome 1 NC_000001.11 (16985958..17011928, complement)\n",
      "MIM: 610513\n",
      "ID: 23400\n",
      "\n",
      "47. PLA2R1\n",
      "Official Symbol: PLA2R1 and Name: phospholipase A2 receptor 1 [Homo sapiens (human)]\n",
      "Other Aliases: CLEC13C, PLA2-R, PLA2G1R, PLA2IR, PLA2R\n",
      "Other Designations: secretory phospholipase A2 receptor; 180 kDa secretory phospholipase A2 receptor; C-type lectin domain family 13 member C; M-type receptor; phospholipase A2 receptor 1, 180kD; phospholipase A2 receptor 1, 180kDa\n",
      "Chromosome: 2; Location: 2q24.2\n",
      "Annotation: Chromosome 2 NC_000002.12 (159923933..160062615, complement)\n",
      "MIM: 604939\n",
      "ID: 22925\n",
      "\n",
      "48. RT1-Ba\n",
      "Official Symbol: RT1-Ba and Name: RT1 class II, locus Ba [Rattus norvegicus (Norway rat)]\n",
      "Other Aliases: BA1\n",
      "Other Designations: rano class II histocompatibility antigen, B alpha chain; MHC class I antigen; MHC class II antigen RT1.B alpha chain; RT1 class II antigen, Ba chain; RT1-B alpha; activated B cell RT1Bl alpha chain\n",
      "Chromosome: 20; Location: 20p12\n",
      "Annotation: Chromosome 20 NC_051355.1 (4575134..4579727)\n",
      "ID: 309621\n",
      "\n",
      "49. NR2F2\n",
      "Official Symbol: NR2F2 and Name: nuclear receptor subfamily 2 group F member 2 [Homo sapiens (human)]\n",
      "Other Aliases: ARP-1, ARP1, CHTD4, COUPTF2, COUPTFB, COUPTFII, NF-E3, SRXX5, SVP40, TFCOUP2\n",
      "Other Designations: COUP transcription factor 2; ADP-ribosylation factor related protein 1; COUP transcription factor II; apolipoprotein A-I regulatory protein 1; apolipoprotein AI regulatory protein 1; chicken ovalbumin upstream promoter transcription factor 2; chicken ovalbumin upstream promoter-transcription factor I\n",
      "Chromosome: 15; Location: 15q26.2\n",
      "Annotation: Chromosome 15 NC_000015.10 (96326046..96340263)\n",
      "MIM: 107773\n",
      "ID: 7026\n",
      "\n",
      "50. SLC25A4\n",
      "Official Symbol: SLC25A4 and Name: solute carrier family 25 member 4 [Homo sapiens (human)]\n",
      "Other Aliases: AAC1, ANT, ANT 1, ANT1, MTDPS12, MTDPS12A, PEO2, PEO3, PEOA2, T1\n",
      "Other Designations: ADP/ATP translocase 1; ADP,ATP carrier protein 1; ADP,ATP carrier protein, heart/skeletal muscle; ADP/ATP carrier 1; adenine nucleotide translocator 1 (skeletal muscle); heart/skeletal muscle ATP/ADP translocator; progressive external ophthalmoplegia 2; progressive external ophthalmoplegia 3; solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4\n",
      "Chromosome: 4; Location: 4q35.1\n",
      "Annotation: Chromosome 4 NC_000004.12 (185143266..185150382)\n",
      "MIM: 103220\n",
      "ID: 291\n",
      "\n",
      "51. CUX1\n",
      "Official Symbol: CUX1 and Name: cut like homeobox 1 [Homo sapiens (human)]\n",
      "Other Aliases: CASP, CDP, CDP/Cut, CDP1, COY1, CUTL1, CUX, Clox, Cux/CDP, GDDI, GOLIM6, Nbla10317, p100, p110, p200, p75\n",
      "Other Designations: protein CASP; Homeobox protein cut-like 1; CCAAT displacement protein; CDP/Cux p200; CUX1 gene Alternatively Spliced Product; cut homolog; golgi integral membrane protein 6; homeobox protein cux-1; mutant CUX1; putative protein product of Nbla10317\n",
      "Chromosome: 7; Location: 7q22.1\n",
      "Annotation: Chromosome 7 NC_000007.14 (101816007..102283958)\n",
      "MIM: 116896\n",
      "ID: 1523\n",
      "\n",
      "52. ITGB6\n",
      "Official Symbol: ITGB6 and Name: integrin subunit beta 6 [Homo sapiens (human)]\n",
      "Other Aliases: AI1H\n",
      "Other Designations: integrin beta-6; integrin, beta 6\n",
      "Chromosome: 2; Location: 2q24.2\n",
      "Annotation: Chromosome 2 NC_000002.12 (160099671..160200272, complement)\n",
      "MIM: 147558\n",
      "ID: 3694\n",
      "\n",
      "53. ACSL4\n",
      "Official Symbol: ACSL4 and Name: acyl-CoA synthetase long chain family member 4 [Homo sapiens (human)]\n",
      "Other Aliases: ACS4, FACL4, LACS4, MRX63, MRX68, XLID63\n",
      "Other Designations: long-chain-fatty-acid--CoA ligase 4; acyl-CoA synthetase 4; arachidonate--CoA ligase; fatty-acid-Coenzyme A ligase, long-chain 4; lignoceroyl-CoA synthase; long-chain acyl-CoA synthetase 4; long-chain fatty-acid-Coenzyme A ligase 4\n",
      "Chromosome: X; Location: Xq23\n",
      "Annotation: Chromosome X NC_000023.11 (109641335..109733257, complement)\n",
      "MIM: 300157\n",
      "ID: 2182\n",
      "\n",
      "54. STC2\n",
      "Official Symbol: STC2 and Name: stanniocalcin 2 [Homo sapiens (human)]\n",
      "Other Aliases: STC-2, STCRP\n",
      "Other Designations: stanniocalcin-2; STC-related protein; stanniocalcin-related protein\n",
      "Chromosome: 5; Location: 5q35.2\n",
      "Annotation: Chromosome 5 NC_000005.10 (173314723..173328414, complement)\n",
      "MIM: 603665\n",
      "ID: 8614\n",
      "\n",
      "55. TAPBP\n",
      "Official Symbol: TAPBP and Name: TAP binding protein [Homo sapiens (human)]\n",
      "Other Aliases: NGS17, TAPA, TPN, TPSN\n",
      "Other Designations: tapasin; NGS-17; TAP binding protein (tapasin); TAP-associated protein\n",
      "Chromosome: 6; Location: 6p21.32\n",
      "Annotation: Chromosome 6 NC_000006.12 (33299694..33314078, complement)\n",
      "MIM: 601962\n",
      "ID: 6892\n",
      "\n",
      "56. PPARGC1B\n",
      "Official Symbol: PPARGC1B and Name: PPARG coactivator 1 beta [Homo sapiens (human)]\n",
      "Other Aliases: ERRL1, PERC, PGC-1(beta), PGC1B\n",
      "Other Designations: peroxisome proliferator-activated receptor gamma coactivator 1-beta; PGC-1-related estrogen receptor alpha coactivator; PPAR-gamma coactivator 1-beta; PPARAGCIbeta; PPARGC-1-beta; PPARgamma coactivator 1 beta; peroxisome proliferator-activated receptor gamma, coactivator 1 beta\n",
      "Chromosome: 5; Location: 5q32\n",
      "Annotation: Chromosome 5 NC_000005.10 (149730310..149857959)\n",
      "MIM: 608886\n",
      "ID: 133522\n",
      "\n",
      "57. BTNL2\n",
      "Official Symbol: BTNL2 and Name: butyrophilin like 2 [Homo sapiens (human)]\n",
      "Other Aliases: BTL-II, BTN7, HSBLMHC1, SS2\n",
      "Other Designations: butyrophilin-like protein 2; butyrophilin-like 2 (MHC class II associated)\n",
      "Chromosome: 6; Location: 6p21.32\n",
      "Annotation: Chromosome 6 NC_000006.12 (32393339..32407181, complement)\n",
      "MIM: 606000\n",
      "ID: 56244\n",
      "\n",
      "58. H2-Aa\n",
      "Official Symbol: H2-Aa and Name: histocompatibility 2, class II antigen A, alpha [Mus musculus (house mouse)]\n",
      "Other Aliases: Aalpha, H-2Aa, H2Aa, I-Aalpha, IAalpha, Ia-1, Ia1\n",
      "Other Designations: histocompatibility 2, class II antigen A, alpha; H-2 class II histocompatibility antigen, A-B alpha chain; H-2 class II histocompatibility antigen, A-F alpha chain; H-2 class II histocompatibility antigen, A-K alpha chain; H-2 class II histocompatibility antigen, A-Q alpha chain; H-2 class II histocompatibility antigen, A-R alpha chain; H-2 class II histocompatibility antigen, A-S alpha chain; H-2 class II histocompatibility antigen, A-U alpha chain; MHC class II antigen alpha chain; MHC-II I-A(d) alpha; histocompatibility 2, class II antigen A, alpha, promoter 1; major histocompatibility protein class II alpha chain\n",
      "Chromosome: 17; Location: 17 17.98 cM\n",
      "Annotation: Chromosome 17 NC_000083.7 (34501718..34506797, complement)\n",
      "ID: 14960\n",
      "\n",
      "59. TLE1\n",
      "Official Symbol: TLE1 and Name: TLE family member 1, transcriptional corepressor [Homo sapiens (human)]\n",
      "Other Aliases: ESG, ESG1, GRG1, TLE-1\n",
      "Other Designations: transducin-like enhancer protein 1; enhancer of split groucho-like protein 1; transducin like enhancer of split 1; transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)\n",
      "Chromosome: 9; Location: 9q21.32\n",
      "Annotation: Chromosome 9 NC_000009.12 (81583683..81689547, complement)\n",
      "MIM: 600189\n",
      "ID: 7088\n",
      "\n",
      "60. LNPEP\n",
      "Official Symbol: LNPEP and Name: leucyl and cystinyl aminopeptidase [Homo sapiens (human)]\n",
      "Other Aliases: CAP, IRAP, P-LAP, PLAP\n",
      "Other Designations: leucyl-cystinyl aminopeptidase; AT (4) receptor; angiotensin IV receptor; cystinyl aminopeptidase; insulin-regulated aminopeptidase; insulin-regulated membrane aminopeptidase; insulin-responsive aminopeptidase; otase; oxytocinase; placental leucine aminopeptidase; vasopressinase\n",
      "Chromosome: 5; Location: 5q15\n",
      "Annotation: Chromosome 5 NC_000005.10 (96936080..97037513)\n",
      "MIM: 151300\n",
      "ID: 4012\n",
      "\n",
      "\n",
      "61. EFNB1\n",
      "Official Symbol: EFNB1 and Name: ephrin B1 [Homo sapiens (human)]\n",
      "Other Aliases: CFND, CFNS, EFB1, EFL3, EPLG2, Elk-L, LERK2\n",
      "Other Designations: ephrin-B1; ELK ligand; eph-related receptor tyrosine kinase ligand 2\n",
      "Chromosome: X; Location: Xq13.1\n",
      "Annotation: Chromosome X NC_000023.11 (68829021..68842160)\n",
      "MIM: 300035\n",
      "ID: 1947\n",
      "\n",
      "62. SPG7\n",
      "Official Symbol: SPG7 and Name: SPG7 matrix AAA peptidase subunit, paraplegin [Homo sapiens (human)]\n",
      "Other Aliases: CAR, CMAR, PGN, SPG5C\n",
      "Other Designations: paraplegin; SPG7, paraplegin matrix AAA peptidase subunit; cell matrix adhesion regulator; spastic paraplegia 7 (pure and complicated autosomal recessive); spastic paraplegia 7 protein\n",
      "Chromosome: 16; Location: 16q24.3\n",
      "Annotation: Chromosome 16 NC_000016.10 (89508388..89557768)\n",
      "MIM: 602783\n",
      "ID: 6687\n",
      "\n",
      "63. PNPLA6\n",
      "Official Symbol: PNPLA6 and Name: patatin like phospholipase domain containing 6 [Homo sapiens (human)]\n",
      "Other Aliases: BNHS, LNMS, NTE, NTEMND, OMCS, SPG39, iPLA2delta, sws\n",
      "Other Designations: patatin-like phospholipase domain-containing protein 6; neuropathy target esterase\n",
      "Chromosome: 19; Location: 19p13.2\n",
      "Annotation: Chromosome 19 NC_000019.10 (7534164..7561767)\n",
      "MIM: 603197\n",
      "ID: 10908\n",
      "\n",
      "64. ITGA7\n",
      "Official Symbol: ITGA7 and Name: integrin subunit alpha 7 [Homo sapiens (human)]\n",
      "Other Designations: integrin alpha-7; integrin alpha 7 chain\n",
      "Chromosome: 12; Location: 12q13.2\n",
      "Annotation: Chromosome 12 NC_000012.12 (55684568..55716400, complement)\n",
      "MIM: 600536\n",
      "ID: 3679\n",
      "\n",
      "65. SH3GL2\n",
      "Official Symbol: SH3GL2 and Name: SH3 domain containing GRB2 like 2, endophilin A1 [Homo sapiens (human)]\n",
      "Other Aliases: CNSA2, EEN-B1, SH3D2A, SH3P4\n",
      "Other Designations: endophilin-A1; Endophilin A1 BAR domain; SH3 domain protein 2A; SH3 domain-containing GRB2-like protein 2; SH3-domain GRB2-like 2; bA335L15.1 (SH3-domain GRB2-like 2); endophilin-1\n",
      "Chromosome: 9; Location: 9p22.2\n",
      "Annotation: Chromosome 9 NC_000009.12 (17579066..17797124)\n",
      "MIM: 604465\n",
      "ID: 6456\n",
      "\n",
      "66. SGPL1\n",
      "Official Symbol: SGPL1 and Name: sphingosine-1-phosphate lyase 1 [Homo sapiens (human)]\n",
      "Other Aliases: NPHS14, RENI, S1PL, SPL\n",
      "Other Designations: sphingosine-1-phosphate lyase 1; SP-lyase 1; SPL 1; hSPL; sphingosine-1-phosphate aldolase\n",
      "Chromosome: 10; Location: 10q22.1\n",
      "Annotation: Chromosome 10 NC_000010.11 (70815948..70881184)\n",
      "MIM: 603729\n",
      "ID: 8879\n",
      "\n",
      "67. ATP2A1\n",
      "Official Symbol: ATP2A1 and Name: ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [Homo sapiens (human)]\n",
      "Other Aliases: ATP2A, SERCA1\n",
      "Other Designations: sarcoplasmic/endoplasmic reticulum calcium ATPase 1; ATPase, Ca++ transporting, cardiac muscle, fast twitch 1; SR Ca(2+)-ATPase 1; calcium pump 1; endoplasmic reticulum class 1/2 Ca(2+) ATPase\n",
      "Chromosome: 16; Location: 16p11.2\n",
      "Annotation: Chromosome 16 NC_000016.10 (28878488..28904466)\n",
      "MIM: 108730\n",
      "ID: 487\n",
      "\n",
      "68. FKTN\n",
      "Official Symbol: FKTN and Name: fukutin [Homo sapiens (human)]\n",
      "Other Aliases: CMD1X, FCMD, LGMD2M, LGMDR13, MDDGA4, MDDGB4, MDDGC4\n",
      "Other Designations: ribitol-5-phosphate transferase FKTN; Fukuyama type congenital muscular dystrophy protein; patient fukutin; ribitol-5-phosphate transferase\n",
      "Chromosome: 9; Location: 9q31.2\n",
      "Annotation: Chromosome 9 NC_000009.12 (105558130..105641118)\n",
      "MIM: 607440\n",
      "ID: 2218\n",
      "\n",
      "69. HYAL2\n",
      "Official Symbol: HYAL2 and Name: hyaluronidase 2 [Homo sapiens (human)]\n",
      "Other Aliases: LUCA2\n",
      "Other Designations: hyaluronidase-2; PH-20 homolog; PH20 homolog; hyal-2; hyaluronoglucosaminidase 2; lung carcinoma protein 2; lysosomal hyaluronidase\n",
      "Chromosome: 3; Location: 3p21.31\n",
      "Annotation: Chromosome 3 NC_000003.12 (50317808..50322745, complement)\n",
      "MIM: 603551\n",
      "ID: 8692\n",
      "\n",
      "70. ATP6V0A2\n",
      "Official Symbol: ATP6V0A2 and Name: ATPase H+ transporting V0 subunit a2 [Homo sapiens (human)]\n",
      "Other Aliases: A2, ARCL, ARCL2A, ATP6A2, ATP6N1D, J6B7, RTF, STV1, TJ6, TJ6M, TJ6S, VPH1, WSS, a2V\n",
      "Other Designations: V-type proton ATPase 116 kDa subunit a 2; A2V-ATPase; ATPase, H+ transporting, lysosomal V0 subunit a2; V-ATPase 116 kDa subunit a 2; V-ATPase 116 kDa subunit a2; V-ATPase subunit a2; V-type proton ATPase 116 kDa subunit a2; lysosomal H(+)-transporting ATPase V0 subunit a 2; lysosomal H(+)-transporting ATPase V0 subunit a2; regeneration and tolerance factor; v-type proton ATPase 116 kDa subunit a; vacuolar proton translocating ATPase 116 kDa subunit a\n",
      "Chromosome: 12; Location: 12q24.31\n",
      "Annotation: Chromosome 12 NC_000012.12 (123712353..123761755)\n",
      "MIM: 611716\n",
      "ID: 23545\n",
      "\n",
      "71. ATP2B2\n",
      "Official Symbol: ATP2B2 and Name: ATPase plasma membrane Ca2+ transporting 2 [Homo sapiens (human)]\n",
      "Other Aliases: DFNA82, PMCA2, PMCA2a, PMCA2i\n",
      "Other Designations: plasma membrane calcium-transporting ATPase 2; ATPase, Ca++ transporting, plasma membrane 2; plasma membrane Ca(2+)-ATPase; plasma membrane Ca2+ pump 2; plasma membrane calcium ATPase; plasma membrane calcium pump\n",
      "Chromosome: 3; Location: 3p25.3\n",
      "Annotation: Chromosome 3 NC_000003.12 (10324023..10708007, complement)\n",
      "MIM: 108733\n",
      "ID: 491\n",
      "\n",
      "72. PRRC2A\n",
      "Official Symbol: PRRC2A and Name: proline rich coiled-coil 2A [Homo sapiens (human)]\n",
      "Other Aliases: BAT2, D6S51, D6S51E, G2\n",
      "Other Designations: protein PRRC2A; HLA-B-associated transcript 2; large proline-rich protein BAT2; proline-rich and coiled-coil-containing protein 2A; protein G2\n",
      "Chromosome: 6; Location: 6p21.33\n",
      "Annotation: Chromosome 6 NC_000006.12 (31620715..31637771)\n",
      "MIM: 142580\n",
      "ID: 7916\n",
      "\n",
      "73. KCNJ8\n",
      "Official Symbol: KCNJ8 and Name: potassium inwardly rectifying channel subfamily J member 8 [Homo sapiens (human)]\n",
      "Other Aliases: KIR6.1, uKATP-1\n",
      "Other Designations: ATP-sensitive inward rectifier potassium channel 8; inward rectifier K(+) channel Kir6.1; inwardly rectifying potassium channel KIR6.1; potassium channel, inwardly rectifying subfamily J member 8; potassium voltage-gated channel subfamily J member 8\n",
      "Chromosome: 12; Location: 12p12.1\n",
      "Annotation: Chromosome 12 NC_000012.12 (21764955..21774706, complement)\n",
      "MIM: 600935\n",
      "ID: 3764\n",
      "\n",
      "74. UBE3C\n",
      "Official Symbol: UBE3C and Name: ubiquitin protein ligase E3C [Homo sapiens (human)]\n",
      "Other Aliases: HECTH2, NDSMBA, NEDSMBA, RAUL\n",
      "Other Designations: ubiquitin-protein ligase E3C; HECT-type ubiquitin transferase E3C; RTA-associated ubiquitin ligase; homologous to E6AP carboxyl terminus homologous protein 2; ubiquitin-protein isopeptide ligase (E3)\n",
      "Chromosome: 7; Location: 7q36.3\n",
      "Annotation: Chromosome 7 NC_000007.14 (157138926..157269370)\n",
      "MIM: 614454\n",
      "ID: 9690\n",
      "\n",
      "75. HLA-DOA\n",
      "Official Symbol: HLA-DOA and Name: major histocompatibility complex, class II, DO alpha [Homo sapiens (human)]\n",
      "Other Aliases: HLA-DNA, HLA-DZA, HLADZ\n",
      "Other Designations: HLA class II histocompatibility antigen, DO alpha chain; HLA-D0-alpha; MHC DN-alpha; MHC DZ alpha; MHC class II antigen DOA; lymphocyte antigen; major histocompatibility complex, class II, DN alpha\n",
      "Chromosome: 6; Location: 6p21.32\n",
      "Annotation: Chromosome 6 NC_000006.12 (33004182..33009591, complement)\n",
      "MIM: 142930\n",
      "ID: 3111\n",
      "\n",
      "76. MOGS\n",
      "Official Symbol: MOGS and Name: mannosyl-oligosaccharide glucosidase [Homo sapiens (human)]\n",
      "Other Aliases: CDG2B, CWH41, DER7, GCS1\n",
      "Other Designations: mannosyl-oligosaccharide glucosidase; epididymis secretory sperm binding protein; glucosidase I; processing A-glucosidase I\n",
      "Chromosome: 2; Location: 2p13.1\n",
      "Annotation: Chromosome 2 NC_000002.12 (74461057..74465382, complement)\n",
      "MIM: 601336\n",
      "ID: 7841\n",
      "\n",
      "77. HLA-DQA2\n",
      "Official Symbol: HLA-DQA2 and Name: major histocompatibility complex, class II, DQ alpha 2 [Homo sapiens (human)]\n",
      "Other Aliases: DC-alpha, DQA1, DX-ALPHA, HLA-DCA, HLA-DXA, HLADQA2\n",
      "Other Designations: HLA class II histocompatibility antigen, DQ alpha 2 chain; DC-1 alpha chain; DX alpha chain; HLA class II histocompatibility antigen, DQ alpha 1 chain; HLA class II histocompatibility antigen, DQ(6) alpha chain; MHC class I antigen; MHC class II DQA1; MHC class II DQA2; MHC class II antigen\n",
      "Chromosome: 6; Location: 6p21.32\n",
      "Annotation: Chromosome 6 NC_000006.12 (32741391..32747198)\n",
      "MIM: 613503\n",
      "ID: 3118\n",
      "\n",
      "78. APLP1\n",
      "Official Symbol: APLP1 and Name: amyloid beta precursor like protein 1 [Homo sapiens (human)]\n",
      "Other Aliases: APLP\n",
      "Other Designations: amyloid beta precursor like protein 1; amyloid beta (A4) precursor-like protein 1; amyloid precursor-like protein 1; amyloid-like protein 1\n",
      "Chromosome: 19; Location: 19q13.12\n",
      "Annotation: Chromosome 19 NC_000019.10 (35868574..35879792)\n",
      "MIM: 104775\n",
      "ID: 333\n",
      "\n",
      "79. CYP2S1\n",
      "Official Symbol: CYP2S1 and Name: cytochrome P450 family 2 subfamily S member 1 [Homo sapiens (human)]\n",
      "Other Aliases: CYPIIS1\n",
      "Other Designations: cytochrome P450 2S1; cytochrome P450, family 2, subfamily S, polypeptide 1; cytochrome P540, subfamily IIS, polypeptide 1; hydroperoxy icosatetraenoate dehydratase; thromboxane-A synthase\n",
      "Chromosome: 19; Location: 19q13.2\n",
      "Annotation: Chromosome 19 NC_000019.10 (41193219..41207539)\n",
      "MIM: 611529\n",
      "ID: 29785\n",
      "\n",
      "80. ATP6AP1\n",
      "Official Symbol: ATP6AP1 and Name: ATPase H+ transporting accessory protein 1 [Homo sapiens (human)]\n",
      "Other Aliases: 16A, ATP6IP1, ATP6S1, Ac45, CF2, VATPS1, XAP-3, XAP3\n",
      "Other Designations: V-type proton ATPase subunit S1; ATPase, H+ transporting, lysosomal (vacuolar proton pump), subunit 1; ATPase, H+ transporting, lysosomal accessory protein 1; ATPase, H+ transporting, lysosomal interacting protein 1; H-ATPase subunit; V-ATPase Ac45 subunit; V-ATPase S1 accessory protein; V-ATPase subunit S1; X-associated protein 3; epididymis secretory sperm binding protein; protein XAP-3; vacuolar ATPase subunit S1; vacuolar proton pump subunit S1\n",
      "Chromosome: X; Location: Xq28\n",
      "Annotation: Chromosome X NC_000023.11 (154428677..154436516)\n",
      "MIM: 300197\n",
      "ID: 537\n",
      "\n",
      "81. B4GALNT1\n",
      "Official Symbol: B4GALNT1 and Name: beta-1,4-N-acetyl-galactosaminyltransferase 1 [Homo sapiens (human)]\n",
      "Other Aliases: GALGT, GALNACT, GalNAc-T, SPG26\n",
      "Other Designations: beta-1,4 N-acetylgalactosaminyltransferase 1; GD2 synthase, GM2 synthase; GM2/GD2 synthase; UDP-Gal:betaGlcNAc beta-1,4-N-acetylgalactosaminyltransferase transferase 1; UDP-N-acetyl-alpha-D-galactosamine:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase (GalNAc-T); beta-1,4-N-acetyl-galactosaminyl transferase 1; beta1,4GalNAc-T\n",
      "Chromosome: 12; Location: 12q13.3\n",
      "Annotation: Chromosome 12 NC_000012.12 (57623409..57633201, complement)\n",
      "MIM: 601873\n",
      "ID: 2583\n",
      "\n",
      "82. RNF5\n",
      "Official Symbol: RNF5 and Name: ring finger protein 5 [Homo sapiens (human)]\n",
      "Other Aliases: RING5, RMA1\n",
      "Other Designations: E3 ubiquitin-protein ligase RNF5; RING-type E3 ubiquitin transferase RNF5; protein G16; ram1 homolog; ring finger protein 5, E3 ubiquitin protein ligase\n",
      "Chromosome: 6; Location: 6p21.32\n",
      "Annotation: Chromosome 6 NC_000006.12 (32178405..32180793)\n",
      "MIM: 602677\n",
      "ID: 6048\n",
      "\n",
      "83. POM121\n",
      "Official Symbol: POM121 and Name: POM121 transmembrane nucleoporin [Homo sapiens (human)]\n",
      "Other Aliases: P145A, POM121\n",
      "Other Designations: nuclear envelope pore membrane protein POM 121; POM121 membrane glycoprotein; nuclear envelope pore membrane protein POM 121A; nuclear pore membrane protein 121 kDa; nucleoporin Nup121\n",
      "Chromosome: 7; Location: 7q11.23\n",
      "Annotation: Chromosome 7 NC_000007.14 (72879357..72951459)\n",
      "MIM: 615753\n",
      "ID: 9883\n",
      "\n",
      "84. SMPD2\n",
      "Official Symbol: SMPD2 and Name: sphingomyelin phosphodiesterase 2 [Homo sapiens (human)]\n",
      "Other Aliases: ISC1, NSMASE, NSMASE1\n",
      "Other Designations: sphingomyelin phosphodiesterase 2; N-SMase; lyso-PAF-PLC; lyso-platelet-activating factor-phospholipase C; neutral sphingomyelinase\n",
      "Chromosome: 6; Location: 6q21\n",
      "Annotation: Chromosome 6 NC_000006.12 (109440724..109443919)\n",
      "MIM: 603498\n",
      "ID: 6610\n",
      "\n",
      "85. ABCA2\n",
      "Official Symbol: ABCA2 and Name: ATP binding cassette subfamily A member 2 [Homo sapiens (human)]\n",
      "Other Aliases: ABC2, IDPOGSA\n",
      "Other Designations: ATP-binding cassette sub-family A member 2; ATP-binding cassette 2; ATP-binding cassette transporter 2; ATP-binding cassette, sub-family A (ABC1), member 2; ATP-binding cassette, sub-family A, member 2\n",
      "Chromosome: 9; Location: 9q34.3\n",
      "Annotation: Chromosome 9 NC_000009.12 (137007234..137028922, complement)\n",
      "MIM: 600047\n",
      "ID: 20\n",
      "\n",
      "86. EXTL3\n",
      "Official Symbol: EXTL3 and Name: exostosin like glycosyltransferase 3 [Homo sapiens (human)]\n",
      "Other Aliases: BOTV, EXTL1L, EXTR1, ISDNA, REGR, RPR\n",
      "Other Designations: exostosin-like 3; EXT-related 1; epididymis secretory sperm binding protein; exostoses (multiple)-like 3; exostosin tumor-like 3; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase; hereditary multiple exostoses gene isolog; putative tumor suppressor protein EXTL3; reg receptor\n",
      "Chromosome: 8; Location: 8p21.1\n",
      "Annotation: Chromosome 8 NC_000008.11 (28607736..28755599)\n",
      "MIM: 605744\n",
      "ID: 2137\n",
      "\n",
      "87. MAN2A1\n",
      "Official Symbol: MAN2A1 and Name: mannosidase alpha class 2A member 1 [Homo sapiens (human)]\n",
      "Other Aliases: AMan II, GOLIM7, MANA2, MANII\n",
      "Other Designations: alpha-mannosidase 2; Golgi alpha-mannosidase II; golgi integral membrane protein 7; mannosidase, alpha type II; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase\n",
      "Chromosome: 5; Location: 5q21.3\n",
      "Annotation: Chromosome 5 NC_000005.10 (109689927..109869625)\n",
      "MIM: 154582\n",
      "ID: 4124\n",
      "\n",
      "88. LY75\n",
      "Official Symbol: LY75 and Name: lymphocyte antigen 75 [Homo sapiens (human)]\n",
      "Other Aliases: CD205, CLEC13B, DEC-205, GP200-MR6, LY-75\n",
      "Other Designations: lymphocyte antigen 75; C-type lectin domain family 13 member B\n",
      "Chromosome: 2; Location: 2q24.2\n",
      "Annotation: Chromosome 2 NC_000002.12 (159803355..159904756, complement)\n",
      "MIM: 604524\n",
      "ID: 4065\n",
      "\n",
      "89. UNC119\n",
      "Official Symbol: UNC119 and Name: unc-119 lipid binding chaperone [Homo sapiens (human)]\n",
      "Other Aliases: CORD24, HRG4, IMD13, POC7, POC7A\n",
      "Other Designations: protein unc-119 homolog A; POC7 centriolar protein homolog A; retinal protein 4; unc-119 homolog\n",
      "Chromosome: 17; Location: 17q11.2\n",
      "Annotation: Chromosome 17 NC_000017.11 (28546707..28552628, complement)\n",
      "MIM: 604011\n",
      "ID: 9094\n",
      "\n",
      "90. TMEM67\n",
      "Official Symbol: TMEM67 and Name: transmembrane protein 67 [Homo sapiens (human)]\n",
      "Other Aliases: JBTS6, MECKELIN, MKS3, NPHP11, TNEM67\n",
      "Other Designations: meckelin; meckel syndrome type 3 protein\n",
      "Chromosome: 8; Location: 8q22.1\n",
      "Annotation: Chromosome 8 NC_000008.11 (93754844..93832653)\n",
      "MIM: 609884\n",
      "ID: 91147\n",
      "\n",
      "91. MFSD8\n",
      "Official Symbol: MFSD8 and Name: major facilitator superfamily domain containing 8 [Homo sapiens (human)]\n",
      "Other Aliases: CCMD, CLN7\n",
      "Other Designations: major facilitator superfamily domain-containing protein 8; ceroid-lipofuscinosis, neuronal 7, late infantile\n",
      "Chromosome: 4; Location: 4q28.2\n",
      "Annotation: Chromosome 4 NC_000004.12 (127917732..127965963, complement)\n",
      "MIM: 611124\n",
      "ID: 256471\n",
      "\n",
      "92. PLXNA1\n",
      "Official Symbol: PLXNA1 and Name: plexin A1 [Homo sapiens (human)]\n",
      "Other Aliases: DWOPNED, NOV, NOVP, PLEXIN-A1, PLXN1\n",
      "Other Designations: plexin-A1; plexin 1; semaphorin receptor NOV\n",
      "Chromosome: 3; Location: 3q21.3\n",
      "Annotation: Chromosome 3 NC_000003.12 (126983115..127037389)\n",
      "MIM: 601055\n",
      "ID: 5361\n",
      "\n",
      "93. PLXNA2\n",
      "Official Symbol: PLXNA2 and Name: plexin A2 [Homo sapiens (human)]\n",
      "Other Aliases: OCT, PLXN2\n",
      "Other Designations: plexin-A2; plexin 2; semaphorin receptor OCT; transmembrane protein OCT\n",
      "Chromosome: 1; Location: 1q32.2\n",
      "Annotation: Chromosome 1 NC_000001.11 (208022242..208244384, complement)\n",
      "MIM: 601054\n",
      "ID: 5362\n",
      "\n",
      "94. LARGE1\n",
      "Official Symbol: LARGE1 and Name: LARGE xylosyl- and glucuronyltransferase 1 [Homo sapiens (human)]\n",
      "Other Aliases: LARGE, MDC1D, MDDGA6, MDDGB6\n",
      "Other Designations: xylosyl- and glucuronyltransferase LARGE1; acetylglucosaminyltransferase-like 1A; acetylglucosaminyltransferase-like protein; glycosyltransferase-like protein LARGE1\n",
      "Chromosome: 22; Location: 22q12.3\n",
      "Annotation: Chromosome 22 NC_000022.11 (33066663..33922824, complement)\n",
      "MIM: 603590\n",
      "ID: 9215\n",
      "\n",
      "95. UGT8\n",
      "Official Symbol: UGT8 and Name: UDP glycosyltransferase 8 [Homo sapiens (human)]\n",
      "Other Aliases: CGT, UGT4\n",
      "Other Designations: 2-hydroxyacylsphingosine 1-beta-galactosyltransferase; UDP-galactose-ceramide galactosyltransferase; ceramide UDP-galactosyltransferase; cerebroside synthase; uridine diphosphate glycosyltransferase 8\n",
      "Chromosome: 4; Location: 4q26\n",
      "Annotation: Chromosome 4 NC_000004.12 (114598402..114678225)\n",
      "MIM: 601291\n",
      "ID: 7368\n",
      "\n",
      "96. ST7\n",
      "Official Symbol: ST7 and Name: suppression of tumorigenicity 7 [Homo sapiens (human)]\n",
      "Other Aliases: ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7\n",
      "Other Designations: suppressor of tumorigenicity 7 protein; family with sequence similarity 4, subfamily A, member 1; suppression of tumorigenicity 7 (breast)\n",
      "Chromosome: 7; Location: 7q31.2\n",
      "Annotation: Chromosome 7 NC_000007.14 (116953501..117230176)\n",
      "MIM: 600833\n",
      "ID: 7982\n",
      "\n",
      "97. SEMA4C\n",
      "Official Symbol: SEMA4C and Name: semaphorin 4C [Homo sapiens (human)]\n",
      "Other Aliases: M-SEMA-F, SEMACL1, SEMAF, SEMAI\n",
      "Other Designations: semaphorin-4C; M-Sema F; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C\n",
      "Chromosome: 2; Location: 2q11.2\n",
      "Annotation: Chromosome 2 NC_000002.12 (96859718..96870830, complement)\n",
      "MIM: 604462\n",
      "ID: 54910\n",
      "\n",
      "98. MGAT1\n",
      "Official Symbol: MGAT1 and Name: alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase [Homo sapiens (human)]\n",
      "Other Aliases: GLCNAC-TI, GLCT1, GLYT1, GNT-1, GNT-I, GnTI, MGAT\n",
      "Other Designations: alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase; N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I; glcNAc-T I; mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase\n",
      "Chromosome: 5; Location: 5q35.3\n",
      "Annotation: Chromosome 5 NC_000005.10 (180784780..180815616, complement)\n",
      "MIM: 160995\n",
      "ID: 4245\n",
      "\n",
      "99. ATP6V0A1\n",
      "Official Symbol: ATP6V0A1 and Name: ATPase H+ transporting V0 subunit a1 [Homo sapiens (human)]\n",
      "Other Aliases: ATP6N1, ATP6N1A, DEE104, NEDEBA, Stv1, VPP1, Vph1, a1\n",
      "Other Designations: V-type proton ATPase 116 kDa subunit a 1; ATPase, H+ transporting, lysosomal V0 subunit a1; ATPase, H+ transporting, lysosomal non-catalytic accessory protein 1 (110/116kD); H(+)-transporting two-sector ATPase, 116 kDa accessory protein A1; V-ATPase 116 kDa subunit a 1; V-ATPase 116 kDa subunit a1; V-ATPase subunit a1; V-type proton ATPase 116 kDa subunit a; V-type proton ATPase 116 kDa subunit a1; clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit; vacuolar adenosine triphosphatase subunit Ac116; vacuolar proton pump subunit 1; vacuolar proton translocating ATPase 116 kDa subunit A; vacuolar-type H(+)-ATPase 115 kDa subunit\n",
      "Chromosome: 17; Location: 17q21.2\n",
      "Annotation: Chromosome 17 NC_000017.11 (42458878..42522579)\n",
      "MIM: 192130\n",
      "ID: 535\n",
      "\n",
      "100. SLC22A18\n",
      "Official Symbol: SLC22A18 and Name: solute carrier family 22 member 18 [Homo sapiens (human)]\n",
      "Other Aliases: BWR1A, BWSCR1A, HET, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5, p45-BWR1A\n",
      "Other Designations: solute carrier family 22 member 18; beckwith-Wiedemann syndrome chromosomal region 1 candidate gene A protein; efflux transporter-like protein; imprinted multi-membrane-spanning polyspecific transporter-like gene 1; imprinted multi-membrane-spanning polyspecific transporter-related protein 1; organic cation transporter-like protein 2; p45 Beckwith-Wiedemann region 1A; tumor-suppressing STF cDNA 5 protein; tumor-suppressing subchromosomal transferable fragment candidate gene 5 protein\n",
      "Chromosome: 11; Location: 11p15.4\n",
      "Annotation: Chromosome 11 NC_000011.10 (2899691..2925246)\n",
      "MIM: 602631\n",
      "ID: 5002\n",
      "\n",
      "\n",
      "Concluído.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'\\n1. HLA-DRB1\\nOfficial Symbol: HLA-DRB1 and Name: major histocompatibility complex, class II, DR beta 1 [Homo sapiens (human)]\\nOther Aliases: DRB1, HLA-DR1B, HLA-DRB, SS1\\nOther Designations: major histocompatibility complex, class II, DR beta 1 precursor; HLA class II histocompatibility antigen, DR-1 beta chain; MHC class II HLA-DR beta 1 chain; human leucocyte antigen DRB1; lymphocyte antigen DRB1\\nChromosome: 6; Location: 6p21.32\\nAnnotation: Chromosome 6 NC_000006.12 (32578775..32589848, complement)\\nMIM: 142857\\nID: 3123\\n\\n2. env\\nEnvelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1]\\nOther Aliases: HIV1gp8\\nOther Designations: Envelope surface glycoprotein gp160, precursor; Envelope surface glycoprotein gp120; Envelope transmembrane domain; hypothetical protein\\nAnnotation:  NC_001802.1 (5771..8341)\\nID: 155971\\n\\n3. TERT\\nOfficial Symbol: TERT and Name: telomerase reverse transcriptase [Homo sapiens (human)]\\nOther Aliases: CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1, TP2, TRT, hEST2, hTRT\\nOther Designations: telomerase reverse transcriptase; telomerase catalytic subunit; telomerase-associated protein 2\\nChromosome: 5; Location: 5p15.33\\nAnnotation: Chromosome 5 NC_000005.10 (1253167..1295068, complement)\\nMIM: 187270\\nID: 7015\\n\\n4. HLA-B\\nOfficial Symbol: HLA-B and Name: major histocompatibility complex, class I, B [Homo sapiens (human)]\\nOther Aliases: AS, B-4901, HLAB\\nOther Designations: major histocompatibility complex, class I, B; HLA class I antigen HLA-B; HLA class I histocompatibility antigen, B alpha chain; MHC HLA-B cell surface glycoprotein; MHC HLA-B transmembrane glycoprotein; MHC class 1 antigen; MHC class I antigen HLA-B alpha chain; MHC class I antigen HLA-B heavy chain; MHC class I antigen SHCHA; MHC class I molecule; leukocyte antigen class I-B\\nChromosome: 6; Location: 6p21.33\\nAnnotation: Chromosome 6 NC_000006.12 (31353875..31357179, complement)\\nMIM: 142830\\nID: 3106\\n\\n5. HLA-A\\nOfficial Symbol: HLA-A and Name: major histocompatibility complex, class I, A [Homo sapiens (human)]\\nOther Aliases: HLAA\\nOther Designations: HLA class I histocompatibility antigen, A alpha chain; HLA class I histocompatibility antigen, A-1 alpha chain; MHC class I antigen HLA-A heavy chain; leukocyte antigen class I-A\\nChromosome: 6; Location: 6p22.1\\nAnnotation: Chromosome 6 NC_000006.12 (29942532..29945870)\\nMIM: 142800\\nID: 3105\\n\\n6. HLA-DQB1\\nOfficial Symbol: HLA-DQB1 and Name: major histocompatibility complex, class II, DQ beta 1 [Homo sapiens (human)]\\nOther Aliases: CELIAC1, HLA-DQB, IDDM1\\nOther Designations: HLA class II histocompatibility antigen, DQ beta 1 chain; MHC class II DQ beta chain; MHC class II HLA-DQ beta glycoprotein; MHC class II antigen DQB1; MHC class II antigen HLA-DQ-beta-1\\nChromosome: 6; Location: 6p21.32\\nAnnotation: Chromosome 6 NC_000006.12 (32659467..32666657, complement)\\nMIM: 604305\\nID: 3119\\n\\n7. tat\\nTat [Human immunodeficiency virus 1]\\nOther Aliases: HIV1gp5\\nOther Designations: Tat\\nAnnotation:  NC_001802.1 (5377..7970)\\nID: 155871\\n\\n8. gag\\nPr55(Gag) [Human immunodeficiency virus 1]\\nOther Aliases: HIV1gp2\\nOther Designations: Pr55(Gag); capsid; matrix; nucleocapsid; p1; p2; p6\\nAnnotation:  NC_001802.1 (336..1838)\\nID: 155030\\n\\n9. HLA-C\\nOfficial Symbol: HLA-C and Name: major histocompatibility complex, class I, C [Homo sapiens (human)]\\nOther Aliases: D6S204, HLA-JY3, HLAC, HLC-C, MHC, PSORS1\\nOther Designations: HLA class I histocompatibility antigen, C alpha chain; HLA-C antigen; MHC class I antigen heavy chain HLA-C; human leukocyte antigen-C alpha chain; major histocompatibility antigen HLA-C\\nChromosome: 6; Location: 6p21.33\\nAnnotation: Chromosome 6 NC_000006.12 (31268749..31272092, complement)\\nMIM: 142840\\nID: 3107\\n\\n10. CD14\\nOfficial Symbol: CD14 and Name: CD14 molecule [Homo sapiens (human)]\\nOther Designations: monocyte differentiation antigen CD14; myeloid cell-specific leucine-rich glycoprotein\\nChromosome: 5; Location: 5q31.3\\nAnnotation: Chromosome 5 NC_000005.10 (140631732..140633701, complement)\\nMIM: 158120\\nID: 929\\n\\n11. POU5F1\\nOfficial Symbol: POU5F1 and Name: POU class 5 homeobox 1 [Homo sapiens (human)]\\nOther Aliases: OCT3, OCT4, OTF-3, OTF3, OTF4, Oct-3, Oct-4, Oct3/4\\nOther Designations: POU domain, class 5, transcription factor 1; POU domain transcription factor OCT4; POU-type homeodomain-containing DNA-binding protein; octamer-binding protein 3; octamer-binding protein 4; octamer-binding transcription factor 3\\nChromosome: 6; Location: 6p21.33\\nAnnotation: Chromosome 6 NC_000006.12 (31164337..31170682, complement)\\nMIM: 164177\\nID: 5460\\n\\n12. LPA\\nOfficial Symbol: LPA and Name: lipoprotein(a) [Homo sapiens (human)]\\nOther Aliases: AK38, APOA, LP\\nOther Designations: apolipoprotein(a); antiangiogenic AK38 protein; apo(a); lipoprotein, Lp(a); lp(a)\\nChromosome: 6; Location: 6q25.3-q26\\nAnnotation: Chromosome 6 NC_000006.12 (160531482..160664275, complement)\\nMIM: 152200\\nID: 4018\\n\\n13. HLA-DQA1\\nOfficial Symbol: HLA-DQA1 and Name: major histocompatibility complex, class II, DQ alpha 1 [Homo sapiens (human)]\\nOther Aliases: CELIAC1, DQ-A1, DQA1, HLA-DQA*, HLA-DQB1, HLA-DQA1\\nOther Designations: HLA class II histocompatibility antigen, DQ alpha 1 chain; DC-1 alpha chain; DC-alpha; HLA class II histocompatibility antigen DQ alpha chain; HLA-DCA; MHC HLA-DQ alpha; MHC class II DQ alpha chain; MHC class II DQA1; MHC class II HLA-DQ-alpha-1; MHC class II antigen DQA1; MHC class II protein\\nChromosome: 6; Location: 6p21.32\\nAnnotation: Chromosome 6 NC_000006.12 (32637406..32655272)\\nMIM: 146880\\nID: 3117\\n\\n14. nef\\nNef [Human immunodeficiency virus 1]\\nOther Aliases: HIV1gp9\\nOther Designations: Nef\\nAnnotation:  NC_001802.1 (8343..8963)\\nID: 156110\\n\\n15. STIM1\\nOfficial Symbol: STIM1 and Name: stromal interaction molecule 1 [Homo sapiens (human)]\\nOther Aliases: D11S4896E, GOK, IMD10, STRMK, TAM, TAM1\\nOther Designations: stromal interaction molecule 1\\nChromosome: 11; Location: 11p15.4\\nAnnotation: Chromosome 11 NC_000011.10 (3854604..4093210)\\nMIM: 605921\\nID: 6786\\n\\n16. HLA-DPB1\\nOfficial Symbol: HLA-DPB1 and Name: major histocompatibility complex, class II, DP beta 1 [Homo sapiens (human)]\\nOther Aliases: DPB1, HLA-DP, HLA-DP1B, HLA-DPB\\nOther Designations: HLA class II histocompatibility antigen, DP beta 1 chain; HLA class II histocompatibility antigen, DP(W4) beta chain; HLA-DP histocompatibility type, beta-1 subunit; MHC HLA DPB1; MHC class II HLA-DP-beta-1; MHC class II antigen DPB1\\nChromosome: 6; Location: 6p21.32\\nAnnotation: Chromosome 6 NC_000006.12 (33075990..33089696)\\nMIM: 142858\\nID: 3115\\n\\n17. CTCF\\nOfficial Symbol: CTCF and Name: CCCTC-binding factor [Homo sapiens (human)]\\nOther Aliases: CFAP108, FAP108, MRD21\\nOther Designations: transcriptional repressor CTCF; 11 zinc finger transcriptional repressor; 11-zinc finger protein; CCCTC-binding factor (zinc finger protein); CTCFL paralog\\nChromosome: 16; Location: 16q22.1\\nAnnotation: Chromosome 16 NC_000016.10 (67562526..67639185)\\nMIM: 604167\\nID: 10664\\n\\n18. SCARB1\\nOfficial Symbol: SCARB1 and Name: scavenger receptor class B member 1 [Homo sapiens (human)]\\nOther Aliases: CD36L1, CLA-1, CLA1, HDLCQ6, HDLQTL6, SR-BI, SRB1\\nOther Designations: scavenger receptor class B member 1; CD36 and LIMPII analogous 1; CD36 antigen (collagen type I receptor, thrombospondin receptor)-like 1; scavenger receptor class B type III\\nChromosome: 12; Location: 12q24.31\\nAnnotation: Chromosome 12 NC_000012.12 (124776856..124863864, complement)\\nMIM: 601040\\nID: 949\\n\\n19. IKBKG\\nOfficial Symbol: IKBKG and Name: inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [Homo sapiens (human)]\\nOther Aliases: AMCBX1, EDAID1, FIP-3, FIP3, Fip3p, IKK-gamma, IKKAP1, IKKG, IMD33, IP, IP1, IP2, IPD2, NEMO, SAIDX, ZC2HC9\\nOther Designations: NF-kappa-B essential modulator; 14.7K (adenovirus E3 protein) interacting protein 3; I-kappa-B kinase subunit gamma; NF-kappa-B essential modifier; ikB kinase subunit gamma; ikB kinase-associated protein 1; incontinentia pigmenti; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma; inhibitor of nuclear factor kappa B kinase subunit gamma\\nChromosome: X; Location: Xq28\\nAnnotation: Chromosome X NC_000023.11 (154541238..154565046)\\nMIM: 300248\\nID: 8517\\n\\n20. vpu\\nVpu [Human immunodeficiency virus 1]\\nOther Aliases: HIV1gp7\\nOther Designations: Vpu\\nAnnotation:  NC_001802.1 (5608..5856)\\nID: 155945\\n\\n21. ERN1\\nOfficial Symbol: ERN1 and Name: endoplasmic reticulum to nucleus signaling 1 [Homo sapiens (human)]\\nOther Aliases: IRE1, IRE1P, IRE1a, hIRE1p\\nOther Designations: serine/threonine-protein kinase/endoribonuclease IRE1; ER to nucleus signalling 1; inositol-requiring 1; inositol-requiring enzyme 1; inositol-requiring protein 1; ire1-alpha; protein kinase/endoribonuclease\\nChromosome: 17; Location: 17q23.3\\nAnnotation: Chromosome 17 NC_000017.11 (64039142..64130144, complement)\\nMIM: 604033\\nID: 2081\\n\\n22. HLA-DRA\\nOfficial Symbol: HLA-DRA and Name: major histocompatibility complex, class II, DR alpha [Homo sapiens (human)]\\nOther Aliases: HLA-DRA1\\nOther Designations: HLA class II histocompatibility antigen, DR alpha chain; MHC class II antigen DRA; histocompatibility antigen HLA-DR alpha\\nChromosome: 6; Location: 6p21.32\\nAnnotation: Chromosome 6 NC_000006.12 (32439887..32445046)\\nMIM: 142860\\nID: 3122\\n\\n23. EHMT2\\nOfficial Symbol: EHMT2 and Name: euchromatic histone lysine methyltransferase 2 [Homo sapiens (human)]\\nOther Aliases: BAT8, C6orf30, G9A, GAT8, KMT1C, NG36\\nOther Designations: histone-lysine N-methyltransferase EHMT2; G9A histone methyltransferase; H3-K9-HMTase 3; HLA-B associated transcript 8; ankyrin repeat-containing protein; euchromatic histone-lysine N-methyltransferase 2; histone H3-K9 methyltransferase 3; histone-lysine N-methyltransferase, H3 lysine-9 specific 3; lysine N-methyltransferase 1C\\nChromosome: 6; Location: 6p21.33\\nAnnotation: Chromosome 6 NC_000006.12 (31879759..31897698, complement)\\nMIM: 604599\\nID: 10919\\n\\n24. EIF2AK3\\nOfficial Symbol: EIF2AK3 and Name: eukaryotic translation initiation factor 2 alpha kinase 3 [Homo sapiens (human)]\\nOther Aliases: PEK, PERK, WRS\\nOther Designations: eukaryotic translation initiation factor 2-alpha kinase 3; PKR-like ER kinase; PRKR-like endoplasmic reticulum kinase; pancreatic EIF2-alpha kinase; pancreatic eIF-2alpha kinase\\nChromosome: 2; Location: 2p11.2\\nAnnotation: Chromosome 2 NC_000002.12 (88556741..88628145, complement)\\nMIM: 604032\\nID: 9451\\n\\n25. TNFRSF10A\\nOfficial Symbol: TNFRSF10A and Name: TNF receptor superfamily member 10a [Homo sapiens (human)]\\nOther Aliases: APO2, CD261, DR4, TRAILR-1, TRAILR1\\nOther Designations: tumor necrosis factor receptor superfamily member 10A; TNF-related apoptosis-inducing ligand receptor 1; TRAIL receptor 1; TRAIL-R1; cytotoxic TRAIL receptor; death receptor 4; tumor necrosis factor receptor superfamily, member 10a\\nChromosome: 8; Location: 8p21.3\\nAnnotation: Chromosome 8 NC_000008.11 (23190452..23225102, complement)\\nMIM: 603611\\nID: 8797\\n\\n26. PON2\\nOfficial Symbol: PON2 and Name: paraoxonase 2 [Homo sapiens (human)]\\nOther Designations: serum paraoxonase/arylesterase 2; A-esterase 2; PON 2; aromatic esterase 2; arylesterase 2; paraoxonase nirs; serum aryldialkylphosphatase 2\\nChromosome: 7; Location: 7q21.3\\nAnnotation: Chromosome 7 NC_000007.14 (95404862..95435028, complement)\\nMIM: 602447\\nID: 5445\\n\\n27. CSNK2B\\nOfficial Symbol: CSNK2B and Name: casein kinase 2 beta [Homo sapiens (human)]\\nOther Aliases: CK2B, CK2N, CSK2B, Ckb1, Ckb2, G5A, POBINDS\\nOther Designations: casein kinase II subunit beta; CK II beta; CSNK2B-LY6G5B-1072; CSNK2B-LY6G5B-1103; CSNK2B-LY6G5B-532; CSNK2B-LY6G5B-560; CSNK2B-LY6G5B-562; Casein kinase II beta subunit; alternative name: G5a, phosvitin; casein kinase 2, beta polypeptide; phosvitin; protein G5a\\nChromosome: 6; Location: 6p21.33\\nAnnotation: Chromosome 6 NC_000006.12 (31666080..31670067)\\nMIM: 115441\\nID: 1460\\n\\n28. CANX\\nOfficial Symbol: CANX and Name: calnexin [Homo sapiens (human)]\\nOther Aliases: CNX, IP90, P90\\nOther Designations: calnexin; epididymis secretory sperm binding protein; major histocompatibility complex class I antigen-binding protein p88\\nChromosome: 5; Location: 5q35.3\\nAnnotation: Chromosome 5 NC_000005.10 (179678656..179731641)\\nMIM: 114217\\nID: 821\\n\\n29. ATF6\\nOfficial Symbol: ATF6 and Name: activating transcription factor 6 [Homo sapiens (human)]\\nOther Aliases: ACHM7A, ATP6alpha, ATF6\\nOther Designations: cyclic AMP-dependent transcription factor ATF-6 alpha; cAMP-dependent transcription factor ATF-6 alpha\\nChromosome: 1; Location: 1q23.3\\nAnnotation: Chromosome 1 NC_000001.11 (161766320..161964070)\\nMIM: 605537\\nID: 22926\\n\\n30. SCNN1A\\nOfficial Symbol: SCNN1A and Name: sodium channel epithelial 1 subunit alpha [Homo sapiens (human)]\\nOther Aliases: BESC2, ENaCa, ENaCalpha, LIDLS3, PHA1B1, SCNEA, SCNN1\\nOther Designations: amiloride-sensitive sodium channel subunit alpha; alpha ENaC-2; alpha-ENaC; alpha-NaCH; amiloride-sensitive epithelial sodium channel alpha subunit; amiloride-sensitive sodium channel subunit alpha 2; epithelial Na(+) channel subunit alpha; nasal epithelial sodium channel alpha subunit; nonvoltage-gated sodium channel 1 subunit alpha; sodium channel epithelial 1 alpha subunit; sodium channel, non voltage gated 1 alpha subunit; sodium channel, non-voltage-gated 1 alpha; sodium channel, nonvoltage-gated 1 alpha\\nChromosome: 12; Location: 12p13.31\\nAnnotation: Chromosome 12 NC_000012.12 (6346847..6377359, complement)\\nMIM: 600228\\nID: 6337\\n\\n31. CD74\\nOfficial Symbol: CD74 and Name: CD74 molecule [Homo sapiens (human)]\\nOther Aliases: CLIP, DHLAG, HLADG, II, Ia-GAMMA, p33\\nOther Designations: HLA class II histocompatibility antigen gamma chain; CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated); CD74 molecule, major histocompatibility complex, class II invariant chain; HLA-DR antigens-associated invariant chain; HLA-DR-gamma; Ia-associated invariant chain; MHC HLA-DR gamma chain; class II MHC-associated invariant chain peptide; gamma chain of class II antigens\\nChromosome: 5; Location: 5q33.1\\nAnnotation: Chromosome 5 NC_000005.10 (150401639..150412910, complement)\\nMIM: 142790\\nID: 972\\n\\n32. GPT\\nOfficial Symbol: GPT and Name: glutamic--pyruvic transaminase [Homo sapiens (human)]\\nOther Aliases: AAT1, ALT, ALT11, SGPT, GPT\\nOther Designations: alanine aminotransferase 1; alanine aminotransferase; alanine transaminase; glutamate pyruvate transaminase 1; glutamic--pyruvic transaminase 1; glutamic-alanine transaminase 1; glutamic-pyruvate transaminase (alanine aminotransferase)\\nChromosome: 8; Location: 8q24.3\\nAnnotation: Chromosome 8 NC_000008.11 (144503068..144507172)\\nMIM: 138200\\nID: 2875\\n\\n33. CCL17\\nOfficial Symbol: CCL17 and Name: C-C motif chemokine ligand 17 [Homo sapiens (human)]\\nOther Aliases: A-152E5.3, ABCD-2, SCYA17, TARC\\nOther Designations: C-C motif chemokine 17; CC chemokine TARC; T cell-directed CC chemokine; chemokine (C-C motif) ligand 17; small inducible cytokine subfamily A (Cys-Cys), member 17; small-inducible cytokine A17; thymus and activation-regulated chemokine\\nChromosome: 16; Location: 16q21\\nAnnotation: Chromosome 16 NC_000016.10 (57396093..57416063)\\nMIM: 601520\\nID: 6361\\n\\n34. HCRT\\nOfficial Symbol: HCRT and Name: hypocretin neuropeptide precursor [Homo sapiens (human)]\\nOther Aliases: NRCLP1, OX, PPOX\\nOther Designations: hypocretin neuropeptide precursor; hypocretin (orexin) neuropeptide; orexin; prepro-orexin; preprohypocretin\\nChromosome: 17; Location: 17q21.2\\nAnnotation: Chromosome 17 NC_000017.11 (42184060..42185452, complement)\\nMIM: 602358\\nID: 3060\\n\\n35. TAP2\\nOfficial Symbol: TAP2 and Name: transporter 2, ATP binding cassette subfamily B member [Homo sapiens (human)]\\nOther Aliases: ABC18, ABCB3, APT2, D6S217E, PSF-2, PSF2, RING11\\nOther Designations: antigen peptide transporter 2; ABC transporter, MHC 2; ATP-binding cassette, sub-family B (MDR/TAP), member 3; peptide supply factor 2; peptide transporter PSF2; peptide transporter involved in antigen processing 2; really interesting new gene 11 protein; transporter 2, ABC (ATP binding cassette); transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)\\nChromosome: 6; Location: 6p21.32\\nAnnotation: Chromosome 6 NC_000006.12 (32821831..32838739, complement)\\nMIM: 170261\\nID: 6891\\n\\n36. GALT\\nOfficial Symbol: GALT and Name: galactose-1-phosphate uridylyltransferase [Homo sapiens (human)]\\nOther Designations: galactose-1-phosphate uridylyltransferase; UDP-glucose--hexose-1-phosphate uridylyltransferase; gal-1-P uridylyltransferase; galactose-1-phosphate uridyl transferase\\nChromosome: 9; Location: 9p13.3\\nAnnotation: Chromosome 9 NC_000009.12 (34646675..34651035)\\nMIM: 606999\\nID: 2592\\n\\n37. EDA\\nOfficial Symbol: EDA and Name: ectodysplasin A [Homo sapiens (human)]\\nOther Aliases: ECTD1, ED1, ED1-A1, ED1-A2-A1, EDA-A2, EDA1, EDA2, HED, HED1, ODT1, STHAGX1, TNLG7C, XHED, XLHED, EDA\\nOther Designations: ectodysplasin-A; X-linked anhidroitic ectodermal dysplasia protein; oligodontia 1; tumor necrosis factor ligand 7C\\nChromosome: X; Location: Xq13.1\\nAnnotation: Chromosome X NC_000023.11 (69616113..70039472)\\nMIM: 300451\\nID: 1896\\n\\n38. APOBEC3A\\nOfficial Symbol: APOBEC3A and Name: apolipoprotein B mRNA editing enzyme catalytic subunit 3A [Homo sapiens (human)]\\nOther Aliases: A3A, ARP3, PHRBN, bK150C2.1\\nOther Designations: DNA dC-&gt;dU-editing enzyme APOBEC-3A; apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A; phorbolin-1; probable DNA dC-&gt;dU-editing enzyme APOBEC-3A\\nChromosome: 22; Location: 22q13.1\\nAnnotation: Chromosome 22 NC_000022.11 (38957609..38963184)\\nMIM: 607109\\nID: 200315\\n\\n39. HLA-DRB5\\nOfficial Symbol: HLA-DRB5 and Name: major histocompatibility complex, class II, DR beta 5 [Homo sapiens (human)]\\nOther Aliases: DRB5*, HLA-DRB5\\nOther Designations: major histocompatibility complex, class II, DR beta 5; DR beta-5; HLA class II histocompatibility antigen, DR-5 beta chain; MHC class II antigen DRB5\\nChromosome: 6; Location: 6p21.32\\nAnnotation: Chromosome 6 NC_000006.12 (32517353..32530287, complement)\\nMIM: 604776\\nID: 3127\\n\\n40. HLA-DRB3\\nOfficial Symbol: HLA-DRB3 and Name: major histocompatibility complex, class II, DR beta 3 [Homo sapiens (human)]\\nOther Aliases: DRB3, HLA-DPB1, HLA-DR1B, HLA-DR3B*, HLA-DRB3\\nOther Designations: major histocompatibility complex, class II, DR beta 3; HLA DRB3; HLA class II histocompatibility antigen, DR beta 3 chain; MHC class II DR beta chain; MHC class II HLA-DR beta 3 chain; MHC class II antigen DR beta 3 chain; MHC class II antigen DRB3; MHC class II protein; human leucocyte antigen DRB3; major histocompatibility complex, class II, DRB3\\nChromosome: 6; Location: 6p21.3\\nMIM: 612735\\nID: 3125\\n\\n41. ROR2\\nOfficial Symbol: ROR2 and Name: receptor tyrosine kinase like orphan receptor 2 [Homo sapiens (human)]\\nOther Aliases: BDB, BDB1, NTRKR2\\nOther Designations: tyrosine-protein kinase transmembrane receptor ROR2; neurotrophic tyrosine kinase receptor-related 2\\nChromosome: 9; Location: 9q22.31\\nAnnotation: Chromosome 9 NC_000009.12 (91722601..91950228, complement)\\nMIM: 602337\\nID: 4920\\n\\n42. HLA-DRB4\\nOfficial Symbol: HLA-DRB4 and Name: major histocompatibility complex, class II, DR beta 4 [Homo sapiens (human)]\\nOther Aliases: DR4, DRB4, HLA-DR4B, HLA-DRB*, HLA-DRB4\\nOther Designations: major histocompatibility complex, class II, DR beta 4; HLA class II histocompatibility antigen, DR beta 4 chain; MHC class II antigen DRB4\\nChromosome: 6; Location: 6p21.3\\nID: 3126\\n\\n43. ATP6AP2\\nOfficial Symbol: ATP6AP2 and Name: ATPase H+ transporting accessory protein 2 [Homo sapiens (human)]\\nOther Aliases: APT6M8-9, ATP6IP2, ATP6M8-9, CDG2R, ELDF10, HT028, M8-9, MRXE, MRXSH, MSTP009, PRR, RENR, XMRE, XPDS\\nOther Designations: renin receptor; ATPase H(+)-transporting lysosomal-interacting protein 2; ATPase, H+ transporting, lysosomal (vacuolar proton pump) membrane sector associated protein M8-9; ATPase, H+ transporting, lysosomal accessory protein 2; ATPase, H+ transporting, lysosomal interacting protein 2; ER-localized type I transmembrane adapter; ER-localized type I transmembrane adaptor; N14F; V-ATPase M8.9 subunit; embryonic liver differentiation factor 10; prorenin receptor; renin/prorenin receptor; vacuolar ATP synthase membrane sector-associated protein M8-9; vacuolar proton ATP synthase membrane sector associated protein M8-9\\nChromosome: X; Location: Xp11.4\\nAnnotation: Chromosome X NC_000023.11 (40580970..40606848)\\nMIM: 300556\\nID: 10159\\n\\n44. CDK7\\nOfficial Symbol: CDK7 and Name: cyclin dependent kinase 7 [Homo sapiens (human)]\\nOther Aliases: CAK, CAK1, CDKN7, HCAK, MO15, STK1, p39MO15\\nOther Designations: cyclin-dependent kinase 7; 39 KDa protein kinase; CDK-activating kinase 1; TFIIH basal transcription factor complex kinase subunit; cell division protein kinase 7; cyclin-dependent kinase 7 (MO15 homolog, Xenopus laevis, cdk-activating kinase); homolog of Xenopus MO15 Cdk-activating kinase; kinase subunit of CAK; serine/threonine kinase stk1; serine/threonine protein kinase 1; serine/threonine protein kinase MO15\\nChromosome: 5; Location: 5q13.2\\nAnnotation: Chromosome 5 NC_000005.10 (69234795..69277430)\\nMIM: 601955\\nID: 1022\\n\\n45. EXT1\\nOfficial Symbol: EXT1 and Name: exostosin glycosyltransferase 1 [Homo sapiens (human)]\\nOther Aliases: EXT, LGCR, LGS, TRPS2, TTV\\nOther Designations: exostosin-1; Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N- acetylglucosaminyltransferase; Langer-Giedion syndrome chromosome region; N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase; exostoses (multiple) 1; glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase; multiple exostoses protein 1; putative tumor suppressor protein EXT1\\nChromosome: 8; Location: 8q24.11\\nAnnotation: Chromosome 8 NC_000008.11 (117794490..118111826, complement)\\nMIM: 608177\\nID: 2131\\n\\n46. ATP13A2\\nOfficial Symbol: ATP13A2 and Name: ATPase cation transporting 13A2 [Homo sapiens (human)]\\nOther Aliases: CLN12, HSA9947, KRPPD, PARK9, SPG78\\nOther Designations: polyamine-transporting ATPase 13A2; ATPase 13A2; ATPase type 13A2; cation-transporting ATPase 13A2; probable cation-transporting ATPase 13A2\\nChromosome: 1; Location: 1p36.13\\nAnnotation: Chromosome 1 NC_000001.11 (16985958..17011928, complement)\\nMIM: 610513\\nID: 23400\\n\\n47. PLA2R1\\nOfficial Symbol: PLA2R1 and Name: phospholipase A2 receptor 1 [Homo sapiens (human)]\\nOther Aliases: CLEC13C, PLA2-R, PLA2G1R, PLA2IR, PLA2R\\nOther Designations: secretory phospholipase A2 receptor; 180 kDa secretory phospholipase A2 receptor; C-type lectin domain family 13 member C; M-type receptor; phospholipase A2 receptor 1, 180kD; phospholipase A2 receptor 1, 180kDa\\nChromosome: 2; Location: 2q24.2\\nAnnotation: Chromosome 2 NC_000002.12 (159923933..160062615, complement)\\nMIM: 604939\\nID: 22925\\n\\n48. RT1-Ba\\nOfficial Symbol: RT1-Ba and Name: RT1 class II, locus Ba [Rattus norvegicus (Norway rat)]\\nOther Aliases: BA1\\nOther Designations: rano class II histocompatibility antigen, B alpha chain; MHC class I antigen; MHC class II antigen RT1.B alpha chain; RT1 class II antigen, Ba chain; RT1-B alpha; activated B cell RT1Bl alpha chain\\nChromosome: 20; Location: 20p12\\nAnnotation: Chromosome 20 NC_051355.1 (4575134..4579727)\\nID: 309621\\n\\n49. NR2F2\\nOfficial Symbol: NR2F2 and Name: nuclear receptor subfamily 2 group F member 2 [Homo sapiens (human)]\\nOther Aliases: ARP-1, ARP1, CHTD4, COUPTF2, COUPTFB, COUPTFII, NF-E3, SRXX5, SVP40, TFCOUP2\\nOther Designations: COUP transcription factor 2; ADP-ribosylation factor related protein 1; COUP transcription factor II; apolipoprotein A-I regulatory protein 1; apolipoprotein AI regulatory protein 1; chicken ovalbumin upstream promoter transcription factor 2; chicken ovalbumin upstream promoter-transcription factor I\\nChromosome: 15; Location: 15q26.2\\nAnnotation: Chromosome 15 NC_000015.10 (96326046..96340263)\\nMIM: 107773\\nID: 7026\\n\\n50. SLC25A4\\nOfficial Symbol: SLC25A4 and Name: solute carrier family 25 member 4 [Homo sapiens (human)]\\nOther Aliases: AAC1, ANT, ANT 1, ANT1, MTDPS12, MTDPS12A, PEO2, PEO3, PEOA2, T1\\nOther Designations: ADP/ATP translocase 1; ADP,ATP carrier protein 1; ADP,ATP carrier protein, heart/skeletal muscle; ADP/ATP carrier 1; adenine nucleotide translocator 1 (skeletal muscle); heart/skeletal muscle ATP/ADP translocator; progressive external ophthalmoplegia 2; progressive external ophthalmoplegia 3; solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4\\nChromosome: 4; Location: 4q35.1\\nAnnotation: Chromosome 4 NC_000004.12 (185143266..185150382)\\nMIM: 103220\\nID: 291\\n\\n51. CUX1\\nOfficial Symbol: CUX1 and Name: cut like homeobox 1 [Homo sapiens (human)]\\nOther Aliases: CASP, CDP, CDP/Cut, CDP1, COY1, CUTL1, CUX, Clox, Cux/CDP, GDDI, GOLIM6, Nbla10317, p100, p110, p200, p75\\nOther Designations: protein CASP; Homeobox protein cut-like 1; CCAAT displacement protein; CDP/Cux p200; CUX1 gene Alternatively Spliced Product; cut homolog; golgi integral membrane protein 6; homeobox protein cux-1; mutant CUX1; putative protein product of Nbla10317\\nChromosome: 7; Location: 7q22.1\\nAnnotation: Chromosome 7 NC_000007.14 (101816007..102283958)\\nMIM: 116896\\nID: 1523\\n\\n52. ITGB6\\nOfficial Symbol: ITGB6 and Name: integrin subunit beta 6 [Homo sapiens (human)]\\nOther Aliases: AI1H\\nOther Designations: integrin beta-6; integrin, beta 6\\nChromosome: 2; Location: 2q24.2\\nAnnotation: Chromosome 2 NC_000002.12 (160099671..160200272, complement)\\nMIM: 147558\\nID: 3694\\n\\n53. ACSL4\\nOfficial Symbol: ACSL4 and Name: acyl-CoA synthetase long chain family member 4 [Homo sapiens (human)]\\nOther Aliases: ACS4, FACL4, LACS4, MRX63, MRX68, XLID63\\nOther Designations: long-chain-fatty-acid--CoA ligase 4; acyl-CoA synthetase 4; arachidonate--CoA ligase; fatty-acid-Coenzyme A ligase, long-chain 4; lignoceroyl-CoA synthase; long-chain acyl-CoA synthetase 4; long-chain fatty-acid-Coenzyme A ligase 4\\nChromosome: X; Location: Xq23\\nAnnotation: Chromosome X NC_000023.11 (109641335..109733257, complement)\\nMIM: 300157\\nID: 2182\\n\\n54. STC2\\nOfficial Symbol: STC2 and Name: stanniocalcin 2 [Homo sapiens (human)]\\nOther Aliases: STC-2, STCRP\\nOther Designations: stanniocalcin-2; STC-related protein; stanniocalcin-related protein\\nChromosome: 5; Location: 5q35.2\\nAnnotation: Chromosome 5 NC_000005.10 (173314723..173328414, complement)\\nMIM: 603665\\nID: 8614\\n\\n55. TAPBP\\nOfficial Symbol: TAPBP and Name: TAP binding protein [Homo sapiens (human)]\\nOther Aliases: NGS17, TAPA, TPN, TPSN\\nOther Designations: tapasin; NGS-17; TAP binding protein (tapasin); TAP-associated protein\\nChromosome: 6; Location: 6p21.32\\nAnnotation: Chromosome 6 NC_000006.12 (33299694..33314078, complement)\\nMIM: 601962\\nID: 6892\\n\\n56. PPARGC1B\\nOfficial Symbol: PPARGC1B and Name: PPARG coactivator 1 beta [Homo sapiens (human)]\\nOther Aliases: ERRL1, PERC, PGC-1(beta), PGC1B\\nOther Designations: peroxisome proliferator-activated receptor gamma coactivator 1-beta; PGC-1-related estrogen receptor alpha coactivator; PPAR-gamma coactivator 1-beta; PPARAGCIbeta; PPARGC-1-beta; PPARgamma coactivator 1 beta; peroxisome proliferator-activated receptor gamma, coactivator 1 beta\\nChromosome: 5; Location: 5q32\\nAnnotation: Chromosome 5 NC_000005.10 (149730310..149857959)\\nMIM: 608886\\nID: 133522\\n\\n57. BTNL2\\nOfficial Symbol: BTNL2 and Name: butyrophilin like 2 [Homo sapiens (human)]\\nOther Aliases: BTL-II, BTN7, HSBLMHC1, SS2\\nOther Designations: butyrophilin-like protein 2; butyrophilin-like 2 (MHC class II associated)\\nChromosome: 6; Location: 6p21.32\\nAnnotation: Chromosome 6 NC_000006.12 (32393339..32407181, complement)\\nMIM: 606000\\nID: 56244\\n\\n58. H2-Aa\\nOfficial Symbol: H2-Aa and Name: histocompatibility 2, class II antigen A, alpha [Mus musculus (house mouse)]\\nOther Aliases: Aalpha, H-2Aa, H2Aa, I-Aalpha, IAalpha, Ia-1, Ia1\\nOther Designations: histocompatibility 2, class II antigen A, alpha; H-2 class II histocompatibility antigen, A-B alpha chain; H-2 class II histocompatibility antigen, A-F alpha chain; H-2 class II histocompatibility antigen, A-K alpha chain; H-2 class II histocompatibility antigen, A-Q alpha chain; H-2 class II histocompatibility antigen, A-R alpha chain; H-2 class II histocompatibility antigen, A-S alpha chain; H-2 class II histocompatibility antigen, A-U alpha chain; MHC class II antigen alpha chain; MHC-II I-A(d) alpha; histocompatibility 2, class II antigen A, alpha, promoter 1; major histocompatibility protein class II alpha chain\\nChromosome: 17; Location: 17 17.98 cM\\nAnnotation: Chromosome 17 NC_000083.7 (34501718..34506797, complement)\\nID: 14960\\n\\n59. TLE1\\nOfficial Symbol: TLE1 and Name: TLE family member 1, transcriptional corepressor [Homo sapiens (human)]\\nOther Aliases: ESG, ESG1, GRG1, TLE-1\\nOther Designations: transducin-like enhancer protein 1; enhancer of split groucho-like protein 1; transducin like enhancer of split 1; transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)\\nChromosome: 9; Location: 9q21.32\\nAnnotation: Chromosome 9 NC_000009.12 (81583683..81689547, complement)\\nMIM: 600189\\nID: 7088\\n\\n60. LNPEP\\nOfficial Symbol: LNPEP and Name: leucyl and cystinyl aminopeptidase [Homo sapiens (human)]\\nOther Aliases: CAP, IRAP, P-LAP, PLAP\\nOther Designations: leucyl-cystinyl aminopeptidase; AT (4) receptor; angiotensin IV receptor; cystinyl aminopeptidase; insulin-regulated aminopeptidase; insulin-regulated membrane aminopeptidase; insulin-responsive aminopeptidase; otase; oxytocinase; placental leucine aminopeptidase; vasopressinase\\nChromosome: 5; Location: 5q15\\nAnnotation: Chromosome 5 NC_000005.10 (96936080..97037513)\\nMIM: 151300\\nID: 4012\\n\\n\\n61. EFNB1\\nOfficial Symbol: EFNB1 and Name: ephrin B1 [Homo sapiens (human)]\\nOther Aliases: CFND, CFNS, EFB1, EFL3, EPLG2, Elk-L, LERK2\\nOther Designations: ephrin-B1; ELK ligand; eph-related receptor tyrosine kinase ligand 2\\nChromosome: X; Location: Xq13.1\\nAnnotation: Chromosome X NC_000023.11 (68829021..68842160)\\nMIM: 300035\\nID: 1947\\n\\n62. SPG7\\nOfficial Symbol: SPG7 and Name: SPG7 matrix AAA peptidase subunit, paraplegin [Homo sapiens (human)]\\nOther Aliases: CAR, CMAR, PGN, SPG5C\\nOther Designations: paraplegin; SPG7, paraplegin matrix AAA peptidase subunit; cell matrix adhesion regulator; spastic paraplegia 7 (pure and complicated autosomal recessive); spastic paraplegia 7 protein\\nChromosome: 16; Location: 16q24.3\\nAnnotation: Chromosome 16 NC_000016.10 (89508388..89557768)\\nMIM: 602783\\nID: 6687\\n\\n63. PNPLA6\\nOfficial Symbol: PNPLA6 and Name: patatin like phospholipase domain containing 6 [Homo sapiens (human)]\\nOther Aliases: BNHS, LNMS, NTE, NTEMND, OMCS, SPG39, iPLA2delta, sws\\nOther Designations: patatin-like phospholipase domain-containing protein 6; neuropathy target esterase\\nChromosome: 19; Location: 19p13.2\\nAnnotation: Chromosome 19 NC_000019.10 (7534164..7561767)\\nMIM: 603197\\nID: 10908\\n\\n64. ITGA7\\nOfficial Symbol: ITGA7 and Name: integrin subunit alpha 7 [Homo sapiens (human)]\\nOther Designations: integrin alpha-7; integrin alpha 7 chain\\nChromosome: 12; Location: 12q13.2\\nAnnotation: Chromosome 12 NC_000012.12 (55684568..55716400, complement)\\nMIM: 600536\\nID: 3679\\n\\n65. SH3GL2\\nOfficial Symbol: SH3GL2 and Name: SH3 domain containing GRB2 like 2, endophilin A1 [Homo sapiens (human)]\\nOther Aliases: CNSA2, EEN-B1, SH3D2A, SH3P4\\nOther Designations: endophilin-A1; Endophilin A1 BAR domain; SH3 domain protein 2A; SH3 domain-containing GRB2-like protein 2; SH3-domain GRB2-like 2; bA335L15.1 (SH3-domain GRB2-like 2); endophilin-1\\nChromosome: 9; Location: 9p22.2\\nAnnotation: Chromosome 9 NC_000009.12 (17579066..17797124)\\nMIM: 604465\\nID: 6456\\n\\n66. SGPL1\\nOfficial Symbol: SGPL1 and Name: sphingosine-1-phosphate lyase 1 [Homo sapiens (human)]\\nOther Aliases: NPHS14, RENI, S1PL, SPL\\nOther Designations: sphingosine-1-phosphate lyase 1; SP-lyase 1; SPL 1; hSPL; sphingosine-1-phosphate aldolase\\nChromosome: 10; Location: 10q22.1\\nAnnotation: Chromosome 10 NC_000010.11 (70815948..70881184)\\nMIM: 603729\\nID: 8879\\n\\n67. ATP2A1\\nOfficial Symbol: ATP2A1 and Name: ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [Homo sapiens (human)]\\nOther Aliases: ATP2A, SERCA1\\nOther Designations: sarcoplasmic/endoplasmic reticulum calcium ATPase 1; ATPase, Ca++ transporting, cardiac muscle, fast twitch 1; SR Ca(2+)-ATPase 1; calcium pump 1; endoplasmic reticulum class 1/2 Ca(2+) ATPase\\nChromosome: 16; Location: 16p11.2\\nAnnotation: Chromosome 16 NC_000016.10 (28878488..28904466)\\nMIM: 108730\\nID: 487\\n\\n68. FKTN\\nOfficial Symbol: FKTN and Name: fukutin [Homo sapiens (human)]\\nOther Aliases: CMD1X, FCMD, LGMD2M, LGMDR13, MDDGA4, MDDGB4, MDDGC4\\nOther Designations: ribitol-5-phosphate transferase FKTN; Fukuyama type congenital muscular dystrophy protein; patient fukutin; ribitol-5-phosphate transferase\\nChromosome: 9; Location: 9q31.2\\nAnnotation: Chromosome 9 NC_000009.12 (105558130..105641118)\\nMIM: 607440\\nID: 2218\\n\\n69. HYAL2\\nOfficial Symbol: HYAL2 and Name: hyaluronidase 2 [Homo sapiens (human)]\\nOther Aliases: LUCA2\\nOther Designations: hyaluronidase-2; PH-20 homolog; PH20 homolog; hyal-2; hyaluronoglucosaminidase 2; lung carcinoma protein 2; lysosomal hyaluronidase\\nChromosome: 3; Location: 3p21.31\\nAnnotation: Chromosome 3 NC_000003.12 (50317808..50322745, complement)\\nMIM: 603551\\nID: 8692\\n\\n70. ATP6V0A2\\nOfficial Symbol: ATP6V0A2 and Name: ATPase H+ transporting V0 subunit a2 [Homo sapiens (human)]\\nOther Aliases: A2, ARCL, ARCL2A, ATP6A2, ATP6N1D, J6B7, RTF, STV1, TJ6, TJ6M, TJ6S, VPH1, WSS, a2V\\nOther Designations: V-type proton ATPase 116 kDa subunit a 2; A2V-ATPase; ATPase, H+ transporting, lysosomal V0 subunit a2; V-ATPase 116 kDa subunit a 2; V-ATPase 116 kDa subunit a2; V-ATPase subunit a2; V-type proton ATPase 116 kDa subunit a2; lysosomal H(+)-transporting ATPase V0 subunit a 2; lysosomal H(+)-transporting ATPase V0 subunit a2; regeneration and tolerance factor; v-type proton ATPase 116 kDa subunit a; vacuolar proton translocating ATPase 116 kDa subunit a\\nChromosome: 12; Location: 12q24.31\\nAnnotation: Chromosome 12 NC_000012.12 (123712353..123761755)\\nMIM: 611716\\nID: 23545\\n\\n71. ATP2B2\\nOfficial Symbol: ATP2B2 and Name: ATPase plasma membrane Ca2+ transporting 2 [Homo sapiens (human)]\\nOther Aliases: DFNA82, PMCA2, PMCA2a, PMCA2i\\nOther Designations: plasma membrane calcium-transporting ATPase 2; ATPase, Ca++ transporting, plasma membrane 2; plasma membrane Ca(2+)-ATPase; plasma membrane Ca2+ pump 2; plasma membrane calcium ATPase; plasma membrane calcium pump\\nChromosome: 3; Location: 3p25.3\\nAnnotation: Chromosome 3 NC_000003.12 (10324023..10708007, complement)\\nMIM: 108733\\nID: 491\\n\\n72. PRRC2A\\nOfficial Symbol: PRRC2A and Name: proline rich coiled-coil 2A [Homo sapiens (human)]\\nOther Aliases: BAT2, D6S51, D6S51E, G2\\nOther Designations: protein PRRC2A; HLA-B-associated transcript 2; large proline-rich protein BAT2; proline-rich and coiled-coil-containing protein 2A; protein G2\\nChromosome: 6; Location: 6p21.33\\nAnnotation: Chromosome 6 NC_000006.12 (31620715..31637771)\\nMIM: 142580\\nID: 7916\\n\\n73. KCNJ8\\nOfficial Symbol: KCNJ8 and Name: potassium inwardly rectifying channel subfamily J member 8 [Homo sapiens (human)]\\nOther Aliases: KIR6.1, uKATP-1\\nOther Designations: ATP-sensitive inward rectifier potassium channel 8; inward rectifier K(+) channel Kir6.1; inwardly rectifying potassium channel KIR6.1; potassium channel, inwardly rectifying subfamily J member 8; potassium voltage-gated channel subfamily J member 8\\nChromosome: 12; Location: 12p12.1\\nAnnotation: Chromosome 12 NC_000012.12 (21764955..21774706, complement)\\nMIM: 600935\\nID: 3764\\n\\n74. UBE3C\\nOfficial Symbol: UBE3C and Name: ubiquitin protein ligase E3C [Homo sapiens (human)]\\nOther Aliases: HECTH2, NDSMBA, NEDSMBA, RAUL\\nOther Designations: ubiquitin-protein ligase E3C; HECT-type ubiquitin transferase E3C; RTA-associated ubiquitin ligase; homologous to E6AP carboxyl terminus homologous protein 2; ubiquitin-protein isopeptide ligase (E3)\\nChromosome: 7; Location: 7q36.3\\nAnnotation: Chromosome 7 NC_000007.14 (157138926..157269370)\\nMIM: 614454\\nID: 9690\\n\\n75. HLA-DOA\\nOfficial Symbol: HLA-DOA and Name: major histocompatibility complex, class II, DO alpha [Homo sapiens (human)]\\nOther Aliases: HLA-DNA, HLA-DZA, HLADZ\\nOther Designations: HLA class II histocompatibility antigen, DO alpha chain; HLA-D0-alpha; MHC DN-alpha; MHC DZ alpha; MHC class II antigen DOA; lymphocyte antigen; major histocompatibility complex, class II, DN alpha\\nChromosome: 6; Location: 6p21.32\\nAnnotation: Chromosome 6 NC_000006.12 (33004182..33009591, complement)\\nMIM: 142930\\nID: 3111\\n\\n76. MOGS\\nOfficial Symbol: MOGS and Name: mannosyl-oligosaccharide glucosidase [Homo sapiens (human)]\\nOther Aliases: CDG2B, CWH41, DER7, GCS1\\nOther Designations: mannosyl-oligosaccharide glucosidase; epididymis secretory sperm binding protein; glucosidase I; processing A-glucosidase I\\nChromosome: 2; Location: 2p13.1\\nAnnotation: Chromosome 2 NC_000002.12 (74461057..74465382, complement)\\nMIM: 601336\\nID: 7841\\n\\n77. HLA-DQA2\\nOfficial Symbol: HLA-DQA2 and Name: major histocompatibility complex, class II, DQ alpha 2 [Homo sapiens (human)]\\nOther Aliases: DC-alpha, DQA1, DX-ALPHA, HLA-DCA, HLA-DXA, HLADQA2\\nOther Designations: HLA class II histocompatibility antigen, DQ alpha 2 chain; DC-1 alpha chain; DX alpha chain; HLA class II histocompatibility antigen, DQ alpha 1 chain; HLA class II histocompatibility antigen, DQ(6) alpha chain; MHC class I antigen; MHC class II DQA1; MHC class II DQA2; MHC class II antigen\\nChromosome: 6; Location: 6p21.32\\nAnnotation: Chromosome 6 NC_000006.12 (32741391..32747198)\\nMIM: 613503\\nID: 3118\\n\\n78. APLP1\\nOfficial Symbol: APLP1 and Name: amyloid beta precursor like protein 1 [Homo sapiens (human)]\\nOther Aliases: APLP\\nOther Designations: amyloid beta precursor like protein 1; amyloid beta (A4) precursor-like protein 1; amyloid precursor-like protein 1; amyloid-like protein 1\\nChromosome: 19; Location: 19q13.12\\nAnnotation: Chromosome 19 NC_000019.10 (35868574..35879792)\\nMIM: 104775\\nID: 333\\n\\n79. CYP2S1\\nOfficial Symbol: CYP2S1 and Name: cytochrome P450 family 2 subfamily S member 1 [Homo sapiens (human)]\\nOther Aliases: CYPIIS1\\nOther Designations: cytochrome P450 2S1; cytochrome P450, family 2, subfamily S, polypeptide 1; cytochrome P540, subfamily IIS, polypeptide 1; hydroperoxy icosatetraenoate dehydratase; thromboxane-A synthase\\nChromosome: 19; Location: 19q13.2\\nAnnotation: Chromosome 19 NC_000019.10 (41193219..41207539)\\nMIM: 611529\\nID: 29785\\n\\n80. ATP6AP1\\nOfficial Symbol: ATP6AP1 and Name: ATPase H+ transporting accessory protein 1 [Homo sapiens (human)]\\nOther Aliases: 16A, ATP6IP1, ATP6S1, Ac45, CF2, VATPS1, XAP-3, XAP3\\nOther Designations: V-type proton ATPase subunit S1; ATPase, H+ transporting, lysosomal (vacuolar proton pump), subunit 1; ATPase, H+ transporting, lysosomal accessory protein 1; ATPase, H+ transporting, lysosomal interacting protein 1; H-ATPase subunit; V-ATPase Ac45 subunit; V-ATPase S1 accessory protein; V-ATPase subunit S1; X-associated protein 3; epididymis secretory sperm binding protein; protein XAP-3; vacuolar ATPase subunit S1; vacuolar proton pump subunit S1\\nChromosome: X; Location: Xq28\\nAnnotation: Chromosome X NC_000023.11 (154428677..154436516)\\nMIM: 300197\\nID: 537\\n\\n81. B4GALNT1\\nOfficial Symbol: B4GALNT1 and Name: beta-1,4-N-acetyl-galactosaminyltransferase 1 [Homo sapiens (human)]\\nOther Aliases: GALGT, GALNACT, GalNAc-T, SPG26\\nOther Designations: beta-1,4 N-acetylgalactosaminyltransferase 1; GD2 synthase, GM2 synthase; GM2/GD2 synthase; UDP-Gal:betaGlcNAc beta-1,4-N-acetylgalactosaminyltransferase transferase 1; UDP-N-acetyl-alpha-D-galactosamine:(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase (GalNAc-T); beta-1,4-N-acetyl-galactosaminyl transferase 1; beta1,4GalNAc-T\\nChromosome: 12; Location: 12q13.3\\nAnnotation: Chromosome 12 NC_000012.12 (57623409..57633201, complement)\\nMIM: 601873\\nID: 2583\\n\\n82. RNF5\\nOfficial Symbol: RNF5 and Name: ring finger protein 5 [Homo sapiens (human)]\\nOther Aliases: RING5, RMA1\\nOther Designations: E3 ubiquitin-protein ligase RNF5; RING-type E3 ubiquitin transferase RNF5; protein G16; ram1 homolog; ring finger protein 5, E3 ubiquitin protein ligase\\nChromosome: 6; Location: 6p21.32\\nAnnotation: Chromosome 6 NC_000006.12 (32178405..32180793)\\nMIM: 602677\\nID: 6048\\n\\n83. POM121\\nOfficial Symbol: POM121 and Name: POM121 transmembrane nucleoporin [Homo sapiens (human)]\\nOther Aliases: P145A, POM121\\nOther Designations: nuclear envelope pore membrane protein POM 121; POM121 membrane glycoprotein; nuclear envelope pore membrane protein POM 121A; nuclear pore membrane protein 121 kDa; nucleoporin Nup121\\nChromosome: 7; Location: 7q11.23\\nAnnotation: Chromosome 7 NC_000007.14 (72879357..72951459)\\nMIM: 615753\\nID: 9883\\n\\n84. SMPD2\\nOfficial Symbol: SMPD2 and Name: sphingomyelin phosphodiesterase 2 [Homo sapiens (human)]\\nOther Aliases: ISC1, NSMASE, NSMASE1\\nOther Designations: sphingomyelin phosphodiesterase 2; N-SMase; lyso-PAF-PLC; lyso-platelet-activating factor-phospholipase C; neutral sphingomyelinase\\nChromosome: 6; Location: 6q21\\nAnnotation: Chromosome 6 NC_000006.12 (109440724..109443919)\\nMIM: 603498\\nID: 6610\\n\\n85. ABCA2\\nOfficial Symbol: ABCA2 and Name: ATP binding cassette subfamily A member 2 [Homo sapiens (human)]\\nOther Aliases: ABC2, IDPOGSA\\nOther Designations: ATP-binding cassette sub-family A member 2; ATP-binding cassette 2; ATP-binding cassette transporter 2; ATP-binding cassette, sub-family A (ABC1), member 2; ATP-binding cassette, sub-family A, member 2\\nChromosome: 9; Location: 9q34.3\\nAnnotation: Chromosome 9 NC_000009.12 (137007234..137028922, complement)\\nMIM: 600047\\nID: 20\\n\\n86. EXTL3\\nOfficial Symbol: EXTL3 and Name: exostosin like glycosyltransferase 3 [Homo sapiens (human)]\\nOther Aliases: BOTV, EXTL1L, EXTR1, ISDNA, REGR, RPR\\nOther Designations: exostosin-like 3; EXT-related 1; epididymis secretory sperm binding protein; exostoses (multiple)-like 3; exostosin tumor-like 3; glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase; hereditary multiple exostoses gene isolog; putative tumor suppressor protein EXTL3; reg receptor\\nChromosome: 8; Location: 8p21.1\\nAnnotation: Chromosome 8 NC_000008.11 (28607736..28755599)\\nMIM: 605744\\nID: 2137\\n\\n87. MAN2A1\\nOfficial Symbol: MAN2A1 and Name: mannosidase alpha class 2A member 1 [Homo sapiens (human)]\\nOther Aliases: AMan II, GOLIM7, MANA2, MANII\\nOther Designations: alpha-mannosidase 2; Golgi alpha-mannosidase II; golgi integral membrane protein 7; mannosidase, alpha type II; mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase\\nChromosome: 5; Location: 5q21.3\\nAnnotation: Chromosome 5 NC_000005.10 (109689927..109869625)\\nMIM: 154582\\nID: 4124\\n\\n88. LY75\\nOfficial Symbol: LY75 and Name: lymphocyte antigen 75 [Homo sapiens (human)]\\nOther Aliases: CD205, CLEC13B, DEC-205, GP200-MR6, LY-75\\nOther Designations: lymphocyte antigen 75; C-type lectin domain family 13 member B\\nChromosome: 2; Location: 2q24.2\\nAnnotation: Chromosome 2 NC_000002.12 (159803355..159904756, complement)\\nMIM: 604524\\nID: 4065\\n\\n89. UNC119\\nOfficial Symbol: UNC119 and Name: unc-119 lipid binding chaperone [Homo sapiens (human)]\\nOther Aliases: CORD24, HRG4, IMD13, POC7, POC7A\\nOther Designations: protein unc-119 homolog A; POC7 centriolar protein homolog A; retinal protein 4; unc-119 homolog\\nChromosome: 17; Location: 17q11.2\\nAnnotation: Chromosome 17 NC_000017.11 (28546707..28552628, complement)\\nMIM: 604011\\nID: 9094\\n\\n90. TMEM67\\nOfficial Symbol: TMEM67 and Name: transmembrane protein 67 [Homo sapiens (human)]\\nOther Aliases: JBTS6, MECKELIN, MKS3, NPHP11, TNEM67\\nOther Designations: meckelin; meckel syndrome type 3 protein\\nChromosome: 8; Location: 8q22.1\\nAnnotation: Chromosome 8 NC_000008.11 (93754844..93832653)\\nMIM: 609884\\nID: 91147\\n\\n91. MFSD8\\nOfficial Symbol: MFSD8 and Name: major facilitator superfamily domain containing 8 [Homo sapiens (human)]\\nOther Aliases: CCMD, CLN7\\nOther Designations: major facilitator superfamily domain-containing protein 8; ceroid-lipofuscinosis, neuronal 7, late infantile\\nChromosome: 4; Location: 4q28.2\\nAnnotation: Chromosome 4 NC_000004.12 (127917732..127965963, complement)\\nMIM: 611124\\nID: 256471\\n\\n92. PLXNA1\\nOfficial Symbol: PLXNA1 and Name: plexin A1 [Homo sapiens (human)]\\nOther Aliases: DWOPNED, NOV, NOVP, PLEXIN-A1, PLXN1\\nOther Designations: plexin-A1; plexin 1; semaphorin receptor NOV\\nChromosome: 3; Location: 3q21.3\\nAnnotation: Chromosome 3 NC_000003.12 (126983115..127037389)\\nMIM: 601055\\nID: 5361\\n\\n93. PLXNA2\\nOfficial Symbol: PLXNA2 and Name: plexin A2 [Homo sapiens (human)]\\nOther Aliases: OCT, PLXN2\\nOther Designations: plexin-A2; plexin 2; semaphorin receptor OCT; transmembrane protein OCT\\nChromosome: 1; Location: 1q32.2\\nAnnotation: Chromosome 1 NC_000001.11 (208022242..208244384, complement)\\nMIM: 601054\\nID: 5362\\n\\n94. LARGE1\\nOfficial Symbol: LARGE1 and Name: LARGE xylosyl- and glucuronyltransferase 1 [Homo sapiens (human)]\\nOther Aliases: LARGE, MDC1D, MDDGA6, MDDGB6\\nOther Designations: xylosyl- and glucuronyltransferase LARGE1; acetylglucosaminyltransferase-like 1A; acetylglucosaminyltransferase-like protein; glycosyltransferase-like protein LARGE1\\nChromosome: 22; Location: 22q12.3\\nAnnotation: Chromosome 22 NC_000022.11 (33066663..33922824, complement)\\nMIM: 603590\\nID: 9215\\n\\n95. UGT8\\nOfficial Symbol: UGT8 and Name: UDP glycosyltransferase 8 [Homo sapiens (human)]\\nOther Aliases: CGT, UGT4\\nOther Designations: 2-hydroxyacylsphingosine 1-beta-galactosyltransferase; UDP-galactose-ceramide galactosyltransferase; ceramide UDP-galactosyltransferase; cerebroside synthase; uridine diphosphate glycosyltransferase 8\\nChromosome: 4; Location: 4q26\\nAnnotation: Chromosome 4 NC_000004.12 (114598402..114678225)\\nMIM: 601291\\nID: 7368\\n\\n96. ST7\\nOfficial Symbol: ST7 and Name: suppression of tumorigenicity 7 [Homo sapiens (human)]\\nOther Aliases: ETS7q, FAM4A, FAM4A1, HELG, RAY1, SEN4, TSG7\\nOther Designations: suppressor of tumorigenicity 7 protein; family with sequence similarity 4, subfamily A, member 1; suppression of tumorigenicity 7 (breast)\\nChromosome: 7; Location: 7q31.2\\nAnnotation: Chromosome 7 NC_000007.14 (116953501..117230176)\\nMIM: 600833\\nID: 7982\\n\\n97. SEMA4C\\nOfficial Symbol: SEMA4C and Name: semaphorin 4C [Homo sapiens (human)]\\nOther Aliases: M-SEMA-F, SEMACL1, SEMAF, SEMAI\\nOther Designations: semaphorin-4C; M-Sema F; sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C\\nChromosome: 2; Location: 2q11.2\\nAnnotation: Chromosome 2 NC_000002.12 (96859718..96870830, complement)\\nMIM: 604462\\nID: 54910\\n\\n98. MGAT1\\nOfficial Symbol: MGAT1 and Name: alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase [Homo sapiens (human)]\\nOther Aliases: GLCNAC-TI, GLCT1, GLYT1, GNT-1, GNT-I, GnTI, MGAT\\nOther Designations: alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase; N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I; glcNAc-T I; mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase\\nChromosome: 5; Location: 5q35.3\\nAnnotation: Chromosome 5 NC_000005.10 (180784780..180815616, complement)\\nMIM: 160995\\nID: 4245\\n\\n99. ATP6V0A1\\nOfficial Symbol: ATP6V0A1 and Name: ATPase H+ transporting V0 subunit a1 [Homo sapiens (human)]\\nOther Aliases: ATP6N1, ATP6N1A, DEE104, NEDEBA, Stv1, VPP1, Vph1, a1\\nOther Designations: V-type proton ATPase 116 kDa subunit a 1; ATPase, H+ transporting, lysosomal V0 subunit a1; ATPase, H+ transporting, lysosomal non-catalytic accessory protein 1 (110/116kD); H(+)-transporting two-sector ATPase, 116 kDa accessory protein A1; V-ATPase 116 kDa subunit a 1; V-ATPase 116 kDa subunit a1; V-ATPase subunit a1; V-type proton ATPase 116 kDa subunit a; V-type proton ATPase 116 kDa subunit a1; clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit; vacuolar adenosine triphosphatase subunit Ac116; vacuolar proton pump subunit 1; vacuolar proton translocating ATPase 116 kDa subunit A; vacuolar-type H(+)-ATPase 115 kDa subunit\\nChromosome: 17; Location: 17q21.2\\nAnnotation: Chromosome 17 NC_000017.11 (42458878..42522579)\\nMIM: 192130\\nID: 535\\n\\n100. SLC22A18\\nOfficial Symbol: SLC22A18 and Name: solute carrier family 22 member 18 [Homo sapiens (human)]\\nOther Aliases: BWR1A, BWSCR1A, HET, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5, p45-BWR1A\\nOther Designations: solute carrier family 22 member 18; beckwith-Wiedemann syndrome chromosomal region 1 candidate gene A protein; efflux transporter-like protein; imprinted multi-membrane-spanning polyspecific transporter-like gene 1; imprinted multi-membrane-spanning polyspecific transporter-related protein 1; organic cation transporter-like protein 2; p45 Beckwith-Wiedemann region 1A; tumor-suppressing STF cDNA 5 protein; tumor-suppressing subchromosomal transferable fragment candidate gene 5 protein\\nChromosome: 11; Location: 11p15.4\\nAnnotation: Chromosome 11 NC_000011.10 (2899691..2925246)\\nMIM: 602631\\nID: 5002\\n\\n'"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pesquisa_ncbi(email,\"HLA-DQA1\",db='gene',retmax=100)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Através da análise do output da função anterior, podemos observar que o ID correspondente ao gene de interesse é o \"3117\". Assim, torna-se possível proceder à gravação do ficheiro de interesse. \n",
    "\n",
    "Utilizando a função **pesquisa_ncbi** e colocando os seguintes parâmetros na função:"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Encontrados 1 resultados em gene. Irá ser processado 1 resultado.\n",
      "\n",
      "Ficheiro gravado.\n",
      "Concluído.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'\\n1. HLA-DQA1\\nOfficial Symbol: HLA-DQA1 and Name: major histocompatibility complex, class II, DQ alpha 1 [Homo sapiens (human)]\\nOther Aliases: CELIAC1, DQ-A1, DQA1, HLA-DQA*, HLA-DQB1, HLA-DQA1\\nOther Designations: HLA class II histocompatibility antigen, DQ alpha 1 chain; DC-1 alpha chain; DC-alpha; HLA class II histocompatibility antigen DQ alpha chain; HLA-DCA; MHC HLA-DQ alpha; MHC class II DQ alpha chain; MHC class II DQA1; MHC class II HLA-DQ-alpha-1; MHC class II antigen DQA1; MHC class II protein\\nChromosome: 6; Location: 6p21.32\\nAnnotation: Chromosome 6 NC_000006.12 (32637406..32655272)\\nMIM: 146880\\nID: 3117\\n\\n'"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pesquisa_ncbi(email,'3117',db='gene',rettype='gb',retmax=1,save='y',display='n')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Foi gravado com sucesso o ficheiro pretendido.\n",
    "\n",
    "### Transferência do ficheiro correspondente à proteína de interesse\n",
    "\n",
    "Passando agora para a identificação e preparação de dados relacionados à proteína codificada pelo gene HLA-DQA1 para análises subsequentes. Utilizando a função pesquisa_ncbi, direcionamos a pesquisa para a base de dados 'protein' da NCBI, procurando recuperar informações específicas sobre a proteína de interesse."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Encontrados 1 resultados em protein. Irão ser processados 10 resultados.\n",
      "\n",
      "LOCUS       DQA1_HUMAN               254 aa            linear   PRI 08-NOV-2023\n",
      "DEFINITION  RecName: Full=HLA class II histocompatibility antigen, DQ alpha 1\n",
      "            chain; AltName: Full=DC-1 alpha chain; AltName: Full=DC-alpha;\n",
      "            AltName: Full=HLA-DCA; AltName: Full=MHC class II DQA1; Flags:\n",
      "            Precursor.\n",
      "ACCESSION   P01909\n",
      "VERSION     P01909.1\n",
      "DBSOURCE    UniProtKB: locus DQA1_HUMAN, accession P01909;\n",
      "            class: standard.\n",
      "            extra\n",
      "            accessions:O19630,O19706,P01907,P01908,P04225,P04226,P05536,P79553,\n",
      "            Q06751,Q29876,Q29994,Q2Q6Y6,Q2Q6Y7,Q2Q6Y8,Q2WCM3,Q30064,Q30067,\n",
      "            Q30068,Q30070,Q30071,Q30072,Q30073,Q30086,Q30101,Q5Y7D5,Q5Y7F5,\n",
      "            Q6ICU6,Q6PR46,Q6QDB1,Q860W2,Q860W4,Q9BD37,Q9TPM3,Q9UM31\n",
      "            created: Jul 21, 1986.\n",
      "            sequence updated: Jul 21, 1986.\n",
      "            annotation updated: Nov 8, 2023.\n",
      "            xrefs: X00033.1, CAA24917.1, X00370.1, X00452.1, CAA25141.1,\n",
      "            M16995.1, AAA59760.1, U92032.1, AAB91990.1, AY663395.1, AAU87978.1,\n",
      "            AY663398.1, AAU87987.1, AY663400.1, AAU87992.1, AY663406.1,\n",
      "            AAU88007.1, AY663411.1, AAU88022.1, AY663413.1, AAU88028.1,\n",
      "            DQ178403.1, ABA86855.1, DQ178400.1, DQ178401.1, DQ178402.1,\n",
      "            DQ178407.1, ABA86856.1, DQ178404.1, DQ178405.1, DQ178406.1,\n",
      "            DQ178411.1, ABA86857.1, DQ178408.1, DQ178409.1, DQ178410.1,\n",
      "            DQ178415.1, ABA86858.1, DQ178412.1, DQ178413.1, DQ178414.1,\n",
      "            M29616.1, AAA59759.1, M29613.1, AF322870.1, AAK11577.1, AF322867.1,\n",
      "            AF322868.1, AF322869.1, AF395700.1, AAM69677.1, AF395697.1,\n",
      "            AF395698.1, AF395699.1, CR450297.1, CAG29293.1, AM042559.1,\n",
      "            CAJ14960.1, AM042560.1, CAJ14961.1, AK313975.1, BAG36689.1,\n",
      "            BX248406.4, AL662789.11, Z84489.1, CAB06491.1, BC008585.1,\n",
      "            AAH08585.1, BC157865.1, AAI57866.1, L46875.1, L46876.1, L46877.1,\n",
      "            L46878.1, L46880.1, L46881.1, M11124.1, AAA59754.1, M20431.1,\n",
      "            AAA59758.1, L34082.1, AAC41950.1, L34085.1, AAC41953.1, L34086.1,\n",
      "            AAC41954.1, L34089.1, AAC41957.1, L34090.1, AAC41958.1, L34092.1,\n",
      "            AAC41960.1, L34093.1, AAC41961.1, L34094.1, AAC41962.1, L42625.1,\n",
      "            AAA85334.1, AY197775.1, AAO45622.1, AY547314.1, AAS49496.1,\n",
      "            AY206406.1, AAO47362.1, AY585236.1, AAT09985.1, M34997.1,\n",
      "            AAA35772.1, M34999.1, AAA74633.1, U85035.1, AAB41891.1, AF109734.1,\n",
      "            AAD56720.1, U03675.1, AAB60341.1, M20506.1, AAA59774.1, J00199.1,\n",
      "            M17846.1, AAA59707.1, HLHUD1, HLHUDQ, HLHUD7, HLHU3C, HLHUDC,\n",
      "            B27628, D34512, NP_002113.2, 1JK8_A, 1S9V_A, 1S9V_D, 1UVQ_A,\n",
      "            2NNA_A, 4GG6_A, 4GG6_C, 4OZF_A, 4OZG_A, 4OZG_C, 4OZH_A, 4OZH_C,\n",
      "            4OZI_A, 4OZI_C, 5KSA_A, 5KSB_A, 5KSB_C, 5KSU_A, 5KSU_D, 5KSV_A,\n",
      "            6MFF_A, 6MFG_A, 6MFG_C, 6U3M_A, 6U3M_C, 6U3N_A, 6XP6_A, 6XP6_D,\n",
      "            7SG0_A, 7SG1_A, 7SG1_F, 7SG2_A, 7SG2_F\n",
      "            xrefs (non-sequence databases): PDBsum:1JK8, PDBsum:1S9V,\n",
      "            PDBsum:1UVQ, PDBsum:2NNA, PDBsum:4GG6, PDBsum:4OZF, PDBsum:4OZG,\n",
      "            PDBsum:4OZH, PDBsum:4OZI, PDBsum:5KSA, PDBsum:5KSB, PDBsum:5KSU,\n",
      "            PDBsum:5KSV, PDBsum:6MFF, PDBsum:6MFG, PDBsum:6U3M, PDBsum:6U3N,\n",
      "            PDBsum:6XP6, PDBsum:7SG0, PDBsum:7SG1, PDBsum:7SG2,\n",
      "            AlphaFoldDB:P01909, SMR:P01909, BioGRID:109362, BioGRID:1529240,\n",
      "            IntAct:P01909, ChEMBL:CHEMBL4105884, TCDB:9.A.75.1.1,\n",
      "            GlyConnect:1986, GlyCosmos:P01909, GlyGen:P01909, iPTMnet:P01909,\n",
      "            BioMuta:HLA-DQA1, DMDM:122188, jPOST:P01909, MassIVE:P01909,\n",
      "            PeptideAtlas:P01909, ProteomicsDB:51510, ABCD:P01909,\n",
      "            Antibodypedia:2728, CPTC:P01909, DNASU:3117,\n",
      "            Ensembl:ENST00000343139.11, Ensembl:ENSP00000339398.5,\n",
      "            Ensembl:ENSG00000196735.13, Ensembl:ENST00000374949.2,\n",
      "            Ensembl:ENSP00000364087.2, Ensembl:ENST00000383251.6,\n",
      "            Ensembl:ENSP00000372738.2, Ensembl:ENSG00000206305.12,\n",
      "            Ensembl:ENST00000395363.5, Ensembl:ENSP00000378767.1,\n",
      "            Ensembl:ENST00000399675.5, Ensembl:ENSP00000382583.1,\n",
      "            Ensembl:ENST00000399678.5, Ensembl:ENSP00000382586.1,\n",
      "            Ensembl:ENST00000418023.5, Ensembl:ENSP00000387892.1,\n",
      "            Ensembl:ENSG00000232062.9, Ensembl:ENST00000444296.6,\n",
      "            Ensembl:ENSP00000413237.2, GeneID:3117, KEGG:hsa:3117,\n",
      "            MANE-Select:ENST00000343139.11, UCSC:uc003obr.4, AGR:HGNC:4942,\n",
      "            CTD:3117, DisGeNET:3117, GeneCards:HLA-DQA1, GeneReviews:HLA-DQA1,\n",
      "            HGNC:4942, HPA:ENSG00000196735, MalaCards:HLA-DQA1, MIM:146880,\n",
      "            neXtProt:NX_P01909, NIAGADS:ENSG00000196735, Orphanet:391490,\n",
      "            Orphanet:930, Orphanet:555, Orphanet:243377, PharmGKB:PA35066,\n",
      "            VEuPathDB:HostDB:ENSG00000196735, HOGENOM:CLU_069380_0_0_1,\n",
      "            InParanoid:P01909, OrthoDB:4118190at2759, PhylomeDB:P01909,\n",
      "            TreeFam:TF333797, PathwayCommons:P01909, Reactome:R-HSA-202424,\n",
      "            Reactome:R-HSA-202427, Reactome:R-HSA-202430,\n",
      "            Reactome:R-HSA-202433, Reactome:R-HSA-2132295,\n",
      "            Reactome:R-HSA-389948, Reactome:R-HSA-877300, SignaLink:P01909,\n",
      "            SIGNOR:P01909, BioGRID-ORCS:3117, ChiTaRS:HLA-DQA1,\n",
      "            EvolutionaryTrace:P01909, GenomeRNAi:3117, Pharos:P01909,\n",
      "            PRO:PR:P01909, Proteomes:UP000005640, RNAct:P01909,\n",
      "            Bgee:ENSG00000196735, ExpressionAtlas:P01909, Genevisible:P01909,\n",
      "            GO:0030669, GO:0030666, GO:0012507, GO:0000139, GO:0031902,\n",
      "            GO:0098553, GO:0005765, GO:0016020, GO:0042613, GO:0005886,\n",
      "            GO:0032588, GO:0030658, GO:0023026, GO:0032395, GO:0042605,\n",
      "            GO:0002250, GO:0019886, GO:0006955, GO:0002503, GO:0050778,\n",
      "            GO:0050870, CDD:cd21008, Gene3D:2.60.40.10, InterPro:IPR007110,\n",
      "            InterPro:IPR036179, InterPro:IPR013783, InterPro:IPR003006,\n",
      "            InterPro:IPR003597, InterPro:IPR011162, InterPro:IPR014745,\n",
      "            InterPro:IPR001003, PANTHER:PTHR19944:SF59, PANTHER:PTHR19944,\n",
      "            Pfam:PF07654, Pfam:PF00993, SMART:SM00407, SMART:SM00920,\n",
      "            SUPFAM:SSF48726, SUPFAM:SSF54452, PROSITE:PS50835, PROSITE:PS00290\n",
      "KEYWORDS    3D-structure; Adaptive immunity; Cell membrane; Direct protein\n",
      "            sequencing; Disulfide bond; Endoplasmic reticulum; Endosome;\n",
      "            Glycoprotein; Golgi apparatus; Immunity; Lysosome; Membrane; MHC\n",
      "            II; Reference proteome; Signal; Transmembrane; Transmembrane helix.\n",
      "SOURCE      Homo sapiens (human)\n",
      "  ORGANISM  Homo sapiens\n",
      "            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\n",
      "            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\n",
      "            Catarrhini; Hominidae; Homo.\n",
      "REFERENCE   1  (residues 1 to 254)\n",
      "  AUTHORS   Chang,H.C., Moriuchi,T. and Silver,J.\n",
      "  TITLE     The heavy chain of human B-cell alloantigen HLA-DS has a variable\n",
      "            N-terminal region and a constant immunoglobulin-like region\n",
      "  JOURNAL   Nature 305 (5937), 813-815 (1983)\n",
      "   PUBMED   6415485\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*02:01).\n",
      "REFERENCE   2  (residues 1 to 254)\n",
      "  AUTHORS   Schenning,L., Larhammar,D., Bill,P., Wiman,K., Jonsson,A.K.,\n",
      "            Rask,L. and Peterson,P.A.\n",
      "  TITLE     Both alpha and beta chains of HLA-DC class II histocompatibility\n",
      "            antigens display extensive polymorphism in their amino-terminal\n",
      "            domains\n",
      "  JOURNAL   EMBO J 3 (2), 447-452 (1984)\n",
      "   PUBMED   6585297\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*05:01).\n",
      "REFERENCE   3  (residues 1 to 254)\n",
      "  AUTHORS   Auffray,C., Lillie,J.W., Arnot,D., Grossberger,D., Kappes,D. and\n",
      "            Strominger,J.L.\n",
      "  TITLE     Isotypic and allotypic variation of human class II\n",
      "            histocompatibility antigen alpha-chain genes\n",
      "  JOURNAL   Nature 308 (5957), 327-333 (1984)\n",
      "   PUBMED   6584734\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ALLELES DQA1*01:02 AND ALLELE\n",
      "            DQA1*03:01).\n",
      "REFERENCE   4  (residues 1 to 254)\n",
      "  AUTHORS   Schiffenbauer,J., Didier,D.K., Klearman,M., Rice,K., Shuman,S.,\n",
      "            Tieber,V.L., Kittlesen,D.J. and Schwartz,B.D.\n",
      "  TITLE     Complete sequence of the HLA DQ alpha and DQ beta cDNA from a\n",
      "            DR5/DQw3 cell line\n",
      "  JOURNAL   J Immunol 139 (1), 228-233 (1987)\n",
      "   PUBMED   3584986\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*05:01).\n",
      "            Erratum:[J Immunol 1991 Mar 1;146(5):1715]\n",
      "REFERENCE   5  (residues 1 to 254)\n",
      "  AUTHORS   Ellis,M.C., Hetisimer,A.H., Ruddy,D.A., Hansen,S.L., Kronmal,G.S.,\n",
      "            McClelland,E., Quintana,L., Drayna,D.T., Aldrich,M.S. and Mignot,E.\n",
      "  TITLE     HLA class II haplotype and sequence analysis support a role for DQ\n",
      "            in narcolepsy\n",
      "  JOURNAL   Immunogenetics 46 (5), 410-417 (1997)\n",
      "   PUBMED   9271631\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*05:01).\n",
      "REFERENCE   6  (residues 1 to 254)\n",
      "  AUTHORS   Raymond,C.K., Kas,A., Paddock,M., Qiu,R., Zhou,Y., Subramanian,S.,\n",
      "            Chang,J., Palmieri,A., Haugen,E., Kaul,R. and Olson,M.V.\n",
      "  TITLE     Ancient haplotypes of the HLA Class II region\n",
      "  JOURNAL   Genome Res 15 (9), 1250-1257 (2005)\n",
      "   PUBMED   16140993\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:01; DQA1*01:02\n",
      "            AND DQA1*03:01).\n",
      "REFERENCE   7  (residues 1 to 254)\n",
      "  AUTHORS   Lee,K.W., Jung,Y.A. and Oh,D.H.\n",
      "  TITLE     Four novel human leukocyte antigen-DQA1 alleles identified in the\n",
      "            Korean population\n",
      "  JOURNAL   Tissue Antigens 68 (2), 167-172 (2006)\n",
      "   PUBMED   16866887\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:02; DQA1*05:06;\n",
      "            DQA1*05:07 AND DQA1*05:08).\n",
      "REFERENCE   8  (residues 1 to 254)\n",
      "  AUTHORS   Jonsson,A.K., Hyldig-Nielsen,J.J., Servenius,B., Larhammar,D.,\n",
      "            Andersson,G., Jorgensen,F., Peterson,P.A. and Rask,L.\n",
      "  TITLE     Class II genes of the human major histocompatibility complex.\n",
      "            Comparisons of the DQ and DX alpha and beta genes\n",
      "  JOURNAL   J Biol Chem 262 (18), 8767-8777 (1987)\n",
      "   PUBMED   3036828\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*03:01).\n",
      "REFERENCE   9  (residues 1 to 254)\n",
      "  AUTHORS   Ashdown,M.L., Leas,L., Gavrilidis,A., Wood,J.M. and Simons,M.J.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (??-JUN-2001) to the EMBL/GenBank/DDBJ databases\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*01:01).\n",
      "REFERENCE   10 (residues 1 to 254)\n",
      "  AUTHORS   Ebert,L., Schick,M., Neubert,P., Schatten,R., Henze,S. and Korn,B.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (??-MAY-2004) to the EMBL/GenBank/DDBJ databases\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DQA1*02:01).\n",
      "REFERENCE   11 (residues 1 to 254)\n",
      "  AUTHORS   Voorter,C.E. and van den Berg-Loonen,E.M.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (??-JUL-2005) to the EMBL/GenBank/DDBJ databases\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:02 AND\n",
      "            DQA1*05:09).\n",
      "REFERENCE   12 (residues 1 to 254)\n",
      "  AUTHORS   Ota,T., Suzuki,Y., Nishikawa,T., Otsuki,T., Sugiyama,T., Irie,R.,\n",
      "            Wakamatsu,A., Hayashi,K., Sato,H., Nagai,K., Kimura,K., Makita,H.,\n",
      "            Sekine,M., Obayashi,M., Nishi,T., Shibahara,T., Tanaka,T.,\n",
      "            Ishii,S., Yamamoto,J., Saito,K., Kawai,Y., Isono,Y., Nakamura,Y.,\n",
      "            Nagahari,K., Murakami,K., Yasuda,T., Iwayanagi,T., Wagatsuma,M.,\n",
      "            Shiratori,A., Sudo,H., Hosoiri,T., Kaku,Y., Kodaira,H., Kondo,H.,\n",
      "            Sugawara,M., Takahashi,M., Kanda,K., Yokoi,T., Furuya,T.,\n",
      "            Kikkawa,E., Omura,Y., Abe,K., Kamihara,K., Katsuta,N., Sato,K.,\n",
      "            Tanikawa,M., Yamazaki,M., Ninomiya,K., Ishibashi,T., Yamashita,H.,\n",
      "            Murakawa,K., Fujimori,K., Tanai,H., Kimata,M., Watanabe,M.,\n",
      "            Hiraoka,S., Chiba,Y., Ishida,S., Ono,Y., Takiguchi,S., Watanabe,S.,\n",
      "            Yosida,M., Hotuta,T., Kusano,J., Kanehori,K., Takahashi-Fujii,A.,\n",
      "            Hara,H., Tanase,T.O., Nomura,Y., Togiya,S., Komai,F., Hara,R.,\n",
      "            Takeuchi,K., Arita,M., Imose,N., Musashino,K., Yuuki,H., Oshima,A.,\n",
      "            Sasaki,N., Aotsuka,S., Yoshikawa,Y., Matsunawa,H., Ichihara,T.,\n",
      "            Shiohata,N., Sano,S., Moriya,S., Momiyama,H., Satoh,N., Takami,S.,\n",
      "            Terashima,Y., Suzuki,O., Nakagawa,S., Senoh,A., Mizoguchi,H.,\n",
      "            Goto,Y., Shimizu,F., Wakebe,H., Hishigaki,H., Watanabe,T.,\n",
      "            Sugiyama,A., Takemoto,M., Kawakami,B., Yamazaki,M., Watanabe,K.,\n",
      "            Kumagai,A., Itakura,S., Fukuzumi,Y., Fujimori,Y., Komiyama,M.,\n",
      "            Tashiro,H., Tanigami,A., Fujiwara,T., Ono,T., Yamada,K., Fujii,Y.,\n",
      "            Ozaki,K., Hirao,M., Ohmori,Y., Kawabata,A., Hikiji,T., Kobatake,N.,\n",
      "            Inagaki,H., Ikema,Y., Okamoto,S., Okitani,R., Kawakami,T.,\n",
      "            Noguchi,S., Itoh,T., Shigeta,K., Senba,T., Matsumura,K.,\n",
      "            Nakajima,Y., Mizuno,T., Morinaga,M., Sasaki,M., Togashi,T.,\n",
      "            Oyama,M., Hata,H., Watanabe,M., Komatsu,T., Mizushima-Sugano,J.,\n",
      "            Satoh,T., Shirai,Y., Takahashi,Y., Nakagawa,K., Okumura,K.,\n",
      "            Nagase,T., Nomura,N., Kikuchi,H., Masuho,Y., Yamashita,R.,\n",
      "            Nakai,K., Yada,T., Nakamura,Y., Ohara,O., Isogai,T. and Sugano,S.\n",
      "  TITLE     Complete sequencing and characterization of 21,243 full-length\n",
      "            human cDNAs\n",
      "  JOURNAL   Nat Genet 36 (1), 40-45 (2004)\n",
      "   PUBMED   14702039\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DQA1*01:01).;\n",
      "            TISSUE=Trachea\n",
      "REFERENCE   13 (residues 1 to 254)\n",
      "  AUTHORS   Mungall,A.J., Palmer,S.A., Sims,S.K., Edwards,C.A., Ashurst,J.L.,\n",
      "            Wilming,L., Jones,M.C., Horton,R., Hunt,S.E., Scott,C.E.,\n",
      "            Gilbert,J.G., Clamp,M.E., Bethel,G., Milne,S., Ainscough,R.,\n",
      "            Almeida,J.P., Ambrose,K.D., Andrews,T.D., Ashwell,R.I.,\n",
      "            Babbage,A.K., Bagguley,C.L., Bailey,J., Banerjee,R., Barker,D.J.,\n",
      "            Barlow,K.F., Bates,K., Beare,D.M., Beasley,H., Beasley,O.,\n",
      "            Bird,C.P., Blakey,S., Bray-Allen,S., Brook,J., Brown,A.J.,\n",
      "            Brown,J.Y., Burford,D.C., Burrill,W., Burton,J., Carder,C.,\n",
      "            Carter,N.P., Chapman,J.C., Clark,S.Y., Clark,G., Clee,C.M.,\n",
      "            Clegg,S., Cobley,V., Collier,R.E., Collins,J.E., Colman,L.K.,\n",
      "            Corby,N.R., Coville,G.J., Culley,K.M., Dhami,P., Davies,J.,\n",
      "            Dunn,M., Earthrowl,M.E., Ellington,A.E., Evans,K.A., Faulkner,L.,\n",
      "            Francis,M.D., Frankish,A., Frankland,J., French,L., Garner,P.,\n",
      "            Garnett,J., Ghori,M.J., Gilby,L.M., Gillson,C.J., Glithero,R.J.,\n",
      "            Grafham,D.V., Grant,M., Gribble,S., Griffiths,C., Griffiths,M.,\n",
      "            Hall,R., Halls,K.S., Hammond,S., Harley,J.L., Hart,E.A.,\n",
      "            Heath,P.D., Heathcott,R., Holmes,S.J., Howden,P.J., Howe,K.L.,\n",
      "            Howell,G.R., Huckle,E., Humphray,S.J., Humphries,M.D., Hunt,A.R.,\n",
      "            Johnson,C.M., Joy,A.A., Kay,M., Keenan,S.J., Kimberley,A.M.,\n",
      "            King,A., Laird,G.K., Langford,C., Lawlor,S., Leongamornlert,D.A.,\n",
      "            Leversha,M., Lloyd,C.R., Lloyd,D.M., Loveland,J.E., Lovell,J.,\n",
      "            Martin,S., Mashreghi-Mohammadi,M., Maslen,G.L., Matthews,L.,\n",
      "            McCann,O.T., McLaren,S.J., McLay,K., McMurray,A., Moore,M.J.,\n",
      "            Mullikin,J.C., Niblett,D., Nickerson,T., Novik,K.L., Oliver,K.,\n",
      "            Overton-Larty,E.K., Parker,A., Patel,R., Pearce,A.V., Peck,A.I.,\n",
      "            Phillimore,B., Phillips,S., Plumb,R.W., Porter,K.M., Ramsey,Y.,\n",
      "            Ranby,S.A., Rice,C.M., Ross,M.T., Searle,S.M., Sehra,H.K.,\n",
      "            Sheridan,E., Skuce,C.D., Smith,S., Smith,M., Spraggon,L.,\n",
      "            Squares,S.L., Steward,C.A., Sycamore,N., Tamlyn-Hall,G., Tester,J.,\n",
      "            Theaker,A.J., Thomas,D.W., Thorpe,A., Tracey,A., Tromans,A.,\n",
      "            Tubby,B., Wall,M., Wallis,J.M., West,A.P., White,S.S.,\n",
      "            Whitehead,S.L., Whittaker,H., Wild,A., Willey,D.J., Wilmer,T.E.,\n",
      "            Wood,J.M., Wray,P.W., Wyatt,J.C., Young,L., Younger,R.M.,\n",
      "            Bentley,D.R., Coulson,A., Durbin,R., Hubbard,T., Sulston,J.E.,\n",
      "            Dunham,I., Rogers,J. and Beck,S.\n",
      "  TITLE     The DNA sequence and analysis of human chromosome 6\n",
      "  JOURNAL   Nature 425 (6960), 805-811 (2003)\n",
      "   PUBMED   14574404\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELES DQA1*01:02;\n",
      "            DQA1*03:01 AND DQA1*05:01).\n",
      "REFERENCE   14 (residues 1 to 254)\n",
      "  AUTHORS   Gerhard,D.S., Wagner,L., Feingold,E.A., Shenmen,C.M., Grouse,L.H.,\n",
      "            Schuler,G., Klein,S.L., Old,S., Rasooly,R., Good,P., Guyer,M.,\n",
      "            Peck,A.M., Derge,J.G., Lipman,D., Collins,F.S., Jang,W., Sherry,S.,\n",
      "            Feolo,M., Misquitta,L., Lee,E., Rotmistrovsky,K., Greenhut,S.F.,\n",
      "            Schaefer,C.F., Buetow,K., Bonner,T.I., Haussler,D., Kent,J.,\n",
      "            Kiekhaus,M., Furey,T., Brent,M., Prange,C., Schreiber,K.,\n",
      "            Shapiro,N., Bhat,N.K., Hopkins,R.F., Hsie,F., Driscoll,T.,\n",
      "            Soares,M.B., Casavant,T.L., Scheetz,T.E., Brown-stein,M.J.,\n",
      "            Usdin,T.B., Toshiyuki,S., Carninci,P., Piao,Y., Dudekula,D.B.,\n",
      "            Ko,M.S., Kawakami,K., Suzuki,Y., Sugano,S., Gruber,C.E.,\n",
      "            Smith,M.R., Simmons,B., Moore,T., Waterman,R., Johnson,S.L.,\n",
      "            Ruan,Y., Wei,C.L., Mathavan,S., Gunaratne,P.H., Wu,J., Garcia,A.M.,\n",
      "            Hulyk,S.W., Fuh,E., Yuan,Y., Sneed,A., Kowis,C., Hodgson,A.,\n",
      "            Muzny,D.M., McPherson,J., Gibbs,R.A., Fahey,J., Helton,E.,\n",
      "            Ketteman,M., Madan,A., Rodrigues,S., Sanchez,A., Whiting,M.,\n",
      "            Madari,A., Young,A.C., Wetherby,K.D., Granite,S.J., Kwong,P.N.,\n",
      "            Brinkley,C.P., Pearson,R.L., Bouffard,G.G., Blakesly,R.W.,\n",
      "            Green,E.D., Dickson,M.C., Rodriguez,A.C., Grimwood,J., Schmutz,J.,\n",
      "            Myers,R.M., Butterfield,Y.S., Griffith,M., Griffith,O.L.,\n",
      "            Krzywinski,M.I., Liao,N., Morin,R., Palmquist,D., Petrescu,A.S.,\n",
      "            Skalska,U., Smailus,D.E., Stott,J.M., Schnerch,A., Schein,J.E.,\n",
      "            Jones,S.J., Holt,R.A., Baross,A., Marra,M.A., Clifton,S.,\n",
      "            Makowski,K.A., Bosak,S. and Malek,J.\n",
      "  CONSRTM   MGC Project Team\n",
      "  TITLE     The status, quality, and expansion of the NIH full-length cDNA\n",
      "            project: the Mammalian Gene Collection (MGC)\n",
      "  JOURNAL   Genome Res 14 (10B), 2121-2127 (2004)\n",
      "   PUBMED   15489334\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELES DQA1*03:01 AND\n",
      "            DQA1*05:01).;\n",
      "            TISSUE=Lymph\n",
      "            Erratum:[Genome Res. 2006 Jun;16(6):804. Morrin, Ryan [corrected to\n",
      "            Morin, Ryan]]\n",
      "REFERENCE   15 (residues 1 to 254)\n",
      "  AUTHORS   Yasunaga,S., Kimura,A. and Sasazuki,T.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (??-JUL-1996) to the EMBL/GenBank/DDBJ databases\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 1-27 (ALLELES\n",
      "            DQA1*01:01/DQA1*01:02/DQA1*01:03; DQA1*01:04; DQA1*01:05;\n",
      "            DQA1*02:01/DQA1*03:01/DQA1*03:03; DQA1*04:01/DQA1*06:01 AND\n",
      "            DQA1*05:01/DQA1*05:03/DQA1*05:05).;\n",
      "            TISSUE=B-cell\n",
      "REFERENCE   16 (residues 1 to 254)\n",
      "  AUTHORS   Moriuchi,J., Moriuchi,T. and Silver,J.\n",
      "  TITLE     Nucleotide sequence of an HLA-DQ alpha chain derived from a DRw9\n",
      "            cell line: genetic and evolutionary implications\n",
      "  JOURNAL   Proc Natl Acad Sci U S A 82 (10), 3420-3424 (1985)\n",
      "   PUBMED   3879967\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 19-254 (ALLELE DQA1*03:02).\n",
      "REFERENCE   17 (residues 1 to 254)\n",
      "  AUTHORS   Lock,C.B., So,A.K., Welsh,K.I., Parkes,J.D. and Trowsdale,J.\n",
      "  TITLE     MHC class II sequences of an HLA-DR2 narcoleptic\n",
      "  JOURNAL   Immunogenetics 27 (6), 449-455 (1988)\n",
      "   PUBMED   3259543\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 23-254 (ALLELE DQA1*01:02).\n",
      "REFERENCE   18 (residues 1 to 254)\n",
      "  AUTHORS   Yasunaga,S., Kimura,A., Hamaguchi,K., Ronningen,K.S. and\n",
      "            Sasazuki,T.\n",
      "  TITLE     Different contribution of HLA-DR and -DQ genes in susceptibility\n",
      "            and resistance to insulin-dependent diabetes mellitus (IDDM)\n",
      "  JOURNAL   Tissue Antigens 47 (1), 37-48 (1996)\n",
      "   PUBMED   8929711\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 24-250 (ALLELE DQA1*03:02/DQA1*03:03)\n",
      "            AND NUCLEOTIDE SEQUENCE [MRNA] OF 24-249 (ALLELES DQA1*01:01;\n",
      "            DQA1*01:03; DQA1*01:04; DQA1*04:01; DQA1*05:03; DQA1*05:05 AND\n",
      "            DQA1*06:01).\n",
      "REFERENCE   19 (residues 1 to 254)\n",
      "  AUTHORS   Yasunaga,S.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (??-JAN-1996) to the EMBL/GenBank/DDBJ databases\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 24-249 (ALLELE DQA1*01:05).\n",
      "REFERENCE   20 (residues 1 to 254)\n",
      "  AUTHORS   Goetz,H., Kratzin,H., Thinnes,F.P., Yang,C.-Y., Kruse,T., Pauly,E.,\n",
      "            Koelbel,S., Egert,G., Wernet,P. and Hilschmann,N.\n",
      "  TITLE     Primary structure of human class II histocompatibility antigens 3rd\n",
      "            communication. Amino acid sequence comparison between DR and DC\n",
      "            subclass antigens derived from a lymphoblastoid B cell line\n",
      "            homozygous at the HLA loci (HLA-A3,3; B7,7; Dw2,2; DR2,2: MT1,1;\n",
      "            Dc1,1: MB1,1)\n",
      "  JOURNAL   Hoppe-Seyler's Z. Physiol. Chem. 364, 749-755 (1983)\n",
      "   PUBMED   6576979\n",
      "  REMARK    PROTEIN SEQUENCE OF 24-89; 102-120 AND 164-212 (ALLELE DQA1*01:02).\n",
      "REFERENCE   21 (residues 1 to 254)\n",
      "  AUTHORS   Kao,H.T., Gregersen,P.K., Tang,J.C., Takahashi,T., Wang,C.Y. and\n",
      "            Silver,J.\n",
      "  TITLE     Molecular analysis of the HLA class II genes in two DRw6-related\n",
      "            haplotypes, DRw13 DQw1 and DRw14 DQw3\n",
      "  JOURNAL   J Immunol 142 (5), 1743-1747 (1989)\n",
      "   PUBMED   2493052\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 24-209 (ALLELE DQA1*05:01).\n",
      "REFERENCE   22 (residues 1 to 254)\n",
      "  AUTHORS   Cordovado,S.K., Hancock,L.N., Simone,A.E., Hendrix,M. and\n",
      "            Mueller,P.W.\n",
      "  TITLE     High-resolution genotyping of HLA-DQA1 in the GoKinD study and\n",
      "            identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and\n",
      "            HLA-DQA1*0404\n",
      "  JOURNAL   Tissue Antigens 65 (5), 448-458 (2005)\n",
      "   PUBMED   15853899\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELES DQA1*04:02 AND\n",
      "            DQA1*04:04).\n",
      "REFERENCE   23 (residues 1 to 254)\n",
      "  AUTHORS   Simone,A.E., Cordovado,S.K., Hendrix,M.M. and Mueller,P.W.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (??-DEC-2002) to the EMBL/GenBank/DDBJ databases\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELE DQA1*06:02).\n",
      "REFERENCE   24 (residues 1 to 254)\n",
      "  AUTHORS   Hancock,L.N., Cordovado,S.K. and Mueller,P.W.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (??-MAR-2004) to the EMBL/GenBank/DDBJ databases\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELE DQA1*01:07).\n",
      "REFERENCE   25 (residues 1 to 254)\n",
      "  AUTHORS   Horn,G.T., Bugawan,T.L., Long,C.M., Manos,M.M. and Erlich,H.A.\n",
      "  TITLE     Sequence analysis of HLA class II genes from insulin-dependent\n",
      "            diabetic individuals\n",
      "  JOURNAL   Hum Immunol 21 (4), 249-263 (1988)\n",
      "   PUBMED   3372263\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-110 (ALLELE DQA1*01:02),\n",
      "            AND NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-109 (ALLELE\n",
      "            DQA1*05:01).\n",
      "REFERENCE   26 (residues 1 to 254)\n",
      "  AUTHORS   Trejaut,J.A., Greville,W.D. and Dunckley,H.\n",
      "  TITLE     Direct Submission\n",
      "  JOURNAL   Submitted (??-JAN-1997) to the EMBL/GenBank/DDBJ databases\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-109 (ALLELE DQA1*05:04).\n",
      "REFERENCE   27 (residues 1 to 254)\n",
      "  AUTHORS   Luo,M., Blanchard,J., Maclean,I. and Brunham,R.\n",
      "  TITLE     Identification of a novel HLA-DQA1 allele (DQA1*0106) by\n",
      "            sequence-based DQA1 typing\n",
      "  JOURNAL   Tissue Antigens 53 (6), 595-596 (1999)\n",
      "   PUBMED   10395113\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 31-109 (ALLELE DQA1*01:06).\n",
      "REFERENCE   28 (residues 1 to 254)\n",
      "  AUTHORS   Marsh,S.G. and Bodmer,J.G.\n",
      "  TITLE     HLA class II nucleotide sequences, 1992\n",
      "  JOURNAL   Tissue Antigens 40 (5), 229-243 (1992)\n",
      "   PUBMED   1362295\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-74 (ALLELE DQA1*05:02).\n",
      "            Correction to:[Tissue Antigens. 1992 Apr;39(4):161-73. PMID:\n",
      "            1529427]\n",
      "REFERENCE   29 (residues 1 to 254)\n",
      "  AUTHORS   Liu,C.P., Bach,F.H. and Wu,S.K.\n",
      "  TITLE     Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype.\n",
      "            Multiple genetic mechanisms in the generation of polymorphic HLA\n",
      "            class II genes\n",
      "  JOURNAL   J Immunol 140 (10), 3631-3639 (1988)\n",
      "   PUBMED   3129499\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 36-254 (ALLELE DQA1*05:01).\n",
      "            Erratum:[J Immunol 1990 Feb 15;144(4):1544]\n",
      "REFERENCE   30 (residues 1 to 254)\n",
      "  AUTHORS   Liu,C.P., Bach,F.H. and Wu,S.K.\n",
      "  JOURNAL   J. Immunol. 144, 15441-15441 (1990)\n",
      "  REMARK    ERRATUM OF PUBMED:3129499.\n",
      "REFERENCE   31 (residues 1 to 254)\n",
      "  AUTHORS   Auffray,C., Korman,A.J., Roux-Dosseto,M., Bono,R. and\n",
      "            Strominger,J.L.\n",
      "  TITLE     cDNA clone for the heavy chain of the human B cell alloantigen DC1:\n",
      "            strong sequence homology to the HLA-DR heavy chain\n",
      "  JOURNAL   Proc Natl Acad Sci U S A 79 (20), 6337-6341 (1982)\n",
      "   PUBMED   6815651\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 40-254 (ALLELE DQA1*03:01).\n",
      "REFERENCE   32 (residues 1 to 254)\n",
      "  AUTHORS   Gyllensten,U.B. and Erlich,H.A.\n",
      "  TITLE     Ancient roots for polymorphism at the HLA-DQ alpha locus in\n",
      "            primates\n",
      "  JOURNAL   Proc Natl Acad Sci U S A 86 (24), 9986-9990 (1989)\n",
      "   PUBMED   2513578\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-102 (ALLELE DQA1*05:01),\n",
      "            AND NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-103 (ALLELE\n",
      "            DQA1*01:02).\n",
      "REFERENCE   33 (residues 1 to 254)\n",
      "  AUTHORS   Turco,E., Care,A., Compagnone-Post,P., Robinson,C., Cascino,I. and\n",
      "            Trucco,M.\n",
      "  TITLE     Allelic forms of the alpha- and beta-chain genes encoding\n",
      "            DQw1-positive heterodimers\n",
      "  JOURNAL   Immunogenetics 26 (4-5), 282-290 (1987)\n",
      "   PUBMED   2888727\n",
      "  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 119-254 (ALLELE DQA1*01:02).\n",
      "REFERENCE   34 (residues 1 to 254)\n",
      "  AUTHORS   Cresswell,P.\n",
      "  TITLE     Invariant chain structure and MHC class II function\n",
      "  JOURNAL   Cell 84 (4), 505-507 (1996)\n",
      "   PUBMED   8598037\n",
      "  REMARK    REVIEW.\n",
      "REFERENCE   35 (residues 1 to 254)\n",
      "  AUTHORS   Villadangos,J.A.\n",
      "  TITLE     Presentation of antigens by MHC class II molecules: getting the\n",
      "            most out of them\n",
      "  JOURNAL   Mol Immunol 38 (5), 329-346 (2001)\n",
      "   PUBMED   11684289\n",
      "  REMARK    REVIEW.\n",
      "REFERENCE   36 (residues 1 to 254)\n",
      "  AUTHORS   Menendez-Benito,V. and Neefjes,J.\n",
      "  TITLE     Autophagy in MHC class II presentation: sampling from within\n",
      "  JOURNAL   Immunity 26 (1), 1-3 (2007)\n",
      "   PUBMED   17241953\n",
      "  REMARK    REVIEW.\n",
      "REFERENCE   37 (residues 1 to 254)\n",
      "  AUTHORS   Rocha,N. and Neefjes,J.\n",
      "  TITLE     MHC class II molecules on the move for successful antigen\n",
      "            presentation\n",
      "  JOURNAL   EMBO J 27 (1), 1-5 (2008)\n",
      "   PUBMED   18046453\n",
      "  REMARK    REVIEW.\n",
      "REFERENCE   38 (residues 1 to 254)\n",
      "  AUTHORS   Berger,A.C. and Roche,P.A.\n",
      "  TITLE     MHC class II transport at a glance\n",
      "  JOURNAL   J Cell Sci 122 (Pt 1), 1-4 (2009)\n",
      "   PUBMED   19092054\n",
      "  REMARK    REVIEW.\n",
      "REFERENCE   39 (residues 1 to 254)\n",
      "  AUTHORS   Beswick,E.J. and Reyes,V.E.\n",
      "  TITLE     CD74 in antigen presentation, inflammation, and cancers of the\n",
      "            gastrointestinal tract\n",
      "  JOURNAL   World J Gastroenterol 15 (23), 2855-2861 (2009)\n",
      "   PUBMED   19533806\n",
      "  REMARK    REVIEW.\n",
      "REFERENCE   40 (residues 1 to 254)\n",
      "  AUTHORS   Lee,K.H., Wucherpfennig,K.W. and Wiley,D.C.\n",
      "  TITLE     Structure of a human insulin peptide-HLA-DQ8 complex and\n",
      "            susceptibility to type 1 diabetes\n",
      "  JOURNAL   Nat Immunol 2 (6), 501-507 (2001)\n",
      "   PUBMED   11376336\n",
      "  REMARK    X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 27-207 OF\n",
      "            HLA-DQA1/HLA-DQB1 HETERODIMER IN COMPLEX WITH INS PEPTIDE, SUBUNIT,\n",
      "            GLYCOSYLATION AT ASN-103, AND DISULFIDE BOND.\n",
      "            Erratum:[Nat Immunol 2001 Sep;2(9):889]\n",
      "REFERENCE   41 (residues 1 to 254)\n",
      "  AUTHORS   Siebold,C., Hansen,B.E., Wyer,J.R., Harlos,K., Esnouf,R.E.,\n",
      "            Svejgaard,A., Bell,J.I., Strominger,J.L., Jones,E.Y. and Fugger,L.\n",
      "  TITLE     Crystal structure of HLA-DQ0602 that protects against type 1\n",
      "            diabetes and confers strong susceptibility to narcolepsy\n",
      "  JOURNAL   Proc Natl Acad Sci U S A 101 (7), 1999-2004 (2004)\n",
      "   PUBMED   14769912\n",
      "  REMARK    X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 24-219 OF\n",
      "            HLA-DQA1/HLA-DQB1 HETERODIMER (HLA-DQ0602) IN COMPLEX WITH HCRT\n",
      "            PEPTIDE, POLYMORPHISM, SUBUNIT, AND DISULFIDE BOND.\n",
      "REFERENCE   42 (residues 1 to 254)\n",
      "  AUTHORS   Kim,C.Y., Quarsten,H., Bergseng,E., Khosla,C. and Sollid,L.M.\n",
      "  TITLE     Structural basis for HLA-DQ2-mediated presentation of gluten\n",
      "            epitopes in celiac disease\n",
      "  JOURNAL   Proc Natl Acad Sci U S A 101 (12), 4175-4179 (2004)\n",
      "   PUBMED   15020763\n",
      "  REMARK    X-RAY CRYSTALLOGRAPHY (2.22 ANGSTROMS) OF 24-216 OF\n",
      "            HLA-DQA1/HLA-DQB1 HETERODIMER (DQ2) IN COMPLEX WITH TRITICUM\n",
      "            AESTIVUM ALPHA/BETA-GLIADIN PEPTIDE, SUBUNIT, AND POLYMORPHISM.\n",
      "REFERENCE   43 (residues 1 to 254)\n",
      "  AUTHORS   Henderson,K.N., Tye-Din,J.A., Reid,H.H., Chen,Z., Borg,N.A.,\n",
      "            Beissbarth,T., Tatham,A., Mannering,S.I., Purcell,A.W., Dudek,N.L.,\n",
      "            van Heel,D.A., McCluskey,J., Rossjohn,J. and Anderson,R.P.\n",
      "  TITLE     A structural and immunological basis for the role of human\n",
      "            leukocyte antigen DQ8 in celiac disease\n",
      "  JOURNAL   Immunity 27 (1), 23-34 (2007)\n",
      "   PUBMED   17629515\n",
      "  REMARK    X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 24-206 OF\n",
      "            HLA-DQA1/HLA-DQB1 HETERODIMER IN COMPLEX WITH TRITICUM AESTIVUM\n",
      "            ALPHA/BETA-GLIADIN, SUBUNIT, AND DISULFIDE BOND.\n",
      "COMMENT     On or before Mar 30, 2010 this sequence version replaced P01908.2,\n",
      "            P05536.1, gi:74721757, gi:74705624, P01907.2, P04225.1, P04226.1,\n",
      "            gi:74706178, gi:74706836, gi:121945665, gi:121948343, gi:121945666,\n",
      "            gi:121941983, gi:74706863, gi:74706866, gi:74706867, gi:74706869,\n",
      "            gi:74706870, gi:74706871, gi:74706872, gi:74709986, gi:74727328,\n",
      "            gi:74713787, gi:74727342, gi:74717483, gi:74720013, gi:70108.\n",
      "            [FUNCTION] Binds peptides derived from antigens that access the\n",
      "            endocytic route of antigen presenting cells (APC) and presents them\n",
      "            on the cell surface for recognition by the CD4 T-cells. The peptide\n",
      "            binding cleft accommodates peptides of 10-30 residues. The peptides\n",
      "            presented by MHC class II molecules are generated mostly by\n",
      "            degradation of proteins that access the endocytic route, where they\n",
      "            are processed by lysosomal proteases and other hydrolases.\n",
      "            Exogenous antigens that have been endocytosed by the APC are thus\n",
      "            readily available for presentation via MHC II molecules, and for\n",
      "            this reason this antigen presentation pathway is usually referred\n",
      "            to as exogenous. As membrane proteins on their way to degradation\n",
      "            in lysosomes as part of their normal turn-over are also contained\n",
      "            in the endosomal/lysosomal compartments, exogenous antigens must\n",
      "            compete with those derived from endogenous components. Autophagy is\n",
      "            also a source of endogenous peptides, autophagosomes constitutively\n",
      "            fuse with MHC class II loading compartments. In addition to APCs,\n",
      "            other cells of the gastrointestinal tract, such as epithelial\n",
      "            cells, express MHC class II molecules and CD74 and act as APCs,\n",
      "            which is an unusual trait of the GI tract. To produce a MHC class\n",
      "            II molecule that presents an antigen, three MHC class II molecules\n",
      "            (heterodimers of an alpha and a beta chain) associate with a CD74\n",
      "            trimer in the ER to form a heterononamer. Soon after the entry of\n",
      "            this complex into the endosomal/lysosomal system where antigen\n",
      "            processing occurs, CD74 undergoes a sequential degradation by\n",
      "            various proteases, including CTSS and CTSL, leaving a small\n",
      "            fragment termed CLIP (class-II-associated invariant chain peptide).\n",
      "            The removal of CLIP is facilitated by HLA-DM via direct binding to\n",
      "            the alpha-beta-CLIP complex so that CLIP is released. HLA-DM\n",
      "            stabilizes MHC class II molecules until primary high affinity\n",
      "            antigenic peptides are bound. The MHC II molecule bound to a\n",
      "            peptide is then transported to the cell membrane surface. In\n",
      "            B-cells, the interaction between HLA-DM and MHC class II molecules\n",
      "            is regulated by HLA-DO. Primary dendritic cells (DCs) also to\n",
      "            express HLA-DO. Lysosomal microenvironment has been implicated in\n",
      "            the regulation of antigen loading into MHC II molecules, increased\n",
      "            acidification produces increased proteolysis and efficient peptide\n",
      "            loading.\n",
      "            [SUBUNIT] Heterodimer of an alpha and a beta subunit; also referred\n",
      "            as MHC class II molecule. In the endoplasmic reticulum (ER) it\n",
      "            forms a heterononamer; 3 MHC class II molecules bind to a CD74\n",
      "            homotrimer (also known as invariant chain or HLA class II\n",
      "            histocompatibility antigen gamma chain). In the endosomal/lysosomal\n",
      "            system; CD74 undergoes sequential degradation by various proteases;\n",
      "            leaving a small fragment termed CLIP on each MHC class II molecule.\n",
      "            MHC class II molecule interacts with HLA_DM, and HLA_DO in B-cells,\n",
      "            in order to release CLIP and facilitate the binding of antigenic\n",
      "            peptides. {ECO:0000269|PubMed:11376336,\n",
      "            ECO:0000269|PubMed:14769912, ECO:0000269|PubMed:15020763,\n",
      "            ECO:0000269|PubMed:17629515}.\n",
      "            [INTERACTION] P01909; P01920: HLA-DQB1; NbExp=8; IntAct=EBI-713389,\n",
      "            EBI-1038012.\n",
      "            [SUBCELLULAR LOCATION] Cell membrane; Single-pass type I membrane\n",
      "            protein. Endoplasmic reticulum membrane; Single-pass type I\n",
      "            membrane protein. Golgi apparatus, trans-Golgi network membrane;\n",
      "            Single-pass type I membrane protein. Endosome membrane; Single-pass\n",
      "            type I membrane protein. Lysosome membrane; Single-pass type I\n",
      "            membrane protein. Note=The MHC class II complex transits through a\n",
      "            number of intracellular compartments in the endocytic pathway until\n",
      "            it reaches the cell membrane for antigen presentation.\n",
      "            [POLYMORPHISM] The following alleles of DQA1 are known: DQA1*01:01,\n",
      "            DQA1*01:02, DQA1*01:03, DQA1*01:04, DQA1*01:05, DQA1*01:06,\n",
      "            DQA1*01:07, DQA1*02:01, DQA1*03:01, DQA1*03:02, DQA1*03:03,\n",
      "            DQA1*04:01, DQA1*04:02, DQA1*04:03, DQA1*04:04, DQA1*05:01,\n",
      "            DQA1*05:02, DQA1*05:03, DQA1*05:04, DQA1*05:05, DQA1*05:06,\n",
      "            DQA1*05:07, DQA1*05:08, DQA1*05:09, DQA1*06:01, DQA1*06:02. The\n",
      "            sequence shown is that of DQA1*05:01.\n",
      "            [POLYMORPHISM] DQ2 (heterodimer of DQA1*05:01/DQB1*02:01) is\n",
      "            associated with more than 90% of celiac disease patients. A\n",
      "            minority displays DQ8 (heterodimer of DQA1*03/DQB1*03:02). DQ0602\n",
      "            (heterodimer of DQA1*01:02/DQB1*06:02) confers dominant protection\n",
      "            against type 1 diabetes (T1D) and strong susceptibility to\n",
      "            narcolepsy.\n",
      "            [SIMILARITY] Belongs to the MHC class II family. {ECO:0000305}.\n",
      "            [SEQUENCE CAUTION] Sequence=AAD56720.1; Type=Erroneous gene model\n",
      "            prediction; Evidence={ECO:0000305}.\n",
      "FEATURES             Location/Qualifiers\n",
      "     source          1..254\n",
      "                     /organism=\"Homo sapiens\"\n",
      "                     /db_xref=\"taxon:9606\"\n",
      "     gene            1..254\n",
      "                     /gene=\"HLA-DQA1\"\n",
      "     Protein         1..254\n",
      "                     /product=\"HLA class II histocompatibility antigen, DQ\n",
      "                     alpha 1 chain\"\n",
      "                     /note=\"DC-1 alpha chain; DC-alpha; HLA-DCA; MHC class II\n",
      "                     DQA1\"\n",
      "                     /UniProtKB_evidence=\"Evidence at protein level\"\n",
      "     Region          1..23\n",
      "                     /region_name=\"Signal\"\n",
      "                     /note=\"/evidence=ECO:0000269|PubMed:6576979.\"\n",
      "     Region          8\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"M -> L (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*04:01 and allele DQA1*06:01; dbSNP:rs1047989).\n",
      "                     /id=VAR_033399.\"\n",
      "     Region          11\n",
      "                     /region_name=\"Conflict\"\n",
      "                     /note=\"A -> S (in Ref. 4; AAA59760).\n",
      "                     /evidence=ECO:0000305.\"\n",
      "     Region          11\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"A -> T (in allele DQA1*05:05, allele DQA1*05:08 and\n",
      "                     allele DQA1*05:09; dbSNP:rs1047992). /id=VAR_033400.\"\n",
      "     Region          17\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"V -> M (in allele DQA1*01:04 and allele DQA1*01:05;\n",
      "                     dbSNP:rs12722039). /id=VAR_050380.\"\n",
      "     Region          18\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"M -> T (in allele DQA1*03:03; dbSNP:rs11545686).\n",
      "                     /id=VAR_050381.\"\n",
      "     Region          23..27\n",
      "                     /region_name=\"Conflict\"\n",
      "                     /note=\"Missing (in Ref. 16; AAA59754).\n",
      "                     /evidence=ECO:0000305.\"\n",
      "     Region          24..254\n",
      "                     /region_name=\"Mature chain\"\n",
      "                     /note=\"HLA class II histocompatibility antigen, DQ alpha 1\n",
      "                     chain. /id=PRO_0000018970.\"\n",
      "     Region          24..216\n",
      "                     /region_name=\"Topological domain\"\n",
      "                     /note=\"Extracellular. /evidence=ECO:0000255.\"\n",
      "     Region          24..119\n",
      "                     /region_name=\"Region of interest in the sequence\"\n",
      "                     /note=\"Alpha-1.\"\n",
      "     Region          24\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"E -> K (in allele DQA1*05:09; dbSNP:rs41545012).\n",
      "                     /id=VAR_060493.\"\n",
      "     Region          25\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"D -> G (in allele DQA1*01:04 and allele DQA1*01:05;\n",
      "                     dbSNP:rs12722042). /id=VAR_050382.\"\n",
      "     Region          29..108\n",
      "                     /region_name=\"MHC_II_alpha\"\n",
      "                     /note=\"Class II histocompatibility antigen, alpha domain;\n",
      "                     pfam00993\"\n",
      "                     /db_xref=\"CDD:425978\"\n",
      "     Region          29..40\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          34\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"Y -> C (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1129740).\n",
      "                     /id=VAR_060494.\"\n",
      "     Region          41..44\n",
      "                     /region_name=\"Hydrogen bonded turn\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          41\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"S -> F (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1071630).\n",
      "                     /id=VAR_033401.\"\n",
      "     Region          44\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"P -> L (in allele DQA1*05:04; dbSNP:rs41549715).\n",
      "                     /id=VAR_060495.\"\n",
      "     Region          45..52\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          48\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"Y -> F (in allele DQA1*02:01, allele DQA1*01:03,\n",
      "                     allele DQA1*06:01 and allele DQA1*06:02;\n",
      "                     dbSNP:rs12722051). /id=VAR_033402.\"\n",
      "     Region          49\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"T -> S (in allele DQA1*03:01, allele DQA1*03:02 and\n",
      "                     allele DQA1*03:03; dbSNP:rs1048023). /id=VAR_033403.\"\n",
      "     Region          55..61\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          57\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"Q -> E (in allele DQA1*01:01, allele DQA1*01:04,\n",
      "                     allele DQA1*01:05, allele DQA1*01:07, allele DQA1*02:01,\n",
      "                     allele DQA1*03:01, allele DQA1*03:02 and allele\n",
      "                     DQA1*03:03; dbSNP:rs10093). /id=VAR_014604.\"\n",
      "     Region          62..65\n",
      "                     /region_name=\"Hydrogen bonded turn\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          63\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"G -> E (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06, allele DQA1*01:07, allele DQA1*02:01,\n",
      "                     allele DQA1*03:01, allele DQA1*03:02 and allele\n",
      "                     DQA1*03:03; dbSNP:rs1142323). /id=VAR_060496.\"\n",
      "     Region          64\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"R -> K (in allele DQA1*01:03; dbSNP:rs36219699).\n",
      "                     /id=VAR_050383.\"\n",
      "     Region          66..71\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          67\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"T -> A (in allele DQA1*01:06; dbSNP:rs41543221).\n",
      "                     /id=VAR_060497.\"\n",
      "     Region          68\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"V -> A (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1142324).\n",
      "                     /id=VAR_060498.\"\n",
      "     Region          70\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"C -> K (in allele DQA1*02:01; requires 2 nucleotide\n",
      "                     substitutions). /id=VAR_060499.\"\n",
      "     Region          70\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"C -> Q (in allele DQA1*03:01, allele DQA1*03:02 and\n",
      "                     allele DQA1*03:03; requires 2 nucleotide substitutions).\n",
      "                     /id=VAR_060500.\"\n",
      "     Region          70\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"C -> R (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1142326).\n",
      "                     /id=VAR_060501.\"\n",
      "     Region          70\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"C -> Y (in dbSNP:rs3207983). /id=VAR_033404.\"\n",
      "     Region          71\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"L -> W (in allele DQA1*01:01, allele\n",
      "                     DQA1*01:02,allele DQA1*01:03, allele DQA1*01:04, allele\n",
      "                     DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07;\n",
      "                     dbSNP:rs1142328). /id=VAR_060502.\"\n",
      "     Region          72..76\n",
      "                     /region_name=\"Helical region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          73\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"V -> D (in dbSNP:rs760671632). /id=VAR_033406.\"\n",
      "     Region          73\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"V -> E (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs3208105).\n",
      "                     /id=VAR_060503.\"\n",
      "     Region          73\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"V -> L (in allele DQA1*02:01, allele DQA1*03:01,\n",
      "                     allele DQA1*03:02 and allele DQA1*03:03;\n",
      "                     dbSNP:rs12722061). /id=VAR_033405.\"\n",
      "     Region          74\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"L -> F (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06, allele DQA1*01:07, allele DQA1*02:01,\n",
      "                     allele DQA1*03:01, allele DQA1*03:02 and allele\n",
      "                     DQA1*03:03; dbSNP:rs9272698). /id=VAR_060504.\"\n",
      "     Region          75\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"R -> H (in allele DQA1*02:01; dbSNP:rs28383449).\n",
      "                     /id=VAR_060505.\"\n",
      "     Region          75\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"R -> S (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs9272699).\n",
      "                     /id=VAR_060506.\"\n",
      "     Region          76\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"Q -> K (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1048052).\n",
      "                     /id=VAR_060507.\"\n",
      "     Region          76\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"Q -> R (in allele DQA1*02:01, allele DQA1*03:01,\n",
      "                     allele DQA1*03:02 and allele DQA1*03:03;\n",
      "                     dbSNP:rs12722069). /id=VAR_060508.\"\n",
      "     Region          77\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"F -> L (in allele DQA1*02:01; dbSNP:rs3188043).\n",
      "                     /id=VAR_060509.\"\n",
      "     Region          78\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"R -> GG (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele\n",
      "                     DQA1*01:05,allele DQA1*01:06 and allele DQA1*01:07;\n",
      "                     dbSNP:rs4193). /id=VAR_060510.\"\n",
      "     Region          78\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"R -> RR (in allele DQA1*03:01, allele DQA1*03:02\n",
      "                     and allele DQA1*03:03). /id=VAR_060511.\"\n",
      "     Region          81..101\n",
      "                     /region_name=\"Helical region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          81\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"P -> R (in allele DQA1*05:02; dbSNP:rs41541412).\n",
      "                     /id=VAR_060512.\"\n",
      "     Region          83\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"F -> G (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06 and allele DQA1*01:07; requires 2\n",
      "                     nucleotide substitutions). /id=VAR_060513.\"\n",
      "     Region          86\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"T -> R (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1142333).\n",
      "                     /id=VAR_033408.\"\n",
      "     Region          88\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"I -> M (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1142334).\n",
      "                     /id=VAR_033409.\"\n",
      "     Region          91\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"L -> A (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06 and allele DQA1*01:07; requires 2\n",
      "                     nucleotide substitutions). /id=VAR_060514.\"\n",
      "     Region          91\n",
      "                     /region_name=\"Conflict\"\n",
      "                     /note=\"L -> H (in Ref. 4; AAA59760).\n",
      "                     /evidence=ECO:0000305.\"\n",
      "     Region          91\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"L -> T (in allele DQA1*04:01, allele DQA1*04:02,\n",
      "                     allele DQA1*04:04, allele DQA1*06:01 and allele\n",
      "                     DQA1*06:02; requires 2 nucleotide substitutions).\n",
      "                     /id=VAR_060515.\"\n",
      "     Region          97\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"S -> I (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06, allele DQA1*01:07, allele DQA1*02:01,\n",
      "                     allele DQA1*03:01, allele DQA1*03:02, allele DQA1*03:03,\n",
      "                     allele DQA1*04:01, allele DQA1*04:02, allele DQA1*04:04,\n",
      "                     allele DQA1*06:01 and allele DQA1*06:02; dbSNP:rs9279910).\n",
      "                     /id=VAR_060516.\"\n",
      "     Region          98\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"L -> M (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1064944).\n",
      "                     /id=VAR_060517.\"\n",
      "     Region          98\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"L -> V (in allele DQA1*03:01, allele DQA1*03:02 and\n",
      "                     allele DQA1*03:03; dbSNP:rs1064944). /id=VAR_060518.\"\n",
      "     Region          101\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"R -> C (in allele DQA1*01:07; dbSNP:rs41542116).\n",
      "                     /id=VAR_060519.\"\n",
      "     Region          102..104\n",
      "                     /region_name=\"Hydrogen bonded turn\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:1JK8.\"\n",
      "     Region          102\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"S -> Y (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1129808).\n",
      "                     /id=VAR_050384.\"\n",
      "     Site            103\n",
      "                     /site_type=\"glycosylation\"\n",
      "                     /note=\"N-linked (GlcNAc...) asparagine.\n",
      "                     /evidence=ECO:0000255.\"\n",
      "     Region          107\n",
      "                     /region_name=\"Conflict\"\n",
      "                     /note=\"A -> P (in Ref. 16; AAA59754).\n",
      "                     /evidence=ECO:0000305.\"\n",
      "     Region          110..204\n",
      "                     /region_name=\"IgC1_MHC_II_alpha_HLA-DQ\"\n",
      "                     /note=\"Class II major histocompatibility complex (MHC)\n",
      "                     alpha chain immunoglobulin domain of histocompatibility\n",
      "                     antigen (HLA) DQ and related proteins; member of the\n",
      "                     C1-set of Ig superfamily (IgSF) domains; cd21008\"\n",
      "                     /db_xref=\"CDD:409599\"\n",
      "     Region          111..119\n",
      "                     /region_name=\"Ig strand A\"\n",
      "                     /note=\"Ig strand A [structural motif]\"\n",
      "                     /db_xref=\"CDD:409599\"\n",
      "     Region          112..204\n",
      "                     /region_name=\"Domain\"\n",
      "                     /note=\"Ig-like C1-type.\"\n",
      "     Region          113..120\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Site            order(115,117..119,121,173,175)\n",
      "                     /site_type=\"other\"\n",
      "                     /note=\"heterodimer interface [polypeptide binding]\"\n",
      "                     /db_xref=\"CDD:409599\"\n",
      "     Region          120..203\n",
      "                     /region_name=\"Region of interest in the sequence\"\n",
      "                     /note=\"Alpha-2.\"\n",
      "     Region          124..126\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:4OZF.\"\n",
      "     Region          124\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"L -> V (in allele DQA1*05:06; dbSNP:rs41555012).\n",
      "                     /id=VAR_060520.\"\n",
      "     Region          127..136\n",
      "                     /region_name=\"Ig strand B\"\n",
      "                     /note=\"Ig strand B [structural motif]\"\n",
      "                     /db_xref=\"CDD:409599\"\n",
      "     Region          128..137\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          129\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"I -> T (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01,\n",
      "                     allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,\n",
      "                     allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01\n",
      "                     and allele DQA1*06:02; dbSNP:rs707952). /id=VAR_050385.\"\n",
      "     Bond            bond(132,188)\n",
      "                     /bond_type=\"disulfide\"\n",
      "                     /note=\"/evidence=ECO:0000255|PROSITE-ProRule:PRU00114,\n",
      "                     ECO:0000269|PubMed:11376336, ECO:0000269|PubMed:14769912,\n",
      "                     ECO:0000269|PubMed:17629515.\"\n",
      "     Site            order(139..141,160..163,169..170,175)\n",
      "                     /site_type=\"other\"\n",
      "                     /note=\"MHC binding domain interface [polypeptide binding]\"\n",
      "                     /db_xref=\"CDD:409599\"\n",
      "     Region          142..148\n",
      "                     /region_name=\"Ig strand C\"\n",
      "                     /note=\"Ig strand C [structural motif]\"\n",
      "                     /db_xref=\"CDD:409599\"\n",
      "     Region          143..148\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Site            143\n",
      "                     /site_type=\"glycosylation\"\n",
      "                     /note=\"N-linked (GlcNAc...) asparagine.\n",
      "                     /evidence=ECO:0000255.\"\n",
      "     Region          150..153\n",
      "                     /region_name=\"Ig strand C'\"\n",
      "                     /note=\"Ig strand C' [structural motif]\"\n",
      "                     /db_xref=\"CDD:409599\"\n",
      "     Region          151..153\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          151\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"H -> Q (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:04, allele DQA1*01:05 and allele\n",
      "                     DQA1*01:07; dbSNP:rs707950). /id=VAR_050386.\"\n",
      "     Region          152\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"S -> A (in allele DQA1*01:03; dbSNP:rs41547417).\n",
      "                     /id=VAR_060521.\"\n",
      "     Region          156\n",
      "                     /region_name=\"Conflict\"\n",
      "                     /note=\"G -> D (in Ref. 3; CAA25141).\n",
      "                     /evidence=ECO:0000305.\"\n",
      "     Region          157..165\n",
      "                     /region_name=\"Ig strand D\"\n",
      "                     /note=\"Ig strand D [structural motif]\"\n",
      "                     /db_xref=\"CDD:409599\"\n",
      "     Region          157..159\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          160\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"T -> I (in allele DQA1*04:02; dbSNP:rs41545514).\n",
      "                     /id=VAR_060522.\"\n",
      "     Region          161\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"S -> I (in allele DQA1*05:08; dbSNP:rs41544114).\n",
      "                     /id=VAR_060524.\"\n",
      "     Region          161\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"S -> R (in allele DQA1*06:02; dbSNP:rs41552014).\n",
      "                     /id=VAR_060523.\"\n",
      "     Region          168..178\n",
      "                     /region_name=\"Ig strand E\"\n",
      "                     /note=\"Ig strand E [structural motif]\"\n",
      "                     /db_xref=\"CDD:409599\"\n",
      "     Region          170..178\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          175\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"Y -> H (in allele DQA1*04:04; dbSNP:rs41550317).\n",
      "                     /id=VAR_060525.\"\n",
      "     Region          178\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"L -> F (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01,\n",
      "                     allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,\n",
      "                     allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01\n",
      "                     and allele DQA1*06:02; dbSNP:rs707949). /id=VAR_060526.\"\n",
      "     Region          182\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"A -> D (in allele DQA1*03:02 and allele DQA1*03:03;\n",
      "                     dbSNP:rs7990). /id=VAR_060527.\"\n",
      "     Region          182\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"A -> S (in allele DQA1*05:03, allele DQA1*05:06 and\n",
      "                     allele DQA1*05:07; dbSNP:rs41561312). /id=VAR_060528.\"\n",
      "     Region          183\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"E -> D (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01,\n",
      "                     allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,\n",
      "                     allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01\n",
      "                     and allele DQA1*06:02; dbSNP:rs707963). /id=VAR_060529.\"\n",
      "     Region          185..192\n",
      "                     /region_name=\"Ig strand F\"\n",
      "                     /note=\"Ig strand F [structural motif]\"\n",
      "                     /db_xref=\"CDD:409599\"\n",
      "     Region          185\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"S -> I (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\n",
      "                     allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01,\n",
      "                     allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,\n",
      "                     allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01\n",
      "                     and allele DQA1*06:02; dbSNP:rs707962). /id=VAR_060530.\"\n",
      "     Region          186..191\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          195..197\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          197\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"K -> E (in allele DQA1*02:01, allele DQA1*03:01,\n",
      "                     allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,\n",
      "                     allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01\n",
      "                     and allele DQA1*06:02; dbSNP:rs2308891). /id=VAR_060531.\"\n",
      "     Region          197\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"K -> Q (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05\n",
      "                     and allele DQA1*01:07; dbSNP:rs2308891). /id=VAR_060532.\"\n",
      "     Region          198..203\n",
      "                     /region_name=\"Ig strand G\"\n",
      "                     /note=\"Ig strand G [structural motif]\"\n",
      "                     /db_xref=\"CDD:409599\"\n",
      "     Region          199..203\n",
      "                     /region_name=\"Beta-strand region\"\n",
      "                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\n",
      "     Region          204..216\n",
      "                     /region_name=\"Region of interest in the sequence\"\n",
      "                     /note=\"Connecting peptide.\"\n",
      "     Region          209\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"A -> T (in allele DQA1*03:01, allele DQA1*03:02 and\n",
      "                     allele DQA1*03:03; dbSNP:rs9272785). /id=VAR_050387.\"\n",
      "     Region          213\n",
      "                     /region_name=\"Conflict\"\n",
      "                     /note=\"E -> D (in Ref. 16; AAA59754).\n",
      "                     /evidence=ECO:0000305.\"\n",
      "     Region          217..239\n",
      "                     /region_name=\"Transmembrane region\"\n",
      "                     /note=\"Helical. /evidence=ECO:0000255.\"\n",
      "     Region          221\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"A -> T (in allele DQA1*01:04; dbSNP:rs35087390).\n",
      "                     /id=VAR_050388.\"\n",
      "     Region          229\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"V -> M (in allele DQA1*01:02; dbSNP:rs9260).\n",
      "                     /id=VAR_033411.\"\n",
      "     Region          230\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"G -> C (in allele DQA1*05:07; dbSNP:rs41545416).\n",
      "                     /id=VAR_060533.\"\n",
      "     Region          237\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"F -> L (in allele DQA1*02:01, allele DQA1*03:01,\n",
      "                     allele DQA1*03:02 and allele DQA1*03:03; dbSNP:rs1048430).\n",
      "                     /id=VAR_033412.\"\n",
      "     Region          240..254\n",
      "                     /region_name=\"Topological domain\"\n",
      "                     /note=\"Cytoplasmic.\"\n",
      "     Region          240\n",
      "                     /region_name=\"Variant\"\n",
      "                     /note=\"R -> Q (in allele DQA1*01:01, allele DQA1*01:02,\n",
      "                     allele DQA1*01:03, allele DQA1*01:04 and allele\n",
      "                     DQA1*01:05; dbSNP:rs1048439). /id=VAR_033413.\"\n",
      "ORIGIN      \n",
      "        1 milnkalmlg alalttvmsp cggedivadh vasygvnlyq sygpsgqyth efdgdeqfyv\n",
      "       61 dlgrketvwc lpvlrqfrfd pqfaltniav lkhnlnslik rsnstaatne vpevtvfsks\n",
      "      121 pvtlgqpnil iclvdnifpp vvnitwlsng hsvtegvset sflsksdhsf fkisyltllp\n",
      "      181 saeesydckv ehwgldkpll khwepeipap mseltetvvc alglsvglvg ivvgtvfiir\n",
      "      241 glrsvgasrh qgpl\n",
      "//\n",
      "\n",
      "\n",
      "Concluído.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'LOCUS       DQA1_HUMAN               254 aa            linear   PRI 08-NOV-2023\\nDEFINITION  RecName: Full=HLA class II histocompatibility antigen, DQ alpha 1\\n            chain; AltName: Full=DC-1 alpha chain; AltName: Full=DC-alpha;\\n            AltName: Full=HLA-DCA; AltName: Full=MHC class II DQA1; Flags:\\n            Precursor.\\nACCESSION   P01909\\nVERSION     P01909.1\\nDBSOURCE    UniProtKB: locus DQA1_HUMAN, accession P01909;\\n            class: standard.\\n            extra\\n            accessions:O19630,O19706,P01907,P01908,P04225,P04226,P05536,P79553,\\n            Q06751,Q29876,Q29994,Q2Q6Y6,Q2Q6Y7,Q2Q6Y8,Q2WCM3,Q30064,Q30067,\\n            Q30068,Q30070,Q30071,Q30072,Q30073,Q30086,Q30101,Q5Y7D5,Q5Y7F5,\\n            Q6ICU6,Q6PR46,Q6QDB1,Q860W2,Q860W4,Q9BD37,Q9TPM3,Q9UM31\\n            created: Jul 21, 1986.\\n            sequence updated: Jul 21, 1986.\\n            annotation updated: Nov 8, 2023.\\n            xrefs: X00033.1, CAA24917.1, X00370.1, X00452.1, CAA25141.1,\\n            M16995.1, AAA59760.1, U92032.1, AAB91990.1, AY663395.1, AAU87978.1,\\n            AY663398.1, AAU87987.1, AY663400.1, AAU87992.1, AY663406.1,\\n            AAU88007.1, AY663411.1, AAU88022.1, AY663413.1, AAU88028.1,\\n            DQ178403.1, ABA86855.1, DQ178400.1, DQ178401.1, DQ178402.1,\\n            DQ178407.1, ABA86856.1, DQ178404.1, DQ178405.1, DQ178406.1,\\n            DQ178411.1, ABA86857.1, DQ178408.1, DQ178409.1, DQ178410.1,\\n            DQ178415.1, ABA86858.1, DQ178412.1, DQ178413.1, DQ178414.1,\\n            M29616.1, AAA59759.1, M29613.1, AF322870.1, AAK11577.1, AF322867.1,\\n            AF322868.1, AF322869.1, AF395700.1, AAM69677.1, AF395697.1,\\n            AF395698.1, AF395699.1, CR450297.1, CAG29293.1, AM042559.1,\\n            CAJ14960.1, AM042560.1, CAJ14961.1, AK313975.1, BAG36689.1,\\n            BX248406.4, AL662789.11, Z84489.1, CAB06491.1, BC008585.1,\\n            AAH08585.1, BC157865.1, AAI57866.1, L46875.1, L46876.1, L46877.1,\\n            L46878.1, L46880.1, L46881.1, M11124.1, AAA59754.1, M20431.1,\\n            AAA59758.1, L34082.1, AAC41950.1, L34085.1, AAC41953.1, L34086.1,\\n            AAC41954.1, L34089.1, AAC41957.1, L34090.1, AAC41958.1, L34092.1,\\n            AAC41960.1, L34093.1, AAC41961.1, L34094.1, AAC41962.1, L42625.1,\\n            AAA85334.1, AY197775.1, AAO45622.1, AY547314.1, AAS49496.1,\\n            AY206406.1, AAO47362.1, AY585236.1, AAT09985.1, M34997.1,\\n            AAA35772.1, M34999.1, AAA74633.1, U85035.1, AAB41891.1, AF109734.1,\\n            AAD56720.1, U03675.1, AAB60341.1, M20506.1, AAA59774.1, J00199.1,\\n            M17846.1, AAA59707.1, HLHUD1, HLHUDQ, HLHUD7, HLHU3C, HLHUDC,\\n            B27628, D34512, NP_002113.2, 1JK8_A, 1S9V_A, 1S9V_D, 1UVQ_A,\\n            2NNA_A, 4GG6_A, 4GG6_C, 4OZF_A, 4OZG_A, 4OZG_C, 4OZH_A, 4OZH_C,\\n            4OZI_A, 4OZI_C, 5KSA_A, 5KSB_A, 5KSB_C, 5KSU_A, 5KSU_D, 5KSV_A,\\n            6MFF_A, 6MFG_A, 6MFG_C, 6U3M_A, 6U3M_C, 6U3N_A, 6XP6_A, 6XP6_D,\\n            7SG0_A, 7SG1_A, 7SG1_F, 7SG2_A, 7SG2_F\\n            xrefs (non-sequence databases): PDBsum:1JK8, PDBsum:1S9V,\\n            PDBsum:1UVQ, PDBsum:2NNA, PDBsum:4GG6, PDBsum:4OZF, PDBsum:4OZG,\\n            PDBsum:4OZH, PDBsum:4OZI, PDBsum:5KSA, PDBsum:5KSB, PDBsum:5KSU,\\n            PDBsum:5KSV, PDBsum:6MFF, PDBsum:6MFG, PDBsum:6U3M, PDBsum:6U3N,\\n            PDBsum:6XP6, PDBsum:7SG0, PDBsum:7SG1, PDBsum:7SG2,\\n            AlphaFoldDB:P01909, SMR:P01909, BioGRID:109362, BioGRID:1529240,\\n            IntAct:P01909, ChEMBL:CHEMBL4105884, TCDB:9.A.75.1.1,\\n            GlyConnect:1986, GlyCosmos:P01909, GlyGen:P01909, iPTMnet:P01909,\\n            BioMuta:HLA-DQA1, DMDM:122188, jPOST:P01909, MassIVE:P01909,\\n            PeptideAtlas:P01909, ProteomicsDB:51510, ABCD:P01909,\\n            Antibodypedia:2728, CPTC:P01909, DNASU:3117,\\n            Ensembl:ENST00000343139.11, Ensembl:ENSP00000339398.5,\\n            Ensembl:ENSG00000196735.13, Ensembl:ENST00000374949.2,\\n            Ensembl:ENSP00000364087.2, Ensembl:ENST00000383251.6,\\n            Ensembl:ENSP00000372738.2, Ensembl:ENSG00000206305.12,\\n            Ensembl:ENST00000395363.5, Ensembl:ENSP00000378767.1,\\n            Ensembl:ENST00000399675.5, Ensembl:ENSP00000382583.1,\\n            Ensembl:ENST00000399678.5, Ensembl:ENSP00000382586.1,\\n            Ensembl:ENST00000418023.5, Ensembl:ENSP00000387892.1,\\n            Ensembl:ENSG00000232062.9, Ensembl:ENST00000444296.6,\\n            Ensembl:ENSP00000413237.2, GeneID:3117, KEGG:hsa:3117,\\n            MANE-Select:ENST00000343139.11, UCSC:uc003obr.4, AGR:HGNC:4942,\\n            CTD:3117, DisGeNET:3117, GeneCards:HLA-DQA1, GeneReviews:HLA-DQA1,\\n            HGNC:4942, HPA:ENSG00000196735, MalaCards:HLA-DQA1, MIM:146880,\\n            neXtProt:NX_P01909, NIAGADS:ENSG00000196735, Orphanet:391490,\\n            Orphanet:930, Orphanet:555, Orphanet:243377, PharmGKB:PA35066,\\n            VEuPathDB:HostDB:ENSG00000196735, HOGENOM:CLU_069380_0_0_1,\\n            InParanoid:P01909, OrthoDB:4118190at2759, PhylomeDB:P01909,\\n            TreeFam:TF333797, PathwayCommons:P01909, Reactome:R-HSA-202424,\\n            Reactome:R-HSA-202427, Reactome:R-HSA-202430,\\n            Reactome:R-HSA-202433, Reactome:R-HSA-2132295,\\n            Reactome:R-HSA-389948, Reactome:R-HSA-877300, SignaLink:P01909,\\n            SIGNOR:P01909, BioGRID-ORCS:3117, ChiTaRS:HLA-DQA1,\\n            EvolutionaryTrace:P01909, GenomeRNAi:3117, Pharos:P01909,\\n            PRO:PR:P01909, Proteomes:UP000005640, RNAct:P01909,\\n            Bgee:ENSG00000196735, ExpressionAtlas:P01909, Genevisible:P01909,\\n            GO:0030669, GO:0030666, GO:0012507, GO:0000139, GO:0031902,\\n            GO:0098553, GO:0005765, GO:0016020, GO:0042613, GO:0005886,\\n            GO:0032588, GO:0030658, GO:0023026, GO:0032395, GO:0042605,\\n            GO:0002250, GO:0019886, GO:0006955, GO:0002503, GO:0050778,\\n            GO:0050870, CDD:cd21008, Gene3D:2.60.40.10, InterPro:IPR007110,\\n            InterPro:IPR036179, InterPro:IPR013783, InterPro:IPR003006,\\n            InterPro:IPR003597, InterPro:IPR011162, InterPro:IPR014745,\\n            InterPro:IPR001003, PANTHER:PTHR19944:SF59, PANTHER:PTHR19944,\\n            Pfam:PF07654, Pfam:PF00993, SMART:SM00407, SMART:SM00920,\\n            SUPFAM:SSF48726, SUPFAM:SSF54452, PROSITE:PS50835, PROSITE:PS00290\\nKEYWORDS    3D-structure; Adaptive immunity; Cell membrane; Direct protein\\n            sequencing; Disulfide bond; Endoplasmic reticulum; Endosome;\\n            Glycoprotein; Golgi apparatus; Immunity; Lysosome; Membrane; MHC\\n            II; Reference proteome; Signal; Transmembrane; Transmembrane helix.\\nSOURCE      Homo sapiens (human)\\n  ORGANISM  Homo sapiens\\n            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;\\n            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;\\n            Catarrhini; Hominidae; Homo.\\nREFERENCE   1  (residues 1 to 254)\\n  AUTHORS   Chang,H.C., Moriuchi,T. and Silver,J.\\n  TITLE     The heavy chain of human B-cell alloantigen HLA-DS has a variable\\n            N-terminal region and a constant immunoglobulin-like region\\n  JOURNAL   Nature 305 (5937), 813-815 (1983)\\n   PUBMED   6415485\\n  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*02:01).\\nREFERENCE   2  (residues 1 to 254)\\n  AUTHORS   Schenning,L., Larhammar,D., Bill,P., Wiman,K., Jonsson,A.K.,\\n            Rask,L. and Peterson,P.A.\\n  TITLE     Both alpha and beta chains of HLA-DC class II histocompatibility\\n            antigens display extensive polymorphism in their amino-terminal\\n            domains\\n  JOURNAL   EMBO J 3 (2), 447-452 (1984)\\n   PUBMED   6585297\\n  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*05:01).\\nREFERENCE   3  (residues 1 to 254)\\n  AUTHORS   Auffray,C., Lillie,J.W., Arnot,D., Grossberger,D., Kappes,D. and\\n            Strominger,J.L.\\n  TITLE     Isotypic and allotypic variation of human class II\\n            histocompatibility antigen alpha-chain genes\\n  JOURNAL   Nature 308 (5957), 327-333 (1984)\\n   PUBMED   6584734\\n  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ALLELES DQA1*01:02 AND ALLELE\\n            DQA1*03:01).\\nREFERENCE   4  (residues 1 to 254)\\n  AUTHORS   Schiffenbauer,J., Didier,D.K., Klearman,M., Rice,K., Shuman,S.,\\n            Tieber,V.L., Kittlesen,D.J. and Schwartz,B.D.\\n  TITLE     Complete sequence of the HLA DQ alpha and DQ beta cDNA from a\\n            DR5/DQw3 cell line\\n  JOURNAL   J Immunol 139 (1), 228-233 (1987)\\n   PUBMED   3584986\\n  REMARK    NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*05:01).\\n            Erratum:[J Immunol 1991 Mar 1;146(5):1715]\\nREFERENCE   5  (residues 1 to 254)\\n  AUTHORS   Ellis,M.C., Hetisimer,A.H., Ruddy,D.A., Hansen,S.L., Kronmal,G.S.,\\n            McClelland,E., Quintana,L., Drayna,D.T., Aldrich,M.S. and Mignot,E.\\n  TITLE     HLA class II haplotype and sequence analysis support a role for DQ\\n            in narcolepsy\\n  JOURNAL   Immunogenetics 46 (5), 410-417 (1997)\\n   PUBMED   9271631\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*05:01).\\nREFERENCE   6  (residues 1 to 254)\\n  AUTHORS   Raymond,C.K., Kas,A., Paddock,M., Qiu,R., Zhou,Y., Subramanian,S.,\\n            Chang,J., Palmieri,A., Haugen,E., Kaul,R. and Olson,M.V.\\n  TITLE     Ancient haplotypes of the HLA Class II region\\n  JOURNAL   Genome Res 15 (9), 1250-1257 (2005)\\n   PUBMED   16140993\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:01; DQA1*01:02\\n            AND DQA1*03:01).\\nREFERENCE   7  (residues 1 to 254)\\n  AUTHORS   Lee,K.W., Jung,Y.A. and Oh,D.H.\\n  TITLE     Four novel human leukocyte antigen-DQA1 alleles identified in the\\n            Korean population\\n  JOURNAL   Tissue Antigens 68 (2), 167-172 (2006)\\n   PUBMED   16866887\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:02; DQA1*05:06;\\n            DQA1*05:07 AND DQA1*05:08).\\nREFERENCE   8  (residues 1 to 254)\\n  AUTHORS   Jonsson,A.K., Hyldig-Nielsen,J.J., Servenius,B., Larhammar,D.,\\n            Andersson,G., Jorgensen,F., Peterson,P.A. and Rask,L.\\n  TITLE     Class II genes of the human major histocompatibility complex.\\n            Comparisons of the DQ and DX alpha and beta genes\\n  JOURNAL   J Biol Chem 262 (18), 8767-8777 (1987)\\n   PUBMED   3036828\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*03:01).\\nREFERENCE   9  (residues 1 to 254)\\n  AUTHORS   Ashdown,M.L., Leas,L., Gavrilidis,A., Wood,J.M. and Simons,M.J.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (??-JUN-2001) to the EMBL/GenBank/DDBJ databases\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*01:01).\\nREFERENCE   10 (residues 1 to 254)\\n  AUTHORS   Ebert,L., Schick,M., Neubert,P., Schatten,R., Henze,S. and Korn,B.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (??-MAY-2004) to the EMBL/GenBank/DDBJ databases\\n  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DQA1*02:01).\\nREFERENCE   11 (residues 1 to 254)\\n  AUTHORS   Voorter,C.E. and van den Berg-Loonen,E.M.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (??-JUL-2005) to the EMBL/GenBank/DDBJ databases\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:02 AND\\n            DQA1*05:09).\\nREFERENCE   12 (residues 1 to 254)\\n  AUTHORS   Ota,T., Suzuki,Y., Nishikawa,T., Otsuki,T., Sugiyama,T., Irie,R.,\\n            Wakamatsu,A., Hayashi,K., Sato,H., Nagai,K., Kimura,K., Makita,H.,\\n            Sekine,M., Obayashi,M., Nishi,T., Shibahara,T., Tanaka,T.,\\n            Ishii,S., Yamamoto,J., Saito,K., Kawai,Y., Isono,Y., Nakamura,Y.,\\n            Nagahari,K., Murakami,K., Yasuda,T., Iwayanagi,T., Wagatsuma,M.,\\n            Shiratori,A., Sudo,H., Hosoiri,T., Kaku,Y., Kodaira,H., Kondo,H.,\\n            Sugawara,M., Takahashi,M., Kanda,K., Yokoi,T., Furuya,T.,\\n            Kikkawa,E., Omura,Y., Abe,K., Kamihara,K., Katsuta,N., Sato,K.,\\n            Tanikawa,M., Yamazaki,M., Ninomiya,K., Ishibashi,T., Yamashita,H.,\\n            Murakawa,K., Fujimori,K., Tanai,H., Kimata,M., Watanabe,M.,\\n            Hiraoka,S., Chiba,Y., Ishida,S., Ono,Y., Takiguchi,S., Watanabe,S.,\\n            Yosida,M., Hotuta,T., Kusano,J., Kanehori,K., Takahashi-Fujii,A.,\\n            Hara,H., Tanase,T.O., Nomura,Y., Togiya,S., Komai,F., Hara,R.,\\n            Takeuchi,K., Arita,M., Imose,N., Musashino,K., Yuuki,H., Oshima,A.,\\n            Sasaki,N., Aotsuka,S., Yoshikawa,Y., Matsunawa,H., Ichihara,T.,\\n            Shiohata,N., Sano,S., Moriya,S., Momiyama,H., Satoh,N., Takami,S.,\\n            Terashima,Y., Suzuki,O., Nakagawa,S., Senoh,A., Mizoguchi,H.,\\n            Goto,Y., Shimizu,F., Wakebe,H., Hishigaki,H., Watanabe,T.,\\n            Sugiyama,A., Takemoto,M., Kawakami,B., Yamazaki,M., Watanabe,K.,\\n            Kumagai,A., Itakura,S., Fukuzumi,Y., Fujimori,Y., Komiyama,M.,\\n            Tashiro,H., Tanigami,A., Fujiwara,T., Ono,T., Yamada,K., Fujii,Y.,\\n            Ozaki,K., Hirao,M., Ohmori,Y., Kawabata,A., Hikiji,T., Kobatake,N.,\\n            Inagaki,H., Ikema,Y., Okamoto,S., Okitani,R., Kawakami,T.,\\n            Noguchi,S., Itoh,T., Shigeta,K., Senba,T., Matsumura,K.,\\n            Nakajima,Y., Mizuno,T., Morinaga,M., Sasaki,M., Togashi,T.,\\n            Oyama,M., Hata,H., Watanabe,M., Komatsu,T., Mizushima-Sugano,J.,\\n            Satoh,T., Shirai,Y., Takahashi,Y., Nakagawa,K., Okumura,K.,\\n            Nagase,T., Nomura,N., Kikuchi,H., Masuho,Y., Yamashita,R.,\\n            Nakai,K., Yada,T., Nakamura,Y., Ohara,O., Isogai,T. and Sugano,S.\\n  TITLE     Complete sequencing and characterization of 21,243 full-length\\n            human cDNAs\\n  JOURNAL   Nat Genet 36 (1), 40-45 (2004)\\n   PUBMED   14702039\\n  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DQA1*01:01).;\\n            TISSUE=Trachea\\nREFERENCE   13 (residues 1 to 254)\\n  AUTHORS   Mungall,A.J., Palmer,S.A., Sims,S.K., Edwards,C.A., Ashurst,J.L.,\\n            Wilming,L., Jones,M.C., Horton,R., Hunt,S.E., Scott,C.E.,\\n            Gilbert,J.G., Clamp,M.E., Bethel,G., Milne,S., Ainscough,R.,\\n            Almeida,J.P., Ambrose,K.D., Andrews,T.D., Ashwell,R.I.,\\n            Babbage,A.K., Bagguley,C.L., Bailey,J., Banerjee,R., Barker,D.J.,\\n            Barlow,K.F., Bates,K., Beare,D.M., Beasley,H., Beasley,O.,\\n            Bird,C.P., Blakey,S., Bray-Allen,S., Brook,J., Brown,A.J.,\\n            Brown,J.Y., Burford,D.C., Burrill,W., Burton,J., Carder,C.,\\n            Carter,N.P., Chapman,J.C., Clark,S.Y., Clark,G., Clee,C.M.,\\n            Clegg,S., Cobley,V., Collier,R.E., Collins,J.E., Colman,L.K.,\\n            Corby,N.R., Coville,G.J., Culley,K.M., Dhami,P., Davies,J.,\\n            Dunn,M., Earthrowl,M.E., Ellington,A.E., Evans,K.A., Faulkner,L.,\\n            Francis,M.D., Frankish,A., Frankland,J., French,L., Garner,P.,\\n            Garnett,J., Ghori,M.J., Gilby,L.M., Gillson,C.J., Glithero,R.J.,\\n            Grafham,D.V., Grant,M., Gribble,S., Griffiths,C., Griffiths,M.,\\n            Hall,R., Halls,K.S., Hammond,S., Harley,J.L., Hart,E.A.,\\n            Heath,P.D., Heathcott,R., Holmes,S.J., Howden,P.J., Howe,K.L.,\\n            Howell,G.R., Huckle,E., Humphray,S.J., Humphries,M.D., Hunt,A.R.,\\n            Johnson,C.M., Joy,A.A., Kay,M., Keenan,S.J., Kimberley,A.M.,\\n            King,A., Laird,G.K., Langford,C., Lawlor,S., Leongamornlert,D.A.,\\n            Leversha,M., Lloyd,C.R., Lloyd,D.M., Loveland,J.E., Lovell,J.,\\n            Martin,S., Mashreghi-Mohammadi,M., Maslen,G.L., Matthews,L.,\\n            McCann,O.T., McLaren,S.J., McLay,K., McMurray,A., Moore,M.J.,\\n            Mullikin,J.C., Niblett,D., Nickerson,T., Novik,K.L., Oliver,K.,\\n            Overton-Larty,E.K., Parker,A., Patel,R., Pearce,A.V., Peck,A.I.,\\n            Phillimore,B., Phillips,S., Plumb,R.W., Porter,K.M., Ramsey,Y.,\\n            Ranby,S.A., Rice,C.M., Ross,M.T., Searle,S.M., Sehra,H.K.,\\n            Sheridan,E., Skuce,C.D., Smith,S., Smith,M., Spraggon,L.,\\n            Squares,S.L., Steward,C.A., Sycamore,N., Tamlyn-Hall,G., Tester,J.,\\n            Theaker,A.J., Thomas,D.W., Thorpe,A., Tracey,A., Tromans,A.,\\n            Tubby,B., Wall,M., Wallis,J.M., West,A.P., White,S.S.,\\n            Whitehead,S.L., Whittaker,H., Wild,A., Willey,D.J., Wilmer,T.E.,\\n            Wood,J.M., Wray,P.W., Wyatt,J.C., Young,L., Younger,R.M.,\\n            Bentley,D.R., Coulson,A., Durbin,R., Hubbard,T., Sulston,J.E.,\\n            Dunham,I., Rogers,J. and Beck,S.\\n  TITLE     The DNA sequence and analysis of human chromosome 6\\n  JOURNAL   Nature 425 (6960), 805-811 (2003)\\n   PUBMED   14574404\\n  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELES DQA1*01:02;\\n            DQA1*03:01 AND DQA1*05:01).\\nREFERENCE   14 (residues 1 to 254)\\n  AUTHORS   Gerhard,D.S., Wagner,L., Feingold,E.A., Shenmen,C.M., Grouse,L.H.,\\n            Schuler,G., Klein,S.L., Old,S., Rasooly,R., Good,P., Guyer,M.,\\n            Peck,A.M., Derge,J.G., Lipman,D., Collins,F.S., Jang,W., Sherry,S.,\\n            Feolo,M., Misquitta,L., Lee,E., Rotmistrovsky,K., Greenhut,S.F.,\\n            Schaefer,C.F., Buetow,K., Bonner,T.I., Haussler,D., Kent,J.,\\n            Kiekhaus,M., Furey,T., Brent,M., Prange,C., Schreiber,K.,\\n            Shapiro,N., Bhat,N.K., Hopkins,R.F., Hsie,F., Driscoll,T.,\\n            Soares,M.B., Casavant,T.L., Scheetz,T.E., Brown-stein,M.J.,\\n            Usdin,T.B., Toshiyuki,S., Carninci,P., Piao,Y., Dudekula,D.B.,\\n            Ko,M.S., Kawakami,K., Suzuki,Y., Sugano,S., Gruber,C.E.,\\n            Smith,M.R., Simmons,B., Moore,T., Waterman,R., Johnson,S.L.,\\n            Ruan,Y., Wei,C.L., Mathavan,S., Gunaratne,P.H., Wu,J., Garcia,A.M.,\\n            Hulyk,S.W., Fuh,E., Yuan,Y., Sneed,A., Kowis,C., Hodgson,A.,\\n            Muzny,D.M., McPherson,J., Gibbs,R.A., Fahey,J., Helton,E.,\\n            Ketteman,M., Madan,A., Rodrigues,S., Sanchez,A., Whiting,M.,\\n            Madari,A., Young,A.C., Wetherby,K.D., Granite,S.J., Kwong,P.N.,\\n            Brinkley,C.P., Pearson,R.L., Bouffard,G.G., Blakesly,R.W.,\\n            Green,E.D., Dickson,M.C., Rodriguez,A.C., Grimwood,J., Schmutz,J.,\\n            Myers,R.M., Butterfield,Y.S., Griffith,M., Griffith,O.L.,\\n            Krzywinski,M.I., Liao,N., Morin,R., Palmquist,D., Petrescu,A.S.,\\n            Skalska,U., Smailus,D.E., Stott,J.M., Schnerch,A., Schein,J.E.,\\n            Jones,S.J., Holt,R.A., Baross,A., Marra,M.A., Clifton,S.,\\n            Makowski,K.A., Bosak,S. and Malek,J.\\n  CONSRTM   MGC Project Team\\n  TITLE     The status, quality, and expansion of the NIH full-length cDNA\\n            project: the Mammalian Gene Collection (MGC)\\n  JOURNAL   Genome Res 14 (10B), 2121-2127 (2004)\\n   PUBMED   15489334\\n  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELES DQA1*03:01 AND\\n            DQA1*05:01).;\\n            TISSUE=Lymph\\n            Erratum:[Genome Res. 2006 Jun;16(6):804. Morrin, Ryan [corrected to\\n            Morin, Ryan]]\\nREFERENCE   15 (residues 1 to 254)\\n  AUTHORS   Yasunaga,S., Kimura,A. and Sasazuki,T.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (??-JUL-1996) to the EMBL/GenBank/DDBJ databases\\n  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 1-27 (ALLELES\\n            DQA1*01:01/DQA1*01:02/DQA1*01:03; DQA1*01:04; DQA1*01:05;\\n            DQA1*02:01/DQA1*03:01/DQA1*03:03; DQA1*04:01/DQA1*06:01 AND\\n            DQA1*05:01/DQA1*05:03/DQA1*05:05).;\\n            TISSUE=B-cell\\nREFERENCE   16 (residues 1 to 254)\\n  AUTHORS   Moriuchi,J., Moriuchi,T. and Silver,J.\\n  TITLE     Nucleotide sequence of an HLA-DQ alpha chain derived from a DRw9\\n            cell line: genetic and evolutionary implications\\n  JOURNAL   Proc Natl Acad Sci U S A 82 (10), 3420-3424 (1985)\\n   PUBMED   3879967\\n  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 19-254 (ALLELE DQA1*03:02).\\nREFERENCE   17 (residues 1 to 254)\\n  AUTHORS   Lock,C.B., So,A.K., Welsh,K.I., Parkes,J.D. and Trowsdale,J.\\n  TITLE     MHC class II sequences of an HLA-DR2 narcoleptic\\n  JOURNAL   Immunogenetics 27 (6), 449-455 (1988)\\n   PUBMED   3259543\\n  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 23-254 (ALLELE DQA1*01:02).\\nREFERENCE   18 (residues 1 to 254)\\n  AUTHORS   Yasunaga,S., Kimura,A., Hamaguchi,K., Ronningen,K.S. and\\n            Sasazuki,T.\\n  TITLE     Different contribution of HLA-DR and -DQ genes in susceptibility\\n            and resistance to insulin-dependent diabetes mellitus (IDDM)\\n  JOURNAL   Tissue Antigens 47 (1), 37-48 (1996)\\n   PUBMED   8929711\\n  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 24-250 (ALLELE DQA1*03:02/DQA1*03:03)\\n            AND NUCLEOTIDE SEQUENCE [MRNA] OF 24-249 (ALLELES DQA1*01:01;\\n            DQA1*01:03; DQA1*01:04; DQA1*04:01; DQA1*05:03; DQA1*05:05 AND\\n            DQA1*06:01).\\nREFERENCE   19 (residues 1 to 254)\\n  AUTHORS   Yasunaga,S.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (??-JAN-1996) to the EMBL/GenBank/DDBJ databases\\n  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 24-249 (ALLELE DQA1*01:05).\\nREFERENCE   20 (residues 1 to 254)\\n  AUTHORS   Goetz,H., Kratzin,H., Thinnes,F.P., Yang,C.-Y., Kruse,T., Pauly,E.,\\n            Koelbel,S., Egert,G., Wernet,P. and Hilschmann,N.\\n  TITLE     Primary structure of human class II histocompatibility antigens 3rd\\n            communication. Amino acid sequence comparison between DR and DC\\n            subclass antigens derived from a lymphoblastoid B cell line\\n            homozygous at the HLA loci (HLA-A3,3; B7,7; Dw2,2; DR2,2: MT1,1;\\n            Dc1,1: MB1,1)\\n  JOURNAL   Hoppe-Seyler\\'s Z. Physiol. Chem. 364, 749-755 (1983)\\n   PUBMED   6576979\\n  REMARK    PROTEIN SEQUENCE OF 24-89; 102-120 AND 164-212 (ALLELE DQA1*01:02).\\nREFERENCE   21 (residues 1 to 254)\\n  AUTHORS   Kao,H.T., Gregersen,P.K., Tang,J.C., Takahashi,T., Wang,C.Y. and\\n            Silver,J.\\n  TITLE     Molecular analysis of the HLA class II genes in two DRw6-related\\n            haplotypes, DRw13 DQw1 and DRw14 DQw3\\n  JOURNAL   J Immunol 142 (5), 1743-1747 (1989)\\n   PUBMED   2493052\\n  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 24-209 (ALLELE DQA1*05:01).\\nREFERENCE   22 (residues 1 to 254)\\n  AUTHORS   Cordovado,S.K., Hancock,L.N., Simone,A.E., Hendrix,M. and\\n            Mueller,P.W.\\n  TITLE     High-resolution genotyping of HLA-DQA1 in the GoKinD study and\\n            identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and\\n            HLA-DQA1*0404\\n  JOURNAL   Tissue Antigens 65 (5), 448-458 (2005)\\n   PUBMED   15853899\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELES DQA1*04:02 AND\\n            DQA1*04:04).\\nREFERENCE   23 (residues 1 to 254)\\n  AUTHORS   Simone,A.E., Cordovado,S.K., Hendrix,M.M. and Mueller,P.W.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (??-DEC-2002) to the EMBL/GenBank/DDBJ databases\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELE DQA1*06:02).\\nREFERENCE   24 (residues 1 to 254)\\n  AUTHORS   Hancock,L.N., Cordovado,S.K. and Mueller,P.W.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (??-MAR-2004) to the EMBL/GenBank/DDBJ databases\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELE DQA1*01:07).\\nREFERENCE   25 (residues 1 to 254)\\n  AUTHORS   Horn,G.T., Bugawan,T.L., Long,C.M., Manos,M.M. and Erlich,H.A.\\n  TITLE     Sequence analysis of HLA class II genes from insulin-dependent\\n            diabetic individuals\\n  JOURNAL   Hum Immunol 21 (4), 249-263 (1988)\\n   PUBMED   3372263\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-110 (ALLELE DQA1*01:02),\\n            AND NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-109 (ALLELE\\n            DQA1*05:01).\\nREFERENCE   26 (residues 1 to 254)\\n  AUTHORS   Trejaut,J.A., Greville,W.D. and Dunckley,H.\\n  TITLE     Direct Submission\\n  JOURNAL   Submitted (??-JAN-1997) to the EMBL/GenBank/DDBJ databases\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-109 (ALLELE DQA1*05:04).\\nREFERENCE   27 (residues 1 to 254)\\n  AUTHORS   Luo,M., Blanchard,J., Maclean,I. and Brunham,R.\\n  TITLE     Identification of a novel HLA-DQA1 allele (DQA1*0106) by\\n            sequence-based DQA1 typing\\n  JOURNAL   Tissue Antigens 53 (6), 595-596 (1999)\\n   PUBMED   10395113\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 31-109 (ALLELE DQA1*01:06).\\nREFERENCE   28 (residues 1 to 254)\\n  AUTHORS   Marsh,S.G. and Bodmer,J.G.\\n  TITLE     HLA class II nucleotide sequences, 1992\\n  JOURNAL   Tissue Antigens 40 (5), 229-243 (1992)\\n   PUBMED   1362295\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-74 (ALLELE DQA1*05:02).\\n            Correction to:[Tissue Antigens. 1992 Apr;39(4):161-73. PMID:\\n            1529427]\\nREFERENCE   29 (residues 1 to 254)\\n  AUTHORS   Liu,C.P., Bach,F.H. and Wu,S.K.\\n  TITLE     Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype.\\n            Multiple genetic mechanisms in the generation of polymorphic HLA\\n            class II genes\\n  JOURNAL   J Immunol 140 (10), 3631-3639 (1988)\\n   PUBMED   3129499\\n  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 36-254 (ALLELE DQA1*05:01).\\n            Erratum:[J Immunol 1990 Feb 15;144(4):1544]\\nREFERENCE   30 (residues 1 to 254)\\n  AUTHORS   Liu,C.P., Bach,F.H. and Wu,S.K.\\n  JOURNAL   J. Immunol. 144, 15441-15441 (1990)\\n  REMARK    ERRATUM OF PUBMED:3129499.\\nREFERENCE   31 (residues 1 to 254)\\n  AUTHORS   Auffray,C., Korman,A.J., Roux-Dosseto,M., Bono,R. and\\n            Strominger,J.L.\\n  TITLE     cDNA clone for the heavy chain of the human B cell alloantigen DC1:\\n            strong sequence homology to the HLA-DR heavy chain\\n  JOURNAL   Proc Natl Acad Sci U S A 79 (20), 6337-6341 (1982)\\n   PUBMED   6815651\\n  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 40-254 (ALLELE DQA1*03:01).\\nREFERENCE   32 (residues 1 to 254)\\n  AUTHORS   Gyllensten,U.B. and Erlich,H.A.\\n  TITLE     Ancient roots for polymorphism at the HLA-DQ alpha locus in\\n            primates\\n  JOURNAL   Proc Natl Acad Sci U S A 86 (24), 9986-9990 (1989)\\n   PUBMED   2513578\\n  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-102 (ALLELE DQA1*05:01),\\n            AND NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-103 (ALLELE\\n            DQA1*01:02).\\nREFERENCE   33 (residues 1 to 254)\\n  AUTHORS   Turco,E., Care,A., Compagnone-Post,P., Robinson,C., Cascino,I. and\\n            Trucco,M.\\n  TITLE     Allelic forms of the alpha- and beta-chain genes encoding\\n            DQw1-positive heterodimers\\n  JOURNAL   Immunogenetics 26 (4-5), 282-290 (1987)\\n   PUBMED   2888727\\n  REMARK    NUCLEOTIDE SEQUENCE [MRNA] OF 119-254 (ALLELE DQA1*01:02).\\nREFERENCE   34 (residues 1 to 254)\\n  AUTHORS   Cresswell,P.\\n  TITLE     Invariant chain structure and MHC class II function\\n  JOURNAL   Cell 84 (4), 505-507 (1996)\\n   PUBMED   8598037\\n  REMARK    REVIEW.\\nREFERENCE   35 (residues 1 to 254)\\n  AUTHORS   Villadangos,J.A.\\n  TITLE     Presentation of antigens by MHC class II molecules: getting the\\n            most out of them\\n  JOURNAL   Mol Immunol 38 (5), 329-346 (2001)\\n   PUBMED   11684289\\n  REMARK    REVIEW.\\nREFERENCE   36 (residues 1 to 254)\\n  AUTHORS   Menendez-Benito,V. and Neefjes,J.\\n  TITLE     Autophagy in MHC class II presentation: sampling from within\\n  JOURNAL   Immunity 26 (1), 1-3 (2007)\\n   PUBMED   17241953\\n  REMARK    REVIEW.\\nREFERENCE   37 (residues 1 to 254)\\n  AUTHORS   Rocha,N. and Neefjes,J.\\n  TITLE     MHC class II molecules on the move for successful antigen\\n            presentation\\n  JOURNAL   EMBO J 27 (1), 1-5 (2008)\\n   PUBMED   18046453\\n  REMARK    REVIEW.\\nREFERENCE   38 (residues 1 to 254)\\n  AUTHORS   Berger,A.C. and Roche,P.A.\\n  TITLE     MHC class II transport at a glance\\n  JOURNAL   J Cell Sci 122 (Pt 1), 1-4 (2009)\\n   PUBMED   19092054\\n  REMARK    REVIEW.\\nREFERENCE   39 (residues 1 to 254)\\n  AUTHORS   Beswick,E.J. and Reyes,V.E.\\n  TITLE     CD74 in antigen presentation, inflammation, and cancers of the\\n            gastrointestinal tract\\n  JOURNAL   World J Gastroenterol 15 (23), 2855-2861 (2009)\\n   PUBMED   19533806\\n  REMARK    REVIEW.\\nREFERENCE   40 (residues 1 to 254)\\n  AUTHORS   Lee,K.H., Wucherpfennig,K.W. and Wiley,D.C.\\n  TITLE     Structure of a human insulin peptide-HLA-DQ8 complex and\\n            susceptibility to type 1 diabetes\\n  JOURNAL   Nat Immunol 2 (6), 501-507 (2001)\\n   PUBMED   11376336\\n  REMARK    X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 27-207 OF\\n            HLA-DQA1/HLA-DQB1 HETERODIMER IN COMPLEX WITH INS PEPTIDE, SUBUNIT,\\n            GLYCOSYLATION AT ASN-103, AND DISULFIDE BOND.\\n            Erratum:[Nat Immunol 2001 Sep;2(9):889]\\nREFERENCE   41 (residues 1 to 254)\\n  AUTHORS   Siebold,C., Hansen,B.E., Wyer,J.R., Harlos,K., Esnouf,R.E.,\\n            Svejgaard,A., Bell,J.I., Strominger,J.L., Jones,E.Y. and Fugger,L.\\n  TITLE     Crystal structure of HLA-DQ0602 that protects against type 1\\n            diabetes and confers strong susceptibility to narcolepsy\\n  JOURNAL   Proc Natl Acad Sci U S A 101 (7), 1999-2004 (2004)\\n   PUBMED   14769912\\n  REMARK    X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 24-219 OF\\n            HLA-DQA1/HLA-DQB1 HETERODIMER (HLA-DQ0602) IN COMPLEX WITH HCRT\\n            PEPTIDE, POLYMORPHISM, SUBUNIT, AND DISULFIDE BOND.\\nREFERENCE   42 (residues 1 to 254)\\n  AUTHORS   Kim,C.Y., Quarsten,H., Bergseng,E., Khosla,C. and Sollid,L.M.\\n  TITLE     Structural basis for HLA-DQ2-mediated presentation of gluten\\n            epitopes in celiac disease\\n  JOURNAL   Proc Natl Acad Sci U S A 101 (12), 4175-4179 (2004)\\n   PUBMED   15020763\\n  REMARK    X-RAY CRYSTALLOGRAPHY (2.22 ANGSTROMS) OF 24-216 OF\\n            HLA-DQA1/HLA-DQB1 HETERODIMER (DQ2) IN COMPLEX WITH TRITICUM\\n            AESTIVUM ALPHA/BETA-GLIADIN PEPTIDE, SUBUNIT, AND POLYMORPHISM.\\nREFERENCE   43 (residues 1 to 254)\\n  AUTHORS   Henderson,K.N., Tye-Din,J.A., Reid,H.H., Chen,Z., Borg,N.A.,\\n            Beissbarth,T., Tatham,A., Mannering,S.I., Purcell,A.W., Dudek,N.L.,\\n            van Heel,D.A., McCluskey,J., Rossjohn,J. and Anderson,R.P.\\n  TITLE     A structural and immunological basis for the role of human\\n            leukocyte antigen DQ8 in celiac disease\\n  JOURNAL   Immunity 27 (1), 23-34 (2007)\\n   PUBMED   17629515\\n  REMARK    X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 24-206 OF\\n            HLA-DQA1/HLA-DQB1 HETERODIMER IN COMPLEX WITH TRITICUM AESTIVUM\\n            ALPHA/BETA-GLIADIN, SUBUNIT, AND DISULFIDE BOND.\\nCOMMENT     On or before Mar 30, 2010 this sequence version replaced P01908.2,\\n            P05536.1, gi:74721757, gi:74705624, P01907.2, P04225.1, P04226.1,\\n            gi:74706178, gi:74706836, gi:121945665, gi:121948343, gi:121945666,\\n            gi:121941983, gi:74706863, gi:74706866, gi:74706867, gi:74706869,\\n            gi:74706870, gi:74706871, gi:74706872, gi:74709986, gi:74727328,\\n            gi:74713787, gi:74727342, gi:74717483, gi:74720013, gi:70108.\\n            [FUNCTION] Binds peptides derived from antigens that access the\\n            endocytic route of antigen presenting cells (APC) and presents them\\n            on the cell surface for recognition by the CD4 T-cells. The peptide\\n            binding cleft accommodates peptides of 10-30 residues. The peptides\\n            presented by MHC class II molecules are generated mostly by\\n            degradation of proteins that access the endocytic route, where they\\n            are processed by lysosomal proteases and other hydrolases.\\n            Exogenous antigens that have been endocytosed by the APC are thus\\n            readily available for presentation via MHC II molecules, and for\\n            this reason this antigen presentation pathway is usually referred\\n            to as exogenous. As membrane proteins on their way to degradation\\n            in lysosomes as part of their normal turn-over are also contained\\n            in the endosomal/lysosomal compartments, exogenous antigens must\\n            compete with those derived from endogenous components. Autophagy is\\n            also a source of endogenous peptides, autophagosomes constitutively\\n            fuse with MHC class II loading compartments. In addition to APCs,\\n            other cells of the gastrointestinal tract, such as epithelial\\n            cells, express MHC class II molecules and CD74 and act as APCs,\\n            which is an unusual trait of the GI tract. To produce a MHC class\\n            II molecule that presents an antigen, three MHC class II molecules\\n            (heterodimers of an alpha and a beta chain) associate with a CD74\\n            trimer in the ER to form a heterononamer. Soon after the entry of\\n            this complex into the endosomal/lysosomal system where antigen\\n            processing occurs, CD74 undergoes a sequential degradation by\\n            various proteases, including CTSS and CTSL, leaving a small\\n            fragment termed CLIP (class-II-associated invariant chain peptide).\\n            The removal of CLIP is facilitated by HLA-DM via direct binding to\\n            the alpha-beta-CLIP complex so that CLIP is released. HLA-DM\\n            stabilizes MHC class II molecules until primary high affinity\\n            antigenic peptides are bound. The MHC II molecule bound to a\\n            peptide is then transported to the cell membrane surface. In\\n            B-cells, the interaction between HLA-DM and MHC class II molecules\\n            is regulated by HLA-DO. Primary dendritic cells (DCs) also to\\n            express HLA-DO. Lysosomal microenvironment has been implicated in\\n            the regulation of antigen loading into MHC II molecules, increased\\n            acidification produces increased proteolysis and efficient peptide\\n            loading.\\n            [SUBUNIT] Heterodimer of an alpha and a beta subunit; also referred\\n            as MHC class II molecule. In the endoplasmic reticulum (ER) it\\n            forms a heterononamer; 3 MHC class II molecules bind to a CD74\\n            homotrimer (also known as invariant chain or HLA class II\\n            histocompatibility antigen gamma chain). In the endosomal/lysosomal\\n            system; CD74 undergoes sequential degradation by various proteases;\\n            leaving a small fragment termed CLIP on each MHC class II molecule.\\n            MHC class II molecule interacts with HLA_DM, and HLA_DO in B-cells,\\n            in order to release CLIP and facilitate the binding of antigenic\\n            peptides. {ECO:0000269|PubMed:11376336,\\n            ECO:0000269|PubMed:14769912, ECO:0000269|PubMed:15020763,\\n            ECO:0000269|PubMed:17629515}.\\n            [INTERACTION] P01909; P01920: HLA-DQB1; NbExp=8; IntAct=EBI-713389,\\n            EBI-1038012.\\n            [SUBCELLULAR LOCATION] Cell membrane; Single-pass type I membrane\\n            protein. Endoplasmic reticulum membrane; Single-pass type I\\n            membrane protein. Golgi apparatus, trans-Golgi network membrane;\\n            Single-pass type I membrane protein. Endosome membrane; Single-pass\\n            type I membrane protein. Lysosome membrane; Single-pass type I\\n            membrane protein. Note=The MHC class II complex transits through a\\n            number of intracellular compartments in the endocytic pathway until\\n            it reaches the cell membrane for antigen presentation.\\n            [POLYMORPHISM] The following alleles of DQA1 are known: DQA1*01:01,\\n            DQA1*01:02, DQA1*01:03, DQA1*01:04, DQA1*01:05, DQA1*01:06,\\n            DQA1*01:07, DQA1*02:01, DQA1*03:01, DQA1*03:02, DQA1*03:03,\\n            DQA1*04:01, DQA1*04:02, DQA1*04:03, DQA1*04:04, DQA1*05:01,\\n            DQA1*05:02, DQA1*05:03, DQA1*05:04, DQA1*05:05, DQA1*05:06,\\n            DQA1*05:07, DQA1*05:08, DQA1*05:09, DQA1*06:01, DQA1*06:02. The\\n            sequence shown is that of DQA1*05:01.\\n            [POLYMORPHISM] DQ2 (heterodimer of DQA1*05:01/DQB1*02:01) is\\n            associated with more than 90% of celiac disease patients. A\\n            minority displays DQ8 (heterodimer of DQA1*03/DQB1*03:02). DQ0602\\n            (heterodimer of DQA1*01:02/DQB1*06:02) confers dominant protection\\n            against type 1 diabetes (T1D) and strong susceptibility to\\n            narcolepsy.\\n            [SIMILARITY] Belongs to the MHC class II family. {ECO:0000305}.\\n            [SEQUENCE CAUTION] Sequence=AAD56720.1; Type=Erroneous gene model\\n            prediction; Evidence={ECO:0000305}.\\nFEATURES             Location/Qualifiers\\n     source          1..254\\n                     /organism=\"Homo sapiens\"\\n                     /db_xref=\"taxon:9606\"\\n     gene            1..254\\n                     /gene=\"HLA-DQA1\"\\n     Protein         1..254\\n                     /product=\"HLA class II histocompatibility antigen, DQ\\n                     alpha 1 chain\"\\n                     /note=\"DC-1 alpha chain; DC-alpha; HLA-DCA; MHC class II\\n                     DQA1\"\\n                     /UniProtKB_evidence=\"Evidence at protein level\"\\n     Region          1..23\\n                     /region_name=\"Signal\"\\n                     /note=\"/evidence=ECO:0000269|PubMed:6576979.\"\\n     Region          8\\n                     /region_name=\"Variant\"\\n                     /note=\"M -> L (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*04:01 and allele DQA1*06:01; dbSNP:rs1047989).\\n                     /id=VAR_033399.\"\\n     Region          11\\n                     /region_name=\"Conflict\"\\n                     /note=\"A -> S (in Ref. 4; AAA59760).\\n                     /evidence=ECO:0000305.\"\\n     Region          11\\n                     /region_name=\"Variant\"\\n                     /note=\"A -> T (in allele DQA1*05:05, allele DQA1*05:08 and\\n                     allele DQA1*05:09; dbSNP:rs1047992). /id=VAR_033400.\"\\n     Region          17\\n                     /region_name=\"Variant\"\\n                     /note=\"V -> M (in allele DQA1*01:04 and allele DQA1*01:05;\\n                     dbSNP:rs12722039). /id=VAR_050380.\"\\n     Region          18\\n                     /region_name=\"Variant\"\\n                     /note=\"M -> T (in allele DQA1*03:03; dbSNP:rs11545686).\\n                     /id=VAR_050381.\"\\n     Region          23..27\\n                     /region_name=\"Conflict\"\\n                     /note=\"Missing (in Ref. 16; AAA59754).\\n                     /evidence=ECO:0000305.\"\\n     Region          24..254\\n                     /region_name=\"Mature chain\"\\n                     /note=\"HLA class II histocompatibility antigen, DQ alpha 1\\n                     chain. /id=PRO_0000018970.\"\\n     Region          24..216\\n                     /region_name=\"Topological domain\"\\n                     /note=\"Extracellular. /evidence=ECO:0000255.\"\\n     Region          24..119\\n                     /region_name=\"Region of interest in the sequence\"\\n                     /note=\"Alpha-1.\"\\n     Region          24\\n                     /region_name=\"Variant\"\\n                     /note=\"E -> K (in allele DQA1*05:09; dbSNP:rs41545012).\\n                     /id=VAR_060493.\"\\n     Region          25\\n                     /region_name=\"Variant\"\\n                     /note=\"D -> G (in allele DQA1*01:04 and allele DQA1*01:05;\\n                     dbSNP:rs12722042). /id=VAR_050382.\"\\n     Region          29..108\\n                     /region_name=\"MHC_II_alpha\"\\n                     /note=\"Class II histocompatibility antigen, alpha domain;\\n                     pfam00993\"\\n                     /db_xref=\"CDD:425978\"\\n     Region          29..40\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          34\\n                     /region_name=\"Variant\"\\n                     /note=\"Y -> C (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1129740).\\n                     /id=VAR_060494.\"\\n     Region          41..44\\n                     /region_name=\"Hydrogen bonded turn\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          41\\n                     /region_name=\"Variant\"\\n                     /note=\"S -> F (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1071630).\\n                     /id=VAR_033401.\"\\n     Region          44\\n                     /region_name=\"Variant\"\\n                     /note=\"P -> L (in allele DQA1*05:04; dbSNP:rs41549715).\\n                     /id=VAR_060495.\"\\n     Region          45..52\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          48\\n                     /region_name=\"Variant\"\\n                     /note=\"Y -> F (in allele DQA1*02:01, allele DQA1*01:03,\\n                     allele DQA1*06:01 and allele DQA1*06:02;\\n                     dbSNP:rs12722051). /id=VAR_033402.\"\\n     Region          49\\n                     /region_name=\"Variant\"\\n                     /note=\"T -> S (in allele DQA1*03:01, allele DQA1*03:02 and\\n                     allele DQA1*03:03; dbSNP:rs1048023). /id=VAR_033403.\"\\n     Region          55..61\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          57\\n                     /region_name=\"Variant\"\\n                     /note=\"Q -> E (in allele DQA1*01:01, allele DQA1*01:04,\\n                     allele DQA1*01:05, allele DQA1*01:07, allele DQA1*02:01,\\n                     allele DQA1*03:01, allele DQA1*03:02 and allele\\n                     DQA1*03:03; dbSNP:rs10093). /id=VAR_014604.\"\\n     Region          62..65\\n                     /region_name=\"Hydrogen bonded turn\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          63\\n                     /region_name=\"Variant\"\\n                     /note=\"G -> E (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06, allele DQA1*01:07, allele DQA1*02:01,\\n                     allele DQA1*03:01, allele DQA1*03:02 and allele\\n                     DQA1*03:03; dbSNP:rs1142323). /id=VAR_060496.\"\\n     Region          64\\n                     /region_name=\"Variant\"\\n                     /note=\"R -> K (in allele DQA1*01:03; dbSNP:rs36219699).\\n                     /id=VAR_050383.\"\\n     Region          66..71\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          67\\n                     /region_name=\"Variant\"\\n                     /note=\"T -> A (in allele DQA1*01:06; dbSNP:rs41543221).\\n                     /id=VAR_060497.\"\\n     Region          68\\n                     /region_name=\"Variant\"\\n                     /note=\"V -> A (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1142324).\\n                     /id=VAR_060498.\"\\n     Region          70\\n                     /region_name=\"Variant\"\\n                     /note=\"C -> K (in allele DQA1*02:01; requires 2 nucleotide\\n                     substitutions). /id=VAR_060499.\"\\n     Region          70\\n                     /region_name=\"Variant\"\\n                     /note=\"C -> Q (in allele DQA1*03:01, allele DQA1*03:02 and\\n                     allele DQA1*03:03; requires 2 nucleotide substitutions).\\n                     /id=VAR_060500.\"\\n     Region          70\\n                     /region_name=\"Variant\"\\n                     /note=\"C -> R (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1142326).\\n                     /id=VAR_060501.\"\\n     Region          70\\n                     /region_name=\"Variant\"\\n                     /note=\"C -> Y (in dbSNP:rs3207983). /id=VAR_033404.\"\\n     Region          71\\n                     /region_name=\"Variant\"\\n                     /note=\"L -> W (in allele DQA1*01:01, allele\\n                     DQA1*01:02,allele DQA1*01:03, allele DQA1*01:04, allele\\n                     DQA1*01:05, allele DQA1*01:06 and allele DQA1*01:07;\\n                     dbSNP:rs1142328). /id=VAR_060502.\"\\n     Region          72..76\\n                     /region_name=\"Helical region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          73\\n                     /region_name=\"Variant\"\\n                     /note=\"V -> D (in dbSNP:rs760671632). /id=VAR_033406.\"\\n     Region          73\\n                     /region_name=\"Variant\"\\n                     /note=\"V -> E (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs3208105).\\n                     /id=VAR_060503.\"\\n     Region          73\\n                     /region_name=\"Variant\"\\n                     /note=\"V -> L (in allele DQA1*02:01, allele DQA1*03:01,\\n                     allele DQA1*03:02 and allele DQA1*03:03;\\n                     dbSNP:rs12722061). /id=VAR_033405.\"\\n     Region          74\\n                     /region_name=\"Variant\"\\n                     /note=\"L -> F (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06, allele DQA1*01:07, allele DQA1*02:01,\\n                     allele DQA1*03:01, allele DQA1*03:02 and allele\\n                     DQA1*03:03; dbSNP:rs9272698). /id=VAR_060504.\"\\n     Region          75\\n                     /region_name=\"Variant\"\\n                     /note=\"R -> H (in allele DQA1*02:01; dbSNP:rs28383449).\\n                     /id=VAR_060505.\"\\n     Region          75\\n                     /region_name=\"Variant\"\\n                     /note=\"R -> S (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs9272699).\\n                     /id=VAR_060506.\"\\n     Region          76\\n                     /region_name=\"Variant\"\\n                     /note=\"Q -> K (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1048052).\\n                     /id=VAR_060507.\"\\n     Region          76\\n                     /region_name=\"Variant\"\\n                     /note=\"Q -> R (in allele DQA1*02:01, allele DQA1*03:01,\\n                     allele DQA1*03:02 and allele DQA1*03:03;\\n                     dbSNP:rs12722069). /id=VAR_060508.\"\\n     Region          77\\n                     /region_name=\"Variant\"\\n                     /note=\"F -> L (in allele DQA1*02:01; dbSNP:rs3188043).\\n                     /id=VAR_060509.\"\\n     Region          78\\n                     /region_name=\"Variant\"\\n                     /note=\"R -> GG (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele\\n                     DQA1*01:05,allele DQA1*01:06 and allele DQA1*01:07;\\n                     dbSNP:rs4193). /id=VAR_060510.\"\\n     Region          78\\n                     /region_name=\"Variant\"\\n                     /note=\"R -> RR (in allele DQA1*03:01, allele DQA1*03:02\\n                     and allele DQA1*03:03). /id=VAR_060511.\"\\n     Region          81..101\\n                     /region_name=\"Helical region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          81\\n                     /region_name=\"Variant\"\\n                     /note=\"P -> R (in allele DQA1*05:02; dbSNP:rs41541412).\\n                     /id=VAR_060512.\"\\n     Region          83\\n                     /region_name=\"Variant\"\\n                     /note=\"F -> G (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06 and allele DQA1*01:07; requires 2\\n                     nucleotide substitutions). /id=VAR_060513.\"\\n     Region          86\\n                     /region_name=\"Variant\"\\n                     /note=\"T -> R (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1142333).\\n                     /id=VAR_033408.\"\\n     Region          88\\n                     /region_name=\"Variant\"\\n                     /note=\"I -> M (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1142334).\\n                     /id=VAR_033409.\"\\n     Region          91\\n                     /region_name=\"Variant\"\\n                     /note=\"L -> A (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06 and allele DQA1*01:07; requires 2\\n                     nucleotide substitutions). /id=VAR_060514.\"\\n     Region          91\\n                     /region_name=\"Conflict\"\\n                     /note=\"L -> H (in Ref. 4; AAA59760).\\n                     /evidence=ECO:0000305.\"\\n     Region          91\\n                     /region_name=\"Variant\"\\n                     /note=\"L -> T (in allele DQA1*04:01, allele DQA1*04:02,\\n                     allele DQA1*04:04, allele DQA1*06:01 and allele\\n                     DQA1*06:02; requires 2 nucleotide substitutions).\\n                     /id=VAR_060515.\"\\n     Region          97\\n                     /region_name=\"Variant\"\\n                     /note=\"S -> I (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06, allele DQA1*01:07, allele DQA1*02:01,\\n                     allele DQA1*03:01, allele DQA1*03:02, allele DQA1*03:03,\\n                     allele DQA1*04:01, allele DQA1*04:02, allele DQA1*04:04,\\n                     allele DQA1*06:01 and allele DQA1*06:02; dbSNP:rs9279910).\\n                     /id=VAR_060516.\"\\n     Region          98\\n                     /region_name=\"Variant\"\\n                     /note=\"L -> M (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1064944).\\n                     /id=VAR_060517.\"\\n     Region          98\\n                     /region_name=\"Variant\"\\n                     /note=\"L -> V (in allele DQA1*03:01, allele DQA1*03:02 and\\n                     allele DQA1*03:03; dbSNP:rs1064944). /id=VAR_060518.\"\\n     Region          101\\n                     /region_name=\"Variant\"\\n                     /note=\"R -> C (in allele DQA1*01:07; dbSNP:rs41542116).\\n                     /id=VAR_060519.\"\\n     Region          102..104\\n                     /region_name=\"Hydrogen bonded turn\"\\n                     /note=\"/evidence=ECO:0007829|PDB:1JK8.\"\\n     Region          102\\n                     /region_name=\"Variant\"\\n                     /note=\"S -> Y (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:06 and allele DQA1*01:07; dbSNP:rs1129808).\\n                     /id=VAR_050384.\"\\n     Site            103\\n                     /site_type=\"glycosylation\"\\n                     /note=\"N-linked (GlcNAc...) asparagine.\\n                     /evidence=ECO:0000255.\"\\n     Region          107\\n                     /region_name=\"Conflict\"\\n                     /note=\"A -> P (in Ref. 16; AAA59754).\\n                     /evidence=ECO:0000305.\"\\n     Region          110..204\\n                     /region_name=\"IgC1_MHC_II_alpha_HLA-DQ\"\\n                     /note=\"Class II major histocompatibility complex (MHC)\\n                     alpha chain immunoglobulin domain of histocompatibility\\n                     antigen (HLA) DQ and related proteins; member of the\\n                     C1-set of Ig superfamily (IgSF) domains; cd21008\"\\n                     /db_xref=\"CDD:409599\"\\n     Region          111..119\\n                     /region_name=\"Ig strand A\"\\n                     /note=\"Ig strand A [structural motif]\"\\n                     /db_xref=\"CDD:409599\"\\n     Region          112..204\\n                     /region_name=\"Domain\"\\n                     /note=\"Ig-like C1-type.\"\\n     Region          113..120\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Site            order(115,117..119,121,173,175)\\n                     /site_type=\"other\"\\n                     /note=\"heterodimer interface [polypeptide binding]\"\\n                     /db_xref=\"CDD:409599\"\\n     Region          120..203\\n                     /region_name=\"Region of interest in the sequence\"\\n                     /note=\"Alpha-2.\"\\n     Region          124..126\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:4OZF.\"\\n     Region          124\\n                     /region_name=\"Variant\"\\n                     /note=\"L -> V (in allele DQA1*05:06; dbSNP:rs41555012).\\n                     /id=VAR_060520.\"\\n     Region          127..136\\n                     /region_name=\"Ig strand B\"\\n                     /note=\"Ig strand B [structural motif]\"\\n                     /db_xref=\"CDD:409599\"\\n     Region          128..137\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          129\\n                     /region_name=\"Variant\"\\n                     /note=\"I -> T (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01,\\n                     allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,\\n                     allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01\\n                     and allele DQA1*06:02; dbSNP:rs707952). /id=VAR_050385.\"\\n     Bond            bond(132,188)\\n                     /bond_type=\"disulfide\"\\n                     /note=\"/evidence=ECO:0000255|PROSITE-ProRule:PRU00114,\\n                     ECO:0000269|PubMed:11376336, ECO:0000269|PubMed:14769912,\\n                     ECO:0000269|PubMed:17629515.\"\\n     Site            order(139..141,160..163,169..170,175)\\n                     /site_type=\"other\"\\n                     /note=\"MHC binding domain interface [polypeptide binding]\"\\n                     /db_xref=\"CDD:409599\"\\n     Region          142..148\\n                     /region_name=\"Ig strand C\"\\n                     /note=\"Ig strand C [structural motif]\"\\n                     /db_xref=\"CDD:409599\"\\n     Region          143..148\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Site            143\\n                     /site_type=\"glycosylation\"\\n                     /note=\"N-linked (GlcNAc...) asparagine.\\n                     /evidence=ECO:0000255.\"\\n     Region          150..153\\n                     /region_name=\"Ig strand C\\'\"\\n                     /note=\"Ig strand C\\' [structural motif]\"\\n                     /db_xref=\"CDD:409599\"\\n     Region          151..153\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          151\\n                     /region_name=\"Variant\"\\n                     /note=\"H -> Q (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:04, allele DQA1*01:05 and allele\\n                     DQA1*01:07; dbSNP:rs707950). /id=VAR_050386.\"\\n     Region          152\\n                     /region_name=\"Variant\"\\n                     /note=\"S -> A (in allele DQA1*01:03; dbSNP:rs41547417).\\n                     /id=VAR_060521.\"\\n     Region          156\\n                     /region_name=\"Conflict\"\\n                     /note=\"G -> D (in Ref. 3; CAA25141).\\n                     /evidence=ECO:0000305.\"\\n     Region          157..165\\n                     /region_name=\"Ig strand D\"\\n                     /note=\"Ig strand D [structural motif]\"\\n                     /db_xref=\"CDD:409599\"\\n     Region          157..159\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          160\\n                     /region_name=\"Variant\"\\n                     /note=\"T -> I (in allele DQA1*04:02; dbSNP:rs41545514).\\n                     /id=VAR_060522.\"\\n     Region          161\\n                     /region_name=\"Variant\"\\n                     /note=\"S -> I (in allele DQA1*05:08; dbSNP:rs41544114).\\n                     /id=VAR_060524.\"\\n     Region          161\\n                     /region_name=\"Variant\"\\n                     /note=\"S -> R (in allele DQA1*06:02; dbSNP:rs41552014).\\n                     /id=VAR_060523.\"\\n     Region          168..178\\n                     /region_name=\"Ig strand E\"\\n                     /note=\"Ig strand E [structural motif]\"\\n                     /db_xref=\"CDD:409599\"\\n     Region          170..178\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          175\\n                     /region_name=\"Variant\"\\n                     /note=\"Y -> H (in allele DQA1*04:04; dbSNP:rs41550317).\\n                     /id=VAR_060525.\"\\n     Region          178\\n                     /region_name=\"Variant\"\\n                     /note=\"L -> F (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01,\\n                     allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,\\n                     allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01\\n                     and allele DQA1*06:02; dbSNP:rs707949). /id=VAR_060526.\"\\n     Region          182\\n                     /region_name=\"Variant\"\\n                     /note=\"A -> D (in allele DQA1*03:02 and allele DQA1*03:03;\\n                     dbSNP:rs7990). /id=VAR_060527.\"\\n     Region          182\\n                     /region_name=\"Variant\"\\n                     /note=\"A -> S (in allele DQA1*05:03, allele DQA1*05:06 and\\n                     allele DQA1*05:07; dbSNP:rs41561312). /id=VAR_060528.\"\\n     Region          183\\n                     /region_name=\"Variant\"\\n                     /note=\"E -> D (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01,\\n                     allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,\\n                     allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01\\n                     and allele DQA1*06:02; dbSNP:rs707963). /id=VAR_060529.\"\\n     Region          185..192\\n                     /region_name=\"Ig strand F\"\\n                     /note=\"Ig strand F [structural motif]\"\\n                     /db_xref=\"CDD:409599\"\\n     Region          185\\n                     /region_name=\"Variant\"\\n                     /note=\"S -> I (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05,\\n                     allele DQA1*01:07, allele DQA1*02:01, allele DQA1*03:01,\\n                     allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,\\n                     allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01\\n                     and allele DQA1*06:02; dbSNP:rs707962). /id=VAR_060530.\"\\n     Region          186..191\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          195..197\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          197\\n                     /region_name=\"Variant\"\\n                     /note=\"K -> E (in allele DQA1*02:01, allele DQA1*03:01,\\n                     allele DQA1*03:02, allele DQA1*03:03, allele DQA1*04:01,\\n                     allele DQA1*04:02, allele DQA1*04:04, allele DQA1*06:01\\n                     and allele DQA1*06:02; dbSNP:rs2308891). /id=VAR_060531.\"\\n     Region          197\\n                     /region_name=\"Variant\"\\n                     /note=\"K -> Q (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04, allele DQA1*01:05\\n                     and allele DQA1*01:07; dbSNP:rs2308891). /id=VAR_060532.\"\\n     Region          198..203\\n                     /region_name=\"Ig strand G\"\\n                     /note=\"Ig strand G [structural motif]\"\\n                     /db_xref=\"CDD:409599\"\\n     Region          199..203\\n                     /region_name=\"Beta-strand region\"\\n                     /note=\"/evidence=ECO:0007829|PDB:6U3M.\"\\n     Region          204..216\\n                     /region_name=\"Region of interest in the sequence\"\\n                     /note=\"Connecting peptide.\"\\n     Region          209\\n                     /region_name=\"Variant\"\\n                     /note=\"A -> T (in allele DQA1*03:01, allele DQA1*03:02 and\\n                     allele DQA1*03:03; dbSNP:rs9272785). /id=VAR_050387.\"\\n     Region          213\\n                     /region_name=\"Conflict\"\\n                     /note=\"E -> D (in Ref. 16; AAA59754).\\n                     /evidence=ECO:0000305.\"\\n     Region          217..239\\n                     /region_name=\"Transmembrane region\"\\n                     /note=\"Helical. /evidence=ECO:0000255.\"\\n     Region          221\\n                     /region_name=\"Variant\"\\n                     /note=\"A -> T (in allele DQA1*01:04; dbSNP:rs35087390).\\n                     /id=VAR_050388.\"\\n     Region          229\\n                     /region_name=\"Variant\"\\n                     /note=\"V -> M (in allele DQA1*01:02; dbSNP:rs9260).\\n                     /id=VAR_033411.\"\\n     Region          230\\n                     /region_name=\"Variant\"\\n                     /note=\"G -> C (in allele DQA1*05:07; dbSNP:rs41545416).\\n                     /id=VAR_060533.\"\\n     Region          237\\n                     /region_name=\"Variant\"\\n                     /note=\"F -> L (in allele DQA1*02:01, allele DQA1*03:01,\\n                     allele DQA1*03:02 and allele DQA1*03:03; dbSNP:rs1048430).\\n                     /id=VAR_033412.\"\\n     Region          240..254\\n                     /region_name=\"Topological domain\"\\n                     /note=\"Cytoplasmic.\"\\n     Region          240\\n                     /region_name=\"Variant\"\\n                     /note=\"R -> Q (in allele DQA1*01:01, allele DQA1*01:02,\\n                     allele DQA1*01:03, allele DQA1*01:04 and allele\\n                     DQA1*01:05; dbSNP:rs1048439). /id=VAR_033413.\"\\nORIGIN      \\n        1 milnkalmlg alalttvmsp cggedivadh vasygvnlyq sygpsgqyth efdgdeqfyv\\n       61 dlgrketvwc lpvlrqfrfd pqfaltniav lkhnlnslik rsnstaatne vpevtvfsks\\n      121 pvtlgqpnil iclvdnifpp vvnitwlsng hsvtegvset sflsksdhsf fkisyltllp\\n      181 saeesydckv ehwgldkpll khwepeipap mseltetvvc alglsvglvg ivvgtvfiir\\n      241 glrsvgasrh qgpl\\n//\\n\\n'"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pesquisa_ncbi(email,'DQA1_HUMAN',db='protein')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Como conseguimos obter o Accession Number da proteína codificada pelo gene de interesse, procedemos à gravação do ficheiro da mesma."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Encontrados 10 resultados em protein. Irá ser processado 1 resultado.\n",
      "\n",
      "Ficheiro gravado.\n",
      "Concluído.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'>sp|P01909.1|DQA1_HUMAN RecName: Full=HLA class II histocompatibility antigen, DQ alpha 1 chain; AltName: Full=DC-1 alpha chain; AltName: Full=DC-alpha; AltName: Full=HLA-DCA; AltName: Full=MHC class II DQA1; Flags: Precursor\\nMILNKALMLGALALTTVMSPCGGEDIVADHVASYGVNLYQSYGPSGQYTHEFDGDEQFYVDLGRKETVWC\\nLPVLRQFRFDPQFALTNIAVLKHNLNSLIKRSNSTAATNEVPEVTVFSKSPVTLGQPNILICLVDNIFPP\\nVVNITWLSNGHSVTEGVSETSFLSKSDHSFFKISYLTLLPSAEESYDCKVEHWGLDKPLLKHWEPEIPAP\\nMSELTETVVCALGLSVGLVGIVVGTVFIIRGLRSVGASRHQGPL\\n\\n'"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pesquisa_ncbi(email,'P01909',db='protein',retmax=1,rettype='fasta',save='Y',display='n')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
